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Our	   current	   understanding	   of	   virulence	   in	   the	   opportunistic	   pathogen	   Candida	   glabrata	   is	   in	   its	  
infancy.	   To	   expand	   our	   understanding	   of	   C.	   glabrata	   virulence,	   an	   investigation	   into	   the	   genes	  
transcriptionally	  regulated	  by	  the	  first	  virulence-­‐moderating	  gene	  to	  be	  discovered	  in	  Candida,	  ACE2,	  
was	  undertaken.	  For	   the	   first	   time	   in	  C.	  glabrata,	  a	  partial	  Ace2p	  regulon	  containing	  12	  previously	  
univestigated	   genes	   that	   show	   Ace2p-­‐dependent	   expression	   has	   been	   defined.	   Study	   of	   their	  
promoter	   regions	   discovered	   possible	   Ace2p	   DNA	   binding	   sites,	   with	   10	   genes	   showing	   possible	  
direct	  regulation	  by	  Ace2p	  in	  C.	  glabrata.	  A	  reductionist	  approach	  was	  employed	  in	  an	  effort	  to	  study	  
the	  effects	  of	  the	  deletion	  of	  each	  of	  the	  12	  partial	  Ace2p-­‐regulon	  genes	  in	  C.	  glabrata	  individually.	  
Both	  phenotypic	  and	  virulence	  analyses	  were	  used	  to	  analyse	  the	  results	  of	  the	  individual	  deletions	  
with	  regard	  to	  the	  extreme	  hypervirulence	  displayed	  by	  the	  ace2	  null	  cells.	  The	  results	  indicate	  that	  
out	   of	   the	   10	   genes	   successfully	   disrupted,	   six	   were	   shown	   to	   be	   significantly	   different	   when	  
compared	  with	  the	  C.	  glabrata	  wild	  type	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidiasis	  and	  
therefore	  hypervirulent.	  
Each	  of	  the	  six	  hypervirulent	  genes	  showed	  100%	  mortality	  after	  five	  days	  post	  infection,	  markedly	  
different	  to	  the	  hypervirulence	  displayed	  by	  the	  ace2	  null,	  which	  displayed	  100%	  mortality	  within	  18	  
hours	   post	   infection,	   and	   to	   the	   wild	   type,	   which	   displayed	   40%	   mortality	   after	   14	   days	   post	  
infection.	  The	  C.	  glabrata	  sic1	  null	  was	  also	  found	  to	  elicit	  significantly	  increased	  cytokine	  release	  in	  
an	  in	  vitro	  macrophage	  infection	  assay,	  as	  measured	  by	  IL-­‐6	  and	  TNFα	  ELISA.	  The	  results	  presented	  
in	  this	  thesis	  therefore	  indicate	  that	  the	  hypervirulence	  and	  immune	  over-­‐stimulation	  shown	  by	  the	  
ace2	  mutant	   in	  C.	   glabrata	   is	  most	   likely	  multifactorial	  with	   a	   combination	   of	   antivirulence	   genes	  
contributing	  to	  the	  extreme	  hypervirulence	  and	  immune	  over-­‐stimulation.	  
During	  the	  course	  of	  investigation	  into	  the	  Ace2p	  regulon,	  a	  novel	  gene	  lacking	  homology	  to	  putative	  
glucanases	  or	  other	  yeast	  genes	  was	  highlighted.	  Therefore	  the	  uncharacterised	  Ace2p	  regulon	  gene	  
DSE1,	  whose	  function	  is	  currently	  unknown,	  was	  investigated.	  Using	  C.	  glabrata	  and	  its	  close	  genetic	  
relative,	   the	  model	  organism	  Saccharomyces	  cerevisiae,	  a	  study	  of	   the	   localisation,	  phenotype	  and	  
structural	  prediction	  revealed	  a	  possible	  enzymatic	  or	  regulatory	  function	  for	  Dse1p,	  localised	  to	  the	  
cell	   budding	   area	   and	   daughter	   cell,	   with	   a	   likely	   role	   in	   cell	  wall	  metabolism	   and	   cell	   separation	  
within	  C.	  glabrata.	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µ	   Micro	  
μF	   Microfarads	  
µg	   Microgram	  
µL	   Microlitre	  
µm	   Micrometre	  
Ω	   Ohm	  
°C	   Degrees	  Celsius	  
3D	   Three-­‐dimensional	  
AIDS	   Acquired	  immunodeficiency	  syndrome	  
ABC	   ATP-­‐binding	  cassette	  
AMEN	   Antagonist	  of	  the	  mitotic	  exit	  network	  
ANOVA	   Analysis	  of	  variance	  
ATP	   Adenosine	  triphosphate	  
BLAST	   Basic	  Local	  Alignment	  Search	  Tool	  
BSI	   Bloodstream	  infection	  
cAMP	   Cyclic	  adenosine	  monophosphate	  
CDK	   cyclin-­‐dependent	  protein	  kinase	  
daddH2O	   Double	  autoclaved	  double	  distilled	  water	  
ddH2O	   Double	  distilled	  water	  
DIC	   Differential	  interference	  microscopy	  
DIG	   Digoxigenin	  
DMEM	   Dulbecco’s	  Modified	  Eagle	  Medium	  
DMSO	   Dimethyl	  sulfoxide	  
DNA	   Deoxyribonucleic	  acid	  
ECM	   Extracellular	  matrix	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EDTA	   Ethylenediaminetetraacetic	  acid	  
EGTA	  	   Ethylene	  glycol-­‐bis(2-­‐aminoethylether)-­‐N’-­‐N’-­‐N’-­‐N’-­‐tetraacetic	  acid	  
ELISA	  	   Enzyme	  Linked	  ImmunoSorbent	  Assay	  
FCS	   Foetal	  calf	  serum	  (also	  known	  as	  FBS,	  Foetal	  bovine	  serum)	  
FRT	   Flippase	  recognition	  target	  
g	  	   Gram	  
GEN	   Geneticin	  (G418)	  
GENR	   Geneticin	  (G418)	  resistance	  marker	  
GFP	   Green	  fluorescent	  protein	  
GM-­‐CSF	   Granulocyte	  monocyte	  colony-­‐stimulating	  factor	  
GMS	  	   Grocott’s	  methenamine	  silver	  and	  light	  green	  
GPI	  	   Glycosylphosphatidylinositol	  
H&E	  	   Haemotoxylin	  and	  eosin	  
hBD	   Human	  beta-­‐densins	  
ICU	   Intensive	  care	  unit	  
IL	   Interleukin	  
IP	   Intraperitoneal	  
IV	   Intravenous	  
kb	   Kilobase	  
kg	   Kilogram	  
kV	   Kilovolts	  
L	   Litre	  
LB	   Luria	  Bertani	  
LEU/Leu	   Leucine	  
LiAc	   Lithium	  acetate	  
M	   Molar	  
MAP	   Mitogen-­‐activated	  protein	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MAPK	   Mitogen-­‐activated	  protein	  kinase	  
MDR	   Multidrug	  resistance	  
MEN	   Mitotic	  exit	  network	  
mg	   Miligram	  
mL	   Mililitre	  
mM	   Milimolar	  
NAT	   Nourseothricin	  
NATR	   Nourseothricin	  resistance	  marker	  
nm	   Nanometer	  
ng	   Nanogram	  
OD	   Optical	  density	  
ORF	   Open	  reading	  frame	  
PBS	   Phosphate	  buffered	  saline	  
PCR	   Polymerase	  chain	  reaction	  
PEG	   Polyethylene	  glycol	  
pH	   Measure	  of	  acidity/alkalinity	  of	  a	  solution	  
PKC	   Protein	  kinase	  C	  
PL	   Phospholipases	  
POI	   Points	  of	  interest	  
RAM	   Regulation	  of	  Ace2p	  transcription	  factor	  and	  polarised	  morphogenesis	  
RNA	   Ribonucleic	  acid	  
RNA-­‐seq	   High-­‐throughput	  sequencing	  of	  cDNA	  made	  from	  RNA	  
ROS	   Reactive	  oxygen	  species	  
rpm	   Revolutions	  per	  minute	  
s	   Second	  
SAPs	   Secreted	  aspartic	  proteases	  
SD	   Synthetic	  dropout	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SDS	   Sodium	  dodecyl	  sulphate	  
SGD	   Saccharomyces	  genome	  database	  
TBE	  	   Tris-­‐borate	  EDTA	  
TBOOH	  	   t-­‐butylhydroperoxide	  
Tet	  	   Tetracycline	  
TNF	   Tumour	  necrosis	  factor	  
TRP/Trp	   Tryptophan	  
TV	   Tail	  vein	  
URA/Ura	   Uracil	  
US	   United	  States	  of	  America	  
UV	   Ultra	  violet	  
V	   Volts	  
v/v	   Volume/volume	  
w/v	   Weight/volume	  
X-­‐Gal	  	   5-­‐bromo-­‐4-­‐chloro-­‐3-­‐indoyl-­‐b-­‐D-­‐galactopyranoside	  
YKO	   Yeast	  Knockout	  
YNB	   Yeast	  nitrogen	  base	  
YPD	  	   Yeast	  peptone	  dextrose	  
YPG	  	   Yeast	  peptone	  glucose	  
	  
	   	  
	  	  
	   	   	  	   	  
10	   	  
	   	  







List	  of	  abbreviations	  and	  acronyms	  ..…………………………………………………………………………………………………6	  
Table	  of	  Contents	  ……………………………………………………………………………………………………………………………10	  
List	  of	  Figures	  ………….………………………………………………………………………………………………………………………14	  
List	  of	  Tables	  ………………………..…………………………………………………………………………………………………………24	  
1	  Introduction	  ..................................................................................................................	  25	  
1.1	  Fungal	  human	  pathogens	  ....................................................................................................	  25	  
1.1.1	  Antifungals	  ..........................................................................................................................	  26	  
1.2	  Non-­‐human	  fungal	  pathogens	  .............................................................................................	  27	  
1.3	  Candida	  epidemiology	  .........................................................................................................	  28	  
1.3.1	  Superficial	  candidiasis	  .........................................................................................................	  29	  
1.3.2	  Invasive	  candidiasis	  and	  candidaemia	  ................................................................................	  30	  
1.4	  Candida	  glabrata	  and	  candidiasis	  ........................................................................................	  31	  
1.4.1	  Candida	  albicans	  virulence	  factors	  .....................................................................................	  32	  
1.4.2	  Candida	  glabrata	  virulence	  factors	  ....................................................................................	  33	  
1.4.3	  C.	  glabrata	  virulence	  analysis	  using	  Caenorhabditis	  elegans	  .............................................	  35	  
1.5	  The	  evolutionary	  relationship	  between	  C.	  glabrata	  and	  S.	  cerevisiae	  ...................................	  36	  
1.5.1	  Phylogeny	  ...........................................................................................................................	  36	  
1.5.2	  Host	  environment	  adaptation	  ............................................................................................	  37	  
1.5.3	  Virulence	  and	  drug	  resistance	  ............................................................................................	  38	  
1.6	  Ace2p	  and	  the	  cell	  cycle	  .......................................................................................................	  39	  
1.6.1	  Yeast	  cell	  cycle	  ....................................................................................................................	  39	  
1.6.2	  Cytokinesis	  and	  cell	  separation	  ...........................................................................................	  39	  
1.6.3	  The	  RAM	  network	  ...............................................................................................................	  41	  
1.7	  Current	  knowledge	  of	  the	  Ace2p	  regulon	  .............................................................................	  42	  
1.7.1	  AMN1	  ..................................................................................................................................	  43	  
1.7.2	  ASH1	  ...................................................................................................................................	  43	  
1.7.3	  BUD9	  ...................................................................................................................................	  44	  
1.7.4	  DSE1	  ....................................................................................................................................	  44	  
1.7.5	  DSE2	  ....................................................................................................................................	  45	  
1.7.6	  DSE3	  ....................................................................................................................................	  46	  
1.7.7	  DSE4/ACF2	  ..........................................................................................................................	  46	  
1.7.8	  EGT2	  ....................................................................................................................................	  46	  
1.7.9	  RME1	  ...................................................................................................................................	  47	  
1.7.10	  SCW11	  ...............................................................................................................................	  47	  
1.7.11	  SIC1	  ...................................................................................................................................	  48	  
	  	  
	   	   	  	   	  
11	   	  
	   	  
1.8	  Role	  of	  cell	  wall	  components	  in	  the	  septum	  .........................................................................	  49	  
1.8.1	  Glucan	  .................................................................................................................................	  49	  
1.8.2	  Chitin	  ...................................................................................................................................	  49	  
1.9	  General	  aims	  of	  the	  project	  .................................................................................................	  50	  
1.10	  Specific	  aims	  of	  the	  project	  ................................................................................................	  50	  
2	  Materials	  and	  Methods	  .................................................................................................	  52	  
2.1	  Chemicals	  and	  reagents	  .......................................................................................................	  52	  
2.2	  Culture	  media,	  strains	  and	  plasmids	  ....................................................................................	  52	  
2.2.1	  Fungal	  strains	  and	  growth	  media	  .......................................................................................	  52	  
2.2.2	  Bacterial	  strains	  and	  growth	  media	  ....................................................................................	  52	  
2.2.3	  Plasmids	  ..............................................................................................................................	  52	  
2.3	  Molecular	  biology	  techniques	  ..............................................................................................	  53	  
2.3.1	  Primers	  ................................................................................................................................	  53	  
2.3.2	  Polymerase	  chain	  reaction	  .................................................................................................	  53	  
2.3.3	  Colony	  polymerase	  chain	  reaction	  .....................................................................................	  53	  
2.3.4	  Linear	  DNA	  and	  PCR	  extraction	  and	  purification	  ................................................................	  53	  
2.3.5	  Enzymatic	  manipulation	  of	  DNA	  .........................................................................................	  53	  
2.3.6	  Agarose	  gel	  electrophoresis	  ...............................................................................................	  53	  
2.3.7	  DNA	  and	  RNA	  quantification	  ...............................................................................................	  54	  
2.3.8	  Isolation	  of	  yeast	  DNA	  ........................................................................................................	  54	  
2.3.9	  Isolation	  of	  yeast	  RNA	  .........................................................................................................	  54	  
2.3.10	  Plasmid	  DNA	  extraction	  ....................................................................................................	  54	  
2.3.11	  Yeast	  transformation	  –	  Electroporation	  ...........................................................................	  54	  
2.3.12	  Yeast	  Transformation	  –	  Lithium	  acetate	  ...........................................................................	  55	  
2.3.13	  Quick	  transformation	  of	  yeast	  cells	  ..................................................................................	  55	  
2.3.14	  Bacterial	  transformation	  ...................................................................................................	  55	  
2.3.15	  Northern	  Analysis	  .............................................................................................................	  55	  
2.3.16	  Southern	  Analysis	  .............................................................................................................	  56	  
3	  Confirmation	  of	  the	  Ace2p	  regulon	  ...............................................................................	  57	  
3.1	  Overview	  .............................................................................................................................	  57	  
3.2	  Materials	  and	  methods	  ........................................................................................................	  59	  
3.2.1	  Northern	  analysis	  of	  Ace2p	  regulon	  in	  C.	  glabrata	  Ace2p	  tet-­‐regulated	  strain	  ..................	  59	  
3.2.2	  Analysis	  of	  the	  upstream	  regions	  of	  Ace2p	  regulon	  genes	  in	  C.	  glabrata	  for	  potential	  
Ace2p	  binding	  sites	  ......................................................................................................................	  59	  
3.3	  Results	  .................................................................................................................................	  60	  
3.3.1	  Ace2p	  transcriptionally	  regulates	  12	  genes	  ........................................................................	  60	  
3.3.2	  Potential	  Ace2p	  binding	  sites	  in	  the	  promoter	  regions	  of	  the	  Ace2p	  regulon	  genes	  .........	  60	  
3.3.3	  Selection	  of	  target	  genes	  for	  deletion	  ................................................................................	  63	  
3.4	  Discussion	  ...........................................................................................................................	  64	  
3.4.1	  Ace2p	  transcriptional	  regulation:	  direct	  or	  indirect?	  .........................................................	  65	  
3.4.2	  C.	  glabrata	  ace2	  clumping	  phenotype	  ................................................................................	  66	  
4	  Study	  of	  the	  Ace2	  regulon	  and	  its	  role	  in	  hypervirulence	  ...............................................	  69	  
4.1	  Overview	  .............................................................................................................................	  69	  
	  	  
	   	   	  	   	  
12	   	  
	   	  
4.1.1	  Conventional	  virulence	  factors	  in	  C.	  glabrata	  ....................................................................	  69	  
4.1.2	  A	  novel	  antivirulence	  gene	  in	  C.	  glabrata	  ...........................................................................	  70	  
4.1.3	  The	  Ace2p	  regulon	  ..............................................................................................................	  70	  
4.2	  Materials	  and	  Methods	  .......................................................................................................	  72	  
4.2.1	  Construction	  of	  ash1,	  bud9,	  dse1,	  dse3,	  egt2	  and	  rme1	  null	  mutants	  by	  fusion	  PCR	  ........	  72	  
4.2.2	  Construction	  of	  amn1,	  acf2,	  scw11b	  and	  sic1	  null	  mutants	  by	  Edlind	  method	  ..................	  74	  
4.2.3	  Reconstitution	  of	  C.	  glabrata	  gene	  deletions	  .....................................................................	  75	  
4.2.4	  Solid	  agar	  phenotypic	  screen	  ..............................................................................................	  77	  
4.2.5	  Difference	  interference	  microscopy	  (DIC)	  ..........................................................................	  79	  
4.2.6	  Growth	  rate	  analysis	  ...........................................................................................................	  79	  
4.2.7	  Murine	  virulence	  studies	  ....................................................................................................	  79	  
4.2.8	  Histological	  examination	  of	  murine	  samples	  ......................................................................	  79	  
4.2.9	  Fungal	  burden	  .....................................................................................................................	  79	  
4.2.10	  Macrophage	  stimulation	  with	  yeast	  .................................................................................	  80	  
4.2.11	  Enzyme-­‐Linked	  ImmunoSorbent	  Assay	  (ELISA)	  cytokine	  analysis	  .....................................	  80	  
4.3	  Results	  .................................................................................................................................	  81	  
4.3.1	  Southern	  blot	  analysis	  ........................................................................................................	  81	  
4.3.2	  Solid	  agar	  phenotypic	  screen	  ..............................................................................................	  81	  
4.3.3	  Phenotypic	  microscopy	  .......................................................................................................	  89	  
4.3.4	  Growth	  rate	  analysis	  ...........................................................................................................	  92	  
4.3.5	  Immune	  suppression	  survival	  pilot	  .....................................................................................	  93	  
4.3.6	  Murine	  virulence	  model	  of	  systemic	  candidiasis	  ................................................................	  94	  
4.3.7	  Fungal	  burden	  ...................................................................................................................	  105	  
4.3.8	  Histology	  ...........................................................................................................................	  106	  
4.3.9	  Macrophage	  stimulation	  assay	  .........................................................................................	  116	  
4.3.10	  Reconstitution	  Northern	  Analysis	  ...................................................................................	  118	  
4.4	  Discussion	  .........................................................................................................................	  119	  
4.4.1	  Deletion	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata	  ...................................................................	  119	  
4.4.2	  Deletion	  screening	  ............................................................................................................	  119	  
4.4.3	  Virulence	  screening	  ..........................................................................................................	  121	  
4.4.4	  Immune	  activation	  and	  septic	  shock	  in	  Ace2p	  regulon	  hypervirulence	  ...........................	  122	  
4.4.5	  Potential	  effects	  of	  deletion	  of	  the	  Ace2p	  regulon	  genes	  ................................................	  123	  
4.4.6	  Ace2p	  regulon	  hypervirulence	  and	  ace2	  ..........................................................................	  126	  
4.4.7	  Implications	  of	  antivirulence	  ............................................................................................	  127	  
5	  Study	  of	  the	  novel	  gene	  DSE1	  in	  yeast	  .........................................................................	  129	  
5.1	  Overview	  ...........................................................................................................................	  129	  
5.2	  Materials	  and	  Methods	  .....................................................................................................	  132	  
5.2.1	  Analysis	  of	  the	  upstream	  region	  of	  DSE1	  in	  S.	  cerevisiae	  for	  potential	  Ace2p	  binding	  sites
	  ...................................................................................................................................................	  132	  
5.2.2	  C.	  glabrata	  Dse1p	  structural	  prediction	  ...........................................................................	  132	  
5.2.3	  C.	  glabrata	  and	  S.	  cerevisiae	  dse1	  null	  vanadate	  sensitivity	  screen	  .................................	  132	  
5.2.4	  Yeast	  dse1	  null	  polarization	  study	  ....................................................................................	  132	  
5.2.5	  Construction	  of	  Dse1p-­‐GFP	  Gateway	  plasmid	  ..................................................................	  133	  
5.2.6	  Localisation	  study	  of	  S.	  cerevisiae	  Dse1p	  in	  known	  interactor	  nulls	  .................................	  133	  
	  	  
	   	   	  	   	  
13	   	  
	   	  
5.2.7	  Growth	  rate	  analysis	  .........................................................................................................	  133	  
5.3	  Results	  ...............................................................................................................................	  134	  
5.3.1	  DSE1	  expression	  is	  Ace2p-­‐dependent	  in	  S.	  cerevisiae	  and	  C.	  glabrata	  .............................	  134	  
5.3.2	  Potential	  Ace2p	  binding	  sites	  in	  the	  promoter	  region	  of	  both	  C.	  glabrata	  and	  S.	  cerevisiae	  
DSE1	  ...........................................................................................................................................	  134	  
5.3.3	  C.	  glabrata	  Dse1p	  structural	  prediction	  ...........................................................................	  135	  
5.3.4	  C.	  glabrata	  dse1	  null	  phenotypic	  screen	  ...........................................................................	  136	  
5.3.5	  C.	  glabrata	  and	  S.	  cerevisiae	  vanadate	  sensitivity	  screen	  .................................................	  136	  
5.3.6	  Yeast	  dse1	  null	  polarization	  study	  ....................................................................................	  138	  
5.3.7	  Localisation	  study	  of	  S.	  cerevisiae	  Dse1p	  in	  known	  interactor	  nulls	  .................................	  139	  
5.3.8	  Growth	  rate	  analysis	  of	  C.	  glabrata	  dse1	  ..........................................................................	  140	  
5.4	  Discussion	  .........................................................................................................................	  141	  
5.4.1	  Ace2p	  direct	  transcriptional	  regulation	  is	  likely	  in	  both	  C.	  glabrata	  and	  S.	  cerevisiae.	  ....	  141	  
5.4.2	  β-­‐propeller	  ........................................................................................................................	  141	  
5.4.3	  Deletion	  of	  DSE1	  induces	  a	  cell	  separation	  defect	  ...........................................................	  142	  
5.4.4	  Localisation	  of	  Dse1p	  ........................................................................................................	  143	  
5.4.5	  Results	  and	  roles	  from	  the	  literature	  ................................................................................	  144	  
5.4.6	  Summary	  ...........................................................................................................................	  146	  
6	  Summary	  and	  Conclusions	  ..........................................................................................	  147	  
6.1	  Summary	  ...........................................................................................................................	  147	  
6.1.1	  The	  Ace2p	  regulon	  in	  C.	  glabrata	  .....................................................................................	  147	  
6.1.2	  DSE1	  a	  novel	  gene	  likely	  to	  be	  involved	  in	  cell	  separation	  in	  C.	  glabrata	  .........................	  148	  
6.2	  Future	  work	  .......................................................................................................................	  149	  
6.3	  Conclusions	  .......................................................................................................................	  151	  
7	  References	  ..................................................................................................................	  153	  
Appendix	  1	  -­‐	  Strains	  .......................................................................................................	  167	  
A1.1	  Yeast	  Strains	  ...................................................................................................................	  167	  
Appendix	  2	  -­‐	  Plasmids	  ....................................................................................................	  169	  
A2.1	  Yeast	  plasmids	  ...................................................................................................................	  169	  
A2.2	  E.	  coli	  plasmids	  ..................................................................................................................	  169	  
Appendix	  3	  –	  Primers	  .....................................................................................................	  170	  
Appendix	  4	  –	  Gene	  deletion	  confirmations	  ....................................................................	  175	  
Appendix	  5	  ....................................................................................................................	  185	  
A5.1	  C.	  elegans	  invertebrate	  model	  of	  innate	  immune	  response	  .............................................	  185	  
A5.1.1	  Materials	  and	  Methods	  ..................................................................................................	  186	  
A5.2	  Study	  and	  comparison	  of	  the	  transcriptome	  of	  Candida	  species	  infection	  of	  murine	  model
	  ...............................................................................................................................................	  187	  
A5.2.1	  Materials	  and	  Methods	  ..................................................................................................	  188	  
	  
	   	  
	  	  
	   	   	  	   	  
14	   	  
	   	  
Figure	  1.1	  –	  C.	  glabrata	   belongs	   to	   the	  Saccharomyces	  clade,	  not	   the	  Candida	  clade.	   Phylogenetic	  
tree	   showing	   the	  evolutionary	   relationships	  of	  C.	   glabrata	   and	   selected	  Candida	   species	  with	  
that	   of	   S.	   cerevisiae	   and	   selected	   Saccharomyces	   species.	   Adapted	   from	   Roetzer	   et	   al.	   2010	  
[104].	   The	   tree	   was	   built	   using	   maximum	   likelihood	   analysis	   of	   concatenated	   alignments	   of	  
1137	   protein	   familys	   that	   exist	   with	   single-­‐copy	   orthologues	   in	   the	   21	   species.	   CTG	   marks	  
genetic	  code	  transition	  event	  that	  recoded	  CUG	  to	  Serine	  (the	  non-­‐CTG	  branch).	  ....................	  37	  
Figure	  1.2	  –	  S.	  cerevisiae	  and	  C.	  glabrata	  ace2	  display	  a	  clumpy,	  cell	  separation	  deficient	  phenotype.	  
Yeast	  was	  grown	  over	  night	  at	  30°C	  or	  37°C,	  180	  rpm,	  and	  visualised	  under	  DIC.	  A)	  S.	  cerevisiae	  
BY4741	   cells	   (B)	  C.	   glabrata	   (HSL122)	  ace2	   cells	   (C)	  S.	   cerevisiae	  ace2	   cells.	   Both	  ace2	   strains	  
display	  a	  cell	  separation	  deficient	  phenotype,	  although	  this	  is	  less	  severe	  in	  S.	  cerevisiae.	  Scale	  
bar	  10	  µm.	  ...................................................................................................................................	  40	  
Figure	  1.3	  –	  Predicted	  model	  of	  the	  RAM	  network	  [132].	  Interacting	  Kic1p,	  Sog2p	  and	  Hym1p	  form	  a	  
complex	  and	  activate	  Mob2p-­‐Cbk1p	  [135,	  136].	  Tao3p	  and	  Ssd1p	  are	  also	  thought	  to	  activate	  
the	  Mob2p-­‐Cbk1p	  complex;	  the	  activated	  Mob2p-­‐Cbk1p	  complex	  activates	  Ace2p,	  which	  in	  turn	  
activates	  the	  transcription	  of	  genes	  required	  for	  cell	  separation,	  the	  cell	  separation	  machinery,	  
which	  leads	  to	  hydrolysis	  of	  the	  primary	  and	  secondary	  septum	  and	  cell	  separation	  [135,	  136].	  
SSD1,	  however,	  has	  been	  shown	  to	  not	  be	  essential	  for	  RAM	  regulation	  of	  Ace2p	  [135,	  136].	  .	  41	  
Figure	  3.1	  –	  C.	  glabrata	  Ace2p	  regulates	  the	  expression	  of	  12	  genes	  putatively	   involved	   in	  cell	  wall	  
biology,	   daughter	   cell	   specific	   expression	   and	   cell	   cycle	   regulation.	   C.	   glabrata	   HLS119	   was	  
cultured	   overnight	   in	   YPD	   in	   the	   absence	   (-­‐,	   ACE2	   de-­‐repressed)	   and	   presence	   (+,	   ACE2	  
repressed)	  of	   200	  mg/mL	  doxycycline.	   Total	   RNA	  was	  extracted	  using	   a	  modified	   acid	  phenol	  
method,	  and	  7	  µg	  was	  loaded	  per	  lane.	  	  The	  upper	  panels	  show	  Northern	  analysis.	  Probes	  were	  
constructed	   using	   internal	   primer	   pairs	   from	   the	   relevant	   gene	   indicated	   above	   each	   pair	   of	  
panels.	   	   Primers	   are	   listed	   in	   Appendix	   3.	   	   The	   lower	   panels	   show	   methylene	   blue	   loading	  
controls.	  In	  the	  presence	  of	  doxycycline	  ACE2	  expression	  is	  repressed	  as	  shown	  by	  the	  lack	  of	  a	  
band	  in	  the	  ACE2	  +	  lane.	  	  All	  other	  genes	  analysed	  show	  a	  loss	  of	  band	  in	  the	  absence	  of	  ACE2	  
expression	  demonstrating	   that	   their	  expression	   in	  C.	  glabrata	   is	  dependent,	  either	  directly	  or	  
indirectly,	  on	  Ace2p.	  ....................................................................................................................	  60	  
Figure	   3.2a	   –	   Potenial	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   the	   Ace2p	  
regulon	  ORFs	   in	  C.	  glabrata.	  The	   intergene	  region	  upstream	  of	   the	  Ace2p	  regulon	  genes	   in	  C.	  
glabrata	   is	   displayed	  with	   potential	   Ace2p	   binding	   sites	   (ACCAGC)	   [220]	  marked	   for	   position	  
relative	   to	   the	   ATG	   of	   the	   Ace2p-­‐dependent	   gene	   of	   interest.	   All	   co-­‐ordinates	   and	  
measurements	  are	   in	  base	  pairs,	  all	   sequences	  were	   taken	   from	  Génolevures	   [171].	  Diagrams	  
are	  not	  to	  scale.	  AMN1	  has	  two	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  FAB1;	  ASH1	  has	  
four	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  MTR2;	  BUD9	  has	  two	  potential	  Ace2p	  binding	  
sites	   between	   it	   and	  KSS1;	  DSE1	   has	   two	  potential	  Ace2p	  binding	   sites	   between	   it	   and	  RSP5;	  
DSE2	   has	   three	   potential	   Ace2p	   binding	   sites	   between	   it	   and	   CH37;	   and	   DSE3	   has	   three	  
potential	  Ace2p	  binding	  sites	  between	  it	  and	  CAGL0C02805g.	  ...................................................	  61	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Figure	   3.2b	   –	   Potenial	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   the	   Ace2p	  
regulon	  ORFs	   in	  C.	  glabrata.	  The	   intergene	  region	  upstream	  of	   the	  Ace2p	  regulon	  genes	   in	  C.	  
glabrata	   is	   displayed	  with	   potential	   Ace2p	   binding	   sites	   (ACCAGC)	   [215]	  marked	   for	   position	  
relative	   to	   the	   ATG	   of	   the	   Ace2p-­‐-­‐-­‐dependent	   gene	   of	   interest.	   All	   co-­‐-­‐-­‐ordinates	   and	  
measurements	  are	   in	  base	  pairs,	  all	   sequences	  were	   taken	   from	  Génolevures	   [165].	  Diagrams	  
are	  not	  to	  scale.	  ACF2	   lacks	  any	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  RMP1;	  EGT2	  has	  
four	   potential	   Ace2p	   binding	   sites	   between	   it	   and	   MDJ2;	   RME1	   lacks	   any	   potential	   Ace2p	  
binding	  sites	  between	  it	  and	  SCM4;	  SCW11α	  has	  three	  potential	  Ace2p	  binding	  sites	  between	  it	  
and	  CWH41;	  SCW11β	  has	   three	  potential	  Ace2p	  binding	   sites	  between	   it	  and	  RRN6;	  and	  SIC1	  
has	  two	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  BOS1.	  .....................................................61	  
Figure	  3.2c	  –	  Four	  Potenial	  Ace2p	  binding	  sites	  exist	  in	  the	  intergene	  region	  upstream	  of	  CTS1	   in	  C.	  
glabrata.	   The	   intergene	   region	   upstream	   of	   CTS1	   in	   C.	   glabrata	   is	   displayed	   with	   potential	  
Ace2p	  binding	  sites	  (ACCAGC)	  [215]	  marked	  for	  position	  relative	  to	  the	  ATG.	  All	  co-­‐-­‐-­‐ordinates	  
and	   measurements	   are	   in	   base	   pairs,	   all	   sequences	   were	   taken	   from	   Génolevures	   [165].	  
Diagrams	   are	   not	   to	   scale.	   CTS1	   has	   four	   potential	   Ace2p	   binding	   sites	   between	   it	   and	  
CAGL0M09757g.	  ..........................................................................................................................62	  
Figure	  4.1	  –	  Construction	  of	  C.	  glabrata	  deletion	  mutants	  by	  homologous	  recombination	  of	  a	  fusion	  
PCR	   deletion	   cassette.	   Primers,	   as	   listed	   in	   Appendix	   3,	   were	   designed	   to	   produce	   products	  
containing	  500	  bp	  of	  homology	  with	  the	  5’	  and	  3’	  UTRs	  of	  the	  target	  gene	  and	  20	  bp	  tails	  of	  the	  
U2	  and	  D2	  regions	  of	  the	  NATR	  cassette.	  The	  deletion	  cassette	  was	  then	  created	  by	  fusion	  PCR	  
essentially	   as	   described	   by	   [240,	   244]	   and	   transformed	   into	   the	  C.	   glabrata	  his3	   strain	   using	  
electroporation.	  Flippase	  recognition	  target	  (FRT)	  sites	  for	  marker	  recycling	  and	  barcodes	  from	  
the	   S.	   cerevisiae	   gene	   deletion	   project	   [242,	   243]	   have	   been	   included	   for	   genes	   with	   S.	  
cerevisiae	  homologues.	  ...............................................................................................................	  72	  
Figure	  4.3	  –	  Plasmid	  map	  of	  pBM51.	  The	  target	  ORF	  for	  reconstitution	  was	  cloned	  into	  pBM51	  [Biao	  
Ma	  (personal	  communication)]	  between	  either	  2172	  (Sal1)	  and	  2211	  (Xma1)	  or	  between	  2199	  
(EcoR1)	  and	  211	  (Xma1)	  using	  the	  respective	  restriction	  digests.	  ...............................................	  77	  
Figure	   4.4	   –	   C.	   glabrata	   ash1,	   bud9,	   dse1,	   egt2	   and	   rme1	   show	   no	   sensitivity	   to	   seven	   test	  
conditions.	  Growth	  phenotypes	   of	   18	  Ace2p	   regulon	  null	  mutants,	   three	  nulls	   for	   each	   gene:	  
ASH1,	  BUD9,	  DSE1,	  DSE3,	  EGT2	  and	  RME1	  and	  the	  parental	  strain	  C.	  glabrata	  his3	   (Δhis3).	  No	  
sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  parental	  control.	  5	  
µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  
Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	  .............................	  82	  
Figure	   4.5	   –	   C.	   glabrata	   ash1,	   bud9,	   dse1,	   egt2	   and	   rme1	   show	   no	   sensitivity	   to	   seven	   test	  
conditions.	  Growth	  phenotypes	   of	   18	  Ace2p	   regulon	  null	  mutants,	   three	  nulls	   for	   each	   gene:	  
ASH1,	  BUD9,	  DSE1,	  DSE3,	  EGT2	  and	  RME1	  and	  the	  parental	  strain	  C.	  glabrata	  his3	   (Δhis3).	  No	  
sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  parental	  control.	  5	  
µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  
Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	  .............................	  83	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Figure	  4.6	  –	  C.	  glabrata	  ash1,	  dse1,	  egt2	  and	  rme1	  show	  mild	  sensitivity	  to	  vanadate	  and	  ash1	  and	  
dse1	  show	  mild	  sensitivity	  to	  caffeine	  test	  conditions.	  Growth	  phenotypes	  of	  18	  Ace2p	  regulon	  
null	   mutants,	   three	   nulls	   for	   each	   gene:	   ASH1,	   BUD9,	  DSE1,	   DSE3,	   EGT2	   and	   RME1	   and	   the	  
parental	   strain	  C.	   glabrata	   his3	   (Δhis3).	   No	   sensitivity	  was	   shown	  by	   any	   of	   the	   null	  mutants	  
when	   compared	   with	   the	   parental	   control	   apart	   from	   2.5mM	   vanadate	   in	   which	   Δash1	   #5,	  
Δash1	  #7,	  Δash1	  #8,	  Δdse1	  #4,	  Δdse1	  #5,	  Δdse1	  #6,	  Δdse3	  #18,	  Δdse3	  #19,	  Δegt2	  #4,	  Δegt2	  #6,	  
Δegt2	  #14,	  Δrme1	  #5,	  and	  Δrme1	  #6	  showed	  sensitivity,	  and	  10	  mM	  caffeine	  to	  which	  Δash1	  #5,	  
Δash1	   #7,	   Δash1	   #8,	   Δdse1	   #4	   and	   Δdse1	   #5	   showed	   a	   sensitivity.	   5	   µL	   of	   each	   strain	   was	  
spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  
three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	  ...................................................................	  84	  
Figure	  4.7	  –	  C.	  glabrata	  amn1,	  acf2,	  scw11β,	  and	  sic1	  show	  no	  sensitivity	  to	  seven	  test	  conditions.	  
Growth	  phenotypes	  of	  12	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  AMN1,	  ACF2,	  
SCW11β,	  and	  SIC1	  and	  the	  parental	  strain	  CgΔΔΔ.	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  
mutants	  when	   compared	  with	   the	   parental	   control.	   5	   µL	   of	   each	   strain	  was	   spotted	   in	   serial	  
dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  
YPD	  at	  37°C	  unless	  otherwise	  stated.	  ..........................................................................................	  86	  
Figure	  4.8	  –	  C.	  glabrata	  amn1,	  acf2,	  scw11β,	  and	  sic1	  show	  no	  sensitivity	  to	  seven	  test	  conditions.	  
Growth	  phenotypes	  of	  12	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  AMN1,	  ACF2,	  
SCW11β,	  and	  SIC1	  and	  the	  parental	  strain	  CgΔΔΔ.	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  
mutants	  when	   compared	  with	   the	   parental	   control.	   5	   µL	   of	   each	   strain	  was	   spotted	   in	   serial	  
dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  
YPD	  at	  37°C	  unless	  otherwise	  stated.	  ..........................................................................................	  87	  
Figure	   4.9	   –	   C.	   glabrata	   amn1,	   acf2	   and	   sic1	   show	  mild	   sensitivity	   to	   vanadate	   and	   amn1,	   acf2,	  
scw11β,	  and	   sic1	   show	  mild	   sensitivity	   to	   caffeine	   test	   conditions.	  Growth	   phenotypes	   of	   12	  
Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  AMN1,	  ACF2,	  SCW11β,	  and	  SIC1	  and	  the	  
parental	   strain	  CgΔΔΔ.	  No	   sensitivity	  was	   shown	  by	  any	  of	   the	  null	  mutants	  when	   compared	  
with	   the	   parental	   control	   apart	   from	   2.5	  mM	   vanadate	   in	  which	   all	   the	  amn1,	   acf2	   and	   sic1	  
mutants	   showed	   mild	   sensitivity.	   All	   the	   mutants	   also	   showed	   mild	   sensitivity	   to	   10	   mM	  
caffeine.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  
cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	  ...............	  88	  
Figure	  4.10	  –	  C.	  glabrata	  dse1	  and	  egt2	  display	  a	  cell	  seperation	  defect	  similar	  to	  HLS122	  (ace2)	   in	  
liquid	   media.	   DIC	   microscopy	   of	   a	   representitive	   sample	   of	   each	   of	   the	   Ace2p	   regulon	   null	  
mutants,	  their	  parental	  control	  and	  an	  ace2	  null,	  HLS122.	  No	  phenotype	  difference	  was	  shown	  
between	  the	  parental	  control	  and	  the	  ash1,	  bud9,	  dse3	  and	  rme1	  null	  mutants.	  Both	  dse1	  and	  
egt2	   null	   cells	   displayed	   a	   cell	   seperation	   defect	   similar,	   but	   not	   as	   pronounced,	   as	   that	  
displayed	   by	   HLS122.	   This	   shows	   that	   both	  DSE1	   and	   EGT2	  may	   encode	   proteins	   that	   play	   a	  
more	  significant	  role	  in	  cell	  seperation	  than	  those	  gene	  nulls	  that	  didn’t	  display	  a	  cell	  separation	  
phenotype.	  Yeast	  strains	  were	  grown	  overnight	  in	  YPD	  at	  37°C,	  180	  rpm,	  diluted,	  and	  grown	  to	  
OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	  ...........................................................................	  90	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Figure	  4.11	  –	  C.	  glabrata	  amn1,	  acf2,	  scw11β	  and	  sic1	  show	  a	  cell	  separation	  competent	  phenotype	  
similar	  to	  the	  parental	  strain	  Cg	  ΔΔΔ	  in	  liquid	  media.	  DIC	  microscopy	  of	  a	  representitive	  sample	  
of	  each	  of	   the	  Ace2p	   regulon	  null	  mutants	  and	   their	  parental	   control	  Cg	  ΔΔΔ.	  No	  phenotypic	  
difference	  was	  shown	  between	  the	  parental	  control	  and	  the	  amn1,	  acf2,	  scw11β	  and	  sic1	  null	  
mutants.	   Yeast	   strains	  were	  grown	  overnight	   in	  YPD	  at	  37°C,	  180	   rpm,	  diluted,	   and	  grown	   to	  
OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	  ...........................................................................	  91	  
Figure	   4.12	   –	  C.	   glabrata	  amn1,	   ash1,	   acf2,	   bud9,	   dse1,	   dse3,	   egt2,	   rme1,	   scw11β	   and	   sic1	   show	  
similarity	  to	  wild	  type	  and	  parental	  growth	  rates.	  The	  growth	  rate	  of	  each	  of	  the	  mutants,	  their	  
parental	  types	  Cg	  his3	  and	  Cg	  ΔΔΔ,	  as	  well	  as	  the	  C.	  glabrata	  wild	  type	  (Cg2001)	  over	  24	  hours.	  
The	  growth	  rates	  of	  amn1,	  ash1,	  acf2,	  bud9,	  dse1,	  dse3,	  egt2,	  rme1,	  scw11β	  and	  sic1	  showed	  
similarity	  to	  that	  of	  their	  respective	  parental	  types	  and	  Cg2001.	  ...............................................	  92	  
Figure	  4.13	  –	  The	  addition	  of	  an	  extra	  immune	  suppression	  step	  at	  day	  -­‐1	  does	  not	  effect	  uninfected	  
control	   group	   survival.	   Survival	   of	   unifected	   mice	   (n	   =	   10,	   open	   squares)	   subjected	   to	   the	  
modified	  immune	  suppression	  regime	  with	  IP	  injection	  of	  200	  mg/kg	  cyclophosphamide	  at	  day	  
0,	  2	  and	  every	  fourth	  day	  remained	  at	  100%	  through	  a	  21	  day	  experiment.	  ..............................	  93	  
Figure	  4.14	  –	  C.	  glabrata	  amn1	  cells	  are	  not	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	   [81]	   (n	   =	   5	   for	   wild	   type	   (open	   squares),	   n	   =	   5	   for	   null	   mutant	   (closed	   triangles)).	  
Intravenous	  infection	  with	  the	  C.	  glabrata	  amn1	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  
phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  60%	  survival	  over	  14	  days.	  .......................................................................................................	  95	  
Figure	  4.15	  –	  C.	  glabrata	  ash1	  cells	  are	  not	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	   [81]	   (n	   =	   5	   for	   wild	   type	   (open	   squares),	   n	   =	   5	   for	   null	   mutant	   (closed	   triangles)).	  
Intravenous	  infection	  with	  the	  	  C.	  glabrata	  ash1	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  
phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  20%	  survival	  over	  14	  days.	  .......................................................................................................	  96	  
Figure	  4.16	  –	  C.	  glabrata	  bud9	  cells	  are	  not	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	   [81]	   (n	   =	   5	   for	   wild	   type	   (open	   squares),	   n	   =	   5	   for	   null	   mutant	   (closed	   triangles)).	  
Intravenous	  infection	  with	  the	  	  C.	  glabrata	  bud9	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  
phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  20%	  survival	  over	  14	  days.	  .......................................................................................................	  97	  
Figure	  4.17	  –	  C.	  glabrata	  dse1	  cells	  are	  not	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	   [81]	   (n	   =	   5	   for	   wild	   type	   (open	   squares),	   n	   =	   5	   for	   null	   mutant	   (closed	   triangles)).	  
Intravenous	  infection	  with	  the	  	  C.	  glabrata	  dse1	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  
phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  60%	  survival	  over	  14	  days.	  .......................................................................................................	  98	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Figure	   4.18	   –	  C.	   glabrata	   dse3	   cells	   are	   hypervirulent	   in	   a	   neutropenic	  murine	  model	   of	   systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	   glabrata	   dse3	   null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  analysis).	  Reconsitution	  of	  DSE3	   resulted	   in	  a	   return	   to	  wild	   type	  
virulence	  levels.	  ...........................................................................................................................	  99	  
Figure	   4.19	   –	  C.	   glabrata	   acf2	   cells	   are	   hypervirulent	   in	   a	   neutropenic	  murine	  model	   of	   systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	   glabrata	   acf2	   null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  analysis).	  Reconsitution	  of	  ACF2	   resulted	   in	  a	   return	   to	  wild	   type	  
virulence	  levels.	  .........................................................................................................................	  100	  
Figure	   4.20	   –	  C.	   glabrata	   egt2	   cells	   are	   hypervirulent	   in	   a	   neutropenic	  murine	  model	   of	   systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	   glabrata	   egt2	   null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  analysis).	  Reconsitution	  of	  EGT2	   resulted	   in	  a	   return	   to	  wild	   type	  
virulence	  levels.	  .........................................................................................................................	  101	  
Figure	   4.21	   –	  C.	   glabrata	   rme1	  cells	   are	   hypervirulent	   in	   a	   neutropenic	  murine	  model	   of	   systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	   glabrata	   rme1	   null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	  Log-­‐rank	  (Mantel-­‐Cox)	  analysis).	  Reconsitution	  of	  RME1	   resulted	   in	  a	  return	  to	  wild	  type	  
virulence	  levels.	  .........................................................................................................................	  102	  
Figure	  4.22	  –	  C.	  glabrata	  sw11β	  cells	  are	  hypervirulent	   in	  a	  neutropenic	  murine	  model	  of	  systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	  strain	   (closed	  triangles)).	   Intravenous	   infection	  with	   the	   	  C.	  glabrata	  scw11β	  null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	  Log-­‐rank	  (Mantel-­‐Cox)	  analysis).	  Reconsitution	  of	  SCW11β	  resulted	  in	  a	  return	  to	  wild	  type	  
virulence	  levels.	  .........................................................................................................................	  103	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Figure	   4.23	   –	   C.	   glabrata	   sic1	   cells	   are	   hypervirulent	   in	   a	   neutropenic	   murine	  model	   of	   systemic	  
candidasis.	   Virulence	   was	   assayed	   in	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  for	  null	  mutant	  (no	  symbol),	  n	  =	  5	  for	  the	  
reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	   glabrata	   sic1	   null	  
mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  
0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	   analysis).	   Reconsitution	   of	   SIC1	   resulted	   in	   a	   return	   to	  wild	   type	  
virulence	  levels.	  .........................................................................................................................	  104	  
Figure	   4.24	   –	   C.	   glabrata	   dse3,	   acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1	   show	   increased	   fungal	   burden	  
when	  compared	  with	   the	  wild	   type	   in	  a	  neutropenic	  murine	  model	  of	   candidaisis.	   The	   fungal	  
burden	  as	  measured	  by	  kidney	  CFU/g	  from	  infected	  mice.	  Kidneys	  were	  extracted	  at	  the	  point	  
of	   sacrifice,	  weighed,	   homogenised,	   diluted,	   plated	  out	   in	   triplicate,	   grown	  overnight	   at	   37°C	  
and	   colony	   forming	   units	   counted.	   The	   CFU	   per	   gram	   per	   kidney	   per	   infected	   animal	   was	  
calculated	   and	   compared	   to	   the	   the	  wild	   type	  with	   dse3,	   acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1	  
showing	  a	  significant	  increase	  in	  fungal	  burden	  when	  compared	  to	  the	  wild	  type	  (unpaired	  two	  
tailed	  t-­‐test,	  p	  <	  0.0001).	  Reconstitution	  of	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1	  returned	  the	  
fungal	  burden	  to	  the	  wild	  type	  levels.	  .......................................................................................	  105	  
Figure	  4.25a	  –	  Histological	  examination	  of	   tissues	   taken	   from	  C.	  glabrata	  wild	   type	  experimentally	  
infected	   mice.	   The	   kidney,	   liver	   and	   lung	   from	   C.	   glabrata	   wild	   type	   infected	   mice	   were	  
removed	  at	  sacrifice	  and	  stained	  using	  GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  
organ	  for	  yeast	  colonisation.	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Figure	   4.26	   –	   C.	   glabrata	   sic1	   shows	   a	   significant	   increase	   in	   TNFα	   production	   in	   a	   macrophage	  
stimulation	  assay	  compared	  to	  the	  wild	  type.	  C.	  glabrata	  2001,	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β,	  
sic1	   and	   sic1::SIC1	   were	   exposed	   to	   RAW	   264.7	   macrophages	   at	   a	   ratio	   of	   30:1	  
fungi:macrophage.	  After	  washing	  off	  unbound	  fungi,	  macrophages	  were	  incubated	  for	  6	  hours	  
at	  37°C,	  with	   supernatants	   then	   collected	   for	   TNFα	  quantification	  by	  ELISA	  kit	   (R&D	  Systems,	  
UK).	   Results	   (mean	   with	   standard	   deviation)	   are	   pooled	   triplicate	   data	   from	   three	   separate	  
experiments.	   C.	   glabrata	   sic1	   showed	   statistically	   significant	   increased	   levels	   of	   TNF-­‐α	  
elicitation	   compared	   to	   the	   wild	   type	   C.	   glabrata	   2001	   (p	   <	   0.005,	   one-­‐way	   ANOVA).	  
Reconsitution	  of	  SIC1	  restored	  TNFα	  elicitation	  to	  wild	  type	  levels.	  .........................................	  116	  
Figure	   4.27	   –	   C.	   glabrata	   sic1	   shows	   a	   significant	   increase	   in	   IL-­‐6	   production	   in	   a	   macrophage	  
stimulation	  assay	  compared	  to	  the	  wild	  type.	  C.	  glabrata	  2001,	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β,	  
sic1	   and	   sic1::SIC1	   were	   exposed	   to	   RAW	   264.7	   macrophages	   at	   a	   ratio	   of	   30:1	  
fungi:macrophage.	  After	  washing	  off	  unbound	  fungi,	  macrophages	  were	  incubated	  for	  6	  hours	  
at	   37°C,	  with	   supernatants	   then	   collected	   for	   IL-­‐6	   quantification	   by	   ELISA	   kit	   (R&D	   Systems).	  
Results	   (mean	   with	   standard	   deviation)	   are	   pooled	   triplicate	   data	   from	   three	   separate	  
experiments.	  C.	  glabrata	  sic1	   showed	  statistically	  significant	   increased	   levels	  of	   IL-­‐6	  elicitation	  
compared	  to	  the	  wild	  type	  C.	  glabrata	  2001	  (p	  <	  0.05,	  one-­‐way	  ANOVA).	  Reconsitution	  of	  SIC1	  
restored	  IL-­‐6	  elicitation	  to	  wild	  type	  levels.	  ...............................................................................	  117	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Figure	   4.28	   –	   C.	   glabrata	   dse3::DSE3,	   acf2::ACF2,	   egt2::EGT2,	   rme1::RME1,	   scw11β::SCW11β	   and	  
sic1::SIC1	   reconstitutions	   display	   expression	   of	   the	   reconstituted	   gene.	   C.	   glabrata	   dse3,	  
dse3::DSE3,	  acf2,	  acf2::ACF2,	  egt2,	  egt2::EGT2,	   rme1,	   rme1::RME1,	   scw11β,	   scw11β::SCW11β,	  
sic1	  and	  sic1::SIC1	  were	  cultured	  in	  selective	  media	  over	  night,	  diluted	  down	  to	  0.1	  OD600	  and	  
allowed	  to	  grow	  for	  three	  hours.	  Total	  RNA	  was	  extracted	  using	  a	  Qiagen	  RNeasy	  mini	  kit	  as	  per	  
the	  manufacturers	   instructions.	  Probes	  were	  constructed	  using	   internal	  primer	  pairs	   from	  the	  
relevant	   gene	   as	   indicated	   above	   each	   pair	   of	   panels.	   Primers	   are	   listed	   in	   Appendix	   3.	   The	  
lower	  panels	  show	  methylene	  blue	  loading	  controls.	  The	  target	  gene	  expression	  is	  suppressed	  
in	  the	  null	  strains	  as	  indicated	  by	  a	  lack	  of	  a	  band	  in	  the	  KO	  lane.	  All	  reconstituted	  strains	  display	  
a	  black	  band	  in	  the	  R	  lane	  indicating	  expression	  of	  the	  reconstituted	  target	  gene.	  .................	  118	  
Figure	   5.1	   –	   Potential	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   DSE1.	   The	  
intergene	  region	  upstream	  of	   the	  DSE1	  S.	  cerevisiae	   is	  displayed	  with	  potential	  Ace2p	  binding	  
sites	   (ACCAGC)	   [220]	   marked	   for	   position	   relative	   to	   the	   ATG	   of	   DSE1.	   C.	   glabrata	   DSE1	   is	  
included	  from	  Figure	  3.2	  for	  reference.	  All	  co-­‐ordinates	  and	  measurements	  are	  in	  base	  pairs,	  all	  
sequences	  were	   taken	   from	  Génolevures	   [171]	  or	  SGD	   [170].	  Diagrams	  are	  not	   to	   scale.	  A.	  C.	  
glabrata	  DSE1	  has	  two	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  RSP5.	  B.	  S.	  cerevisiae	  DSE1	  
has	  three	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  RSP5.	  .................................................	  134	  
Figure	  5.2	  –	  Structural	  prediction	  of	  C.	  glabrata	  Dse1p	  reveals	  a	  β-­‐propeller	  structure.	  Analysis	  of	  the	  
predicted	   structure,	   kindly	   performed	   by	   Dr.	   Talavera,	   University	   of	   Manchester,	   of	   the	   N-­‐
terminus,	   minus	   20bps,	   of	   C.	   glabrata	   Dse1p	   predicts	   a	   β-­‐propeller	   structure.	   The	   arrows	  
represent	  β-­‐sheets	  and	  the	  coil	  an	  α-­‐helix.	  This	  predicted	  functional	  structure	  may	  indicate	  an	  
enzymatic	  function	  for	  the	  N-­‐terminus	  of	  Dse1p	  [269].	  ............................................................	  135	  
Figure	   5.3	   –	   C.	   glabrata	   dse1	   and	   S.	   cerevisiae	   dse1	   display	   no	   difference	   in	   vanadate	   sensitivity	  
when	   compared	   to	   their	   respective	  wild	   type	   strains.	  Growth	  phenotypes	  of	   the	  wild	   type	  C.	  
glabrata	   strain	   Cg2001,	   C.	   glabrata	   dse1,	   the	   S.	   cerevisiae	   wild	   type	   strain	   BY4741,	   and	   S.	  
cerevisiae	  dse1.	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  
wild	   type	   control.	   S.	   cerevisiae	   shows	   increased	   vanadate	   resistance	  when	   compared	  with	  C.	  
glabrata.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  
104.	  Strains	  were	  grown	  for	  three	  days	  on	  YPD	  with	  the	  0.5	  mM,	  1	  mM,	  2	  mM,	  4	  mM,	  5	  mM	  or	  6	  
mM	  of	  vanadate	  at	  30°C.	  ...........................................................................................................	  137	  
Figure	   5.4	   –	   Polarisation	  of	  C.	   glabrata	   and	  S.	   cerevisiae	  dse1	   is	   unchanged	   compared	   to	   the	  wild	  
type.	  Chart	  showing	  cell	  polarisation	  as	  measured	  the	  ratio	  of	  Length:Width	  for	  a	  sample	  of	  C.	  
glabrata	  wild	  type	  (Cg2001),	  C.	  glabrata	  dse1	  null	   (Cg	  Δdse1),	  S.	  cerevisiae	  wild	  type	  (BY4741)	  
and	   S.	   cerevisiae	   dse1	   null	   (Sc	   Δdse1).	   No	   significant	   difference	   was	   observed	   between	   the	  
polarity	   of	   either	   of	   the	   dse1	   nulls	   and	   their	   associated	   wild	   type	   strains	   in	   their	   respective	  
species.	  Yeast	  strains	  were	  grown	  overnight	  in	  YPD	  at	  30°C/37°C,	  180	  rpm,	  diluted,	  and	  grown	  
to	  OD600	   0.5-­‐1,	  washed,	  mounted	   and	   visualised.	   Photos	  were	   then	   analysed	   for	   cell	   polarity	  
using	  Image	  J.	  ............................................................................................................................	  138	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Figure	   5.5	   –	   Localisation	   of	   S.	   cerevisiae	   Dse1p-­‐GFP	   is	   altered	   in	   zds2	   null	   mutant.	   Florescence	  
microscopy	  of	  a	   representitive	  sample	  of	   the	  S.	  cerevisiae	  Dse1p-­‐GFP	   library	  strain,	  as	  well	  as	  
BY4741	  and	  known	  interactors	  boi1,	  boi2,	  zds2,	  ste4	  and	  ste11	  with	  pSRSG-­‐GD1	  (Dse1-­‐GFP)	  and	  
their	   parental	   control	   BY4741.	   All	   strains	   show	   similar	   localisation	   to	   the	   Dse1-­‐GFP	   library	  
strain,	   with	   Dse1p	   primarily	   located	   to	   the	   bud	   neck	   area,	   apart	   from	   zds2	   in	   which	   Dse1p	  
localised	   to	   the	   cell	  wall	   but	  not	   the	  bud	  neck.	   Yeast	   strains	  were	  grown	  overnight	   in	  YPD	  at	  
30°C,	  180	  rpm,	  diluted,	  and	  grown	  to	  OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	  .............	  139	  
Figure	  S.1	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  amn1	  null	  mutant.	  A	  null	  allele	  of	  C.	  
glabrata	  AMN1	  was	   constructed	  as	  described	   in	  Chapter	  4.	   	  A.	   The	  C.	   	   glabrata	  AMN1	   locus.	  
Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  stop	  codon	  (+1536)	  of	  AMN1	  are	  shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  AMN1	  deletion	  cassette.	  A	  
675	  bp	   fragment	  of	  S.	   cerevisiae	  TRP1	  was	  amplified	   flanked	  by	  60	  bps	  of	  AMN1	  5’	  and	  3’	  as	  
described	   in	  Chapter	  4.	   	   C.	   Targeted	   integration	  of	   the	  AMN1	  deletion	   cassette	   at	   the	  AMN1	  
locus	   removing	   1536	   bps	   of	  AMN1	   from	   +1	   to	   +1536.	   	   D.	   Southern	   analysis	   of	   putative	   null	  
alleles	  of	  AMN1.	  Total	  genomic	  DNA	  was	  digested	  with	  NsiI	  and	  probed	  with	  672	  bp	  fragment	  
of	   ScTRP1	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   1023	   bp	   NSiI	   fragment.	   The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  3,	  
5	  and	  9.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  AMN1	   (A)	  or	  ScTRP1	   (B,	  C).	  
The	  diagram	  is	  not	  to	  scale.	  .......................................................................................................	  175	  
Figure	   S.2	  –	  Construction	  and	   confirmation	  of	   the	  C.	  glabrata	  ash1	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	   ASH1	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	   C.	   	   glabrata	   ASH1	   locus.	  
Coding	   regions	  are	   shown	   in	  blue,	  ATG	   (+1)	  and	   stop	   codon	   (+2139)	  of	  ASH1	   are	   shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  ASH1	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	  flanked	  by	  471	  bps	  and	  538	  bps	  of	  ASH1	  5’	  and	  3’	  respectively	  as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  ASH1	  deletion	  cassette	  at	  the	  ASH1	  locus	  
removing	  2229	  bps	  of	  ASH1	  from	  -­‐68	  to	  +2161.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  
ASH1.	  Total	  genomic	  DNA	  was	  digested	  with	  ClaI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  
cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  4744	  bp	  ClaI	  fragment.	  The	  presence	  
of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  5,	  7	  and	  8,	  
with	   a	   slanted	  gel	   resulting	   in	   sloping	  bands.	   The	   coordinates	   are	   shown	   relative	   to	   the	   start	  
codon	  of	  ASH1	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  ..............................	  176	  
Figure	  S.3	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  bud9	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	   BUD9	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	  C.	   	   glabrata	   BUD9	   locus.	  
Coding	   regions	  are	  shown	   in	  blue,	  ATG	   (+1)	  and	  stop	  codon	   (+1590)	  of	  BUD9	   are	   shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  BUD9	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	  flanked	  by	  504	  bps	  and	  484	  bps	  of	  BUD9	  5’	  and	  3’	  respectively	  as	  
described	   in	   Chapter	   4.	   	   C.	   Targeted	   integration	   of	   the	  BUD9	   deletion	   cassette	   at	   the	  BUD9	  
locus	   removing	   1693	   bps	   of	  BUD9	   from	   -­‐29	   to	   +1664.	   	   D.	   Southern	   analysis	   of	   putative	   null	  
alleles	  of	  BUD9.	  Total	  genomic	  DNA	  was	  digested	  with	  NSiI	  and	  probed	  with	  567	  bp	  fragment	  of	  
the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  3138	  bp	  NsiI	  fragment.	  The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  6,	  
7	  and	  8.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  BUD9	  (A)	  or	  the	  NAT	  cassette	  
(B,	  C).	  The	  diagram	  is	  not	  to	  scale.	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  177	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Figure	   S.4	  –	  Construction	  and	   confirmation	  of	   the	  C.	   glabrata	  dse1	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	   DSE1	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	   C.	   	   glabrata	   DSE1	   locus.	  
Coding	   regions	   are	   shown	   in	  blue,	  ATG	   (+1)	   and	   stop	   codon	   (+1704)	  of	  DSE1	   are	   shown.	   The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  DSE1	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	   flanked	  by	  516	  bps	  and	  531	  bps	  of	  DSE1	  5’	  and	  3’	   respectively	  as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  DSE1	  deletion	  cassette	  at	  the	  DSE1	  locus	  
removing	  1747	  bps	  of	  DSE1	   from	  -­‐4	   to	  +1743.	   	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  
DSE1.	  Total	  genomic	  DNA	  was	  digested	  with	  FspI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  
cassette	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   3100	   bp	   FspI	   fragment.	   The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  4,	  
5,	  6.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  DSE1	  (A)	  or	  the	  NAT	  cassette	  (B,	  
C).	  The	  diagram	  is	  not	  to	  scale.	  ..................................................................................................	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Figure	   S.5	  –	  Construction	  and	   confirmation	  of	   the	  C.	   glabrata	  dse3	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	   DSE3	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	   C.	   	   glabrata	   DSE3	   locus.	  
Coding	   regions	   are	   shown	   in	  blue,	  ATG	   (+1)	   and	   stop	   codon	   (+1317)	  of	  DSE3	   are	   shown.	   The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  DSE3	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	   flanked	  by	  492	  bps	  and	  494	  bps	  of	  DSE3	  5’	  and	  3’	   respectively	  as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  DSE3	  deletion	  cassette	  at	  the	  DSE3	  locus	  
removing	  1364	  bps	  of	  DSE3	  from	  -­‐44	  to	  +1320.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  
DSE3.	  Total	  genomic	  DNA	  was	  digested	  with	  SpeI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  
cassette	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   7508	   bp	   SpeI	   fragment.	   The	  
presence	  of	  a	  band	  confirms	  that	  correct	   integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  
10,	  12,	  18,	  19	  and	  21.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  DSE3	  (A)	  or	  the	  
NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  .......................................................................	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Figure	   S.6	   –	   Construction	   and	   confirmation	  of	   the	  C.	   glabrata	   acf2	   null	  mutant.	   A	   null	   allele	   of	  C.	  
glabrata	   ACF2	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	   C.	   	   glabrata	   ACF2	   locus.	  
Coding	   regions	   are	   shown	   in	  blue,	  ATG	   (+1)	   and	   stop	   codon	   (+2313)	  of	  ACF2	   are	   shown.	   The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  ACF2	  deletion	  cassette.	  A	  
675	   bp	   fragment	   of	   S.	   cerevisiae	   TRP1	  was	   amplified	   flanked	   by	   60	   bps	   of	  ACF2	   5’	   and	   3’	   as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  ACF2	  deletion	  cassette	  at	  the	  ACF2	  locus	  
removing	  2313	  bps	  of	  ACF2	   from	  +1	  to	  +2313.	   	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  
ACF2.	  Total	  genomic	  DNA	  was	  digested	  with	  XbaI	  and	  probed	  with	  672	  bp	  fragment	  of	  ScTRP1	  
as	  described	   in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  1182	  bp	  XbaI	   fragment.	  The	  presence	  of	  a	  
band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred.	  The	  coordinates	  are	  shown	  
relative	  to	  the	  start	  codon	  of	  ACF2	  (A)	  or	  ScTRP1	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  ..............	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Figure	   S.7	   –	  Construction	   and	   confirmation	  of	   the	  C.	   glabrata	   egt2	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	   EGT2	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	   C.	   	   glabrata	   EGT2	   locus.	  
Coding	   regions	  are	   shown	   in	  blue,	  ATG	   (+1)	   and	   stop	   codon	   (+2031)	  of	  EGT2	   are	   shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  EGT2	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	  flanked	  by	  494	  bps	  and	  483	  bps	  of	  EGT2	  5’	  and	  3’	   respectively	  as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  EGT2	  deletion	  cassette	  at	  the	  EGT2	  locus	  
removing	  2101	  bps	  of	  EGT2	  from	  -­‐27	  to	  +2031.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  
EGT2.	  Total	  genomic	  DNA	  was	  digested	  with	  BstBI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  
cassette	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   4778	   bp	   BstBI	   fragment.	   The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  4,	  
6	  and	  14.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  EGT2	  (A)	  or	  the	  NAT	  cassette	  
(B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  ............................................................................................	  181	  
Figure	  S.8	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	   rme1	  null	  mutant.	  A	  null	  allele	  of	  C.	  
glabrata	   RME1	   was	   constructed	   as	   described	   in	   Chapter	   4.	   	   A.	   The	  C.	   	   glabrata	   RME1	   locus.	  
Coding	  regions	  are	  shown	   in	  blue,	  ATG	  (+1)	  and	  stop	  codon	   (+1644)	  of	  RME1	  are	  shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  RME1	  deletion	  cassette.	  A	  
NAT	  cassette	  was	  amplified	  flanked	  by	  463	  bps	  and	  508	  bps	  of	  RME1	  5’	  and	  3’	  respectively	  as	  
described	   in	   Chapter	   4.	   	   C.	   Targeted	   integration	   of	   the	  RME1	  deletion	   cassette	   at	   the	  RME1	  
locus	   removing	  1850	  bps	  of	  RME1	   from	   -­‐150	   to	  +1700.	   	  D.	   Southern	  analysis	  of	  putative	  null	  
alleles	  of	  RME1.	  Total	  genomic	  DNA	  was	  digested	  with	  NsiI	  and	  probed	  with	  567	  bp	  fragment	  of	  
the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  5624	  bp	  NsiI	  fragment.	  The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  1,	  
5,	  6,	  7	  and	  8.	  The	  coordinates	  are	   shown	   relative	   to	   the	   start	   codon	  of	  RME1	   (A)	  or	   the	  NAT	  
cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  ..............................................................................	  182	  
Figure	  S.9	  –	  Construction	  and	  confirmation	  of	  the	  C.	  glabrata	  scw11β	  null	  mutant.	  A	  null	  allele	  of	  C.	  
glabrata	  SCW11β	  was	  constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  SCW11β	  locus.	  
Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  stop	  codon	  (+1497)	  of	  SCW11β	  are	  shown.	  The	  
upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  SCW11β	  deletion	  cassette.	  
A	  675	  bp	  fragment	  of	  S.	  cerevisiae	  TRP1	  was	  amplified	  flanked	  by	  60	  bps	  of	  SCW11β	  5’	  and	  3’	  as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  SCW11β	  deletion	  cassette	  at	  the	  SCW11β	  
locus	   removing	  1497	  bps	  of	  SCW11β	   from	  +1	   to	  +1497.	   	  D.	  Southern	  analysis	  of	  putative	  null	  
alleles	  of	  SCW11β.	  Total	  genomic	  DNA	  was	  digested	  with	  ClaI	  and	  probed	  with	  672	  bp	  fragment	  
of	   ScTRP1	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   848	   bp	   ClaI	   fragment.	   The	  
presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  1,	  
4	  and	  5.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  SCW11β	  (A)	  or	  ScTRP1	  (B,	  C).	  
The	  diagram	  is	  not	  to	  scale.	  .......................................................................................................	  183	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Figure	  S.10	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	   sic1	   null	  mutant.	  A	  null	   allele	  of	  C.	  
glabrata	  SIC1	  was	  constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  Sic1	  locus.	  Coding	  
regions	  are	  shown	   in	  blue,	  ATG	   (+1)	  and	  stop	  codon	   (+849)	  of	  SIC1	   are	  shown.	  The	  upstream	  
and	   downstream	   genes	   are	   also	   shown.	   	   B.	   The	  C.	   glabrata	  SIC1	   deletion	   cassette.	   A	   675	   bp	  
fragment	  of	  S.	  cerevisiae	  TRP1	  was	  amplified	  flanked	  by	  60	  bps	  of	  Sic1	  5’	  and	  3’	  as	  described	  in	  
Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  Sic1	  deletion	  cassette	  at	  the	  Sic1	  locus	  removing	  849	  
bps	  of	  SIC1	  from	  +1	  to	  +849.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  SIC1.	  Total	  genomic	  
DNA	   was	   digested	   with	   NsiI	   and	   probed	   with	   672	   bp	   fragment	   of	   ScTRP1	   as	   described	   in	  
Chapter	  4.	  The	  null	  allele	  yielded	  a	  1062	  bp	  NsiI	  fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  
correct	   integration	  of	   the	  cassette	  has	  occurred	   for	  mutants	  2,	  9	  and	  13.	  The	  coordinates	  are	  
shown	  relative	  to	  the	  start	  codon	  of	  SIC1	  (A)	  or	  ScTRP1	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	  ....	  184	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1	   Introduction	  
	  
1.1	  Fungal	  human	  pathogens	  
Fungi	   form	   part	   of	   the	   normal	   flora	   of	   humans	   colonising	   the	   skin,	   mucosal	   surfaces,	   the	  
gastrointestinal	   and	  urinary	   tracts,	   as	  well	   as	  practically	   every	   surface	  we	   touch;	  but	   for	   the	  most	  
part	   they	   cause	   no	   clinical	   symptoms.	   The	   human	   immune	   system	   has	   proven	   quite	   adept	   at	  
managing	  most	   fungal	   species,	   which	   has	   led	   to	   the	   common	   belief	   that	   fungi	   are	   not	   important	  
contributors	  to	  human	  disease	  [1].	  Within	  the	  last	  20	  to	  30	  years,	  advances	  in	  medical	  science	  have	  
brought	   about	   increased	   life	   expectancy,	   even	   for	   the	   most	   critically	   ill	   patients.	   It	   is	   this	  
development	   that	   has	   caused	   a	   dramatic	   increase	   in	   the	   ‘at	   risk’	   demographic,	   and	   has	   allowed	  
fungal	   pathogens	   to	   thrive	   and	   flourish	   in	   the	   human	   environment,	   becoming	   a	   not	   insignificant	  
clinical	   burden	   [2].	   Fungal	   species	   now	  make	   up	   a	   significant	   proportion	   of	   nosocomial	   infections	  
with	   Candida	   species	   alone	   accounting	   for	   between	   10	   and	   15%	   of	   all	   nosocomial	   blood	   stream	  
infections	   (BSIs)	   acquired	   from	   the	   various	   surfaces	   and	   commensal	   colonisation	   found	  within	   the	  
clinical	  setting	  [3],	  and	  have	  played	  critical	  roles	  in	  patient	  survival	  worldwide.	  	  
Most	   pathogenic	   species	   of	   fungi	   can	   be	   classified	   as	   deep	   or	   superficial	   of	   which	   dermatophyte	  
opportunistic	   pathogens	   are	   a	   subset	   of	   superficial.	   For	   instance,	   a	   reduction	   in	   the	   immune	  
competency	  of	  patients	  allows	  Candida	  species	  to	  turn	  from	  a	  commensal	  organism	  into	  a	  pathogen.	  
The	   subject	   of	   this	   study,	  Candida	   glabrata,	   falls	   within	   that	   classification	   as	   a	   true	   opportunistic	  
pathogen,	   which	   fails	   to	   cause	   disease	   in	   immunocompetent	   patients,	   and	   is	   only	   virulent	   in	   the	  
immunocompromised	  population.	  	  
Fungal	   pathogens	   range	   from	   the	   superficial,	   yet	   extremely	   irritating,	   Trichophyton	   and	   Candida	  
species	   that	   cause	   Athlete’s	   Foot	   [4]	   and	   vulvovaginal	   candidiasis	   respectively,	   to	   the	   deadly	  
systemic	  infections	  of	  immunocompetent	  individuals	  caused	  by	  Cryptococcus	  gattii	  [5].	  The	  majority	  
of	   clinical	   burden	   comes	   from	   a	   combination	   of	   superficial	   and	   systemic	   infections	   caused	   by	  
opportunistic	   pathogens	   in	   the	   immunocompromised.	   For	   instance,	   it	   is	   estimated	   that	   systemic	  
infections	   caused	   by	   Candida	   species	   alone	   account	   for	   an	   $800	   million	   burden	   on	   medical	  
treatment	   in	   the	   US	   [6],	   not	   to	   mention	   the	   cost	   of	   over	   the	   counter	   medication,	   practitioner	  
visitation	  hours	  and	  prescriptions	  for	  superficial	  Candida	  infections.	  
The	   list	   of	   pathogenic	   mycoses	   is	   still	   expanding	   to	   this	   day,	   and	   ranges	   from	   yeasts	   such	   as	   C.	  
glabrata	  and	  Cryptococcus	  neoforms,	  through	  dimorphic	  fungi	  like	  Candida	  albicans	  and	  Histoplasma	  
capsulatum,	   to	   true	   hyphal	   fungi	   such	   as	   Aspergillus	   fumigatus	   [2].	   The	   most	   common	   cause	   of	  
fungal	  pathogenesis	   in	  the	  US	  has	  been	  shown	  to	  be	  Candida	  species,	  which	  alone	  account	  for	  10-­‐
15%	  of	  hospital-­‐acquired	  BSIs	   [3,	  7,	  8].	   	   This	   represents	  an	   incidence	  of	  72.8	   cases	  per	  million	  per	  
year,	   with	   a	   case-­‐fatality	   percentage	   of	   33.9%	   for	   first	   episode	   infections	   [2,	   8].	   The	   next	   most	  
prevalent	   invasive	   fungal	   species	   is	   C.	   neoformans,	   with	   65.5	   cases	   per	   million	   per	   year;	   then	  
Coccidioides	   immitis,	   with	   15.3	   cases	   per	   million	   per	   year;	   and	   rounding	   out	   the	   double	   figure	  
percentages	  are	  Aspergillus	  species	  with	  12.4	  cases	  per	  million	  per	  year	  [2,	  8].	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1.1.1	  Antifungals	  
Treating	  pathogenic	  fungi	  has	  always	  been	  a	  clinical	  challenge	  due	  to	  many	  factors.	  The	  eukaryotic	  
nature	   of	   fungi	   has	   posed	   a	   serious	   obstacle	   to	   be	   overcome	   because	   the	   similarities	   in	   cellular	  
processes	  between	   fungi	   and	  other	  eukaryotes	  makes	   specifically	   targeting	   fungi	   very	  difficult	   [1].	  
For	   instance,	  amphotericin-­‐B	  can	  cause	  significant	   levels	  of	   toxicity	   in	   the	  patient	  due	   its	  ability	   to	  
bind	  to	  host	  sterols	  as	  well	  as	  those	  of	  a	  fungal	  nature	  [1].	  Another	  issue	  is	  the	  increasing	  resistance	  
found	  in	  species,	  like	  A.	  fumigatus	  and	  C.	  glabrata,	  to	  another	  effective	  antifungal	  species,	  azoles,	  in	  
particular	   fluconazole	   [1],	   which	   further	   limits	   the	   effective	   list	   of	   available	   active	   antifungals.	  
Diagnosis	  and	  successful	  treatment	  of	  fungal	  pathogens	  is	  also	  hampered	  by	  the	  poor	  sensitivity	  of	  
current	   detection	   methods,	   which	   are	   especially	   weak	   for	   cases	   of	   invasive	   aspergillosis,	   where	  
blood	  culture	  tests	  often	  fail	  [9].	  
Coming	   into	   the	   turn	   of	   the	   millennium,	   although	   only	   having	   a	   short	   list	   to	   choose	   from,	   the	  
availability	  of	  antifungals	  stood	  at	  an	  all-­‐time	  high,	  which	  combined	  with	  improved	  clinical	  practices	  
including	  prophylaxis,	  has	  meant	  that	  the	  incidence	  of	  systemic	  fungal	  infections	  in	  neutropenic	  and	  
other	   immune	  deficient	  patients	   is	  on	   the	  decline	   [10,	   11].	   Instead	  a	   shift	  of	   the	  primary	   focus	  of	  
fungal	   pathogens	   from	   the	   intensive	   care	  unit	   (ICU)	   to	  other	   general	   and	   surgery	  wards	  has	  been	  
observed	  [12],	  meaning	  that	  fungal	  disease	  is	  no	  longer	  only	  an	  affliction	  of	  the	  critically	  ill,	  but	  one	  
that	  effects	  a	  wider	  hospitalised	  population.	  
Most	   commonly	   used	   antifungal	   agents	   act	   against	   ergosterol,	   a	   component	   of	   fungal	   cell	  
membranes,	  which	  either	  have	  an	  inhibitory	  action	  on	  its	  biosynthesis	  or	  bind	  directly	  to	  ergosterol	  
disrupting	   the	   proper	   form	   and	   function	   of	   plasma	   membranes	   within	   fungi	   [1].	   The	   antifungal	  
agents	  currently	   in	  clinical	  use	  can	  be	  divided	   into	  five	  groups.	  First	  the	  azoles,	  which	   include	  both	  
imidazoles	   and	   triazoles,	   target	   the	   demethylation	   of	   lanosterol	   to	   zymosterol	   during	   ergosterol	  
synthesis	   by	   binding	   to	   and	   inhibiting	   the	   heme	   component	   of	   the	   cytochrome	   P450-­‐dependent	  
14α-­‐demethylase	   encoded	   by	   ERG11,	   thereby	   blocking	   ergosterol	   production	   [1].	   The	   second,	  
polyenes	   such	  as	   terbinafine	  and	  amphotericin-­‐B,	  are	   thought	   to	  bind	   to	  ergosterol	  directly	   in	   the	  
cell	  membrane	  and	  possibly	  create	  aqueous	  pores	  changing	  the	  permeability	  of	  the	  cells	  and	  leading	  
to	   cell	   death	   [1].	   The	   third	   group,	   fluoropyrimidines	   such	  as	  5-­‐fluorocytosine,	   are	  used	   to	  a	   lesser	  
extent	  by	  clinicians	  and	  display	  a	  limited	  spectrum	  of	  activity	  [1];	  they	  are	  therefore	  primarily	  used	  in	  
combination	  with	   amphotericin-­‐B	   [1].	   The	   5-­‐fluorocytosine	   is	   thought	   to	   be	   taken	   up	   by	   sensitive	  
cells	  and	  converted	   to	  5-­‐fluorouracil,	   and	   then	   to	  5-­‐fluorouridylic	  acid,	  which	   is	   then	   incorporated	  
into	   the	   fungal	   RNA	   inhibiting	   protein	   synthesis	   [1,	   13].	   Strains	   without	   cytosine	   deaminase	   are	  
therefore	   immune	   to	   5-­‐fluorocytosine	   treatment	   [13].	   The	   fourth	   group	   of	   antifungals	   are	   the	  
allylamines	  and	  thiocarbamates,	  which	  inhibit	  ergosterol	  synthesis	  upstream	  of	  the	  action	  of	  azoles,	  
by	   inhibiting	   squalene	   epoxidase,	   which	  works	   in	   conjunction	  with	   (2,3)-­‐oxidosqualene	   cyclase	   to	  
convert	  squalene	  to	   lanosterol	   [1,	  14].	  The	  fifth	  group,	   the	  echinocandins	  such	  as	  caspofungin	  and	  
micafungin,	  are	  currently	  thought	  to	  be	  the	  gold	  standard	  for	  treatment	  of	  candidaemia	  [15].	  They	  
are	   fungicidal,	   binding	   to	   and	   inhibiting	   the	   fungal	   cell	   wall	   enzyme	   complex	   β-­‐1,3-­‐D-­‐glucan	  
synthase,	  preventing	  the	  production	  of	  the	  β-­‐1,3-­‐glucan	  that	  forms	  the	  major	  structural	  component	  
of	   the	   fungal	   cell	   wall	   along	   with	   β-­‐1,6-­‐glucan	   [16,	   17].	   Both	   polyenes	   and	   echinocandins	   are	  
therefore	  fungicidal,	  and	  as	  such	  show	  a	  lower	  potential	  for	  resistance	  development	  [1].	  The	  rest	  of	  
the	  antifungal	  drugs	  in	  clinical	  use	  are	  fungistatic,	  and	  therefore	  have	  shown	  a	  propensity	  to	  cause	  
resistance	  development	  in	  certain	  fungal	  species	  [1].	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Antifungal	   resistance	   can	   develop	   via	   several	   routes	  within	   different	   fungal	   species,	   including	   the	  
overexpression	  of	  targeted	  pathway	  genes,	  amino	  acid	  substitutions	  within	  subunits	  of	  drug	  targets	  
and	   upregulation	   of	   drug	   efflux	   pumps.	   Like	  many	   species	   of	   bacteria,	   fungal	   species	   are	   able	   to	  
rapidly	   acquire	   resistance	   to	   certain	   antifungals,	   such	   as	   azoles,	   through	   the	   over	   expression	   of	  
multidrug	   resistance	   transporters,	   such	   as	   the	   major	   facilitator	   and	   ATP-­‐binding	   cassette	   (ABC)	  
classes.	  	  For	  instance,	  C.	  glabrata	  can	  upregulate	  the	  expression	  of	  two	  ABC	  transporter	  genes	  CDR1	  
and	  PDH1	  (CDR2),	  which	  actively	  export	  azoles	  from	  the	  fungal	  cell	  [18].	  In	  this	  way,	  increased	  efflux	  
of	  the	  antifungal	  compound	  from	  the	  cell	  enables	  the	  fungus	  to	  rapidly	  decrease	  the	  concentration	  
of	   the	   active	   antifungal	   agent	   within	   the	   cell,	   restoring	   normal	   cell	   function.	   Another	   method	   of	  
antifungal	   resistance	   can	   take	   the	   form	   of	   upregulation	   of	   the	   antifungal	   drug’s	   target	   gene	  
expression.	  For	  instance,	  C.	  glabrata	  upregulates	  the	  expression	  of	  the	  target	  of	  azole	  species	  itself,	  
ERG11,	  reducing	  the	  impact	  of	  the	  antifungal	  drug	  on	  the	  production	  of	  ergosterol	  [19].	  Some	  fungal	  
species	   are	   also	   capable	   of	   developing	   mutations	   within	   the	   target	   of	   the	   antifungal	   agent.	   For	  
instance,	   a	   common	   resistance	   mechanism	   of	   fungal	   species	   to	   the	   antifungal	   action	   of	  
echinocandins	  takes	  the	  form	  of	  small	  mutations	  of	  the	  target	  itself,	  Fks1p	  –	  a	  major	  subunit	  of	  the	  
fungal	   glucan	   synthase	   [20].	   Two	   amino	   acid	   substitutions	   in	   two	   so	   called	   “hot-­‐spots”	  within	   the	  
structure	   of	   Fks1p	   reduce	   its	   sensitivity	   to	   echinocandins	   by	   several	   thousand	   fold,	   conferring	  
resistance	  to	  the	  antifungal	  drug’s	  disruption	  of	  the	  glucan	  synthase	  pathway	  [20].	  
Due	  to	  the	  potential	  for	  resistance	  development	  to	  antifungal	  therapy	  by	  pathogenic	  fungal	  species,	  
it	  is	  crucial	  that	  continuing	  research	  is	  performed	  into	  novel	  fungal	  specific	  drug	  targets,	  in	  an	  effort	  
to	  combat	  the	  inevitable	  development	  of	  resistant	  strains.	  Some	  examples	  of	  promising	  target	  areas	  
currently	   under	   investigation	   for	   potential	   drug	   development	   include	   the	   fungal	   cell	   wall,	   its	  
maintenance,	   biosynthesis	   and	   structural	   integrity;	   fungal	   fatty	   acid	   synthase,	   which	   shows	  
significant	  structural	  differences	  to	  that	  of	   the	  human	  housekeeping	  proteins	   filling	   the	  same	  role;	  
two-­‐component	   regulatory	   systems	   that	   play	   a	   role	   in	   sensing	   of	   the	   environment	   in	   fungi,	   but	  
crucially	   have	   not	   been	   described	   in	   mammalian	   cells,	   and	   so	   pose	   suitable	   drug	   targets;	   and	  
virulence	  genes	  bespoke	   to	   fungi,	  which	  are	  obvious	   targets	   for	  drug	  discovery	  and	  may	  have	   the	  
potential	  to	  not	  only	  have	  effective	  therapeutic	  value	  as	  virulence	  attenuators,	  but	  also	  to	  avoid	  the	  
development	  of	  resistance	  [1].	  
	  
1.2	  Non-­‐human	  fungal	  pathogens	  
Although	   this	   project	   focuses	   on	   pathogenic	   fungi	   that	   target	   man,	   it’s	   important	   to	   note	   that	  
pathogenic	  fungi	  pose	  problems	  for	  many	  forms	  of	  life,	  including	  those	  that	  we	  cultivate	  or	  require	  
for	  human	  survival.	  Microbial	  plant	  pathogens	  are	  a	  major	  limiting	  factor	  of	  global	  crop	  production	  
accounting	  for	  losses	  in	  the	  region	  of	  14%	  of	  potential	  yield,	  which	  equates	  to	  about	  US$220	  billion	  
lost	  per	  annum	  [21].	  Fungal	  plant	  pathogens	  account	  for	  some	  of	  the	  most	  notorious	  microbial	  plant	  
diseases	   including	  the	  potato	   late	  blight,	  wheat	  stem	  rust,	  rice	  blast	  and	  grapevine	  downy	  mildew,	  
which	   have	   impacted	   heavily	   on	   global	   economies	   and	   caused	   famine	   and	   economic	   collapse	  
throughout	  the	  ages	  [21].	  The	  first	  description	  of	  a	  fungal	  plant	  pathogen	  was	  the	  potato	  late	  blight,	  
which	  was	  defined	  by	  Anton	  de	  Barry,	   the	   father	  of	  Plant	  Pathology,	   in	  1861	   [21,	  22].	   Since	   then,	  
many	   fungal	   plant	   pathogens	   have	   been	   the	   focus	   of	   research	   into	   both	   crop	   resistance	   and	  
pesticide	  development.	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Non-­‐human	  animal	   fungal	  pathogens	  are	  also	  an	   issue	   in	   the	  global	   environment.	  Amphibians	  are	  
particularly	   susceptible	   to	   fungal	   infection.	   The	   fungal	   pathogen	   Batrachochytrium	   dendrobatidis,	  
which	   causes	   the	  disease	  Chytridiomycosis	   has	  been	  blamed	   for	   the	   current	  population	  decline	   in	  
frog	  species	  in	  certain	  areas	  [23].	  It	  infects	  the	  keratinized	  epidermis	  of	  metamorph	  and	  adult	  stages	  
of	  the	  amphibian	  life	  cycle,	  as	  well	  as	  the	  tooth	  rows	  and	  jaw	  sheaths	  of	  larvae,	  leaving	  populations	  
crippled	   especially	   in	   Ranid	   frog	   species	   [23,	   24].	   Unfortunately,	  B.	   dendrobatidis,	   survives	   in	   the	  
larval	   stages	   of	   the	   amphibians	   without	   causing	   significant	   mortality,	   and	   so	   creates	   an	   endemic	  
disease	  with	  a	  larval	  stage	  reservoir	  [23].	  
Fungal	  pathogens	  have	  also	  been	  demonstrated	  to	  be	  a	  significant	  burden	  on	  insect	  populations.	  A	  
critical	  example	  of	  this	  on	  the	  global	  scale	  is	  the	  recent	  decline	  in	  managed	  honeybee	  populations.	  
Managed	  honeybees	  carry	  out	  approximately	  90%	  of	  commercial	  pollination	  for	  agriculture,	  and	  so	  
their	  decline	  in	  health	  has,	  and	  will	  have,	  a	  serious	  impact	  on	  human	  food	  security	  [25].	  The	  obligate	  
microsporidial	   fungal	  parasite,	  Nosema	  ceranae,	  has	  been	   implicated	   in	  playing	  a	  major	  role	   in	  the	  
population	  decline	  of	  the	  western	  honeybee,	  Apis	  mellifera	  [25,	  26].	  Microsporidia	  exist	  outside	  the	  
host	  only	   in	  a	  metabolically	   inactive,	  spore	  form,	  with	   its	   life	  cycle	  totally	  dependent	  on	  entry	   into	  
host	  cells	  [25].	  The	  spore	  germinates	  within	  the	  host	  and	  injects	  sporoplasm	  into	  target	  cells	  through	  
a	  physical	  puncture	  in	  the	  cell	  membrane.	  From	  there	  the	  fungi	  proliferate	  and	  form	  more	  spores	  for	  
dissemination	  [25].	  Study	  of	  the	  molecular	  and	  cellular	  mechanisms	  of	  interactions	  between	  Nosema	  
species	   and	  Apis	   species	  have	  been	   restricted	  due	   to	   the	   lack	  of	   cell	   culture	   systems	   for	  Nosema,	  
something	  that	  has	  thankfully	  recently	  been	  resolved	  [25].	  	  
It	   is	   clear	   that	   fungal	   pathogens	   pose	   significant	   burden	   on	   not	   only	   human	   health,	   but	   also	   the	  
health	   of	   the	  wider	   environment	   and	   human	  managed	   agriculture.	   It	   is	   therefore	   imperative	   that	  
research	   into	   all	   areas	  of	   pathogenic	   fungal	   biology	   is	   carried	  out	  with	   an	   aim	   to	  discover	   cellular	  
processes,	   structure	   and	   virulence	  mechanisms	   for	   both	  a	   better	   understanding	  of	   fungal	   burden,	  
but	  also	  in	  aid	  of	  therapeutic	  discovery.	  
	  
1.3	  Candida	  epidemiology	  
Candida	  species	  form	  a	  group	  of	  fungi	  consisting	  of	  approximately	  154	  separate	  species	  belonging	  to	  
the	   class	   Ascomycetes,	   order	   of	   the	   Saccharomycetales	   and	   the	   family	   Saccharomycetaceae	   [27].	  
The	  name	  Candida	  comes	  from	  the	  Latin	  phrase	  toga	  candida	  meaning	  a	  special	  white	  robe	  worn	  by	  
the	  Roman	  Senate,	  so	  called	  because	  of	  the	  whitish	  appearance	  of	  colonies	  on	  solid	  plate	  agar	  [27].	  
The	   name	   was	   first	   applied	   to	   the	   agent	   of	   thrush,	   which	   was	   later	   isolated	   and	   classified	   as	   C.	  
albicans.	   Candida	   species	   exist	   primarily	   as	   non-­‐pathogenic	   commensals,	   forming	   up	   part	   of	   the	  
normal	  flora	  of	  human	  beings	  and	  are	  found	  wildly	  throughout	  the	  environment	   including	  the	  soil,	  
water	  and	  on	  plants	   [27].	  Despite	   their	  majority	  commensal	   status,	  more	   than	  17	  Candida	  species	  
have	  been	  reported	  as	  etiologic	  agents	  of	  BSIs	  [11,	  28].	  About	  95%	  of	  these	  BSIs	  are	  caused	  by	  four	  
Candida	   species,	   C.	   albicans,	   C.	   glabrata,	   Candida	   parapsilosis	   and	   Candida	   tropicalis,	   with	   the	  
remaining	   5%	   made	   up	   by	   approximately	   13	   different	   species	   [28,	   29].	   The	   majority	   of	   Candida	  
species	  do	  not	  exhibit	  a	  true	  sexual	  cycle,	  but	  are	  polymorphic	   in	  form,	  able	  to	  exist	   in	  colonies	  as	  
budding	  yeast,	  or	  projecting	  hyphae	  or	  pseudohyphae.	  The	  ability	  to	  form	  true	  or	  pseudohyphae	  is	  
thought	  to	  play	  a	  role	  in	  colonisation,	  dissemination	  and	  virulence	  within	  host	  systems	  [30],	  although	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C.	  glabrata,	  a	  haploid	  yeast,	   lacks	  any	  real	   form	  of	  pseudo	  or	  true	  hyphal	   formations	  except	  when	  
cultured	  on	  solid	  nitrogen	  starvation	  media	  [31].	  
Having	   been	   considered	   clinically	   insignificant	   for	   many	   years,	   life-­‐threatening	   infections	   due	   to	  
opportunistic	  and	  pathogenic	  fungi	  have	  shown	  a	  dramatic	  increase	  in	  incidence	  in	  the	  past	  20	  years	  
[32-­‐34].	  This	  has	  primarily	  been	  due	  to	  the	  increasing	  size	  of	  at	  risk	  groups,	  which	  includes	  patients	  
on	   immunosuppressive	   regimes	   such	   as	   those	   receiving	   transplants	   and	   cancer	   patients,	   patients	  
with	  AIDs	  and	  other	  immunodeficiency	  disease	  patients,	  as	  well	  as	  the	  elderly	  [33,	  34].	  Opportunistic	  
fungi	   such	   as	   Candida,	   Aspergillus,	   Cryptococcus	   and	   other	   non-­‐Candida	   yeasts,	   have	   become	   an	  
increasing	  threat,	  not	  helped	  by	  broad-­‐spectrum	  antibiotics	  use	  and	  increasingly	  invasive	  procedures	  
with	   prolonged	   catheter	   use	   in	   ICUs	   [32-­‐34].	   However,	   with	   approximately	   73	   million	   cases	  
worldwide	   per	   year,	   Candida	   infections	   remain	   one	   of	   the	   most	   dominant	   and	   important	   of	  
opportunistic	  mycoses	  [8].	  
	  
1.3.1	  Superficial	  candidiasis	  
Candida	   species	   cause	   a	   wide	   range	   of	   infections,	   from	   superficial	   candidiasis	   of	   the	   skin	   and	  
mucosal	   surfaces,	   which	   are	   frequently	   community	   acquired	   and	   cause	   significant	   morbidity,	   to	  
invasive	   or	   deep	   candidiasis	   infections	   [11].	   The	   most	   widespread	   and	   well	   known	   of	   Candida	  
infections	   is	  vulvovaginal	  candidiasis,	  colloquially	  known	  as	  thrush,	  which	  an	  estimated	  75%	  of	   the	  
female	  population	  will	   suffer	   from	  at	   least	  once	   in	   their	   lives	   [35],	  with	  between	  5-­‐10%	  of	   suffers	  
acquiring	  reoccurring	   infections	  of	  at	   least	  three	  cases	  a	  year	  [36].	  C.	  albicans	   represents	  the	  most	  
common	  cause	  of	  vulvovaginal	  candidiasis	  [35],	  but	   it	  also	  exists	  as	  a	  commensal	  organism	  in	  both	  
the	  gastrointestinal	  and	  genitourinary	  tracts	  [37].	  	  Some	  individuals	  may	  have	  developed	  a	  Candida-­‐
specific	  adaptive	  immune	  response,	  which	  could	  protect	  them	  from	  the	  commensal	  turning	  into	  an	  
opportunistic	  pathogen	  under	  normal	  conditions;	  however	  it	  is	  also	  possible	  that	  C.	  albicans	  fails	  to	  
invade	  the	  host	  epithelia	  and	  therefore	  remains	  commensal	  under	  these	  conditions.	  [37],	  Of	  course	  
conditions	  can	  change	  for	  both	  the	  host	  and	  organism,	  leading	  to	  symptomatic	  infections,	  and	  while	  
they	   are	   largely	   treatable	  with	  modern	   antifungals	   including	   azoles	   and	   amphotericin	   B,	   the	   high	  
prevalence	   correlates	   with	   large	   amounts	   of	  money	   spent	   on	   over-­‐counter	  medication,	   physician	  
visits	  and	  prescriptions	  [37].	  
Candiduria,	   yeast	   infection	   of	   the	   urine,	   is	   another	   common	   urinary	   tract	   infection.	   Patients	   are	  
often	  asymptomatic,	  but	  C.	  albicans	  has	  been	  shown	  to	  be	  the	  most	  common	  isolate,	  even	  though	  
tracing	   the	   cause	   of	   infection	   can	   be	   difficult	   due	   to	   the	   lack	   of	   diagnostic	   tests	   that	   effectively	  
discriminate	   between	   infection	   and	   colonisation	   [38,	   39].	   An	   estimated	   50,000	   episodes	   of	  
candiduria	  occur	  annually	  in	  the	  United	  States,	  with	  risk	  factors	  including	  catheterisation,	  antibiotic	  
exposure,	  diabetes,	  age	  and	  sex	  [38,	  40,	  41].	  While	  antifungal	  therapy	  is	  effective	  at	  reducing	  patient	  
symptoms,	  candiduria	  in	  asymptomatic	  patients	  seems	  to	  be	  unaffected,	  and	  therefore	  only	  certain	  
groups	  of	  patients,	  mainly	  those	  at	  risk	  of	  developing	  candidiasis	  such	  as	  neutropenic	  patients,	  are	  
recommended	  for	  treatment	  [39].	  
Candida	   species	  are	  often	   found	   in	   the	  oral	   cavity	  as	  part	  of	   the	  natural	   flora	  but	  cause	  particular	  
issues	   for	   cancer	  patients,	  who	  have	   reduced	   immune	  protection	  as	  a	   result	  of	   their	   therapy,	   and	  
patients	   with	   immune	   deficiency	   disorders	   [42].	   Although	   the	   pathogenesis	   of	   oral	   candidiasis	   is	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currently	  not	  well	  understood,	  common	  superficial	   infections	  can	  progress	  and	  penetrate	   the	  host	  
tissue,	   with	   BSI-­‐Oral	   complications	   remaining	   a	   major	   source	   of	   illness	   despite	   a	   variety	   of	  
antifungals	  being	  clinically	  available	  to	  treat	  them	  [42].	  
	  
1.3.2	  Invasive	  candidiasis	  and	  candidaemia	  
Invasive	   infection,	   as	   opposed	   to	   superficial	   infection,	   of	   Candida	   species,	   systemic/invasive	  
candidiasis	  or	  candidaemia,	  are	  a	  significant	  cause	  of	   life	  threatening	   infection,	  and	  are	  a	  common	  
and	   important	   cause	   of	   morbidity	   and	   mortality	   within	   hospitalised	   patients	   [10,	   11].	   The	   most	  
common	  form	  of	  deep	  Candida	   infection	   is	  candidaemia,	  which	  has	  an	  associated	  overall	  mortality	  
rate	   of	   between	   30-­‐40%	   [43-­‐45].	   Candida	   species	   form	   an	   important	   part	   of	   hospital-­‐acquired	  
infections	  and	  remain	  the	  fourth	  leading	  cause	  of	  nosocomial	  BSIs	  in	  the	  United	  States	  [44,	  45].	  They	  
account	   for	   between	   roughly	   7000	   to	   28000	   hospital-­‐acquired	   cases	   a	   year,	   and	   approximately	  
63000	  cases	  from	  all	  points	  of	  infection	  [10],	  with	  about	  11200	  deaths	  in	  total	  per	  annum	  [10].	  It	  was	  
estimated	   that	   each	   case	   of	   candidaemia	   in	   the	   US	   cost	   between	   $34000	   and	   $44000	   to	   treat,	  
bringing	   the	   total	   annual	   attributable	   cost	   to	   $800	   million	   in	   the	   US	   alone	   [6].	   Despite	   this,	   the	  
sources	  of	  candidaemia	  are	  poorly	  understood,	  although	  it	  has	  been	  assumed	  that	  gut	  colonization	  
could	   possibly	   be	   responsible	   for	   onset	   of	   systemic	   candidiasis	   in	   some	   immune	   compromised	  
patients	  [46].	  
Population	  based	  epidemiological	   study	  of	   candidaemia	  has	   shown	   that	   the	   incidence	  of	   different	  
Candida	  infection	  varies	  by	  geographic	  region.	  For	  instance,	  studies	  from	  Canada	  and	  Europe,	  show	  
that	  with	  the	  exception	  of	  Denmark,	  incidence	  of	  candidaemia	  is	  significantly	  lower	  than	  the	  US	  [11].	  
This	   is	  most	   likely	   due	   to	   the	   differences	   in	   population	   demographics,	  with	   certain	   sectors	   of	   the	  
population	  found	  to	  be	  at	  greater	  risk.	  For	  example,	  although	  age	  was	  a	  primary	  risk	  factor	  across	  all	  
races,	  with	  infants	  less	  than	  one	  year	  of	  age	  and	  adults	  over	  the	  age	  of	  65	  showing	  higher	  rates	  of	  
infection,	  studies	  conducted	  in	  the	  US	  found	  that	  incidence	  of	  candidaemia	  was	  over	  fourfold	  higher	  
in	  blacks	  from	  any	  age	  group	  [11].	  Other	  risk	  factors	  for	  candidaemia	  and	  candidiasis	  are	  similar	  to	  
those	   of	   superficial	   Candida	   infections,	   with	   the	   use	   of	   systemic	   antibiotics,	   corticosteroids,	  
catheterisation,	   plus	   chemotherapy	   and	   radiotherapy	  within	   cancer	   patients,	   immune	   suppression	  
and	  diabetics	  all	  showing	  higher	  rates	  and	  risks	  of	  infection	  [10,	  11].	  	  
Incidence	  rates	  of	  Candida	  BSIs	  within	  hospitals	  have	  changed	  in	  recent	  years,	  from	  the	  ICUs	  towards	  
a	  general	  ward	  setting	  [10,	  11].	   It	  has	  been	  shown	  that	  only	  36%	  of	  Candida	  BSIs	  occur	   in	  the	  ICU,	  
while	   28%	   were	   community	   acquired,	   representing	   a	   10%	   increase	   over	   five	   year	   period	   in	   the	  
Baltimore	  area	  of	  the	  US	  [12].	  Other	  studies	  have	  corroborated	  this	  showing	  that	  more	  candidaemia	  
cases	  are	  now	   reported	   from	  general	  medical	   and	   surgery	  wards	   than	   those	  dealing	  with	  patients	  
with	   immune	   deficiencies	   [10,	   45].	   This	   change	   has	   been	   brought	   about	   by	   the	   increased	   use	   of	  
antifungal	   chemoprophylaxis	   and	   shortened	   periods	   of	   neutropenia	   preventing	   colonization	   by	  
Candida	  species	  [47].	  Although	  it	   is	  not	  clear	  why	  the	  incidence	  of	  candidiasis	  has	  increased	  within	  
non-­‐ICU	   wards	   it	   is	   likely	   that	   increased	   catheterisation	   and	   antibiotic	   use	   in	   clearance	   of	  
bacteraemia,	   an	  aging	  population	  and	  extensive	   colonisation	  of	   surfaces	  within	   the	   clinical	   setting	  
have	  contributed	  to	  the	  apparent	  increased	  or	  sustained	  level	  of	  candidiasis	   in	  non-­‐ICU	  wards.	  It	   is	  
also	  possible	   that	   the	  shift	   towards	  non-­‐albicans	  Candida	  species	  has	  also	  contributed	   to	   the	  non-­‐
ICU	  candidiasis	   incidence,	  being	  more	  prevalent	  in	  different	  at	  risk,	  yet	  not	  ICU-­‐bound	  groups	  [10].	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Epidemiological	   data,	   however,	  maintains	   that	   candidaemia	   incidence	  has	   not	   decreased	  over	   the	  
last	  20	  years	  as	  a	  whole	  and	  remains	  a	  significant	  global	  problem	  [11].	  
While	  C.	  albicans	   remains	   the	   largest	   single	  cause	  of	   invasive	  candidiasis	  globally,	  a	   recent	   shift	   in	  
the	  distribution	  of	  Candida	  species	  causing	  candidiasis	  has	  meant	  that,	   in	  the	  US	  for	  instance,	  non-­‐
albicans	   Candida	   species	   now	   account	   for	   54.4%	   of	   candidaemia	   cases	   [48].	   The	   change	   in	  
proportion	  of	  albicans	   isolation	  has	  revolved	  around	  the	  increasing	  incidence	  of	  the	  azole	  resistant	  
C.	   glabrata	   and	   C.	   tropicalis	   [10].	   This	   shift	   has	   been	   suggested	   as	   being	   caused	   in	   part,	   by	   the	  
widespread	  use	  of	  azoles,	  and	  in	  particular	  fluconazole,	  for	  treatment	  of	  candidaemia	  and	  associated	  
Candida	  infections	  [49,	  50].	  Given	  that	  other	  non-­‐albicans	  species	  show	  greater	  resistance	  to	  azoles	  
than	   C.	   albicans,	   extensive	   use	   of	   fluconazole	   has	   potentially	   selected	   against	   C.	   albicans	   and	  
positively	  selected	  for	  the	  most	  resistant	  of	  them	  all,	  C.	  glabrata	  [51].	  The	  reason	  for	  the	  increased	  
clinical	  prevalence	  of	  non-­‐albicans	  Candida	  species	  is	  still	  up	  for	  debate	  and	  has	  been	  suggested	  as	  
being	  down	  to	  one	  (or	  both)	  of	  two	  causes	  [50].	  Either	  non-­‐albicans	  Candida	  species	  infections	  are	  
actually	   growing	   in	   number	   as	   some	   studies	   have	   suggested	   [49],	   or	   their	   increasing	   isolation	   is	  
simply	  due	  to	  a	  reduction	   in	  C.	  albicans	   incidence,	  which	  has	  altered	  the	  proportion	  of	   isolation	  of	  
non-­‐albicans	   Candida	   species	   but	   not	   their	   overall	   number.	   Whether	   non-­‐albicans	   Candida	  
infections	  are	  actually	   increasing	   in	  number	  or	  not,	  C.	  glabrata’s	   innate	  and	  acquired	  resistance	  to	  
fluconazole	   combined	   with	   its	   recorded	   increasing	   prevalence	   poses	   a	   real	   problem	   for	   current	  
candidaemia	  treatment.	  
	  
1.4	  Candida	  glabrata	  and	  candidiasis	  
C.	   glabrata	   displays	   a	   varying	   distribution	   within	   Candida	   BSIs	   depending	   heavily	   on	   patient	  
demographics.	  For	  instance,	  C.	  glabrata	  was	  found	  predominantly	  in	  older	  patients	  with	  the	  highest	  
percentage	  found	  in	  the	  over	  80	  years	  old	  group	  of	  the	  SENTRY	  Antimicrobial	  Surveillance	  Program	  
[52].	   Interestingly	   the	   same	   study	   found	   that	   the	   most	   resistant	   strains	   to	   antifungals	   including	  
anidulafungin,	   caspofungin,	   micafungin,	   fluconazole,	   all	   showing	   a	   16.7%	   resistance	   rate,	  
posaconazole	  showing	  5.6%,	  and	  voriconazole	  showing	  11.1%,	  were	  found	  from	  isolates	  taken	  from	  
the	  20-­‐39	  years	  old	  age	  group	   [52].	  These	   results	   indicate	   that	  although	  prevalence	  of	  C.	  glabrata	  
increases	  with	  age,	  the	  percentage	  rates	  of	  resistance	  actually	  decrease	  with	  age	  [52,	  53].	  This	  also	  
suggests	  that	  as	  the	  world’s	  population	  experiences	  greater	  and	  greater	  life	  expectancy,	  C.	  glabrata	  
will	   become	   more	   and	   more	   prevalent	   in	   hospitalised	   candidaemia	   patients	   within	   that	   aging	  
population.	  
The	   C.	   glabrata	   prevalence	   also	   varies	   with	   geographical	   region.	   Almost	   all	   studies	   from	   the	   US	  
indicate	  that	  C.	  glabrata	  has	  over	  taken	  C.	  tropicalis	  as	  the	  second	  most	  common	  cause	  of	  Candida	  
BSIs	  after	  C.	  albicans	  with	  between	  a	  20-­‐24%	  share	  [10].	  However,	  in	  other	  countries	  such	  as	  those	  
that	  form	  part	  of	  Latin	  America,	  only	  about	  4-­‐7%	  of	  candidaemia	  cases	  were	  caused	  by	  C.	  glabrata	  
[10].	   It	   is	  unknown	  why	  such	  geographic	  differences	  occur	   in	  C.	  glabrata	  prevalence,	  although	   the	  
mechanism	  by	  which	  blood	  isolates	  are	  taken	  and	  identified	  has	  been	  suggested	  as	  contributing	  to	  
the	  variation,	  along	  with	  azole	  use	  and	  median	  patient	  age	  [10].	  
The	  risk	  factors	  associated	  with	  C.	  glabrata	  isolation	  as	  opposed	  to	  other	  Candida	  species	  are	  largely	  
unclear.	  Certain	  studies	  have	  pointed	  to	  the	  use	  of	  fluconazole	  as	  a	  predisposing	  factor,	  which	  would	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make	  sense	  when	  combined	  with	  the	  knowledge	  that	  C.	  glabrata	   is	   innately	   less	  sensitive	  to	  azole	  
treatment	  [54].	  However,	  various	  studies	  have	  also	  confused	  the	  issue,	  finding	  that	  azole	  use	  did	  not	  
contribute	   to	   an	   increase	   in	  C.	   glabrata	   isolation	   [55,	   56].	   The	   age	  of	   the	  patient	   certainly	   has	   an	  
impact	  on	  the	   incidence	  of	  C.	  glabrata,	  with	  Malani	  et	  al.	   showing	  that	  C.	  glabrata	   colonisation	  of	  
the	  oral	   cavity	   increased	  with	  age,	   as	  well	   as	  with	   the	  use	  of	  psychotropic	  drugs	  and	  denture	  use	  
[57].	  Unfortunately,	  other	  than	  age,	  these	  studies	  show	  how	  complex	  an	  issue	  identifying	  risk	  factors	  
for	  species	  specificity	  can	  be,	  with	  many	  conflicting	  factors	  reported	  [47].	  For	  clinicians,	  a	   lack	  of	  a	  
clear-­‐cut	  set	  of	  risk	  factors	  for	  clinical	  identification	  of	  C.	  glabrata	  prevalence	  impacts	  on	  their	  ability	  
to	   choose	   appropriate	   antifungal	   strategy	   due	   to	   the	   azole	   resistance	   of	   the	   species.	   Delay	   in	  
initiation	   of	   appropriate	   antifungal	   therapy	   has	   been	   linked	   to	   increased	  mortality	   [58],	   but	   non-­‐
clinical	   methods	   of	   antifungal	   susceptibility	   tests	   can	   take	   48-­‐96	   hours	   to	   complete,	   while	  
conventional	   biochemical	   species	   identification	   also	   takes	   a	   significant	   amount	   of	   time	   [47].	   The	  
recent	   introduction	  of	  matrix-­‐assisted	   laser	  desorption	   ionization–time	  of	   flight	   (MALDI-­‐TOF)	  mass	  
spectrometry	  for	  fungal	  species	  identification	  has	  proved	  to	  be	  a	  both	  rapid	  and	  reliable	  method	  of	  
identification	   of	   yeasts	   and	   yeast-­‐like	   fungi	   [59],	   allowing	   faster	   confirmation	   of	   species	   and	  
therefore	  the	  correct	  therapeutic	  agent	  or	  combination.	  
	  
1.4.1	  Candida	  albicans	  virulence	  factors	  
Most	   Candida	   species	   are	   opportunistic	   pathogens	   that	   can	   survive	   in	   both	   a	   commensal	   or	  
pathogenic	   form,	   inhabiting	  most	   surfaces	   and	   organs	   of	   the	   human	   body	   [60].	   Unlike	   the	  model	  
organism	   Saccharomyces	   cerevisiae,	   many	   Candida	   specific	   genes	   encode	   catabolic	   proteins	   that	  
likely	   account	   for	   its	   ability	   to	   survive	   in	   either	   commensal	   or	   pathogenic	   state.	   This	   ability	   of	  
Candida	  to	  survive	  in	  various	  distinct	  environments	  contributes	  to	  its	  versatility	  as	  an	  opportunistic	  
pathogen	  and	  its	  ability	  to	  cause	  disease	  at	  several	  anatomical	  sites	  in	  the	  host	  [60].	  
C.	  albicans	  has	  several	  characterised	  virulence	   factors	  described	   in	   the	   literature.	  Cell	   surface	  host	  
interaction	   genes	   are	   an	   important	   part	   of	   virulence	   in	  C.	   albicans	   like	   so	  many	   other	   pathogenic	  
organisms.	   Adhesins,	   cell	   surface	   biomolecules	   that	   help	   C.	   albicans	   adhere	   to	   host	   cells	   and	  
surfaces,	  are	  crucial	  to	  virulence	  in	  C.	  albicans	  shown	  by	  the	  avirulence	  of	  non-­‐adherent	  strains	  [61].	  
Adhesins	  aid	  in	  the	  avoidance	  of	  clearance	  through	  adherence	  to	  host	  cells,	  host	  proteins	  and	  other	  
microbial	  competitors	  [60]	  forming	  the	  first	  stage	  of	  colonization	  and	  persistence	  in	  the	  host.	  Several	  
C.	   albicans	   proteins	   have	   been	   found	   to	   bind	   to	   host	   cell	   extracellular	   matrix	   (ECM)	   proteins	  
including	  collagen	  (I	  and	  IV),	  fibrinogen,	  fibronectin	  and	  laminin	  [62-­‐64].	  Two	  such	  genes,	  ALS1	  and	  
ALS5	  (ALA1)	  have	  been	  shown	  to	  be	  essential	  for	  virulence	  [65].	  The	  proteins	  they	  encode	  have	  been	  
shown	   to	   play	   a	   role	   in	   adherence	   similar	   to	   the	   α-­‐agglutinin	   cell-­‐cell	   recognition	   protein	   in	   S.	  
cerevisiae	   [66-­‐68].	   Int1p,	   an	   ECM	   binding	   protein	   similar	   to	   mammalian	   integrins,	   has	   also	   been	  
shown	   to	   be	   important	   in	   virulence,	   adherence	   and	   filamentation	   in	   C.	   albicans	   [69].	   Hwp1p,	   an	  
outer	  surface	  mannoprotein,	  has	  recently	  been	  shown	  to	  be	  crucial	  to	  adherence	  and	  virulence	  [70,	  
71].	  An	  α-­‐1,2-­‐mannosyl	  transferase	  residing	  in	  the	  medial	  Golgi,	  Mnt1p,	  has	  also	  been	  shown	  to	  play	  
a	   role	   in	   adherence	   through	  O-­‐linked	  mannosylation	   of	   proteins	   and	   virulence,	  with	   null	  mutants	  
displaying	  an	  avirulent	  phenotype	  [72].	  Many	  other	  adhesin	  like	  genes	  have	  been	  identified	  and	  are	  
currently	  under	  investigation	  with	  a	  likelihood	  most	  will	  play	  a	  role	  in	  virulence	  [60].	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Other	   important	  molecules	   that	   play	   a	   role	   in	  C.	   albicans	   virulence	   include	   those	   associated	  with	  
morphogenesis,	   a	   characteristic	   only	   C.	   albicans	   shares	   with	   Candida	   dubliniensis	   in	   the	   Candida	  
family	  [60].	  Morphogenesis	  is	  the	  process	  of	  reversible	  conversion	  between	  an	  isotropic,	  unicellular	  
yeast	  phenotype	  and	  an	  apical,	  hyphal	  and	  pseudohyphal	  phenotype	  [60].	  Current	  understanding	  of	  
the	  link	  between	  phenotype	  switching	  and	  virulence	  is	  in	  its	  infancy,	  but	  it’s	  clear	  from	  preliminary	  
findings	  that	  the	  dimorphic	  nature	  of	  C.	  albicans	  plays	  a	  significant	  role	  in	  its	  ability	  to	  cause	  disease	  
[73,	  74].	  Proteins	  involved	  in	  invasion	  have	  also	  been	  shown	  to	  play	  a	  role	  in	  virulence	  using	  animal	  
models.	  C.	  albicans	  has	   two	   families	  of	  proteins	   related	   to	   the	   invasion	  of	  host	  cells.	  The	  secreted	  
aspartyl	  proteinases	  (SAPs)	  form	  a	  family	  of	  at	  least	  nine	  genes	  of	  which	  six,	  SAP1-­‐6,	  have	  a	  role	  in	  
virulence	  [69,	  71].	  The	  second	  invasion	  related	  family	  of	  genes,	  the	  phospholipases	  (PL),	  consist	  of	  at	  
least	  four	  genes	  of	  which	  PLB1	  has	  been	  identified	  to	  play	  a	  role	  in	  virulence	  with	  plb1	  cells	  found	  to	  
exhibit	   a	   60%	   reduction	   in	  mortality	   compared	   to	  wild	   type	  C.	   albicans	   [75].	   Phenotype	   switching	  
[76],	   where	   a	   yeast	   colony	   changes	   phenotype	   appearing	   rough,	   smooth	   or	   changing	   colour	   in	  
response	  to	  stress,	  such	  as	  low	  level	  UV	  light	  doses,	  may	  also	  play	  a	  role	  in	  virulence.	  The	  plasticity	  
this	   switching	   provides	   has	   been	   suggested	   as	   the	   route	   by	   which	   asexual	   fungi,	   including	   some	  
Candida	   species,	   gain	   phenotypic	   diversity	   [77].	   Isolated	   C.	   albicans	   strains	   from	   systemically	  
infected	  patients	  show	  higher	  levels	  of	  switching	  than	  the	  wild	  type	  [78],	  inferring	  there	  might	  be	  a	  
link	   between	   their	   ability	   to	   cause	   disease	   and	   their	   ability	   to	   switch	   phenotype.	   This	   link	   is,	  
however,	  still	  open	  to	  interpretation	  and	  has	  yet	  to	  be	  thoroughly	  investigated	  [60].	  For	  an	  extensive	  
review	  of	  virulence	  in	  C.	  albicans	  please	  see	  Calderone	  et	  al.	  2001	  [60]	  and	  Brown	  et	  al.	  2007	  [79].	  
	  
1.4.2	  Candida	  glabrata	  virulence	  factors	  
Our	   current	   understanding	   of	   the	   virulence	   and	   host	   interactions	   of	   C.	   glabrata	   is	   limited	   when	  
compared	  with	  C.	  albicans.	  C.	  glabrata	   is	  a	  phylogenetically	  distinct	   fungus	   to	  C.	  albicans	   [77]	  and	  
shows	   a	   high	   degree	   of	   synteny	  within	   its	   haploid	   genome	  with	   the	  model	   organism	  S.	   cerevisiae	  
[77].	   C.	   glabrata,	   however,	   shares	   similarities	   and	   differences	   with	   C.	   albicans	   when	   it	   comes	   to	  
virulence.	   SAPs	   show	   less	   importance	   in	   C.	   glabrata	   compared	   with	   C.	   albicans.	   C.	   glabrata	   has	  
multiple	  orthologues	  of	  S.	  cerevisiae	  extracellular	  glycosyl	  phosphatidylinositol	  (GPI)-­‐linked	  aspartyl	  
proteases,	   but	   appears	   not	   to	   produce	   significant	   levels	   of	   proteinase	   activity	   in	   vitro	   [80].	   In	  
contrast	  phospholipase	  genes	   in	  C.	  glabrata	   show	  similar	  activity	   to	   their	  C.	  albicans	   counterparts.	  
They	  exhibit	  higher	  activity	  from	  persistent	  candidiasis	  isolates	  than	  from	  non	  [75],	  however	  the	  link	  
between	  C.	  glabrata	  PLB	  genes,	  orthologues	  of	  S.	  cerevisiae	  PLB	  genes,	  and	  virulence	  has	  yet	  to	  be	  
proven	  [77].	  C.	  glabrata	  also	   lacks	  the	  true	  morphological	  switching	  that	  aids	  the	  tissue	   infiltration	  
demonstrated	   by	   C.	   albicans,	   showing	   only	   pseudohyphal	   formation	   in	   nitrogen	   starvation	  
conditions	   [31].	   Ste12p	   is	   a	   highly	   conserved	   transcriptional	   regulator,	   which	   is	   also	   found	   in	   S.	  
cerevisiae	   [81].	   It	   is	   activated	   by	   the	   mitogen-­‐activated	   protein	   (MAP)	   kinase	   signalling	   cascade	  
involved	  in	  pseudohyphal	  formation	  and	  has	  been	  characterised	  in	  C.	  glabrata	  showing	  importance	  
for	   virulence	   [81].	   Clinical	   isolates	   however,	   lack	   any	   pseudohyphal	   forms	   [77]	   questioning	   the	  
significance	  of	  pseudohyphal	  formation	  in	  C.	  glabrata	  pathogenesis.	  STE11	  and	  STE20	  have	  also	  been	  
highlighted	  in	  virulence	  in	  C.	  glabrata.	  Both	  genes	  encode	  protein	  kinases	  that	  play	  important	  roles	  
in	  several	  signalling	  cascades	  including	  the	  response	  to	  hypertonic	  stress,	  an	  important	  factor	  in	  the	  
host-­‐pathogen	   interaction	   and	   therefore,	   unsurprisingly,	   both	   proteins	   are	   required	   for	   wild	   type	  
levels	  of	  virulence	  [82,	  83].	  Another	  virulence	  factor	  in	  C.	  albicans	  has	  recently	  been	  identified	  in	  C.	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glabrata.	  Phenotypic	  switching	  has	  been	  shown	  in	  C.	  glabrata	  and	  was	  observed	  to	  be	  selective	  to	  
anatomical	  site	  of	  clinical	  isolation	  [84].	  This	  indicates	  that	  phenotypic	  switching	  likely	  plays	  a	  role	  in	  
environmental	  adaptation	  in	  C.	  glabrata	  [77]	  and	  therefore	  a	  role	  in	  virulence.	  
Adherence	   in	   C.	   glabrata	   is,	   for	   the	   most	   part,	   mediated	   by	   a	   family	   of	   GPI-­‐anchored	   cell	   wall	  
proteins	  similar	  to	  the	  ALS	  and	  HWP1	  genes	  found	  in	  C.	  albicans	  called	  the	  Epithelial	  Adhesion	  (EPA)	  
family	  [85].	  Investigation	  of	  the	  EPA	  family	  of	  genes	  has	  shown	  strains	  of	  C.	  glabrata	  that	  encode	  at	  
least	  23	  EPA	  genes	  [77].	  Most	  of	  the	  EPA	  genes	  are	  encoded	  on	  sub-­‐telomeric	  loci	  and	  are	  subject	  to	  
chromatin-­‐based	   transcriptional	   silencing	   [86,	   87].	  EPA1	   has	   been	   shown	   to	   be	   crucial	   for	   in	   vitro	  
adherence	   [86,	   87]	   likely	  due	   to	   the	  unusually	   low	   level	   expression	  of	   the	  other	  EPA	   genes	  under	  
laboratory	  culture	  conditions.	  The	  same	  cannot	  be	  said	  for	  in	  vivo	  adherence	  [88]	  in	  which	  other	  EPA	  
genes	  play	  a	  role	  that	  indicates	  redundancy	  in	  the	  EPA	  gene	  family.	  Transcriptional	  silencing	  mutants	  
have	  been	  found	  to	  be	  hyperadherent	  and	  show	  greater	  infiltration	  of	  the	  kidney	  than	  the	  wild	  type	  
from	  a	  disseminated	  candidiasis	  model	  [86,	  89].	  EPA1,	  EPA6	  and	  EPA7	  have	  all	  been	  shown	  to	  play	  
roles	  in	  this	  hyperadherent	  phenotype	  indicating	  that	  EPA	  expression	  could	  be	  a	  significant	  factor	  in	  
virulence	   [86].	   EPA6	   has	   also	   been	   shown	   to	   be	   important	   in	   biofilm	   formation	   [90].	   Biofilm	  
formation	  can	  be	  a	  significant	  clinical	  burden	  with	  colonization	  of	  inert	  surfaces	  like	  catheters,	  which	  
not	  only	  causes	  unintentional	  C.	  glabrata	   inoculation,	  but	  also	  allows	  for	  a	  synergistic	  binding	  of	  C.	  
albicans	   to	   an	   existing	   C.	   glabrata	   biofilm	   [91].	   Nicotinamide	   adenine	   dinucleotide	   (NAD+)	  
abundance	   has	   been	   shown	   to	   play	   a	   crucial	   role	   in	  EPA	   expression	  within	  C.	   glabrata	   due	   to	   its	  
auxotrophy	   for	   nicotinic	   acid	   [89].	   Low	   environmental	   niacin	   levels,	   representing	   the	   vitamin	  
precursors	  for	  NAD+	  synthesis,	  have	  been	  shown	  to	  inhibit	  transcriptional	  silencing	  of	  the	  EPA	  genes,	  
due	  to	  the	  lack	  of	  NAD+	  co-­‐substrate	  binding,	  resulting	  in	  increased	  adhesion	  and	  infiltration	  of	  host	  
urinary	  tract	  [89,	  92].	  
Clinical	  treatment	  failure	  of	  C.	  glabrata	  infection	  is	  often	  attributed	  to	  the	  yeast’s	  innate	  resistance	  
to	   azoles	   such	   as	   fluconazole.	   Azoles	   selectively	   inhibit	   lanosterol	   14-­‐α-­‐demethylase,	   which	   is	  
involved	   in	   the	   ergosterol	   biosynthesis	   pathway	   [19].	   This	   in	   turn	   affects	  many	  other	   biosynthesis	  
pathways	  and	   the	  cell	  membrane	  structure	   [19].	  C.	  glabrata	   is	  not	  only	   innately	   resistant	   to	  azole	  
action	  but	  is	  able	  to	  rapidly	  acquire	  resistance	  to	  azoles	  through	  over	  expression	  of	  two	  ATP-­‐binding	  
cassette	  (ABC)	  transporter	  genes	  CDR1	  and	  PDH1	  (CDR2)	  [18],	  which	  cause	  azole	  efflux	  from	  the	  cell	  
or	  upregulation	  of	  the	  target	  gene	  itself	  ERG11	  [19].	  C.	  glabrata’s	  haploid	  nature	  allows	  it	  to	  rapidly	  
acquire	  resistance	  mutations	  that	  might	  otherwise	  be	  blocked	  by	  the	  presence	  of	  a	  dominant	  allele	  
in	  diploid	  genomes	   like	  that	  possessed	  by	  C.	  albicans	  [52].	  Recent	  work	  by	  Polakova	  et	  al.	   [93]	  has	  
shown	   that	   clinical	   isolates	   of	   C.	   glabrata	   exhibit	   rapid	   changes	   in	   chromosomal	   organisation	  
creating	   duplicated	   genes	   including	   ABC	   transporters,	   proteases	   and	   phospholipase	   B	   genes.	   This	  
enhances	  survival	  in	  host	  systems,	  due	  to	  the	  subsequent	  upregulation	  of	  the	  effector	  proteins	  [93].	  
Petite	  strains	  of	  C.	  glabrata	  also	  show	  high	  levels	  of	  azole	  resistance	  through	  their	  self-­‐inhibition	  of	  
mitochondrial	   function	   that	   results	   in	   a	   greater	   quantity	   of	   free	   ergosterols	   [94].	   This	   loss	   of	  
mitochondrial	  function	  can	  be	  either	  permanent	  or	  reversible	  [94]	  and	  shows	  some	  evidence	  of	  an	  
epigenetic	  mechanism	  utilised	   to	   switch	   between	   respiratory-­‐competent	   and	   –incompetent	   states	  
[95].	   This	  may	   explain	   the	   difference	   shown	   between	   in	   vitro	   and	   in	   vivo	   pharmacological	   results	  
from	  clinical	  isolate	  azole	  treatment	  [95].	  
C.	  glabrata	  is	  also	  more	  resistant	  than	  other	  Candida	  species	  to	  most	  antimicrobial	  proteins	  secreted	  
by	   mammalian	   cells.	   Human	   beta-­‐defensins	   (hBD),	   a	   family	   of	   small	   antimicrobial	   and	   antiviral	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proteins	   secreted	   by	   epithelial	   cells,	   show	   a	   lower	   fungicidal	   activity	   against	   C.	   glabrata	   than	   C.	  
albicans	   for	   example	   [96].	   Both	   histatins,	   a	   group	  of	   salivary	   antifungal	   proteins	   and	  magainins,	   a	  
group	   of	   cationic	   antifungal	   proteins	   derived	   from	   frog	   dermal	   glands,	   also	   showed	   a	   lower	  
fungicidal	  activity	  against	  C.	  glabrata	  than	  C.	  albicans	  [97].	  It	  should	  be	  noted	  that	  other	  studies	  have	  
shown	  human	  histatin-­‐5	  to	  be	  an	  effective	  fungicidal	  agent	  against	  C.	  glabrata	  [98,	  99].	  C.	  glabrata	  
also	   shows	  a	  decreased	  cytokine	   response	   from	   the	  host	  when	  compared	  with	  C.	  albicans	   using	  a	  
reconstituted	  human	  epithelial	  in	  vitro	  model	  [100].	  C.	  glabrata	  oral	  candidiasis	  clinical	  isolates	  failed	  
to	   show	   significant	   interleukin-­‐1α	   (IL-­‐1α),	   IL-­‐8	   or	   tumour	   necrosis	   factor	   (TNF)	   induction	   and	   only	  
weak	   increases	   in	   granulocyte	   monocyte	   colony-­‐stimulating	   factor	   (GM-­‐CSF)	   levels	   [95,	   100].	  
Variation	   in	   cytokine	   response	   was,	   however,	   found	   between	   strains	   of	   C.	   glabrata	   with	   isolates	  
from	  oesophageal	  candidiasis	  showing	  higher	  cytokine	  induction	  than	  oral	  candidiasis	   isolates	  [95].	  
Also	  of	  note	  was	  the	  fact	  that	  although	  C.	  glabrata	  killed	  up	  to	  60%	  of	  oral	  epithelial	  cells	   in	  a	  36-­‐
hour	  co-­‐culture	  system,	  it	  was	  found	  to	  be	  less	  cytotoxic	  than	  C.	  albicans	  and	  failed	  to	  infiltrate	  an	  in	  
vitro	   3D	   model	   of	   human	   oral	   mucosa	   [95].	   This	   could	   explain	   the	   difficulty	   that	   immune	  
compromised	   patients	   experience	   in	   clearing	   C.	   glabrata	   candidiasis	   even	   with	   heavy	   antifungal	  
treatments.	   Failure	   of	   C.	   glabrata	   to	   induce	   an	   appropriate	   cytokine	   response	   therefore	   stifles	  
recruitment	  of	  immune	  cells	  to	  the	  site	  of	  infection	  and	  subsequent	  immune	  clearance.	  
In	   2004	   the	   first	   virulence	   moderating	   gene	   or	   antivirulence	   factor	   in	   Candida,	   ACE2	   was	  
characterised	  by	  Kamran	  et	  al.	  [7].	  The	  S.	  cerevisiae	  homologue	  ACE2	  encodes	  a	  transcription	  factor	  
associated	  with	  cell	  separation	  [7].	  It	  exhibits	  transcriptional	  control,	  either	  directly	  or	  indirectly	  over	  
some	  11	  known	  genes,	  and	  has	  been	  shown	  to	  regulate	  the	  transcription	  of	  machinery	  essential	  to	  
cell	   separation	   in	   budding	   yeast	   including	   the	   chitinase	   CTS1	   [101,	   102].	   The	   C.	   glabrata	   strain	  
HLS122,	  an	  ace2	  null,	  was	  shown	  to	  be	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  candidiasis,	  
with	  100%	  mortality	  within	  18-­‐hours	  post	   infection	   [7].	  The	  extreme	  hypervirulence	  was	  shown	  to	  
be	   independent	  of	   the	  clumpy	  phenotype	  exhibited	  by	  HLS122	  through	  chitinase	   treatment	  of	   the	  
yeast	   cells	   prior	   to	   inoculation,	   which	   allowed	   the	   clumped	   daughter	   cells,	   deficient	   in	   CTS1	  
expression,	   to	   separate	   from	   their	  mothers	   [7].	   Inoculation	   of	   the	   separated	   strain	   resulted	   in	   an	  
overwhelming,	   fatal	   systemic	  disease	  with	   a	   200-­‐fold	   lower	   inoculum	   required	   for	   100%	  mortality	  
than	   similarly	   treated	  wild	   type	   cells	   and	  ACE2	   reconstituted	  HLS121	   cells	   [7].	   This	   discovery	   of	   a	  
virulence-­‐moderating	   factor	   in	  C.	  glabrata	  may	  have	  power	   to	   reveal	  novel	   insights	   into	   the	  host-­‐
pathogen	  interactions	  crucial	  to	  the	  development	  of	  disease	  by	  this	  opportunistic	  pathogen.	  
1.4.3	  C.	  glabrata	  virulence	  analysis	  using	  Caenorhabditis	  elegans	  
Virulence	   analysis	   of	   C.	   glabrata	   is	   commonly	   conducted	   using	   a	   neutropenic	   murine	   model	   of	  
disseminated	   candidiasis	   [7,	   81].	   In	   an	   effort	   to	   define	   a	   complementary	   invertebrate	  model,	   the	  
nematode	   Caenorhabditis	   elegans	   was	   investigated	   as	   a	   suitable	   virulence	   model	   organism.	   A	  
feeding	   infection	   assay	   was	   adapted	   from	   previous	   work	   with	   S.	   cerevisiae	   [103]	   for	   use	   with	   C.	  
glabrata,	   including	   an	   intermediate	   disease	   phenotype	   marked	   by	   post	   anal	   region	   swelling.	  
Unfortunately	  a	  baseline	  of	  C.	  glabrata	  infectivity	  of	  C.	  elegans	  could	  not	  be	  set.	  An	  overview	  of	  the	  
experiments	  is	  presented	  in	  Appendix	  5.1.	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1.5	  The	  evolutionary	  relationship	  between	  C.	  glabrata	  and	  S.	  cerevisiae	  
1.5.1	  Phylogeny	  
Much	   of	   the	  work	   in	   C.	   glabrata	   is	   aided	   by	   inferences	   from	   its	   close	   genetic	   relative	   the	  model	  
organism	   S.	   cerevisiae.	   C.	   glabrata	   shares	   a	   recent	   common	   ancestor	   with	   seven	   of	   the	  
Saccharomyces	   family	   as	   displayed	   in	   Figure	   1.1	   [104].	   It	   belongs	   to	   a	   different	   clade	   than	   other	  
Candida	   species	   including	   albicans,	   which	   display	   a	   recoding	   of	   the	   CUG	   codon	   to	   Serine,	   and	  
belongs	   to	   the	   clade	   that	   includes	   Saccharomyces	   species,	   Kluyveromyces	   species	   and	   Ashbya	  
gossypii	   [104].	   This	   likely	   evolutionary	   separation	   means	   that	   the	   perceived	   species	   ability	   of	  
Candida	   to	   act	   as	   opportunistic	   pathogens	   could	   have	   potentially	   developed	   independently	   for	  C.	  
glabrata	  to	  the	  rest	  of	  the	  Candida	  species,	  including	  C.	  albicans	  [104],	  although	  that	  is	  still	  open	  to	  
interpretation.	  
As	   a	   result	   of	   the	   close	   phylogenetic	   link	   between	  C.	   glabrata	   and	   S.	   cerevisiae,	   the	   two	   budding	  
yeasts	   show	   very	   similar	   genetic	   homology	   with	   a	   similar	   G+C	   content	   of	   38.8%	   and	   38.3%	  
respectively	   [77].	   C.	   glabrata	   and	   S.	   cerevisiae	   have	   a	   total	   of	   5448	   and	   5988	   identified	   ORFs	  
respectively,	   out	   of	   which	   they	   share	   some	   4945	   orthologues	   with	   an	   average	   65%	   amino	   acid	  
identity	  between	   them	   [77,	  105].	  Both	   show	  a	   similar	   stress	   response	  and	   respiratory	  metabolism	  
[106,	  107],	  similar	  cellular	  processes	  such	  as	  cytokinesis	  and	  cell	  separation,	  while	  many	  genes	  can	  
be	   complemented	   between	   the	   two	   strains,	   which	   is	   common	   practice	   in	   the	   investigation	   of	   C.	  
glabrata	  gene	  function	  [108].	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Figure	   1.1	   –	   C.	   glabrata	   belongs	   to	   the	   Saccharomyces	   clade,	   not	   the	   Candida	   clade.	   Phylogenetic	   tree	   showing	   the	  
evolutionary	   relationships	   of	   C.	   glabrata	   and	   selected	   Candida	   species	   with	   that	   of	   S.	   cerevisiae	   and	   selected	  
Saccharomyces	  species.	  Adapted	  from	  Roetzer	  et	  al.	  2010	  [104].	  The	  tree	  was	  built	  using	  maximum	  likelihood	  analysis	  of	  
concatenated	  alignments	  of	  1137	  protein	  familys	  that	  exist	  with	  single-­‐copy	  orthologues	   in	  the	  21	  species.	  CTG	  marks	  
genetic	  code	  transition	  event	  that	  recoded	  CUG	  to	  Serine	  (the	  non-­‐CTG	  branch).	  
	  
1.5.2	  Host	  environment	  adaptation	  
Despite	   the	   apparent	   similarities,	   C.	   glabrata	   and	   S.	   cerevisiae	   show	   crucial	   differences	   when	   it	  
comes	   to	   environmental	   adaption	   and	   ability	   to	   cause	   disease.	   The	   first	   difference	   in	   terms	   of	  
environmental	   adaptation	   is	   the	   variation	   in	   optimal	   growth	   temperature.	   S.	   cerevisiae,	   like	  many	  
other	  yeasts	  optimally	  grows	  at	  30°C	  and	  below	  [104].	   In	  contrast,	  C.	  glabrata	  grows	  faster	  overall	  
than	  S.	  cerevisiae	  with	  its	  optimum	  growth	  temperature	  being	  37°C,	  but	  showing	  good	  growth	  rates	  
up	   to	   around	   39°C	   [104].	   This	   evolutionary	   shift	   between	   optimum	   growth	   at	   30°C	   and	   37°C	   is	  
crucial	   to	   the	   ability	   of	   C.	   glabrata	   to	   colonise	   the	   host	   as	   both	   a	   commensal	   and	   opportunistic	  
pathogen.	  C.	  glabrata	  has	  also	  been	  considered	  to	  have	  undergone	  an	  increased	  rate	  of	  gene	  loss,	  or	  
reductive	  evolution,	  from	  its	  common	  ancestor	  with	  S.	  cerevisiae,	  with	  loss	  of	  galactose,	  phosphate,	  
nitrogen	  and	  sulphur	  metabolism	  being	  standout	  examples,	  as	  well	  as	  auxotrophies	  to	  nicotinic	  acid,	  
pyridoxine	  and	  thiamine,	  which	  C.	  glabrata	  relies	  on	  its	  host	  to	  overcome	  [77,	  104,	  109,	  110].	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The	  C.	  glabrata	   genome	  also	  contains	   several	  genes	   that	  are	  not	   found	  within	   the	  S.	   cerevisiae	  or	  
Saccharomyces	   family	  genome.	  These	   include	  a	  putative	  aspartate	   racemase	   that	  appears	   to	  have	  
originated	  from	  a	  bacterial	  origin	  and	  acts	  to	  inter-­‐convert	  optical	  isomers	  of	  aspartate	  [111],	  as	  well	  
as	  a	  variable	  number	  of	  EPA	  genes	  that	  although	  they	  have	  functional	  homologues	   in	  S.	  cerevisiae	  
FLO	  genes,	  do	  not	  show	  sequence	  similarity	  [104].	  C.	  glabrata	  also	  features	  expanded	  sets	  of	  genes	  
that	   have	   S.	   cerevisiae	   homologues,	   but	   are	   more	   numerous.	   Several	   relate	   to	   the	   cell	   wall	   and	  
include	   six	   extra	   genes	   encoding	   extracellular	   GPI-­‐linked	   aspartyl	   proteases	   and	   eight	   genes	  
encoding	  α-­‐1,3-­‐mannosyltransferases	  involved	  in	  cell	  wall	  biosynthesis	  [104].	  These	  genes	  are	  linked	  
with	  adhesion	  and	  cell	  wall	  structure	  and	  likely	  evolved	  through	  adaptation	  to	  the	  host	  environment.	  
	  
1.5.3	  Virulence	  and	  drug	  resistance	  
In	   virulence	   terms,	   C.	   glabrata	   and	   S.	   cerevisiae	   are	   quite	   different.	   S.	   cerevisiae	   has	   only	   been	  
shown	   to	   be	   able	   to	   cause	   fungemia	   in	   certain	   immunocompromised	   patients	   that	   are	   given	  
Saccharomyces	   boulardii	   supplements	   as	   a	   treatment	   for	  Clostridium	  difficile-­‐associated	   diarrhoea	  
[112].	   In	   contrast,	   C.	   glabrata	   has	   been	   found	   be	  much	  more	   adept	   at	   causing	   disease,	   albeit	   in	  
similarly	  immunocompromised	  patients	  and	  the	  elderly,	  as	  previously	  discussed.	  It	   is	   likely	  that	  the	  
genetic	   differences	   linked	   to	   cell	   adhesion	   and	   adaptation	   to	   the	   host	   environment	   between	   C.	  
glabrata	  and	  S.	  cerevisiae	  account	  for	  the	  apparent	  virulence	  of	  C.	  glabrata.	  
The	  pathogenic	  yeast	  C.	  glabrata	  also	  exhibits	  much	  greater	  antifungal	  drug	  resistance	  than	  that	  of	  
S.	  cerevisiae.	  C.	  glabrata	  is	  both	  innately	  resistant	  to	  azoles	  and	  can	  also	  quickly	  acquire	  resistance	  to	  
other	  antifungals	  [104].	  The	  two	  yeasts	  share	  some	  of	  the	  signalling	  pathways	  that	  create	  the	  anti-­‐
toxicity	  and	  drug	   response	   revolving	  around	  PRD1	   [104].	  Crucially	   the	  C.	  glabrata	   genes	  CDR1	   and	  
CDR2,	   which	   encode	   drug	   efflux	   pumps	   that	   actively	   eject	   antifungals	   and	   are	   transcriptionally	  
regulated	  by	  PRD1,	  can	  be	  upregulated	  through	  gain	  of	  function	  mutations	  within	  PRD1	  and	  loss	  of	  
mitochondrial	  function,	  which	  is	  also	  linked	  with	  increased	  ergosterol	  availability	  [18,	  113].	  As	  these	  
drug	  resistant	  adaptations	  evolved	   in	  C.	  glabrata	  before	  the	   introduction	  of	  azoles	   into	  the	  clinical	  
setting,	  it	  is	  thought	  that	  they	  were	  formed	  by	  adaptation	  to	  frequent	  exposure	  to	  toxic	  substances	  
as	  part	  of	  the	  mucosal	  flora	  [104].	  
It	   is	   clear	   that	  C.	   glabrata	   shares	   a	   close	   common	   ancestor	  with	   S.	   cerevisiae,	  which	  makes	   them	  
genetically	   similar	   and	  means	   that	  many	   cellular	  processes	  are	   carried	  out	  by	  both	   functional	   and	  
genetic	  homologues	  between	  the	  two	  species.	  This	  means	  that	  S.	  cerevisiae	  can	  be	  used	  as	  a	  model	  
for	  studying	  and	  inferring	  gene	  function	  within	  C.	  glabrata	  for	  genes	  that	  share	  genetic	  homologues.	  
It’s	   also	   very	   clear	   that	  C.	   glabrata	   is	   a	   distinct	   fungus	   from	   both	   S.	   cerevisiae	   and	   its	   frequently	  
associated	  Candida	   species	   relative,	  C.	   albicans.	   Therefore	   caution	  must	   be	   applied	  when	  making	  
inferences	  between	  C.	  glabrata	  and	  either	  C.	  albicans	  or	  S.	  cerevisiae.	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1.6	  Ace2p	  and	  the	  cell	  cycle	  
1.6.1	  Yeast	  cell	  cycle	  
Ace2p	  plays	  a	  significant	  role	   in	  the	  final	  act	  of	  the	  cell	  cycle	   in	  budding	  yeast,	  cell	  separation.	  The	  
budding	  yeast	  cell	  cycle,	  as	  characterised	  in	  S.	  cerevisiae,	  is	  a	  complex	  and	  closely	  controlled	  series	  of	  
events	   concluding	   in	   the	  production	  of	   progeny.	   The	   cell	   cycle	   can	  be	   arbitrarily	   divided	   into	   four	  
phases:	  M,	  which	  encompasses	  mitosis	  and	  cell	  division;	  G1,	  the	  longest	  part	  of	  the	  cell	  cycle,	  which	  
forms	   a	   period	   of	   growth	   and	   preparation	   including	   START	   initiation;	   S,	   a	   phase	   exclusive	   to	  
eukaryotes	  in	  which	  DNA	  synthesis	  occurs;	  and	  G2,	  in	  which	  the	  cell	  prepares	  for	  mitosis	  [114].	  Each	  
mother	   cell	   can	   bud	  once	   during	   its	   cell	   cycle	   and	  development	   is	   closely	   controlled	   by	  G-­‐protein	  
signalling	  through	  Cdc42p	  [115].	  Checkpoints	   in	   the	  cell	  cycle	  closely	  regulate	  the	  transition	  to	  the	  
next	   phase	   and	   prevent	   premature	   progression.	   START	   is	   one	   such	   checkpoint	   that	   allows	  
conditional	  transition	  through	  late	  G1	  and	  budding	  initiation	  in	  the	  mother	  cell,	  dependent	  on	  several	  
conditions	  including	  the	  size	  of	  the	  cell	  and	  the	  nutrient	  content	  of	  the	  growth	  media	  [116].	  As	  the	  
cell	   cycle	  progresses	   the	  daughter	  cell	  must	   reach	  a	  critical	   size	  before	  cell	  division	  can	   take	  place	  
allowing	   the	   mother	   and	   daughter	   cells	   to	   undergo	   cytokinesis	   and	   cell	   separation	   [116].	   The	  
budding	  yeast	  S.	  cerevisiae	  regulates	  its	  cell	  cycle	  progression	  through	  cyclical	  activation	  of	  at	  least	  
nine	  cell-­‐cycle	  dependent	  transcription	  factors,	  which	  can	  be	  divided	  into	  three	  sets	  [115]	  and	  many	  
cyclin-­‐dependent	   protein	   kinases	   (CDKs),	   which	   synchronise	   at	   least	   800	   transcripts	   [117].	   In	   S.	  
cerevisiae	  MBF,	  a	  complex	  of	  Mbp1p	  and	  Swi6p,	  and	  SBF,	  a	  complex	  of	  Swi4p	  and	  Swi6p,	  regulate	  
the	  expression	  of	  genes	  involved	  in	  the	  late	  G1	  phase	  [115,	  118,	  119].	  Gene	  transcription	  in	  G2/M	  is	  
normally	   controlled	   by	   Mcm1p	   together	   with	   Ndd1p,	   which	   is	   recruited	   by	   the	   forkhead	   factors	  
Fkh1p	  or	  Fkh2p	   in	   late	  G2	   [115,	  118,	  119].	  However,	   it	  has	  been	  shown	   that	  Fkh1p	  and	  Fkh2p	  are	  
able	  to	  bind	  directly	  to	  the	  promoters	  of	  G1/S	  phase	  genes	  in	  the	  absence	  of	  Mcm1p	  [115,	  118,	  119].	  
Mcm1p	  has	  also	  been	  shown	  to	  activate	  the	  expression	  of	  M/G1	  genes	  independently	  of	  Fkh1p	  and	  
Fkh2p	  [120,	  121].	  This	  shows	  that	  transcription	  factors	  are	  able	  to	  alter	  their	  own	  transcriptional	  co-­‐
operativity	   in	   order	   to	   activate	   expression	   of	   phase	   specific	   genes,	   which	   adds	   another	   level	   of	  
complexity	  and	   fine	   tuning	   to	  cell	   cycle	   regulation	   [115].	  Ace2p	  and	  a	  closely	   related	   transcription	  
factor	  Swi5p	  regulate	  gene	  transcription	  throughout	  the	  cell	  cycle	  and	  activate	  gene	  transcription	  in	  
the	  final	  stages,	  G1/M	  phase,	  of	  the	  cell	  cycle	  leading	  to	  cytokinesis	  and	  cell	  separation	  [101].	  All	  the	  
cycle	   dependent	   transcription	   factors	   are	   serially	   linked	   to	   one	   another,	   each	   one	   activating	   the	  
expression	  of	  the	  next	  to	  control	  the	  subsequent	  phase	  of	  the	  cell	  cycle	  [115].	  
	  
1.6.2	  Cytokinesis	  and	  cell	  separation	  
The	  final	  stage	  of	  the	  cell	  cycle	  in	  most	  eukaryotes	  is	  cytokinesis,	  where	  by	  the	  mother	  and	  daughter	  
cells	  become	  compartmentalised	  [122].	  Cytokinesis	  occurs	  through	  the	  division	  and	  isolation	  of	  the	  
cytoplasm	  by	  the	  mother	  cell	  membranes	  after	  duplication	  and	  segregation	  of	  the	  genetic	  material	  
has	   taken	   place,	   producing	   two	   independent	   cells	   [122].	   In	   S.	   cerevisiae,	   the	  mitotic	  exit	  network	  
(MEN)	   group	   of	   proteins	   ensure	   chromosome	   segregation	   is	   complete	   before	   cytokinesis,	   the	  
penultimate	   step	   in	   the	   cell	   cycle,	   can	   take	   place	   through	   ubiquitin	   ligase	   mediated	   proteolytic	  
degradation	   and	   inactivation	   of	   the	   mitotic	   kinase	   complex	   formed	   by	   Cdc28p	   plus	   one	   of	   the	  
regulatory	  subunits	  encoded	  by	  CLB1-­‐4	  [123].	  The	  process	  of	  cytokinesis	  encompasses	  three	  phases;	  
the	   first	   is	   appropriate	   selection	  of	   a	   division	   site,	   chosen	   late	   in	  G1	   as	   the	  bud	  begins	   to	   emerge	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[124].	  The	  second	  is	  the	  assembly	  of	  protein	  complexes	  at	  the	  site	  of	  division	  where	  a	  septin	  ring	  is	  
assembled	  as	  a	  scaffold	  for	  the	  eventual	  assembly	  of	  the	  contractile	  actomyosin	  ring	  [122].	  The	  final	  
phase	  of	  cytokinesis	  can	  be	  thought	  of	  as	  the	  operation	  of	  the	  pre-­‐assembled	  machinery	  at	  the	  site	  
of	  division,	  leading	  to	  constriction	  of	  the	  actomyosin	  ring	  that	  in	  turn	  allows	  septum	  formation	  and	  
the	  division	  of	  the	  cytoplasm	  [122].	   In	  this	  way,	  all	  cell	  cycle	  ties	  are	  severed	  between	  mother	  and	  
daughter	   allowing	   uncoupling	   in	   subsequent	   rounds	   of	   cell	   division	   [125].	   On	   completion	   of	  
cytokinesis	  the	  two	  discrete	  cell	  units,	  mother	  and	  daughter	  cells,	  remain	  attached	  via	  a	  tri-­‐laminar	  
septum	  to	  each	  other	  until	  cell	  separation	  can	  take	  place,	  allowing	  dispersal	  of	  the	  cells.	  
	  
Figure	  1.2	  –	  S.	  cerevisiae	  and	  C.	  glabrata	  ace2	  display	  a	  clumpy,	  cell	  separation	  deficient	  phenotype.	  Yeast	  was	  grown	  
over	  night	  at	  30°C	  or	  37°C,	  180	  rpm,	  and	  visualised	  under	  DIC.	  A)	  S.	  cerevisiae	  BY4741	  cells	  (B)	  C.	  glabrata	  (HSL122)	  ace2	  
cells	   (C)	  S.	   cerevisiae	  ace2	   cells.	   Both	  ace2	   strains	   display	   a	   cell	   separation	   deficient	   phenotype,	   although	   this	   is	   less	  
severe	  in	  S.	  cerevisiae.	  Scale	  bar	  10	  µm.	  
Cell	   separation	   is	   the	   process	   of	   degradation	  of	   the	   cell	  wall	   ring	   and	   the	   tri-­‐laminar	   septum	   that	  
separates	  the	  mother	  and	  daughter	  cells;	  allowing	  the	  daughter	  cell	  to	  dissociate	  from	  the	  mother	  
cell	  [126].	  Successful	  completion	  of	  cell	  separation	  is	  the	  result	  of	  the	  highly	  regulated	  assembly	  of	  a	  
series	   of	   components	   to	   the	  mother-­‐daughter	   neck	   throughout	   the	   cell	   division	   cycle	   [125].	   In	   S.	  
cerevisiae	  many	  proteins	  have	  been	  shown	  to	  play	  important	  roles	  in	  the	  final	  stage	  of	  cytokinesis.	  
Glucan	  β1,3-­‐glucosidases	  such	  as	  Dse2p	  and	  Scw11p	  have	  been	  shown	  to	  be	  directed	  to	  the	  site	  of	  
cell	  separation	  along	  with	  an	  endoglucanase	  Egt2p	  [127,	  128].	  Chitinase	  activity	  has	  also	  been	  shown	  
to	  play	  an	  important	  part	  with	  Cts1p	  directed	  to	  the	  site	  of	  the	  bud	  neck	  [129].	  Other	  proteins	  have	  
subsequently	  been	  shown	  to	  be	  important	  to	  cell	  separation	  including	  Dse4p	  (also	  known	  as	  Eng1p),	  
an	   endo	   glucan	   β1,3-­‐glucosidase	   [130]	   and	   Gpi7p,	   which	   plays	   a	   role	   in	   the	   biosynthesis	   of	  
glycosylphosphatidylinositol,	  another	  component	  of	  the	  cell	  wall	  [131].	  
Misregulation	  or	  disruption	  of	  these	  proteins	  has	  been	  shown	  to	  effect	  cell	  separation	  and	  cause	  cell	  
separation	   defective	   cells	   such	   as	   the	   clumpy	   phenotype	   cells	   illustrated	   in	   Figure	   1.2	   [132].	   In	  
budding	   yeast	   the	   cell	   wall	   consists	   of	   a	   complex	   of	   glucose	   polysaccharides	   (glucans),	   manno-­‐
proteins	  and	  chitin	  [125].	  Chitin	  itself	  is	  mainly	  found	  in	  the	  mother-­‐daughter	  bud	  neck	  and	  primary	  
septum	   [125].	  Cts1p	   is	   responsible	   for	  hydrolysis	  of	   the	   chitin	   components	  of	   the	  primary	   septum	  
that	  contributes	  to	  cell	  separation	  [125].	  It	  has	  also	  been	  found	  by	  several	  groups	  studying	  budding	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yeast	   cell	   separation	   that	   absence	   of	   glucanases,	   such	   as	   Dse4p	   [133],	   Dse2p	   [101]	   and	   Scw11p	  
[134],	   leads	   to	   failure	   of	   cell	   separation	   with	   loss	   of	   hydrolysis	   of	   the	   secondary	   septum	   and	  
surrounding	  cell	  wall	  that	  hold	  the	  mother	  and	  daughter	  cells	  together	  [125].	  The	  series	  of	  hydrolytic	  
enzymes	   that	   are	   responsible	   for	   completion	   of	   cell	   separation	   are	   closely	   regulated	   in	   their	  
expression	  and	  function	  [125].	  	  
Some	  of	  the	  genes	  involved	  in	  cell	  separation	  are	  expressed	  asymmetrically	  in	  the	  daughter	  cell	  due	  
to	   the	   localisation	   of	   two	   transcription	   factors	   Swi5p	   and	   Ace2p,	   which	   show	   a	   high	   degree	   of	  
similarity	  between	  themselves	  and	  overlapping	  transcriptional	  regulation	  in	  S.	  cerevisiae	  [101,	  133].	  
Swi5p	   has	   been	   shown	   to	   regulate	   the	   expression	   of	  AIM44,	   PCL9,	   PIR1	   and	   the	   uncharacterised	  
gene	  YNL046W	  [101,	  130],	  whereas	  Ace2p	  exhibits	  transcriptional	  control	  over	  CTS1,	  DSE1,	  DSE2	  and	  
SCW11	  among	  others	  [101,	  132].	  The	  asymmetrical	  transcription	  of	  these	  important	  cell	  separation	  
components	   is	  due	  to	  the	   localisation	  of	  Swi5p	  and	  Ace2p	  to	  the	  daughter	  cell	  nucleus	   [101,	  133].	  
Localisation	   of	   the	   transcribed	   products	   to	   the	   daughter	   side	   of	   the	   bud	   neck	   has	   also	   been	  
suggested	   to	   be	   very	   important	   for	   correct	   function	   [129].	   An	   investigation	   using	   C-­‐terminal	  
deletions	  of	  CTS1	  showed	  alteration	   in	  the	  trafficking	  of	  Cts1p	  resulted	   in	  cell	  separation	  defective	  
mutants	  [129].	  
	  
1.6.3	  The	  RAM	  network	  
Ace2p	   is	  a	  zinc	  finger-­‐like	  DNA	  binding	  transcription	  factor	  associated	  with	  the	  regulation	  of	  genes	  
that	   participate	   in	   the	   early	   G1	   to	  M	   phase	   of	   the	   cell	   cycle	   in	   S.	   cerevisiae	   [101].	   Ace2p	   exhibits	  
transcriptional	   control	  over	   the	   cell	   separation	  machinery	  and	  has	  been	   shown	   to	   cause	  a	   clumpy	  
growth	  phenotype	  when	  deleted	  in	  both	  S.	  cerevisiae	  and	  C.	  glabrata	   [132].	   	  The	  transcription	  and	  
localisation	  of	  Ace2p	  is	  controlled	  by	  a	  network	  of	  proteins,	  similar	  to	  MEN,	  called	  the	  regulation	  of	  
Ace2p	  transcription	   factor	  and	  polarised	  morphogenesis	   (RAM)	  signalling	  network	  shown	   in	  Figure	  
1.3	   [135].	   The	   RAM	   network	   also	   controls	   polarised	   growth,	   cellular	   morphogenesis	   and	  
maintenance	  of	   cellular	   integrity,	   and	  has	  been	   shown	   to	  be	   crucial	   for	   cell	   viability	   except	   in	   the	  
absence	  of	  Ssd1p	  [136].	  
	  
Figure	   1.3	   –	   Predicted	   model	   of	   the	   RAM	   network	   [132].	   Interacting	   Kic1p,	   Sog2p	   and	   Hym1p	   form	   a	   complex	   and	  
activate	   Mob2p-­‐Cbk1p	   [135,	   136].	   Tao3p	   and	   Ssd1p	   are	   also	   thought	   to	   activate	   the	   Mob2p-­‐Cbk1p	   complex;	   the	  
activated	  Mob2p-­‐Cbk1p	   complex	   activates	  Ace2p,	  which	   in	   turn	   activates	   the	   transcription	   of	   genes	   required	   for	   cell	  
separation,	   the	   cell	   separation	   machinery,	   which	   leads	   to	   hydrolysis	   of	   the	   primary	   and	   secondary	   septum	   and	   cell	  
separation	  [135,	  136].	  SSD1,	  however,	  has	  been	  shown	  to	  not	  be	  essential	  for	  RAM	  regulation	  of	  Ace2p	  [135,	  136].	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The	  RAM	  network	   is	   known	   to	   contain	  at	   least	   six	  proteins:	  Mob2p,	  Cbk1p,	  Tao3p,	   Sog2p,	  Hym1p	  
and	  Kic1p	  [135].	  Disruption	  of	  any	  one	  of	  the	  six	  encoding	  genes	  results	  in	  cell	  separation	  defective	  
mutants	  and	  low	  levels	  of	  ACE2	  transcription	  [135].	  The	  current	  model	  of	  the	  RAM	  network	  (Figure	  
1.3)	  shows	  that	  Kic1p,	  Sog2p	  and	  Hym1p	  interact	  to	  activate	  a	  Mob2p-­‐Cbk1p	  complex,	  which	  in	  turn	  
activates	  ACE2	   transcription	   leading	  to	  cell	   separation	  [135].	  Tao3p	  and	  Ssd1p	  are	  also	  believed	  to	  
activate	   Mob2p-­‐Cbk1p,	   however	   RAM	   regulation	   of	   ACE2	   expression	   has	   been	   shown	   to	   be	  
independent	  of	  SSD1	  [136].	  In	  Schizosaccharomyces	  pombe	  the	  protein	  kinase	  Kic1p	  has	  been	  shown	  
to	   regulate	   septum	   formation	   and	   hence	   is	   involved	   in	   polarised	   growth	   and	   cell	   wall	   integrity,	  
interacting	   with	   a	   centrin	   related	   Cdc31p	   [137].	   Sog1p	   shares	   a	   weak	   similarity	   with	   the	   amino	  
terminus	   of	   the	   adenylate	   cyclase	   of	   S.	   cerevisiae	   and	   is	   necessary	   for	   Cbk1p	   activity	   and	   cell	  
morphogenesis	  [135].	  HYM1,	  an	  orthologue	  of	  the	  Aspergillus	  nidulans	  hyphal	  growth	  factor	  HYMa,	  
encodes	  a	  protein	  with	  a	  likely	  role	  in	  polarised	  morphogenesis	  in	  association	  with	  Kic1p	  [135,	  138].	  
Not	  much	  is	  currently	  known	  about	  TAO3	  although	  it	  has	  been	  shown	  to	  be	  conserved	  in	  both	  yeast	  
and	   human	   genomes	   indicating	   a	   possible	   important	   biological	   function	   [139].	   Ssd1p	   has	   been	  
implicated	  in	  the	  function	  of	  Sit4p,	  a	  phosphatase,	  and	  is	  believed	  to	  be	  a	  suppressor	  of	  TAO3	  and	  
CBK1	  expression	  as	  it	  has	  been	  shown	  that	  disruption	  of	  SSD1	  rescues	  the	  growth	  defect	  of	  tao3	  and	  
cbk1	   null	  mutants	   therefore	   indicating	   a	   role	   in	   polarised	  morphogenesis	   [139,	   140].	   Cbk1p	   itself	  
plays	  a	  role	  in	  polarised	  growth	  and	  controls	  the	  localisation	  of	  Ace2p	  to	  the	  daughter	  nucleus	  [135,	  
141].	  In	  the	  other	  half	  of	  the	  complex	  Mob2p	  is	  a	  member	  of	  the	  MOB	  family	  and	  is	  related	  to	  the	  
MEN	   proteins	  Mob1p	   and	   Dbf2p	   [135,	   141].	   The	   RAM	   network	   has	   therefore	   been	   shown	   to	   be	  
crucial	  for	  cell	  separation	  and	  dissemination	  of	  progeny.	  Investigation	  into	  the	  genes	  responsible	  for	  
the	  end	  result	  of	  cell	  separation	  induced	  by	  ACE2	  expression	  is	  therefore	  needed	  to	  fully	  understand	  
the	  mechanism	  of	  cell	  separation	  and	  the	  role	  it	  plays	  in	  virulence.	  
	  
1.7	  Current	  knowledge	  of	  the	  Ace2p	  regulon	  
The	  genes	  currently	  known	  to	  be	  transcriptionally	   regulated,	  either	  directly	  or	   indirectly,	  by	  Ace2p	  
[101,	   133]	   have	   been	   characterised	   individually,	   some	   to	   a	   greater	   extent	   than	   others	   in	   S.	  
cerevisiae.	  Considering	  Ace2p’s	  role	  as	  a	  regulator	  of	  cell	  separation,	  it’s	  not	  surprising	  that	  most	  of	  
them	  play	  a	  role	  in	  cell	  separation,	  forming	  part	  of	  the	  cell	  separation	  machinery.	  CTS1	  for	  example	  
encodes	   a	   cell	   wall	   associated	   chitinase	   that	   hydrolyses	   the	   chitin	   in	   the	   septum,	  which	   together	  
with	   other	   hydrolytic	   enzymes,	   allows	  mother	   and	   daughter	   cells	   to	   separate	   [129].	   CTS1	   and	   its	  
Ace2p-­‐depenence	   have	   been	   well	   characterised	   in	   S.	   cerevisiae,	   as	   well	   as	   previously	   being	  
investigated	   in	   relation	   to	   virulence	   in	   C.	   glabrata	   [142].	   The	   other	   genes	   of	   the	   Ace2p	   regulon,	  
AMN1,	  ASH1,	  BUD9,	  DSE1,	  DSE2,	  DSE3,	  ACF2/DSE4,	  EGT2,	  RME1,	  SCW11α,	  SCW11β	  and	  SIC1,	  have	  
yet	   to	   be	   investigated	   in	   C.	   glabrata	   in	   relation	   to	   their	   Ace2p-­‐dependence	   and	   possible	  
antivirulence,	  or	  virulence	  moderating,	  activity,	  but	  their	  functions	  in	  S.	  cerevisiae	  have	  been	  widely	  
documented,	   ranging	   from	   cell	  wall	   glucanases	   that	   help	   hydrolyse	   the	   secondary	   septum,	   to	   cell	  
cycle	  regulators,	  regulators	  of	  mating-­‐type	  and	  bud	  site	  selection.	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1.7.1	  AMN1	  
In	   S.	   cerevisiae,	   Amn1p,	   a	   daughter-­‐cell	   expressed	   protein,	   has	   been	   shown	   to	   localise	   to	   the	  
daughter	   cell	   cytoplasm	   and	   nucleus	   [143]	   performing	   a	   role	   in	   cell	   cycle	   progression	   and	  
inactivation	   of	   the	   MEN	   group	   of	   proteins	   as	   part	   of	   the	   AMEN	   (antagonist	   of	   MEN)	   group	   of	  
proteins	  [144].	  Wang	  et	  al.	  showed	  that	  AMN1	  overexpression	  was	  toxic	  to	  MEN	  mutants	  and	  also	  
slowed	  the	  growth	  of	  wild	  type	  cells	  causing	  cell	  cycle	  arrest	  or	  delays	  in	  mitotic	  exit	  [144].	  They	  also	  
showed	  that	  amn1	  null	  mutants	  present	  with	  inappropriate	  mitotic	  exit	  during	  spindle	  assembly	  or	  
nuclear	  orientation	   checkpoints	   [144]	   indicating	   that	  Amn1p	   is	   involved	   in	  a	   cell	   cycle	  progression	  
checkpoint	  that	  occurs	  at	  the	  completion	  of	  mitotic	  exit.	  AMN1	  expression	  is	  induced	  as	  part	  of	  the	  
AMEN	   upon	   completion	   of	  mitotic	   exit	   and	   blocks	   G-­‐protein	   signalling	   by	   binding	   to	   Tem1p,	   a	   G	  
protein	   located	   on	   the	   spindle	   pole	   body	   [144].	   This	   in	   turn	   prevents	   Tem1p	   binding	   to	   and	  
activating	   Cdc15p,	   resulting	   in	   inhibition	   of	   both	   Cdc14p	   and	   MEN	   activation	   [144].	   With	   MEN	  
inhibited,	   the	   cells	   are	   then	   able	   to	   progress	   into	   START	   and	   enter	   S	   phase,	   in	   which	   Amn1p	   is	  
actively	  destroyed	  reversing	  AMEN	  [144].	  Amn1p	  has	  also	  been	  shown	  to	  display	  strong	  self-­‐linkage	  
meaning	   that	   its	   expression	   level	   is	   linked	   to	   its	   own	   locus	   in	   the	   genome	   and	   local	   variation,	  
therefore	   it	   has	   been	   proposed	   to	   indirectly	   negatively	   regulate	   itself	   in	   trans	   in	   the	   diploid	   S.	  
cerevisiae	  [145].	  Amn1p	  may	  also	  play	  a	  role	  in	  mating	  having	  been	  shown	  to	  regulate	  the	  binding	  of	  
Ste12p	  to	  the	  pheromone	  response	  elements	  (PREs),	  with	  AMN1	  deletion	  increasing	  Ste12p	  binding	  
to	   PREs,	   inferring	   that	   Amn1p	   plays	   a	   role	   in	   regulating	   transcription	   under	   a	   vegetative	   state	  
through	  Ste12p	  [146].	  The	  C.	  glabrata	  homologue	  of	  S.	  cerevisiae	  AMN1	  is	  CAGL0H07491g.	  
	  
1.7.2	  ASH1	  
ASH1,	  asymmetric	  synthesis	  of	  HO,	  is	  a	  protein	  involved	  in	  the	  control	  of	  mating-­‐type	  switching,	  and	  
therefore	   cell	   fate,	   in	  S.	   cerevisiae	   [147].	   Regulation	  of	  HO,	   a	   gene	   that	   encodes	   an	  endonuclease	  
that	  initiates	  replacement	  of	  the	  mating-­‐type	  locus	  with	  code	  from	  one	  of	  two	  mating-­‐type	  cassettes	  
(a	  or	  α)	   in	  haploid	  S.	   cerevisiae	  cells,	  prevents	  daughter	   cells	  or	   those	   that	  have	   yet	   to	  bud,	   from	  
being	  able	  to	  switch	  mating-­‐type	  [148].	  	  Ash1p	  is	  expressed	  in	  daughter	  cells	  and	  is	  localized	  to	  the	  
daughter	   cell	   nucleus	   in	   G1,	   controlling	   the	   initiation	   of	   mating-­‐type	   switching	   by	   repressing	   the	  
transcription	  of	  HO	  in	  G1,	  but	  also	  shows	  some	  control	  over	  the	  frequency	  of	  mating-­‐type	  switching	  
in	  mother	  cells	  through	  perdurance	  [147,	  149].	  Over	  expression	  of	  Ash1p	   in	  mother	  cells	  has	  been	  
shown	  to	  prevent	  mating-­‐type	  switching	  [147].	  Likewise,	  disruption	  of	  ASH1	  causes	  de-­‐repression	  of	  
HO	   transcription	  and	   therefore	  mating-­‐type	   switching	   [147].	  Ash1p	  has	   also	  been	   shown	   to	   affect	  
the	  expression	  of	  SWI5	  in	  S.	  cerevisiae	  daughter	  cells	  [147].	  ASH1	  encodes	  a	  GATA-­‐like	  transcription	  
factor	   that	   binds	   to	   the	   promoter	   region	   of	   HO	   with	   its	   C-­‐terminal	   zinc-­‐finger-­‐like	   domain	   and	  
suppressing	  the	  transcription	  of	  HO	  with	  its	  N-­‐terminal	  in	  a	  mechanism	  that	  is	  independent	  of	  Swi5p	  
binding	  [149].	  Ash1p	  binds	  to	  a	  consensus	  sequence	  similar	  to	  that	  of	  GATA-­‐1	  (YTGAT)	  that	  has	  also	  
been	   shown	   to	   exist	   in	   promoter	   regions	   of	   genes	   other	   than	   HO	   and	   could	   indicate	   a	   greater	  
regulatory	  role	  for	  Ash1p	  [149,	  150].	  ASH1	  has	  been	  shown	  to	  be	  essential	  for	  pseudohyphal	  growth	  
in	   both	   haploid	   and	   diploid	   S.	   cerevisiae	   cells	   independently	   of	   the	   previously	   described	   MAPK	  
cascade	  and	  Ste12p	   for	   instance,	  with	  ASH1	  over	  expression	  causing	  an	   increase	   in	   the	  number	  of	  
pseudohyphal	  projections	   in	   response	  to	  nitrogen	  starvation	   [150].	  ASH1	   transcription	   is	   regulated	  
by	  Ace2p,	  but	   its	   translation	   is	   thought	   to	  be	   regulated	   through	   the	  action	  of	   several	  RNA-­‐binding	  
proteins,	   including	   Puf6p,	   that	   are	   thought	   to	   supress	   ASH1	   translation,	   which	   is	   released	   by	   CK	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phosphorylation	  and	  the	  general	  transcription	  factor	  Fun12p	  that	  acts	  to	  promote	  ASH1	  expression	  
[151].	  Localisation	  of	  ASH1	  mRNA	  to	  the	  bud	  tip	   is	  actin	  cytoskeleton-­‐dependent	   involving	  SHE2-­‐5,	  
LOC1	   and	   the	   type	   V	   myosin	   Myo4p	   (SHE1),	   through	   She2p	   binding	   [152-­‐154].	   The	   C.	   glabrata	  
homologue	  of	  S.	  cerevisiae	  ASH1	  is	  CAGL0D00462g.	  
	  
1.7.3	  BUD9	  
Bud9p,	  as	  the	  name	  suggests,	  is	  thought	  to	  be	  involved	  in	  the	  bipolar	  budding	  formation	  in	  diploid	  S.	  
cerevisiae	   cells	   acting	   as	   a	   cortical	   landmark	   [155-­‐157].	  BUD9	   encodes	   a	   cell	  membrane	   targeted	  
protein	   that	   is	   predicted	   to	   have	   two	   hydrophobic	   membrane-­‐spanning	   domains	   separated	   by	   a	  
short	   hydrophilic	   domain	   that	   likely	   performs	   the	   signalling	   function	   of	   the	   protein,	   and	   a	   large,	  
heavily	   glycosylated	  N-­‐terminal	   extracytoplasmic	   domain,	  which	  may	   play	   a	   role	   in	   anchoring	   the	  
protein	  in	  position	  in	  the	  cell	  membrane	  by	  interacting	  with	  the	  cell	  wall	  [156].	  Bud9p	  is	  partnered	  
by	  another	  bud	  site	  selection	  associated	  protein,	  Bud8p,	  which	  although	  not	  thought	  to	  play	  a	  role	  in	  
the	  axial	  budding	  pattern	  displayed	  by	  haploid	  S.	  cerevisiae	  cells,	  together	  they	  are	  thought	  to	  mark	  
the	  distal	  and	  proximal	  poles	  for	  bud	  site	  selection	  respectively	  in	  diploid	  cells	  [155,	  156].	  Diploid	  S.	  
cerevisiae	  bud8	  and	  bud9	  mutants	  display	  almost	  exclusive	  budding	  to	  the	  proximal	  and	  distal	  poles	  
respectively	   [156].	   Bud9p	   has	   also	   been	   shown	   to	   be	   localised	   to	   the	   daughter	   cell	   side	   of	   the	  
mother-­‐daughter	  bud	  neck	  [143]	  and	  remains	  in	  place	  during	  cell	  division	  [156].	  Correct	  expression	  
and	   localisation	  of	  Bud9p	   is	  both	  cell	  cycle	  dependent	  and	  Rax1p/Rax2p-­‐dependent	  [158],	  and	  has	  
been	  shown	  to	  be	  dependent	  on	  actin	  and	  septin	  for	  correct	  delivery	  to	  the	  bud	  neck	  and	  proximal	  
pole	  [157,	  159].	  Kato	  et	  al.	  have	  also	  shown	  Bud9p	  localisation	  to	  be	  dependent	  on	  the	  EKC/KEOPS	  
complex,	  a	  group	  of	  proteins	  involved	  in	  telomere	  maintenance	  and	  transcriptional	  regulation	  [160,	  
161],	  separate	  from	  Bud9p’s	  dependence	  on	  of	  Rax2p	  and	  septin	  [157],	  which	  they	  suggest	  might	  be	  
involved	  with	  the	  timing	  of	  BUD9	  expression	  rather	  than	  playing	  a	  direct	  role	  in	  localisation	  or	  as	  a	  
downstream	  element	  from	  Rax2p	  and	  septin.	  Once	  properly	  localised	  it	  is	  thought	  that	  Bud9p	  acts	  as	  
a	  landmark	  for	  the	  proximal	  pole,	  recruiting	  a	  GTPase	  signalling	  complex	  formed	  from	  Rsr1p,	  Bud2p	  
and	   Bud5p	   when	   appropriate,	   which	   then	   transmits	   the	   positional	   information	   to	   Cdc42p	   and	  
Cdc24p	  for	  establishment	  of	  cell	  polarity	  via	  recruitment	  of	  the	  budding	  machinery	  [157,	  162].	  The	  C.	  
glabrata	  homologue	  of	  S.	  cerevisiae	  BUD9	  is	  CAGL0K04191g.	  
	  
1.7.4	  DSE1	  
DSE1	  is	  an	  Ace2p	  regulated	  gene	  that	  currently	  has	  no	  known	  function	  in	  S.	  cerevisiae	  [101,	  163].	  It	  is	  
known	  to	  be	  expressed	  other	  Ace2p	  regulated	  genes	  in	  the	  run	  up	  to	  cell	  separation	  along	  with	  the	  
rest	   of	   the	   cell	   separation	   machinery,	   is	   repressed	   by	   Swi5p	   and	   shows	   daughter	   cell	   specific	  
expression	  [101,	  133,	  143].	  Doolin	  et	  al.	  also	  showed	  that	  dse1	  null	  S.	  cerevisiae	  diploid	  cells	  display	  
a	   cell	   separation	   defect	   that	   was	   not	   found	   in	   haploid	   lab	   strains,	   and	   a	   sensitivity	   to	   cell	   wall	  
targeted	   conditions	   such	   as	   SDS,	   calcofluor	   white	   and	   caffeine,	   indicating	   a	   possible	   role	   in	   cell	  
separation	   and	   cell	   wall	  metabolism	   [101].	   Interaction	   data	   from	   S.	   cerevisiae	   shows	   32	   different	  
interactions,	  with	  Boi1p,	   Boi2p,	   Ste4p	   and	   Zds2p	  physical	   interactions	  possibly	   indicating	   a	   role	   in	  
bud	  formation	  or	  bud	  site	  selection	  [163-­‐165].	  Dse1p	  has	  also	  been	  shown	  to	  physically	  interact	  with	  
Ste11p,	  which	  is	  involved	  in	  pseudohyphal	  growth,	  plays	  a	  role	  in	  virulence	  in	  C.	  glabrata	  and,	  along	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with	   Ste4p,	   has	   been	   implicated	   in	   pheromone	   sensing	   [82,	   165,	   166].	   Both	   Boi1p	   and	   Boi2p	   are	  
thought	   to	   play	   a	   role	   in	   polar	   growth	   localising	   to	   the	   bud	   cortex	   with	   double	   null	   mutants	  
displaying	  an	  abnormally	  large,	  round	  phenotype	  that	  is	  prone	  to	  lysis,	  plus	  buds	  showing	  defective	  
bud	  formation	  and	  disruption	  of	  cell	  polarity	  maintenance	  [167].	  Boi1p	  and	  Boi2p	  have	  been	  shown	  
to	  interact	  with	  Bem1p	  a	  protein	  that	  helps	  establish	  the	  cellular	  polarity	  required	  for	  budding	  [168].	  
Recent	  evidence	  also	  points	   to	  a	  possible	  bud	  site	   selection	   role	   for	  Dse1p	   in	  haploid	  S.	   cerevisiae	  
cells,	   with	   over	   expression	   causing	   a	   budding-­‐within-­‐birth-­‐scar	   phenotype,	   a	   typically	   highly	  
protected	  area	  that	  forbids	  budding,	  and	  activation	  of	  the	  cell	  wall	   integrity	  pathway	  [163].	  Draper	  
et	  al.	  also	  showed	  that	   in	  S.	  cerevisiae	  over	  expression	  of	  Dse1p	  induced	  invasive	  growth,	  and	  was	  
presumed	  to	  be	  a	  positive	  regulator	  of	  invasive	  growth	  through	  its	  interaction	  with	  Ste11p	  [166].	  It	  
was	   also	   shown	   that	   overexpression	   of	   Dse1p	   caused	   interference	   with	   the	   pheromone	   sensing	  
pathway,	   conferring	   resistance	   to	   cell	   cycle	   arrest	   in	   G1	   in	   response	   to	  mating	   factor	   and	   equally	  
causing	  two-­‐fold	  sensitivity	  to	  pheromone-­‐induced	  cell	  cycle	  arrest	  in	  dse1	  null	  cells	  [166].	  Draper	  et	  
al.	   also	   hypothesised	   that	   Dse1p	   had	   a	   role	   in	   cross-­‐talk	   between	   the	   pheromone	   and	   invasive	  
growth	  pathways	  due	  to	  its	  ability	  to	  bind	  to	  both	  a	  Ste4p	  complex	  and	  Ste11p	  [166].	  In	  C.	  albicans,	  
Daher	   et	   al.	   hypothesised	  DSE1	   to	   be	   an	   essential	   gene	   due	   to	   their	   inability	   to	   construct	   a	   null	  
strain,	   only	   managing	   a	   heterozygote	   haploinsufficient	   strain	   [169].	   The	   haploinsuffient	   DSE1	   C.	  
albicans	   strain	   showed	   increased	   sensitivity	   to	   calcofluor	   white,	   SDS	   and	   oxidative	   stress,	   with	  
slightly	  decreased	  levels	  of	  chitin	  deposition	  in	  the	  cell	  wall,	  as	  well	  as	  increased	  filamentous	  growth	  
levels	  on	  both	  solid	  and	  liquid	  media	  [169].	  Daher	  et	  al.	  also	  found	  their	  DSE1	  haploinsufficient	  strain	  
to	  be	  attenuated	  in	  virulence	  with	  a	  delayed	  adhesion	  [169].	  DSE1	  has	  little	  homology	  to	  other	  genes	  
regulated	   by	   Ace2p,	   however,	   including	   Dse2p	   or	   Dse4p/Acf2p,	   or	   any	   other	   gene	   in	   the	   S.	  
cerevisiae,	  C.	  glabrata	  or	  C.	  albicans	  genome	  [170,	  171].	  The	  C.	  glabrata	  homologue	  of	  S.	  cerevisiae	  
DSE1	  is	  CAGL0K02277g.	  
	  
1.7.5	  DSE2	  
DSE2	   encodes	   a	   putative	   GPI-­‐anchored	   cell	   surface	   protein	   with	   similarities	   to	   another	   Ace2p	  
controlled	   gene,	  DSE4,	  and	   sequence	   similarity	   to	  previously	   characterised	  glucanases	   [101].	  DSE2	  
expression	  is	  also	  reduced	  by	  the	  transcriptional	  regulator	  and	  Ace2p	  homologue,	  Sw15p,	  with	  swi5	  
cells	   showing	  at	   least	  a	  25%	   increase	   in	  DSE2	  expression	  compared	   to	  wild	   type	  S.	   cerevisiae	   cells	  
[101].	   In	  haploid	  S.	   cerevisiae	   cells	  DSE2	  disruption	  showed	  no	  appreciable	  phenotype,	  but	  diploid	  
dse2	   cells	   exhibit	   cell	   separation	  defects	   forming	   long	   chains	   of	   cells	  with	  unipolar	   budding	   [101].	  
DSE2	   disruption	   also	   causes	   enhanced	   pseudo-­‐hyphal	   production	   on	   nitrogen-­‐poor	   medium	   and	  
increased	   resistance	   to	   lactic	   acid	   media	   [101,	   172].	   DSE2	   expression	   is	   also	   down	   regulated	   in	  
response	  to	  bovine	  protein	  kinase	  C-­‐α	  (PKCα)	  activation	  and	  by	  cAMP	  [173,	  174].	  Dse2p	  is	  localised	  
to	  the	  cell	  wall	  and	  the	  septum	  separating	  the	  mother	  and	  daughter	  cells	  [101].	  Dse2p	  is	  therefore	  
thought	  to	  be	   involved	   in	  cell	  separation,	  helping	  to	  hydrolyse	  the	  septum	  or	  surrounding	  cell	  wall	  
after	  cytokinesis	  [133].	  The	  C.	  glabrata	  homologue	  of	  S.	  cerevisiae	  DSE2	  is	  CAGL0G05896g.	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1.7.6	  DSE3	  
DSE3	   unlike	   DSE2	   and	   DSE4/ACF2	   does	   not	   share	   a	   sequence	   similarity	   with	   other	   known	   yeast	  
glucanases	   and	   has	   yet	   to	   be	   characterised,	   but	   is	   likely	   involved	   in	   daughter	   cell	   fate	   due	   to	   its	  
daughter	  cell	  specific	  expression	  and	  localisation	  to	  the	  bud	  neck	  [133,	  143].	  Doolin	  et	  al.	  found	  DSE3	  
expression	   to	   be	   regulated	  by	   both	  Ace2p	   and	   its	   homologue	   Swi5p,	  with	   a	   double	   deletion	  ace2	  
swi5	   required	   to	   produce	   minimal	   DSE3	   expression	   in	   haploid	   S.	   cerevisiae	   cells	   [101].	   DSE3	  
expression	  was	  also	  shown	  to	  not	  be	   induced	  by	  α-­‐factor	  [133],	  and	  was	  enhanced	  twofold	  by	  the	  
deletion	  of	  AMN1	   in	   a	  S.	   cerevisiae	   diploid	  natural	   isolate	  derivative	   [175],	  which	   could	   indicate	  a	  
down-­‐stream	   role	   for	   Dse3p	   from	   the	  MEN	   activation	   inhibitor.	   The	   C.	   glabrata	   homologue	   of	   S.	  
cerevisiae	  DSE3	  is	  CAGL0C02827g.	  
	  
1.7.7	  DSE4/ACF2	  
In	  C.	   glabrata	  one	   of	   the	  Ace2p	   regulon	   genes,	  CAGL0M04565g,	   has	   homology	   to	   both	  DSE4	   and	  
ACF2	  in	  S.	  cerevisiae,	  which	  form	  part	  of	  the	  glycosyl	  hydrolase	  family	  81	  (GHF81)	  [171,	  176,	  177].	  Up	  
until	   recently	   the	   gene	  was	   designated	   as	  DSE4	  within	  C.	   glabrata,	   but	   is	   currently	   designated	   as	  
ACF2	  as	   it	  has	  been	  discovered	  that	  CAGL0M04565g	  has	  good	  synteny	  with	  ACF2,	  sharing	  a	  similar	  
spot	  in	  the	  C.	  glabrata	  genome	  to	  the	  orthologous	  ORF	  within	  S.	  cerevisiae	  genome	  [105,	  171].	  In	  S.	  
cerevisiae	  DSE4	   (ENG1)	   and	  ACF2	   (ENG2)	   encode	  endo-­‐1,3-­‐β-­‐glucanases	  with	  highly	   specific	  1,3-­‐β-­‐
linkage	  activity	  and	   little	   sequence	   similarity	   to	  other	  yeast	  1,3-­‐β-­‐glucanase	  encoding	  genes	   [130].	  
DSE4	  is	  transcriptionally	  regulated	  by	  Ace2p,	  peaking	  in	  expression	  during	  the	  M/G1	  transition	  and	  is	  
heavily	   glycosylated	   [130].	   ACF2,	   however,	   shows	   no	   periodic	   fluctuation	   in	   expression	   levels	  
throughout	   the	  cell	   cycle,	  but	  has	   increased	  expression	  during	  sporulation,	  matching	   the	   temporal	  
pattern	   of	  midterm	  meiosis	   genes	   such	   as	   SPO12	   [130].	   Baladron	   et	   al	   also	   showed	   Dse4p	   to	   be	  
localised	   to	   the	   bud	   neck,	   accumulating	   on	   the	   daughter	   cell	   side	   of	   the	   septum	   [130].	   Diploid	   S.	  
cerevisiae	  null	  cells	  for	  both	  dse4	  and	  acf2,	  as	  well	  as	  double	  mutants,	  displayed	  no	  sensitivity	  to	  cell	  
wall	   targeted	   conditions	   such	   as	   calcofluor	  white	   and	   congo	   red,	   indicating	   that	   neither	  DSE4	  nor	  
ACF2	  play	  a	  significant	  role	  in	  general	  cell	  wall	  architecture	  [130].	  However,	  diploid	  dse4	  cells	  in	  both	  
S.	   cerevisiae	   and	   C.	   albicans	   showed	   a	   cell	   separation	   defect,	   with	   small	   clusters	   of	   cells	   visible,	  
which,	  coupled	  with	  the	  septum	  localisation,	   indicates	  that	  Dse4p	  helps	  to	  degrade	  the	  septum	  for	  
cell	   separation	   [130,	  177].	  S.	   cerevisiae	  acf2	  null	   cells	   showed	  no	  appreciable	  phenotype,	  but	   in	  S.	  
pombe	  diploid	  acf2	  cells	  showed	  a	  failure	  in	  ascus	  cell	  wall	  hydrolysis	  and	  ascospore	  release,	  which	  
coupled	  with	  the	   increased	  expression	  during	  sporulation	   in	  S.	  cerevisiae	   clearly	   indicates	  a	  role	   in	  
intracellular	  1,3-­‐β-­‐glucan	  hydrolysis	  in	  sporulation	  [130,	  178].	  The	  C.	  glabrata	  gene	  CAGL0M04565g,	  




EGT2	  encodes	  a	  glycosylphosphatidylinositol	   (GPI)-­‐anchored	  cell	  wall	  endoglucanase	  that	  has	  been	  
shown	   to	   be	   involved	   in	   cell	   separation	   due	   to	   a	   delay	   in	   cell	   separation	   shown	   by	   egt2	   null	   S.	  
cerevisiae	   cells	   [127].	   It	   is	  expressed	   in	   the	  early	   stages	  of	  G1	   immediately	  after	  mitosis	  and	   is	  not	  
expressed	   in	   cells	   arrested	  with	  α-­‐factor	   [127].	   In	   exponentially	   growing	   cells	   Kovacech	   et	   al.	   and	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others	  showed	  that	  S.	  cerevisiae	  EGT2	  can	  be	  transcriptionally	  regulated	  by	  both	  Swi5p	  and	  Ace2p	  in	  
both	  mother	   and	  daughter	   cells	   [101,	   127,	   133,	   179].	  However,	  Colman-­‐Lerner	  et	   al.	   showed	   that	  
saturated	   culture	   daughter	   cell	   specific	   expression	   of	   EGT2	   was	   dependent	   on	   Ace2p	   and	  
independent	   of	   Swi5p	   [133].	   Recent	   analysis	   in	   C.	   glabrata	   has	   also	   showed	   that	   EGT2	   could	   be	  
under	  the	  sole	  regulation	  of	  Ace2p	  and	  not	  Swi5p	  [180].	  It	  is	  thought	  that	  Egt2p	  plays	  a	  role	  in	  cell	  
separation	   through	   the	   hydrolysis	   of	   mother-­‐daughter	   septum	   [127,	   133].	   The	   C.	   glabrata	  
homologue	  of	  S.	  cerevisiae	  EGT2	  is	  CAGL0D02530g.	  
	  
1.7.9	  RME1	  
Rme1p,	  as	  its	  name	  suggests,	  is	  a	  zinc	  finger	  protein	  that	  acts	  as	  a	  regulator	  of	  meiosis,	  which	  in	  S.	  
cerevisiae	  is	  a	  haploid	  specific	  gene	  with	  its	  transcription	  directly	  suppressed	  in	  MATa/α	  diploid	  cells	  
by	   the	   a1-­‐α2	   gene	   product	   complex	   [181,	   182].	   RME1	   has	   been	   shown	   to	   prevent	   meiosis	   and	  
subsequent	  sporulation	  in	  haploid	  cells	  [182].	  Rme1p	  acts	  to	  transcriptionally	  repress	  the	  expression	  
of	   IME1,	   a	   protein	   required	   for	   expression	   of	   IME2	   and	   other	   meiotic	   genes,	   by	   binding	   to	   an	  
upstream	  element	  directly,	  acting	   independently	  of	  the	  environmental	  signal	   [181-­‐185].	  As	  a	  distal	  
repressor,	  Rme1p	   represses	   IME1	   expression	  by	  binding	   to	   two	  binding	   sites	  over	  1600	  base	  pairs	  
upstream	   of	   the	   IME1	   ORF	   and	   blocks	   the	   binding	   of	   the	   transcriptional	   activator	   Hap1p	   to	   an	  
upstream	   activation	   sequence,	   known	   as	   activator	   exclusion	   [186,	   187].	   Rme1p	   transcriptional	  
repression	  is	  dependent	  on	  specific	  sequences	  flanking	  the	  Rme1p	  binding	  sites,	  which	  together	  are	  
called	   the	   Rme1p	   response	   element	   (RRE),	   on	   a	   modulation	   region,	   and	   on	   RGR1	   and	   SIN4	  
expression	  forming	  two	  subunits	  of	  the	  Mediator	  RNA	  polymerase	  II	  associated	  complex	  [185-­‐188].	  
Rme1p	   has	   also	   been	   found	   to	   be	   able	   to	   promote	   mitosis	   through	   direct	   activation	   of	   the	  
expression	  of	  the	  G1	  cyclin,	  CLN2	   through	  binding	  to	  two	  RREs	  present	   in	  the	  CLN2	  promoter	  [189,	  
190].	  Overexpression	  of	  RME1	  has	  been	  shown	  to	  cause	  a	  reduction	  in	  cell	  size	  that	  is	  dependent	  on	  
Cln2p,	  bypassing	  the	  CLN2	  activation	  requirement	  for	  the	  SBF	  (Swi4p-­‐Swi6p)	  or	  MBF	  (Mbp1-­‐Swi6p)	  
transcription	  factor	  complexes,	  while	  rme1	  mutants	  display	  increased	  cell	  size	  and	  reduced	  steady-­‐
state	   levels	   of	   CLN2	   expression	   [189,	   190].	   In	   S.	   cerevisiae	   RME1	   expression	   is	   transcriptionally	  
regulated	   by	   Swi5	   and	   Ace2p,	   shows	   cell	   cycle	   regulated	   transcript	   levels	   peaking	   at	   the	   M/G1	  
boundary	   in	   both	   haploid	   and	   diploid	   cells,	   and	   shows	   nuclear	   localisation	   in	   G1	   [191].	   The	   C.	  
glabrata	  homologue	  of	  S.	  cerevisiae	  RME1	  is	  CAGL0K04257g.	  
	  
1.7.10	  SCW11	  
SCW11	   encodes	   a	   SDS-­‐soluble	   cell	   wall	   protein	   and	   shows	   sequence	   homology	   to	   other	   cell	   wall	  
glucanase	  genes	  including	  BGL2,	  which	  encodes	  an	  endo-­‐β-­‐glucanase,	  and	  Dse2p	  and	  Dse4p/Acf2p,	  
which	  have	  been	  highlighted	  in	  playing	  a	  role	  in	  degradation	  of	  the	  cell	  wall	  during	  cell	  separation	  as	  
previously	   discussed	   [133,	   134].	   In	   S.	   cerevisiae	   and	   C.	   albicans,	   SCW11	   has	   been	   shown	   to	   be	  
transcriptionally	   regulated	   by	   Ace2p	   but	   not	   Swi5p	   [101,	   192],	   down	   regulated	   in	   response	   to	  
genotoxicity,	  and	  also	  to	  be	  regulated	  by	  Ste12p	  and	  therefore	  may	  have	  roles	  in	  conjugation	  [134,	  
193,	  194].	  Cappellaro	  et	  al.	  found	  S.	  cerevisiae	  scw11	  cells	  to	  display	  a	  cell	  separation	  defect,	  which	  
strengthens	   the	   theory	   that	   Scw11p	   may	   be	   involved	   in	   the	   cell	   separation-­‐dependent	   glucan	  
hydrolysis	  of	  the	  septum	  [134].	  Teparić	  et	  al.	  also	  found	  that	  Scw11p	  acts	  antagonistically	  with	  other	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closely	   related	   cell	   wall	   proteins	   Scw3p	   and	   Scw10p,	   relieving	   an	   increased	   mortality	   phenotype	  
shown	   by	   scw3scw10	   double	   deletion	   mutants	   when	   disrupted	   itself	   [195].	   This	   suggests	   that	  
Scw11p	  forms	  part	  of	  catabolic	  side	  of	  the	  dynamic	  equilibrium	  displayed	  by	  the	  cell	  wall	   in	  yeast,	  
which	  ties	  in	  well	  with	  the	  assumption	  that	  it	  plays	  a	  role	  in	  septum	  hydrolysis	  during	  cell	  separation	  
[125,	  195].	  In	  C.	  albicans	  SCW11	  has	  shown	  altered	  expression	  in	  response	  to	  certain	  conditions	  like	  
caspofungin	   treatment,	   which	   decreases	   expression,	   and	   high	   iron	   concentration	   that	   increases	  
expression,	  while	  conversely	  in	  S.	  cerevisiae,	  reduced	  SCW11	  expression	  has	  been	  shown	  under	  high	  
iron	   conditions	   [196,	   197].	   As	   expected,	   reduced	   expression	   of	   SCW11	   is	   also	   found	   in	   hyphal	   C.	  
albicans	   compared	   to	  yeast	   form,	  as	  well	  as	  pseudohyphal	  S.	   cerevisiae	   cells	   [197-­‐200].	   It	  has	  also	  
been	   suggested	   that	   SCW11	   is	   essential	   in	   C.	   albicans	   due	   to	   the	   apparent	   inability	   to	   create	   a	  
homozygous	   scw11	   null	   strain,	   and	   has	   been	   shown	   to	   be	   a	   consistent	   part	   of	   the	   C.	   albicans	  
secretome	   [201-­‐203].	   Two	   C.	   glabrata	   homologues	   of	   S.	   cerevisiae	   SCW11	   have	   been	   found,	  
CAGL0A01474g	  and	  CAGL0E02915g,	  henceforth	  referred	  to	  as	  SCW11α	  and	  SCW11β	  respectively.	  
	  
1.7.11	  SIC1	  
SIC1,	  a	  Swi5p	  and	  Ace2p	  regulated	  gene	  encoding	  a	  cyclin	  dependent	  kinase	  inhibitor,	  plays	  a	  role	  in	  
the	  control	  of	  the	  G1/S-­‐phase	  transition	  [101,	  204].	  In	  S.	  cerevisiae	  Swi5p	  has	  been	  shown	  to	  control	  
SIC1	   transcription	   at	   the	   end	   of	  mitosis	   ready	   for	   G1	   as	   part	   of	   the	   ‘SIC1	   cluster’	   [204-­‐207].	   Over	  
expression	   of	  SIC1	   has	   been	   shown	   to	   cause	   a	   subset	   of	   elongated,	   single	   nucleate	   budding	   cells,	  
while	  sic1	  null	  cells	  display	  partial	  mitotic	  arrest,	  premature	  DNA	  replication	  and	  genome	  instability	  
[208].	   	   Sic1p	   binds	   to	   and	   inhibits	   the	   Cdk1p-­‐Clbp	   (previously	   known	   as	   Cdc28p)	   histone	   kinase	  
complexes,	  which	  are	  responsible	  for	  initiation	  of	  DNA	  replication	  in	  budding	  cells	  [209,	  210].	  Cdk1-­‐
Clbp	  complex	  inhibition	  acts	  as	  a	  checkpoint	  preventing	  premature	  S-­‐phase	  progression	  and	  ensures	  
genomic	   integrity	   [209,	   210].	   Sic1p	   has	   been	   shown	   to	   be	   destroyed	   by	   ubiquitin-­‐dependent	  
proteolysis,	   which	   releases	   the	   Cdk1-­‐Clbp	   complex	   to	   then	   initiate	   DNA	   replication	   and	   transition	  
into	  S-­‐phase	  [211].	  Sic1p	  is	  targeted	  for	  ubiquitination	  by	  multi-­‐site	  phosphorylation	  by	  the	  Cdk1p-­‐
Clnp	  kinase	  complexes	  at	  a	  minimum	  of	   six	  out	  of	  nine	  possible	   suboptimal	  phosphorylation	  sites,	  
which	  then	  allows	  it	  to	  be	  recognised	  by	  the	  F-­‐box	  protein	  Cdc4p	  [210,	  212].	  By	  requiring	  at	  least	  six	  
phosphorylation	   events	   at	   suboptimal	   CDK	   sites,	   Sic1p	   recognition	   by	   the	   Skp1p-­‐Cdc53p-­‐Cdc4p	  
(SCFCdc4p)	  complex	  is	  Cdk1p-­‐Clnp	  concentration	  dependent,	  imposing	  a	  Cdk1p-­‐Clnp	  kinase	  threshold	  
on	   Sic1p	   recognition	  by	   SCFCdc4p,	  which	   allows	   fine-­‐tuning	  of	   the	  de-­‐inhibition	  of	   Cdk1p-­‐Clnp	   [211,	  
212].	  Once	  phosphorylated,	  Sic1p	  is	  recognised	  by	  SCFCdc4p,	  which	  then	  recruits	  Cdc34p	  to	  form	  the	  
ubiquitin	  ligase	  complex	  for	  Sic1p	  ubiquitination,	  destroying	  it	  and	  releasing	  the	  Cdk1-­‐Clbp	  complex	  
allowing	  it	  to	  initiate	  DNA	  replication	  and	  transition	  into	  S-­‐phase	  [211].	  Sic1p	  has	  also	  been	  shown	  to	  
be	  a	  functional	  homologue	  of	  mammalian	  Kip1p	  [209]	  and	  is	  localised	  to	  both	  the	  cytoplasm	  and	  the	  
nucleus	   of	   the	   daughter	   cell	   [143,	   205].	   The	   C.	   glabrata	   homologue	   of	   S.	   cerevisiae	   SIC1	   is	  
CAGL0L13222g.	  
The	  Ace2p	  regulon	  therefore	  includes	  genes	  involved	  in	  cell	  separation,	  cell	  cycle	  regulation	  and	  bud	  
site	   selection,	   as	   well	   as	   two	   genes	   of	   as	   yet	   unknown	   function.	   From	   hydrolytic	   enzymes	   to	  
transcriptional	   regulators,	  Ace2p	  maintains	   their	  cell	  cycle	  regulated	  expression	  and	  contributes	  to	  
their	  daughter	  cell	  specific	  localisation.	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1.8	  Role	  of	  cell	  wall	  components	  in	  the	  septum	  
The	   fungal	   cell	   wall	   is	   responsible	   for	  maintaining	   cell	   shape,	   protecting	   the	   fungal	   cell	   from	   the	  
environment,	   enabling	   adherence	   to	   host	   surfaces	   and	   acts	   as	   an	   anchor	   point	   for	  many	   cell	  wall	  
associated	   proteins.	   In	   budding	   yeast,	   the	   cell	   wall	   also	   forms	   the	   septum	   that	   binds	   mother	   to	  
daughter	   until	   cell	   separation	   can	   take	   place.	   The	   main	   constituents	   of	   the	   cell	   wall,	   glucan	   and	  
chitin,	   form	  critical	   linkages	  between	  budding	  cells	  and	   it	   is	   their	  hydrolysis	  by	  components	  of	   the	  
cell	  separation	  machinery	  that	  allows	  dissemination	  of	  progeny	  [125].	  
	  
1.8.1	  Glucan	  
The	  glucan	  component	  of	  the	  cell	  wall	  is	  comprised	  of	  chains	  of	  glucose	  molecules	  primarily	  linked	  in	  
a	  β-­‐1,3	  configuration	  with	  some	  β-­‐1,6-­‐glucan	  linkages	  interspersed	  across	  the	  chains.	  Glucan	  forms	  
the	  major	   structural	   component	   of	   the	   cell	  wall	   in	  S.	   cerevisiae	   [16],	   and	   is	   formed	  by	   the	   glucan	  
synthase	   that	   creates	  β-­‐1,3-­‐linkages	  between	  glucose	   residues	  creating	   long	  polysaccharide	  chains	  
[213].	  The	  glucan	  chains	  are	  branched	  at	  every	  50-­‐60	  or	  so	  residues	  to	  other	  β-­‐1,3-­‐glucans,	  which	  in	  
turn	  are	  cross-­‐linked	  with	  chitin,	  β-­‐1,6-­‐glucans	  and	  other	  mannoproteins	  to	   form	  a	  strong	  core	  for	  
the	  cell	  wall	  [214].	  Glucan	  has	  been	  shown	  to	  be	  an	  integral	  part	  of	  the	  fungal	  cell	  wall	  and	  essential	  
for	   viability	   in	   both	   S.	   cerevisiae	   and	   C.	   albicans,	   and	   others,	   through	   disruption	   of	   the	   glucan	  
synthase	  complex	  [215,	  216].	  This	   indicates	  that	  the	  glucan	  synthase	  pathway	  is	  a	  viable	  target	  for	  
antifungal	   drug	   development,	   and	   indeed	   it	   has	   been	   shown	   that	   the	   action	   of	   echinocandins	  
revolves	  around	  inhibition	  of	  the	  β-­‐1,3-­‐glucan	  synthase	  [217].	  
	  
1.8.2	  Chitin	  
Chitin,	  although	  only	  a	  small	  part	  of	  the	  cell	  wall	  by	  mass	  [126],	  forms	  the	  other	  major	  component	  of	  
structural	  integrity	  of	  the	  cell	  wall	  due	  to	  its	  high	  tensile	  strength.	  Like	  glucan,	  chitin	  is	  made	  up	  of	  a	  
long	   chain	   of	   glucose-­‐derived	  molecules,	   this	   time	   in	   the	   form	   of	  N-­‐acetylglucosamine,	  which	   are	  
linked	  together	  by	  the	  chitin	  synthase.	  The	  long	  chains	  of	  chitin	  are	  linked	  by	  hydrogen	  bonds,	  which	  
combine	   to	   create	   a	   strong	   crystalline,	   microfibrillar	   structure,	   which	   is	   then	   in	   turn	   linked	   with	  
glucan	  and	  other	  components	  of	  the	  cell	  wall.	  Chitin,	  like	  glucan,	  has	  been	  shown	  to	  be	  essential	  for	  
viability	  in	  both	  S.	  cerevisiae	  and	  C.	  albicans,	  as	  disruption	  of	  all	  the	  chitin	  synthase	  redundant	  genes	  
results	  in	  non-­‐viable	  strains	  [218,	  219].	  Chitin	  has	  been	  shown	  to	  form	  the	  main	  structural	  link	  within	  
the	  primary	   septum	  that	  holds	  mother	  and	  daughter	   together,	  as	  disruption	  of	   the	  chitinase	  CTS1	  
forms	   large	   cell	   clumps	   deficient	   in	   cell	   separation	   [129].	   Like	   the	   glucan	   synthase	   pathway,	   the	  
chitin	  synthase	  pathway	  forms	  a	  viable	  antifungal	  drug	  target.	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1.9	  General	  aims	  of	  the	  project	  
This	   study	   aims	   to	   investigate	   the	   underlying	   cause	   of	   the	   antivirulence	   potential	   of	   the	   cell	  
separation	   associated	   transcription	   factor	   Ace2p	   in	   C.	   glabrata	   by	   studying	   the	   genes	   that	   show	  
Ace2p-­‐dependent	  expression.	  Through	  analysis	  of	  the	  genes	  regulated	  by	  Ace2p	  it	  is	  hoped	  that	  we	  
can	  begin	   to	  understand	   the	  mechanism	   for	   the	  antivirulence	  and	   the	  genes	   that	  play	  a	   role	   in	   it,	  
building	  further	  insight	  into	  C.	  glabrata	  virulence	  both	  in	  vitro	  and	  in	  vivo,	  which	  is	  still	  very	  much	  in	  
its	  infancy	  when	  compared	  to	  other	  human	  pathogens.	  
	  
1.10	  Specific	  aims	  of	  the	  project	  
To	   further	   study	   the	   effect	   of	  ace2	  within	  C.	   glabrata	   by	   defining	   the	  Ace2p	   regulon	   -­‐-­‐	   the	   genes	  
under	  the	  transcriptional	  regulation	  of	  Ace2p.	  This	  will	  enable	  us	  to	  see	  which	  genes	  in	  C.	  glabrata	  
contribute	  to	  the	  antivirulence	  of	  ACE2	  and	  will	  provide	  targets	  for	  deletion	  and	  further	  study	  within	  
this	  project.	  Due	  to	  the	  unavailability	  of	  suitable	  and	  cost	  effective	  array	  tools	  for	  C.	  glabrata	  at	  the	  
time,	  to	  achieve	  this	  Northern	  analysis	  of	  a	  tet-­‐regulated	  ACE2	  strain	  (HLS119)	  will	  be	  conducted	  to	  
show	  whether	  the	  genes	  highlighted	  as	  being	  controlled	  by	  Ace2p,	  through	  homology	  to	  S.	  cerevisiae	  
genes,	  localisation	  studies	  and	  promoter	  analysis,	  show	  Ace2p-­‐dependent	  expression	  in	  C.	  glabrata.	  
To	  investigate	  the	  potential	  for	  direct	  control	  of	  expression	  by	  Ace2p	  by	  promoter	  analysis.	  This	  will	  
allow	  us	   to	  highlight	   those	  genes	   that	   are	  potentially	  directly	   transcriptionally	   regulated	  by	  Ace2p	  
and	  define	  whether	  the	  Ace2p	  binding	  sites,	  homologous	  to	  those	  found	  in	  S.	  cerevisiae,	  exist	  in	  C.	  
glabrata.	   To	   achieve	   this,	   the	   promoter	   region	   sequences	   of	   the	   Ace2p-­‐dependent	   genes	   will	   be	  
searched	  for	  the	  central	  consensus	  sequence	  of	  the	  Ace2p	  binding	  site	  as	  defined	  by	  Dohrmann	  et	  
al.	  [220]	  using	  a	  GIBBS	  analysis	  or	  similar.	  
To	   create	   deletions	   of	   each	   of	   the	   previously	   uninvestigated	   genes	   of	   the	   Ace2p	   regulon	   in	   C.	  
glabrata.	   Through	   individual	   deletion	   of	   the	   previously	   uninvestigated	   genes	   shown	   to	   be	   Ace2p-­‐
dependent	  in	  C.	  glabrata,	  it	  will	  then	  be	  possible	  to	  conduct	  both	  in	  vitro	  and	  in	  vivo	  analysis	  of	  their	  
antivirulent	  potential	  and	  in	  turn,	  their	  contribution	  to	  the	  hypervirulence	  displayed	  by	  ace2	  cells	  in	  
C.	  glabrata	  [7].	  To	  achieve	  this	  gene	  deletion	  techniques,	   including	  the	  high	  throughput	  fusion	  PCR	  
and	  Edlind	  methods,	  will	  be	  employed	   to	  disrupt	   the	  genes,	  which	  will	   then	  be	  confirmed	  via	  PCR	  
and	  Southern	  analysis.	  
To	   study	   the	   potential	   hypervirulent	   effects	   of	   previously	   uninvestigated	   Ace2p	   regulon	   gene	  
deletions	   to	   determine	   their	   contribution	   to	   the	   extreme	   hypervirulence	   displayed	   by	  C.	   glabrata	  
ace2	   cells	   [7].	   This	   will	   be	   achieved	   through	   the	   use	   of	   in	   vivo	   virulence	   analysis.	   A	   neutropenic	  
murine	  model	   of	   candidiasis	  will	   be	   used	   to	   assay	   the	   virulence	   of	   each	   individual	   Ace2p	   regulon	  
deletion	  and	  compared	  to	  the	  C.	  glabrata	  wild	  type.	  
To	  study	  the	  potential	  immune	  over-­‐stimulation	  effects	  of	  previously	  uninvestigated	  Ace2p	  regulon	  
gene	  deletions	   to	   determine	   their	   contribution	   to	   the	   extreme	   immune	   activation	  displayed	  by	  C.	  
glabrata	  ace2	   cells	   [7].	   This	  will	   be	   achieved	   through	   the	   use	   of	   an	   in	   vitro	  macrophage	   infection	  
assay.	   After	   a	   short	   infection	   the	   supernatant	   will	   be	   assayed	   for	   cytokine	   release	   via	   ELISA	   as	   a	  
measure	  of	  immune	  activation	  and	  compared	  to	  that	  elicited	  by	  the	  C.	  glabrata	  wild	  type.	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To	  investigate	  the	  role	  and	  function	  of	  the	  novel	  gene	  DSE1	  within	  C.	  glabrata.	  This	  will	  be	  achieved	  
through	   the	   study	   of	   the	   gene	   in	   both	   C.	   glabrata	   and	   its	   close	   genetic	   relative	   S.	   cerevisiae,	   by	  
studying	   its	   possible	   Ace2p-­‐dependence,	   by	   disrupting	   it	   within	   C.	   glabrata,	   and	   by	   studying	   its	  
sensitivity	   to	   phenotypic	   stress	   conditions.	   The	   localisation	   of	   Dse1p	   will	   also	   be	   looked	   at	   in	   S.	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2	   Materials	  and	  Methods	  
These	  are	  the	  general	  materials	  and	  methods	  common	  throughout	  the	  study.	  Specific	  materials	  and	  
methods	  that	  only	  apply	  to	  particular	  chapters	  are	  included	  in	  the	  appropriate	  chapter.	  
	  
2.1	  Chemicals	  and	  reagents	  
All	   chemicals	   used	   within	   this	   study	   were	   purchased	   from	   Sigma	   or	   Fisher	   Chemicals	   unless	  
otherwise	  stated.	  
	  
2.2	  Culture	  media,	  strains	  and	  plasmids	  
2.2.1	  Fungal	  strains	  and	  growth	  media	  
Please	  see	  Appendix	  1	  for	  all	  strains	  used	  within	  this	  study.	  Fungal	  cells	  were	  routinely	  cultured	  using	  
yeast	  extract	  peptone	  dextrose	  (YPD)	  (2%	  (w/v)	  peptone,	  2%	  (w/v)	  glucose,	  1%	  (w/v)	  yeast	  extract)	  
or	  synthetic	  dropout	  medium	  (SD)	  (0.68%	  (w/v)	  yeast	  nitrogen	  base	  without	  amino	  acids	  (Difco,	  BD,	  
UK),	  2%	  (w/v)	  glucose)	  and	  the	  appropriate	  dropout	  mix	  (Clontech,	  France)	  at	  30°C	  (S.	  cerevisiae,	  C.	  
glabrata	  or	  C.	  albicans)	  or	  37°C	  (C.	  glabrata	  or	  C.	  albicans)	  at	  180	  rpm.	  Selective	  agents	  and	  stress	  
condition	  chemicals	  were	  added	  prior	  to	  growth	  for	  specific	  strains	  and	  for	  specific	  experiments.	  For	  
culture	  on	  solid	  media	  2%	  (w/v)	  agar	  was	  added	  prior	   to	  autoclaving.	  Strains	  were	  stored	  at	   room	  
temperature	  for	  up	  to	  4	  weeks	  or	  2	  months	  at	  4°C	  on	  solid	  agar	  plates,	  or	  for	  long	  term	  storage	  in	  
50%	   (v/v)	   glycerol	   at	   -­‐80°C.	   Specific	   descriptions	   of	   strain	   constructions	   are	   given	   in	   the	   relevant	  
chapters.	  
	  
2.2.2	  Bacterial	  strains	  and	  growth	  media	  
XL-­‐10	   and	   TOP10	   Escherichia	   coli	   competent	   cells	   were	   cultured	   in	   standard	   Luria	   Bertani	   (LB)	  
medium,	   2%	   (w/v)	  GibcoBRL	   LB	  Broth	  Base	   (Life	   Technologies,	  UK).	   Liquid	   cultures	  were	   routinely	  
incubated	  at	  30°C	  or	  37°C,	  180	  rpm.	  Solid	  medium	  was	  produced	  by	  the	  addition	  of	  2%	  (w/v)	  agar	  
prior	   to	   autoclaving.	   When	   required,	   ampicillin,	   geneticin	   or	   gentamycin	   was	   added	   to	   a	   final	  
concentration	  of	  100	  μg/mL	  after	  autoclaving	  and	  once	  the	  media	  had	  cooled	  to	  below	  55°C.	  Strains	  
were	  stored	  for	  up	  to	  4	  weeks	  at	  4°C	  in	  a	  fridge	  or	  cold	  room.	  
	  
2.2.3	  Plasmids	  
Please	   see	   Appendix	   2	   for	   a	   list	   of	   all	   the	   plasmids	   either	   used	   or	   constructed	   during	   this	   study.	  
Details	  regarding	  construction	  of	  plasmids	  made	  during	  this	  study	  are	  given	  in	  the	  relevant	  chapters.	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2.3	  Molecular	  biology	  techniques	  
2.3.1	  Primers	  	  
Oligonucleotides	  were	  purchased	  from	  Sigma-­‐Genosys	  (Dorset,	  UK)	  or	  Integrated	  DNA	  Technologies	  
(Leuven,	  Belgium).	  Primers	  are	  listed	  in	  the	  text	  where	  appropriate,	  or	  in	  Appendix	  3.	  
	  
2.3.2	  Polymerase	  chain	  reaction	  
PCRs	  were	  performed	  as	  described	  by	  Saiki	  et	  al.	   [221]	  using	  protocols	  dependent	  on	   the	  enzyme	  
manufacturer.	   Each	   reaction	   was	   optimised	   individually	   specific	   to	   the	   template	   and	  
oligonucleotides	   in	   use.	   Enzymes	   used	   included	   GoTaq	   Flexi	   DNA	   Polymerase	   (Promega,	   UK),	  
RedTaqTM	   DNA	   polymerase	   (Sigma-­‐Genosys,	   UK),	   AdvantageTM	   2	   PCR	   Enzyme	   System	   (BD	  
Biosciences,	  UK),	  BIO-­‐X-­‐ACTTM	  Short	  Polymerase	  (Bioline,	  UK),	  BIO-­‐X-­‐ACTTM	  Long	  Polymerase	  (Bioline,	  
UK)	  and	  Platinum	  Taq	  (Invitrogen,	  UK).	  
	  
2.3.3	  Colony	  polymerase	  chain	  reaction	  
Colony	  PCRs	  were	  performed	  as	  described	  by	  Liang	  and	  Richardson	  [222]	  using	  protocols	  dependent	  
on	   the	   enzyme	  manufacturer.	   Each	   reaction	  was	   optimised	   individually	   specific	   to	   the	   colony	   and	  
oligonucleotides	   in	  use.	  The	  enzymes	  used	  primarily	  were	  GoTaq	  Flexi	  DNA	  Polymerase	   (Promega,	  
UK)	  and	  RedTaq	  DNA	  polymerase	  (Sigma-­‐Genosys,	  UK).	  
	  
2.3.4	  Linear	  DNA	  and	  PCR	  extraction	  and	  purification	  
Linear	  DNA	  and	  PCR	  fragments	  were	  routinely	  purified	  from	  1%	  (w/v)	  agarose	  gels	  or	  from	  solution	  
using	  a	  QIAquick®	  Gel	  Extraction	  Kit	  (Qiagen	  Ltd,	  UK)	  according	  to	  manufacturer’s	  instructions.	  
	  
2.3.5	  Enzymatic	  manipulation	  of	  DNA	  
DNA	  was	  modified	  as	  appropriate	  by	  restriction	  endonuclease	  digestion	  and	  blunt	  ending	  [223]	  using	  
appropriate	   enzymes	   purchased	   from	   New	   England	   Biolabs	   (UK).	   All	   enzymatic	   reactions	   were	  
performed	  according	  to	  manufacturer’s	  instructions.	  
	  
2.3.6	  Agarose	  gel	  electrophoresis	  
Samples	  of	  DNA	  were	  routinely	  separated	  on	  1%	  (w/v)	  agarose	  gels	  made	  with	  TBE	  (Tris-­‐Borate:	  4	  
mM	  EDTA,	  0.089	  M	  trizma	  base)	  with	  the	  addition	  of	  0.5	  µg/mL	  Sybr	  safe	  (Invitrogen,	  UK).	  
Samples	  of	  RNA	  were	   routinely	   separated	  on	  1%	   (w/v)	  agarose	  gels	  made	  with	  10	  mM	  phosphate	  
buffer	  pH	  7.4.	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2.3.7	  DNA	  and	  RNA	  quantification	  
Nucleic	   acid	   concentrations	   were	   quantified	   via	   spectrophotometric	   measurement	   using	   a	  
NanoDrop-­‐1000	  spectrophotometer	  (Labtech	  International,	  UK).	  
	  
2.3.8	  Isolation	  of	  yeast	  DNA	  
DNA	   extractions	   were	   performed	   using	   a	   MasterPure	   Yeast	   DNA	   purification	   kit	   (Epicentre	  
Biotechnologies,	  UK)	  according	  to	  manufacturer’s	  instructions.	  
	  
2.3.9	  Isolation	  of	  yeast	  RNA	  
RNA	   was	   extracted	   using	   an	   acid	   phenol	   method	   modified	   from	   that	   described	   previously	   [224].	  
Briefly,	   50	  mL	  of	   saturated	   culture	  was	   collected	  by	   centrifugation,	  washed	   in	   ice	   cold	  ddH2O	  and	  
resuspended	   in	  400	  μL	  TES	   (10	  mM	  Tris-­‐HCl	   (pH	  7.5),	  10	  mM	  EDTA,	  0.5%	   (w/v)	  SDS).	  Then	  400	  μL	  
acid	  phenol	  was	  added	  and	  the	  cells	  vortexed	  and	  incubated	  for	  65°C	  for	  1	  hour.	  Cells	  were	  collected	  
by	  centrifugation	  and	  the	  aqueous	  phase	  transferred	  to	  a	  new	  microfuge	  tube.	  A	  further	  400	  μL	  acid	  
phenol	  was	  added,	  vortexed	  vigorously	  and	  then	  centrifuged.	  Next,	  400	  μL	  chloroform	  was	  added	  to	  
the	  aqueous	  phase,	  vortexed	  and	  then	  centrifuged.	  Finally,	  40	  μL	  3	  M	  sodium	  acetate	  (pH	  5.2)	  and	  1	  
mL	  of	  ice-­‐cold	  100%	  ethanol	  was	  added	  to	  the	  supernatant	  and	  the	  mixture	  incubated	  at	  -­‐80°C	  for	  1	  
hour,	  the	  pellet	  collected	  by	  centrifugation	  and	  washed	  in	  ice-­‐cold	  70%	  (w/v)	  ethanol,	  air-­‐dried	  and	  
resuspended	  in	  50	  μL	  ddH2O	  to	  be	  stored	  at	  -­‐80°C.	  	  	  
	  
2.3.10	  Plasmid	  DNA	  extraction	  
Plasmids	   were	   extracted	   from	   overnight	   LB	   cultures	   of	   appropriate	   E.	   coli	   strains	   using	   a	  
QIAprep®Spin	  Miniprep	  Kit	  (Qiagen	  Ltd,	  UK)	  according	  to	  manufacturer’s	  instructions.	  Plasmids	  were	  
stored	  at	  4°C	  or	  -­‐20°C	  in	  O.1	  x	  TE	  (10	  mM	  Tris-­‐HCl	  (pH	  8),	  1	  mM	  EDTA	  (pH	  8)).	  
	  
2.3.11	  Yeast	  transformation	  –	  Electroporation	  
Yeast	  cells	  were	  transformed	  using	  a	  modification	  of	  the	  electroporation	  protocol	  [225].	  Briefly,	  1	  mL	  
of	   a	   saturated	  overnight	   culture	  was	   transferred	   into	  50	  mL	  pre-­‐warmed	  YPD	  and	   incubated	   for	  a	  
further	   3	   hours	   at	   37°C	   (C.	   glabrata)	   or	   30°C	   (S.	   cerevisiae),	   180	   rpm.	   Cells	   were	   harvested	   by	  
centrifugation,	  washed	  in	  sterile	  water	  and	  resuspended	  in	  8	  mL	  ddH2O,	  1	  mL	  10	  x	  TE	  (10	  mM	  Tris-­‐
HCl	  (pH	  8),	  1	  mM	  EDTA	  (pH	  8))	  and	  1	  mL	  1	  M	  Lithium	  acetate	  and	  incubated	  at	  30°C	  for	  30	  min	  at	  
130	  rpm.	  Then	  250	  μL	  1	  M	  dithiotheitol	  (DTT)	  was	  added	  and	  incubated	  for	  a	  further	  60	  min	  at	  30°C,	  
130	   rpm.	   Cells	  were	   then	   harvested,	   after	   the	   40	  mL	   of	   ddH2O,	   by	   centrifugation.	   All	   consequent	  
procedures	  were	  performed	  at	  4°C.	  The	  cells	  were	  resuspended	  in	  25	  mL	  ice-­‐cold	  ddH2O,	  harvested	  
by	   centrifugation,	   washed	   in	   5	  mL	   sorbitol	   (1	  M)	   and	   resuspended	   in	   550	   μL	   sorbitol	   (1	  M).	   The	  
competent	   cells	   (45	   μL	   per	   reaction)	  were	   transferred	   to	   pre-­‐chilled	  microfuge	   tubes	   and	   100	   ng	  
DNA	  added,	  mixed	  and	  left	  at	  4°C	  for	  10	  minutes.	  The	  competent	  cell	  mixture	  was	  then	  transferred	  
to	  pre-­‐chilled	  electroporation	  cuvettes	  and	  pulsed	  at	  1.5	  kV,	  25	  μF,	  200	  Ω.	  The	  cells	  were	  recovered	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by	  gentle	  mixing	  with	  950	  μL	  YPD.	  For	  cells	  transformed	  with	  a	  CloneNAT	  deletion	  cassette	  the	  cells	  
were	   incubated	   for	   four	   hours	   at	   30°C	   and	   plated	   onto	   YPD	   plates	   containing	   200	   μg/mL	  
nourseothricin.	  For	  deletion	  cassettes	  with	  other	  markers,	  the	  cells	  were	  incubated	  for	  30	  minutes	  at	  
30°C	  and	  plated	  out	  onto	  appropriate	  SC	  drop	  out	  media.	  Both	  were	  incubated	  for	  two	  to	  four	  days	  
at	  30°C	  or	  37°C.	  
	  
2.3.12	  Yeast	  Transformation	  –	  Lithium	  acetate	  
Yeast	  cells	  were	  transformed	  using	  a	  modification	  of	  the	  lithium	  acetate	  protocol	  [226].	  Briefly,	  1	  mL	  
of	   a	   saturated	  overnight	   culture	  was	   transferred	   into	  50	  mL	  pre-­‐warmed	  YPD	  and	   incubated	   for	  a	  
further	   two	   hours	   at	   37°C	   (C.	   glabrata)	   or	   30°C	   (S.	   cerevisiae),	   180	   rpm.	   Cells	   were	   harvested	   by	  
centrifugation,	  washed	   in	   sterile	  water	  with	   1	   x	   108	   cells	  were	   used	   for	   each	   transformation.	   The	  
cells	  were	  resuspended	  in	  1	  mL	  lithium	  acetate	  (LiAc)	  (100	  mM)	  and	  incubated	  at	  30°C	  for	  15	  min.	  
Cells	   were	   pelleted,	   the	   supernatant	   removed	   and	   360	   μL	   transformation	   mix	   (33%	   (w/v)	  
polyethylene	  glycol	  (PEG)	  3350,	  0.1	  M	  LiAc,	  0.3	  mg/mL	  boiled	  and	  chilled	  salmon	  sperm	  DNA,	  200-­‐
500	   ng	  DNA	  per	   transformation)	  was	   added.	   The	  mixture	  was	   vortexed,	   incubated	   at	   30°C	   for	   30	  
minutes,	   then	   subjected	   to	   heat-­‐shock	   at	   42°C	   for	   20	   min.	   The	   cells	   were	   harvested	   by	  
centrifugation,	   resuspended	   into	   50	   μL	   ddH2O,	   plated	   onto	   appropriate	   SC	   dropout	   media	   and	  
incubated	  for	  two	  to	  four	  days	  at	  30°C	  or	  37°C.	  	  
	  
2.3.13	  Quick	  transformation	  of	  yeast	  cells	  
A	  colony	  of	  cells	  was	  added	  to	  500	  μL	  transformation	  mix	  (50%	  (w/v)	  PEG	  4000,	  0.1	  M	  LiAc,	  10	  mM	  
Tris-­‐HCl	   (pH	   7.5),	   0.0025	   mM	   EDTA	   pH8),	   500-­‐1000	   ng	   DNA	   for	   transformation	   and	   0.05	   mg/mL	  
boiled	  and	  chilled	  salmon	  sperm	  DNA.	  The	  mixture	  was	  vortexed,	  and	  incubated	  at	  25°C	  overnight,	  
then	  plated	  onto	  appropriate	  media	  and	  incubated	  for	  two	  to	  five	  days	  at	  30°C	  or	  37°C.	  
	  
2.3.14	  Bacterial	  transformation	  
E.	  coli	  cells	  were	  transformed	  using	  the	  heat	  shock	  method	  previously	  described	  [227].	  
	  
2.3.15	  Northern	  Analysis	  
Northerns	  were	  performed	  using	  a	  modification	  of	  the	  Northern	  technique	  [228].	  All	  glassware	  was	  
cleaned	  of	  RNAase	  prior	  to	  use	  and	  double	  autoclaved	  ddH2O	  (daddH2O)	  used	  throughout.	  Briefly,	  7	  
μL	  RNA	  (10	  μg	  RNA	  plus	  daddH2O)	  and	  15	  μL	  master	  mix	  (11.25	  μL	  DMSO,	  0.45	  μL	  phosphate	  buffer	  
(100	  mM),	  3.3	  μL	  glyoxal)	  were	   incubated	  at	  50°C	   for	  one	  hour,	   then	  chilled	  on	   ice.	   The	  RNA	  was	  
separated	  by	  agarose	  gel	  electrophoresis	  at	  100	  V	  until	  the	  samples	  had	  run	  ⅔	  of	  the	  way	  though	  the	  
gel.	  The	  gel	  was	  blotted	  overnight	  onto	  positively	  charged	  nylon	  membrane	  (Roche	  Diagnostics,	  UK).	  
The	  RNA	  was	  fixed	  by	  UV	  cross	   linking	  then	  5%	  (v/v)	  acetic	  acid,	  stained	   in	  methylene	  blue	  buffer,	  
rinsed	  in	  sterile	  water.	  The	  blot	  was	  pre-­‐hybridised	  in	  pre-­‐warmed	  DIG	  Easy	  Hyb	  (Roche	  Diagnostics,	  
UK)	  for	  two	  hours	  and	  hybridised	  overnight	  at	  50°C	  against	  a	  DIG	  DNA	  probe	  prepared	  using	  a	  PCR	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DIG	  probe	  synthesis	  kit	  (Roche	  Diagnostics,	  UK).	  The	  membrane	  was	  then	  washed	  in	  a	  low	  stringency	  
buffer	  (2	  x	  SSC,	  0.1%	  (w/v)	  SDS)	  at	  room	  temperature,	  high	  stringency	  buffer	  (0.1	  x	  SSC,	  0.1%	  (w/v)	  
SDS)	  at	  50°C	  and	  washing	  buffer	   (0.1	  M	  maleic	  acid,	  0.15	  M	  NaCl,	  pH	  7.5,	  0.3%	  (v/v)	  Tween	  20)	  at	  
room	  temperature.	  The	  membrane	  was	  blocked	  with	  blocking	  solution	   (1%	   (w/v)	  blocking	  powder	  
(Roche	   Diagnostics,	   UK)	   in	   0.1	   M	   maleic	   acid,	   0.15	   M	   NaCl	   (pH	   7.5))	   for	   one	   hour	   at	   25°C	   and	  
subsequently	   incubated	   with	   75	   mU/mL	   anti-­‐DIG-­‐AP	   antibody	   (Roche	   Diagnostics,	   UK)	   for	   30	  
minutes.	   The	  membrane	  was	  washed	   in	  washing	   buffer	   followed	  by	   a	   three	  minute	   incubation	   in	  
detection	  buffer	   (0.1	  M	  Tris-­‐HCl,	   0.1	  M	  NaCl,	  pH	  9.5)	   and	  detection	  was	  performed	  with	  CDP-­‐Star	  
(Roche	  Diagnostics,	  UK)	  and	  using	  Kodak	  biomax	  MR	  film	  (Hertfordshire,	  UK).	  	  
	  
2.3.16	  Southern	  Analysis	  
Southerns	  were	  performed	  using	  a	  modification	  of	  the	  Southern	  technique	  [229].	  Briefly,	  1-­‐5	  μg	  of	  
digested	  DNA	  was	  separated	  by	  agarose	  gel	  electrophoresis	  overnight.	  Following	  depurination	  (250	  
mM	  HCl),	   denaturation	   (0.5	  M	  NaOH,	   1.5	  M	  NaCl),	   neutralisation	   (0.5	  M	   Tris-­‐HCl	   (pH	   7.5),	   1.5	  M	  
NaCl)	  and	  equilibration	   in	  20	  x	  SSC	   (3	  M	  NaCl,	  300	  mM	  sodium	  citrate	   (pH	  7))	   the	  gel	  was	  blotted	  
overnight	   onto	   positively	   charged	   nylon	  membrane	   (Roche	   Diagnostics,	   UK).	   The	   DNA	  membrane	  
was	   fixed	   by	   UV	   cross-­‐linking	   then	   rinsed	   in	   sterile	   water	   and	   allowed	   to	   dry.	   The	   blot	   was	   pre-­‐
hybridised	   in	   pre-­‐warmed	   digoxigenin	   (DIG)	   Easy	   Hyb	   (Roche	   Diagnostics,	   UK)	   for	   two	   hours	   and	  
hybridised	  overnight	  against	  a	  DIG	  DNA	  probe	  prepared	  from	  the	  PCR	  fragment	  of	   the	  target	  DNA	  
using	  a	  PCR	  DIG	  probe	  synthesis	  kit	  (Roche	  Diagnostics,	  UK).	  The	  membrane	  was	  then	  washed	  in	  low	  
stringency	  buffer	  (2	  x	  SSC,	  0.1%	  (w/v)	  SDS)	  at	  room	  temperature,	  high	  stringency	  buffer	  (0.5	  x	  SSC,	  
0.1	  %	   (w/v)	  SDS)	  at	  65°C	  and	  washing	  buffer	   (0.1	  M	  maleic	  acid,	  0.15	  M	  NaCl	   (pH	  7.5),	  0.3%	   (v/v)	  
Tween	   20)	   at	   room	   temperature.	   The	  membrane	  was	   blocked	   (1%	   (w/v)	   blocking	   powder	   (Roche	  
Diagnostics,	  UK)	  in	  0.1	  M	  maleic	  acid,	  0.15	  M	  NaCl	  (pH	  7.5))	  for	  one	  hour	  at	  25°C	  and	  subsequently	  
incubated	   with	   75	   mU/mL	   anti-­‐DIG-­‐AP	   antibody	   (Roche	   Diagnostics,	   UK)	   for	   30	   minutes.	   The	  
membrane	  was	  washed	  in	  washing	  buffer	  followed	  by	  a	  3	  minute	  incubation	  in	  detection	  buffer	  (0.1	  
M	  Tris-­‐HCl,	  0.1	  M	  NaCl,	  pH	  9.5)	  and	  detection	  was	  performed	  with	  CDP-­‐Star	  (Roche	  Diagnostics,	  UK)	  
and	  using	  Kodak	  biomax	  MR	  film	  (Hertfordshire,	  UK).	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3	   Confirmation	  of	  the	  Ace2p	  regulon	  
	  
3.1	  Overview	  
The	  principle	  aim	  of	  this	  study	  is	  to	  unearth	  the	  cause	  of	  the	  hypervirulent	  phenotype	  shown	  by	  ace2	  
C.	   glabrata	   cells	   by	  Kamran	  et	   al.	   [7].	  Understanding	   the	  mechanisms	  behind	  Candida	   virulence	   is	  
crucial	   to	   our	   ability	   to	   develop	   new	   strategies	   to	   combat	   the	   increasing	   microbial	   problem	  
presented	   by	   pathogenic	   fungi.	   Recent	   data	   from	   genetic	   and	   proteomic	   research	   into	   Candida	  
virulence	  should	  provide	  greater	  targeting	  accuracy	  for	  both	  new	  and	  existing	  antifungal	  treatments,	  
on	  their	  own	  or	  in	  combination,	  toward	  essential	  fungal	  virulence	  mechanisms.	  It	  is	  also	  hoped	  that	  
new	  directly-­‐virulence	  related	  gene	  or	  protein	  targets	  can	  be	  identified	  for	  novel	  antifungal	  therapy	  
development	   such	   as	   direct	   inhibition,	   degradation,	   or	   even	   signature	   masking	   to	   prevent	   septic	  
shock.	   The	   fungal	   cell	  wall	   serves	   as	   the	  primary	   layer	   of	   defence	   in	   a	   hostile	   environment	   and	   is	  
therefore	   a	   common	   antifungal	   target.	   It	   also	   serves	   as	   the	   anchor	   point	   that	   ties	   mother	   to	  
daughter	  prior	  to	  cell	  separation	  and	  in	  cell	  separation	  deficient	  mutants.	  Several	  components	  of	  the	  
cell	   separation	  machinery,	  which	   interact	   directly	  with	   the	   cell	   wall	   during	   budding,	   show	  Ace2p-­‐
dependent	   expression	   in	   S.	   cerevisiae	   [101].	   It	   is	   hoped	   that	   by	   investigating	   the	   mechanism	  
underlying	   the	   hypervirulent	   effect	   displayed	   by	   ace2,	   our	   understanding	   of	   the	   mechanics	   of	   a	  
virulence	  moderating	  gene	  and	  its	  effects	  on	  or	  via	  the	  cell	  separation	  machinery	  will	  shed	  new	  light	  
on	  the	  pathogenicity	  of	  C.	  glabrata	  and	  other	  Candida	  species,	  as	  resilient	  fungal	  pathogens.	  
Ace2p,	   a	   transcription	   factor	   regulated	  by	   the	  RAM	  network	  of	  proteins	   [135]	   and	   involved	   in	   the	  
regulation	  and	  maintenance	  of	   the	  cell	   separation	  machinery,	  has	  been	  shown	  to	  cause	  a	  clumpy,	  
cell	  separation	  deficient	  growth	  phenotype	  in	  its	  absence	  in	  both	  S.	  cerevisiae	  and	  C.	  glabrata	  [132].	  
In	  C.	   glabrata,	  ace2	   null	   cells	   have	   been	   shown	   to	   cause	   hypervirulence	   in	   a	   neutropenic	  murine	  
model	  of	  systemic	  candidiasis,	  independent	  of	  the	  cell	  clumping	  shown	  on	  solid	  and	  liquid	  media	  [7].	  
Interaction	   data	   from	   S.	   cerevisiae	   has	   shown	   that	   Ace2p	   interacts	   with	   and	   influences	   the	  
transcription	  of	  several	  genes	  [230].	  Out	  of	  these	  genes	  several	  are	  known	  to	  form	  part	  of	  the	  cell	  
separation	   machinery	   including	   the	   chitinase	   Cts1p,	   glucan	   β1,3-­‐glucosidases	   Dse2p,	   Acf2p	  
(previously	  known	  as	  Dse4p	  in	  C.	  glabrata)	  and	  Scw11p,	  plus	  an	  endoglucanase	  Egt2p.	  
The	  experiments	  contained	  within	  this	  chapter	  were	  designed	  to	  define	  a	  partial	  Ace2p	  regulon	  in	  C.	  
glabrata,	  a	  collection	  of	  genes	  that	  show	  Ace2p-­‐dependent	  expression,	  to	  be	  used	  throughout	  the	  
rest	   of	   this	   project.	   In	   S.	   cerevisiae	   Ace2p	   and	   its	   homologue	   Swi5p,	   have	   been	   shown	   to	   exhibit	  
transcription	   regulation	   over	   an	   overlapping	   group	   of	   genes	   [101,	   133].	   Included	   in	   the	   Ace2p	  
dependent,	   Swi5p-­‐independent,	   group	  were	   the	   genes	  CTS1,	  DSE1,	  DSE2,	  DSE4	   and	  SCW11,	  while	  
the	   Swi5p-­‐dependent,	   Ace2p-­‐independent	   group	   included	   then	   genes	  AIM44,	   PCL9,	   PIR1	   and	   the	  
uncharacterised	   gene	  YNL046W	   [101,	   130].	  A	   group	   of	   genes	  were	   also	   found	   to	   be	   regulated	   by	  
both	  Ace2p	  and	  Swi5p,	  which	   included	  AMN1,	  ASH1,	  DSE3,	  EGT2,	  RME1	  and	  SIC1	  [101].	  BUD9	  was	  
also	   highlighted	   as	   showing	   possible	   Ace2p-­‐dependent	   expression,	   having	   been	   shown	   to	   be	  
daughter	   cell	   specific	   with	   G1	   expression,	   localised	   to	   the	   bud	   neck	   and	   to	   possess	   two	   adjacent	  
potential	  Ace2p	  binding	  sequences	  in	  its	  promoter	  region	  in	  C.	  glabrata	  [143,	  158,	  171,	  220].	  Due	  to	  
the	   lack	   of	   easily	   accessible	   and	   cost	   efficient	  microarray	   technologies	   for	  C.	   glabrata	   at	   the	   time	  
[231],	   and	   the	   availability	   of	   the	   tet-­‐regulated	  ACE2	   strain	  HLS119,	   it	  was	  decided	   that	   the	  Ace2p	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dependence	   of	   a	   selection	   of	  C.	   glabrata	   homologues	   of	   genes	   shown	   to	   be	   Ace2p-­‐dependent	   in	  
their	   expression	   in	   S.	   cerevisiae	   [101],	   were	   to	   be	   analysed	   by	   Northern	   analysis.	   The	   mRNA	  
transcripts	   from	   the	   previously	   uninvestigated	   genes	   AMN1,	   ASH1,	   BUD9,	   DSE1,	   DSE2,	   DSE3,	  
ACF2/DSE4,	  EGT2,	  RME1,	  SCW11α,	  SCW11β	  and	  SIC1	  were	  shown	  to	  be	  undetectable	  in	  the	  absence	  
of	   ACE2	   expression,	   while	   detectable	   in	   the	   presence	   of	   ACE2	   expression,	   and	   therefore	  
transcriptionally	   regulated	   in	   an	   Ace2p-­‐dependent	  manner	   in	  C.	   glabrata.	  Once	   Ace2p-­‐dependent	  
expression	  was	  confirmed	  for	  the	  set	  of	  12	  C.	  glabrata	  genes,	  they	  were	  identified	  as	  candidates	  for	  
targeted	  deletion	   and	   virulence	   analysis	   in	   a	   systemic	  model	   of	   candidiasis	   going	   forward.	   The	   12	  
genes	  therefore	  define	  the	  partial	  Ace2p	  regulon	  in	  C.	  glabrata	  as	  used	  throughout	  the	  rest	  of	  this	  
study,	  which	  lacks	  the	  previously	  investigated	  CTS1	  [142]	  and	  possibly	  other	  genes	  yet	  to	  be	  found	  to	  
be	  regulated	  by	  Ace2p.	  
The	  12	  genes	  of	  the	  partial	  Ace2p	  regulon	  studied	  within	  this	  project,	  have	  been	  shown	  play	  roles	  in	  
cell	  separation,	  cell	  wall	  and	  cell	  cycle	  progression	  within	  S.	  cerevisiae,	  as	  detailed	  in	  section	  1.7	  of	  
the	   Introduction.	   Briefly,	   Amn1p	   is	   an	   inhibitor	   of	   G-­‐protein	   signalling	   involved	   in	   cell	   cycle	  
progression	  and	  inhibition	  of	  mitotic	  exit	  through	  Tem1p	  binding,	  which	  prevents	  Cdc15p	  activation	  
and	  subsequent	  activation	  of	   the	  MEN	  [144].	  Ash1p	  plays	  a	  role	   in	  the	  control	  of	  cell	   fate	  through	  
regulation	   of	   mating-­‐type	   switching	   [149].	   It	   directly	   inhibits	   HO	   expression,	   which	   prevents	   the	  
mating-­‐type	  locus	  switching	  between	  a	  and	  α.	  Bud9p	  is	  a	  cell	  membrane	  targeted	  protein	  involved	  
in	   bud	   site	   selection,	  which	   acts	   as	   a	   cortical	   landmark	   in	   bipolar	   budding	   formation	   in	   diploid	   S.	  
cerevisiae	  cells	   [155-­‐157].	  DSE1	   encodes	  a	  protein	   that	   currently	  has	  no	   known	   function.	   It	   shows	  
little	  homology	   to	  other	  yeast	  genes,	  but	   is	   suggested	   to	  play	  a	   role	   in	  bud	  site	  selection;	   invasive	  
growth,	  or	  mating	  [163,	  166].	  DSE2,	  DSE4/ACF2,	  EGT2	  and	  SCW11	  are	  all	  thought	  to	  encode	  cell	  wall	  
targeted	  glucanases,	  and	  display	  daughter	  cell	   specific	  expression,	   localising	   to	   the	  bud	  neck	   [101,	  
127,	  130,	  195].	  They	  therefore	  likely	  play	  a	  role	  in	  septum	  hydrolysis	  and	  cell	  separation	  [101,	  127,	  
130,	   195].	   DSE3	   encodes	   another	   protein	   of	   unknown	   function.	   However,	   it	   has	   been	   shown	   to	  
exhibit	  daughter	  cell	  specific	  expression	  and	  localisation	  to	  the	  bud	  neck.	  It	  therefore	  is	  likely	  to	  play	  
a	  role	  in	  determining	  daughter	  cell	  fate	  [133,	  143].	  RME1	  encodes	  a	  zinc	  finger-­‐like	  distal	  repressor	  
protein,	   which	   regulates	   meiosis	   through	   inhibition	   of	   IME1	   expression	   [181-­‐185].	   Finally,	   SIC1	  
encodes	   a	   cyclin-­‐dependent	   kinase	   inhibitor,	   which	   binds	   to	   and	   inhibits	   the	   Cdk1p-­‐Clbp	   histone	  
kinase	  complexes,	  preventing	  premature	  transition	  to	  S-­‐phase	  and	  ensuring	  genomic	  integrity	  [209,	  
210].	  	  
Another	  gene	  that	  displays	  Ace2p-­‐dependent	  expression,	  CTS1,	  has	  already	  been	   investigated	   in	  C.	  
glabrata	   for	   virulence	   phenotypes.	   Although	  C.	   glabrata	   cts1	  null	  mutants	   display	   a	   hypervirulent	  
phenotype,	   CTS1	  deletion	  does	  not	   completely	   explain	   the	   extent	   of	   the	  hypervirulent	   phenotype	  
shown	  by	  C.	  glabrata	  ace2	  null	  mutants	  [142].	  CTS1	  encodes	  a	  cell	  wall	  chitinase	  that	  is	  responsible	  
for	  hydrolysis	  of	  the	  chitin	  septum	  for	  cell	  separation	  [102,	  129].	  
In	  an	  effort	  to	  discover	  the	  effects	  of	  ACE2	  deletion	  within	  C.	  glabrata,	  in	  this	  chapter	  we	  will	  show	  
that	   12	   genes	   display	   Ace2p-­‐dependent	   expression	   and	   that	   out	   of	   those	   12	   genes,	   10	   contain	  
potential	  Ace2p-­‐binding	   sites	  within	   their	  promoter	   regions,	   indicating	   that	   they	  are	   likely	  directly	  
transcriptionally	  regulated	  by	  Ace2p	  in	  C.	  glabrata.	  We	  will	  also	  define	  the	  partial	  Ace2p	  regulon	  to	  
be	  used	   throughout	   the	   rest	  of	   this	   study	   in	  an	  effort	   to	   study	   the	  virulence	  moderating	  effect	  of	  
Ace2p	  in	  C.	  glabrata.	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3.2	  Materials	  and	  methods	  
3.2.1	  Northern	  analysis	  of	  Ace2p	  regulon	  in	  C.	  glabrata	  Ace2p	  tet-­‐regulated	  strain	  
HLS119,	   a	   tet-­‐regulatory	  mutant	  of	  C.	   glabrata	  ACE2	   [180],	  was	   grown	  overnight	   in	   50	  mL	  YPD	  at	  
37°C,	  180	  rpm	  shaking,	  with	  and	  without	   the	  presence	  of	  doxycycline	   (200	  µg/mL).	  The	  cells	  were	  
harvested	  by	  centrifugation	  and	  total	  RNA	  was	  then	  extracted	  via	  a	  modified	  acid	  phenol	  method,	  as	  
described	  in	  section	  2.3.9.	  
Northern	   analysis	   was	   then	   performed	   on	   the	   total	   RNA	   samples	   as	   described	   in	   section	   2.3.15.	  
Briefly,	   the	   total	   RNA	  was	   quantified	   by	  Nanodrop	   and	   then	   incubated	   at	   50°C	   for	   one	   hour	  with	  
DMSO,	   100	  mM	  phosphate	  buffer	   and	   glyoxal.	   The	  RNA	  was	   then	   loaded	   at	   7	  µg	  per	  well	   for	   gel	  
electrophoresis	  and	  then	  blotted	  overnight.	  A	  DIG	  DNA-­‐based	  probe	  was	  constructed	  for	  each	  gene	  
using	   internal	   primers	   listed	   in	   Appendix	   3	   and	   a	   Roche	   DIG	   probe	   kit,	   according	   to	   the	  
manufacturer’s	   instructions.	   The	  membranes	  were	   then	  probed	  overnight,	  washed	  and	  developed	  
on	  film.	  
	  
3.2.2	  Analysis	  of	  the	  upstream	  regions	  of	  Ace2p	  regulon	  genes	  in	  C.	  glabrata	   for	  potential	  Ace2p	  
binding	  sites	  
C.	  glabrata	  gene	  sequences	  were	  downloaded	  from	  the	  Génolevures	  C.	  glabrata	  genome	  database	  
[171]	  and	  analysed	   for	  potential	   consensus	  motifs	  using	  Gibbs	  analysis	   [232].	  The	  sequences	  were	  
also	  imported	  into	  Serial	  Cloner,	  version	  2.1,	  Serial	  Basics,	  France.	  The	  open	  reading	  frames	  (ORFs)	  
were	  then	  mapped,	  while	  the	  intergene	  regions	  upstream	  of	  the	  target	  genes	  highlighted	  with	  Gibbs	  
analysis	  were	  analysed	  for	  potential	  Ace2p	  binding	  sites	  (ACCAGC)	  and	  their	  reverse	  complements	  as	  
defined	  in	  S.	  cerevisiae	  by	  Dohrmann	  et	  al.	  [220].	  The	  potential	  binding	  sites	  were	  then	  marked	  and	  
the	  distance	  in	  base	  pairs	  to	  the	  start	  codon	  of	  the	  target	  gene	  was	  calculated	  for	  each.	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3.3	  Results	  
3.3.1	  Ace2p	  transcriptionally	  regulates	  12	  genes	  	  
As	  discussed	  previously,	  expression	  and	  interaction	  data	  from	  S.	  cerevisiae	  [101,	  133,	  230]	  indicated	  
that	  Ace2p	   could	   exhibit	   transcriptional	   control	   over	   a	   group	  of	   genes	   that	   includes	   12	  previously	  
uninvestigated	  genes.	  To	  confirm	  that	  the	  genes	  selected	  to	  take	  forward	  for	  virulence	  analysis	  were	  
part	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata,	  a	  tet-­‐regulated	  mutant	  strain	  for	  ACE2	  (HLS119)	  was	  used	  
to	  assay	  for	  the	  presence	  or	  absence	  of	  the	  12	  gene	  transcripts	  thought	  to	  exhibit	  Ace2p-­‐dependent	  
expression.	  Northern	  analysis	  was	  used	  to	  detect	  the	  presence	  of	  mRNA	  for	  each	  of	  the	  12	  genes	  in	  
the	  presence	  or	  absence	  of	  Ace2p.	  The	  results	  show	  (Figure	  3.1)	  that	  the	  expression	  of	  AMN1,	  ASH1,	  
BUD9,	  DSE1,	  DSE2,	  DSE3,	  ACF2	  (DSE4),	  EGT2,	  RME1,	  SCW11α,	  SCW11β,	  and	  SIC1	  is	  Ace2p-­‐dependent	  
and	  therefore	  form	  part	  of	  the	  Ace2p	  regulon	  as	  defined	  here.	  
	  
Figure	  3.1	  –	  C.	  glabrata	  Ace2p	  regulates	  the	  expression	  of	  12	  genes	  putatively	  involved	  in	  cell	  wall	  biology,	  daughter	  cell	  
specific	  expression	  and	  cell	  cycle	  regulation.	  C.	  glabrata	  HLS119	  was	  cultured	  overnight	  in	  YPD	  in	  the	  absence	  (-­‐,	  ACE2	  
de-­‐repressed)	  and	  presence	  (+,	  ACE2	   repressed)	  of	  200	  mg/mL	  doxycycline.	  Total	  RNA	  was	  extracted	  using	  a	  modified	  
acid	  phenol	  method,	  and	  7	  µg	  was	  loaded	  per	  lane.	  	  The	  upper	  panels	  show	  Northern	  analysis.	  Probes	  were	  constructed	  
using	  internal	  primer	  pairs	  from	  the	  relevant	  gene	  indicated	  above	  each	  pair	  of	  panels.	  	  Primers	  are	  listed	  in	  Appendix	  3.	  	  
The	  lower	  panels	  show	  methylene	  blue	  loading	  controls.	  In	  the	  presence	  of	  doxycycline	  ACE2	  expression	  is	  repressed	  as	  
shown	  by	  the	  lack	  of	  a	  band	  in	  the	  ACE2	  +	  lane.	  	  All	  other	  genes	  analysed	  show	  a	  loss	  of	  band	  in	  the	  absence	  of	  ACE2	  
expression	  demonstrating	  that	  their	  expression	  in	  C.	  glabrata	  is	  dependent,	  either	  directly	  or	  indirectly,	  on	  Ace2p.	  
 
3.3.2	  Potential	  Ace2p	  binding	  sites	  in	  the	  promoter	  regions	  of	  the	  Ace2p	  regulon	  genes	  
Having	   shown	   that	   the	   expression	   of	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  DSE2,	  DSE3,	  ACF2	   (DSE4),	   EGT2,	  
RME1,	  SCW11α,	  SCW11β,	  and	  SIC1	  is	  Ace2p-­‐dependent	  in	  C.	  glabrata,	  the	  upstream	  regions	  of	  each	  
of	  the	  Ace2p	  regulon	  genes	  was	  analysed	  for	  potential	  Ace2p	  binding	  sites	  (ACCAGC)	  as	  defined	  by	  
Dohrmann	  et	  al.	   [220].	  Using	  sequences	  from	  the	  Génolevures	  C.	  glabrata	  genome	  database	  [171]	  
and	  Gibbs	  analysis	  [232]	  it	  was	  possible	  to	  identify	  a	  potential	  shared	  motif	  in	  10	  out	  of	  the	  12	  genes,	  
as	  well	  as	  the	  C.	  glabrata	  homologue	  of	  CTS1.	  Screening	  of	  each	  of	  the	  10	  genes	  and	  CTS1	  showed	  at	  
least	   two	   Ace2p	   binding	   sites	   within	   the	   intergene	   region	   upstream	   of	   the	   start	   codon	   and	  
downstream	  of	   the	  next	  closest	  gene	  ORF.	  The	  site	  positions	  are	  mapped	  below	   in	  Figures	  3.2a,	  b	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and	  c	   in	  relation	  to	  the	  start	  codon	  of	  the	  target	  gene,	  with	  all	  co-­‐ordinates	  and	  sizes	  measured	  in	  
base	  pairs.	  
	  
Figure	   3.2a	   –	   Potenial	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   the	   Ace2p	   regulon	   ORFs	   in	   C.	  
glabrata.	   The	   intergene	   region	  upstream	  of	   the	  Ace2p	   regulon	  genes	   in	  C.	  glabrata	   is	  displayed	  with	  potential	  Ace2p	  
binding	  sites	  (ACCAGC)	  [220]	  marked	  for	  position	  relative	  to	  the	  ATG	  of	  the	  Ace2p-­‐dependent	  gene	  of	   interest.	  All	  co-­‐
ordinates	  and	  measurements	  are	  in	  base	  pairs,	  all	  sequences	  were	  taken	  from	  Génolevures	  [171].	  Diagrams	  are	  not	  to	  
scale.	  AMN1	  has	  two	  potential	  Ace2p	  binding	  sites	  between	   it	  and	  FAB1;	  ASH1	  has	   four	  potential	  Ace2p	  binding	  sites	  
between	  it	  and	  MTR2;	  BUD9	  has	  two	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  KSS1;	  DSE1	  has	  two	  potential	  Ace2p	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binding	   sites	  between	   it	   and	  RSP5;	  DSE2	   has	   three	  potential	  Ace2p	  binding	   sites	  between	   it	   and	  CH37;	   and	  DSE3	   has	  
three	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  CAGL0C02805g.	  
	  
	  
Figure	   3.2b	   –	   Potenial	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   the	   Ace2p	   regulon	   ORFs	   in	   C.	  
glabrata.	   The	   intergene	   region	  upstream	  of	   the	  Ace2p	   regulon	  genes	   in	  C.	  glabrata	   is	  displayed	  with	  potential	  Ace2p	  
binding	  sites	  (ACCAGC)	  [220]	  marked	  for	  position	  relative	  to	  the	  ATG	  of	  the	  Ace2p-­‐dependent	  gene	  of	   interest.	  All	  co-­‐
ordinates	  and	  measurements	  are	  in	  base	  pairs,	  all	  sequences	  were	  taken	  from	  Génolevures	  [171].	  Diagrams	  are	  not	  to	  
scale.	  ACF2	   lacks	  any	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  RMP1;	  EGT2	  has	  four	  potential	  Ace2p	  binding	  sites	  
between	  it	  and	  MDJ2;	  RME1	  lacks	  any	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  SCM4;	  SCW11α 	  has	  three	  potential	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Ace2p	  binding	  sites	  between	  it	  and	  CWH41;	  SCW11β 	  has	  three	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  RRN6;	  and	  
SIC1	  has	  two	  potential	  Ace2p	  binding	  sites	  between	  it	  and	  BOS1.	  
	  
Figure	   3.2c	   –	   Four	   Potenial	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   region	   upstream	   of	   	   CTS1	   in	   C.	   glabrata.	   The	  
intergene	  region	  upstream	  of	  CTS1	  in	  C.	  glabrata	  is	  displayed	  with	  potential	  Ace2p	  binding	  sites	  (ACCAGC)	  [220]	  marked	  
for	  position	  relative	   to	   the	  ATG.	  All	   co-­‐ordinates	  and	  measurements	  are	   in	  base	  pairs,	  all	   sequences	  were	  taken	   from	  
Génolevures	   [171].	   Diagrams	   are	   not	   to	   scale.	   CTS1	   has	   four	   potential	   Ace2p	   binding	   sites	   between	   it	   and	  
CAGL0M09757g.	  
	  
3.3.3	  Selection	  of	  target	  genes	  for	  deletion	  
Having	  identified	  that	  the	  12	  previously	  uninvestigated	  genes	  show	  Ace2p-­‐dependent	  expression	  in	  
C.	  glabrata	  as	  shown	  in	  Figure	  3.1,	  all	  12	  genes	  were	  selected	  for	  genetic	  deletion	  for	  further	  study	  
into	  the	  effects	  of	  the	  partial	  Ace2p	  regulon	  on	  virulence	  within	  chapter	  4.	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3.4	  Discussion	  
The	   experiments	   outlined	   in	   this	   chapter	   have	   shown	   for	   the	   first	   time	   that	   a	   group	   of	   12	   genes	  
exhibit	   Ace2p-­‐dependent	   expression	   in	   C.	   glabrata.	   Through	   the	   use	   of	   Northern	   analysis	   and	  
HLS119,	  a	  tetracycline	  transcriptionally-­‐regulated	  mutant	  for	  C.	  glabrata	  ACE2,	  it	  was	  shown	  that	  in	  
the	  presence	  of	  ACE2	  expression	  all	  12	  gene	  transcripts	  were	  detectable	  by	  Northern	  blot,	  illustrated	  
in	  Figure	  3.1.	  It	  was	  also	  shown	  that	  in	  the	  absence	  of	  ACE2	  expression	  under	  doxycycline	  conditions,	  
all	  12	  gene	  transcripts	  were	  undetectable	  (Figure	  3.1).	   It	   is	  therefore	  possible	  to	  define	  part	  of	  the	  
Ace2p	  regulon	  in	  C.	  glabrata	  and	  confirm	  the	  Ace2p-­‐dependence	  of	  the	  expression	  of	  the	  C.	  glabrata	  
orthologues	  of	  S.	  cerevisiae	  genes	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  DSE2,	  DSE3,	  ACF2	  (DSE4),	  EGT2,	  RME1,	  
and	  SIC1	  in	  C.	  glabrata.	  The	  majority	  of	  these	  results	  show	  similarity	  to	  the	  observations	  of	  Doolin	  et	  
al.	   in	   S.	   cerevisiae	   [101],	   in	   which	   it	   was	   found	   that	   some	   genes,	  DSE1,	   DSE2	   and	   SCW11	   display	  
Ace2p-­‐dependance	   independent	   of	   Swi5p.	   It	   is	   interesting	   to	   note	   however,	   that	   the	   results	   also	  
indicate	   that	   in	   C.	   glabrata,	   AMN1,	   ASH1,	   DSE3,	   EGT2,	   RME1	   and	   SIC1	   show	   Ace2p-­‐dependent	  
expression	  independent	  of	  Swi5p	  and	  aren’t	  detectable	  by	  Northern	  analysis	  in	  stationary	  cells	  in	  the	  
absence	   of	  ACE2	   expression.	   Doolin	   et	   al.	   showed	   that	   in	  S.	   cerevisiae,	   the	   expression	   of	   the	   five	  
genes	  is	  regulated	  by	  both	  Ace2p	  and	  Swi5p,	  requiring	  a	  double	  knockout	  of	  ace2-­‐swi5	  to	  result	   in	  
near	  total	  suppression	  of	  expression	  [101].	  The	  difference	  in	  results	  between	  the	  two	  studies	  could	  
indicate	   that	   the	  Ace2p-­‐Swi5p	   transcriptional	   regulation	  overlap	   is	   different	   in	  C.	   glabrata	   than	  S.	  
cerevisiae.	   The	   two	   budding	   yeast,	   although	   close	   genetic	   relatives,	   are	   distinct	   species	   and	   show	  
differences	  in	  their	  cellular	  processes,	  not	  least	  of	  all	  virulence,	  drug	  resistance	  and	  ploidy	  (reviewed	  
by	   Roetzer	   et	   al.	   [104]).	   Recently	   in	   C.	   glabrata,	   EGT2	   expression	   was	   suggested	   as	   being	   solely	  
Ace2p-­‐dependent	  and	  independent	  on	  Swi5p	  [180],	  which	  the	  results	  from	  this	  study	  corroborate.	  
The	  dependence	  difference	  could	  also	  be	  down	  to	  the	  disparity	  in	  cell	  growth	  phase	  at	  the	  time	  of	  
harvesting	   in	   the	   experiments,	   as	   Doolin	   et	   al.	   harvested	   cells	   in	   mid-­‐logarithmic	   or	   exponential	  
growth	  phase,	  whereas	   the	  cells	  used	   in	   this	  study	  were	  harvested	   from	  overnight	  cultures,	  which	  
were	   therefore	   in	   the	  stationary	  growth	  phase.	   It	  has	  been	  shown	   that	  at	   least	  one	  gene	  shows	  a	  
different	   pattern	   of	   Ace2p-­‐Swi5p	   regulation	   in	   exponential	   and	   stationary	   phase	   cells,	   with	   EGT2	  
expression	  being	  shown	  to	  be	  Ace2p-­‐dependent	  and	  Swi5p-­‐independent	  in	  a	  saturated	  S.	  cerevisiae	  
culture	   [133].	   To	   fully	   clarify	   the	   difference	   in	   Ace2p-­‐Swi5p	   dependent	   regulation	   between	   C.	  
glabrata	   and	   S.	   cerevisiae,	   further	   analysis	   of	   gene	   expression	   from	   HLS119	   cells	   in	   exponential	  
growth	  phase	  would	  be	  needed.	  Northern	  analysis	  of	  the	  expression	  of	  C.	  glabrata	  genes	  with	  and	  
without	  the	  presence	  of	  Swi5p	  would	  also	  clarify	  whether	  Swi5p	  plays	  a	  role	  in	  the	  regulation	  of	  the	  
Ace2p	  regulon	  and	  Ace2p-­‐dependent	  genes.	  
Having	  been	  shown	  to	  exhibit	  Ace2p-­‐dependent	  expression,	  it	  has	  also	  been	  shown	  for	  the	  first	  time	  
that	   BUD9	   expression	   is	   Ace2p-­‐dependent	   in	   C.	   glabrata.	   Ace2p-­‐dependent	   expression	   was	  
hypothesised	  based	  on	  the	  presence	  of	  two	  adjacent	  Ace2p	  binding	  sites	  within	  the	  promoter	  region	  
of	  BUD9	  [171],	  which	  have	  been	  shown	  to	  be	  required	  for	  Ace2p	  binding	  and	  direct	  transcriptional	  
regulation	  [220].	  
The	   expression	   of	   two	   separate	   orthologues	   of	   S.	   cerevisiae	   SCW11	   was	   found	   to	   be	   Ace2p-­‐
dependent	   in	  C.	  glabrata	   and	  have	  been	  named	  SCW11α	   (SCW11a)	   (CAGL0A01474g)	  and	  SCW11β	  
(SCW11b)	  (CAGL0E02915g)	  henceforth.	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3.4.1	  Ace2p	  transcriptional	  regulation:	  direct	  or	  indirect?	  
By	   studying	   the	   upstream	   promoter	   regions	   of	   the	   known	   Ace2p-­‐dependent	   gene	   CTS1	   and	   the	  
known	   Swi5p-­‐dependent	   gene	  HO	   in	   S.	   cerevisiae,	   Dohrmann	   et	   al.	   showed	   that	   both	   Ace2p	   and	  
Swi5p	   share	   a	   common	   binding	   site	   marked	   by	   a	   six	   base	   core	   sequence,	   ACCAGC	   [220].	   They	  
hypothesised	   that	   Ace2p	   bound	   co-­‐operatively	   to	   two	   adjacent	   sites	   to	   enhance	  Ace2p-­‐specificity	  
and	  regulation	  of	  CTS1	  expression,	  although	  they	  could	  not	  prove	  co-­‐operative	  binding	  in	  vitro	  [220].	  
They	   also	   suggested	   that	   Swi5p	   binding	   to	   Ace2p-­‐dependent	   genes	   was	   inhibited	   by	   a	   negative	  
sequence	  element	  that	  was	  downstream	  of	  the	  potential	  Ace2p	  binding	  sites	   [220],	  and	  suggested	  
that	  an	  unmapped	  gene,	  which	  they	  referred	  to	  as	  NCE3,	  was	  responsible	  for	  Swi5p	  inhibition,	  due	  
to	   the	  ability	  of	  Swi5p	   to	   induce	  CTS1	  expression	   in	  ace2	  nce3	  double	  mutants	   [220].	  Because	   the	  
NCE3	   region	   is	  as	  yet	  unmapped	   in	  S.	  cerevisiae,	   it	   is	  not	  possible	   to	  search	   for	  a	  homologue	   in	  C.	  
glabrata.	  	  
Although	  only	  DNA-­‐binding	  assays	  like	  those	  originally	  implemented	  by	  Dohrmann	  et	  al.	  [220]	  could	  
conclusively	  show	  the	  binding	  site	  of	  C.	  glabrata	  Ace2p	  and	  Swi5p,	  it	   is	  interesting	  to	  consider	  that	  
due	   to	   the	  sequence	  conservation	  between	  S.	   cerevisiae	   and	  C.	  glabrata	  with	   respect	   to	   the	  ACE2	  
and	  SWI5	  genes,	  BLAST	  scores	  of	  413E-­‐115	  and	  209E-­‐84	  respectively	  [171],	  it	  could	  be	  possible	  that	  the	  
core	  of	  the	  binding	  sites	  for	  C.	  glabrata	  Ace2p	  and	  Swi5p	  could	  be	  similar	  or	  the	  same	  to	  that	  of	  the	  
S.	  cerevisiae	  genes.	  To	  that	  end	  the	  upstream	  intergene	  sequence	  between	  CTS1	  and	  the	  next	  ORF,	  
the	   uncharacterised	   gene	   CAGL0M09757g,	   was	   analysed	   in	   C.	   glabrata	   to	   see	   if	   potential	   Ace2p	  
binding	   sites	   were	   detectable.	   As	   shown	   in	   Figure	   3.2c,	   four	   potential	   Ace2p	   binding	   sites	   were	  
found	  in	  the	  upstream	  region.	  The	  number,	  four	  instead	  of	  the	  three	  found	  in	  the	  S.	  cerevisiae	  CTS1	  
promoter,	   the	   spacing	  between	   the	  potential	   sites,	   and	   the	   sequences	   surrounding	   them	  differ	   to	  
what	  was	  found	  by	  Dohrmann	  et	  al.	  [220],	  but	  each	  of	  the	  potential	  sites	  were	  within	  relatively	  close	  
proximity	  of	  one	  another,	  ranging	  between	  116	  and	  26	  base	  pairs	  separation.	  Using	  this	  knowledge	  
combined	   with	   Gibbs	   analysis	   of	   the	   promoter	   regions	   of	   each	   of	   the	   target	   genes,	   once	   Ace2p-­‐
dependent	  expression	  was	  confirmed	  for	  the	  Ace2p	  regulon	  genes	  in	  C.	  glabrata,	  the	  next	  step	  was	  
to	   look	   at	   their	   upstream	   regulatory	   regions	   to	   see	   if	   potential	   Ace2p	   binding	   sites	   exist	   in	   their	  
promoters	  similar	  to	  the	  ones	  found	  for	  CTS1.	  	  
The	  results	  displayed	  in	  Figures	  3.2a	  and	  3.2b	  show	  that	  for	  10	  of	  the	  12	  genes,	  at	  least	  two	  potential	  
Ace2p	  binding	  sites	  were	  found.	  Some	  of	   the	  potential	  Ace2p	  binding	  sites	  were	  placed	  outside	  of	  
the	   assumed	   size	   of	   the	   normal	   upstream	   promoter	   region,	   being	   over	   1000	   base	   pairs	   from	   the	  
start	  codon	  of	  the	  ORF.	  AMN1	  has	  an	  ACCAGC	  site	  at	  -­‐1131	  base	  pairs	  from	  the	  ATG,	  while	  another	  
one	  is	  much	  closer	  to	  the	  ORF	  at	  -­‐194	  base	  pairs	  from	  the	  start	  codon.	  This	  could	  indicate	  that	  the	  
promoter	  region	  of	  AMN1	  is	  quite	  large,	  extending	  past	  -­‐1137	  base	  pairs	  from	  the	  ATG.	  It	  could	  also	  
show	   that	  AMN1	   only	  has	  one	  active	  potential	  Ace2p	  binding	   site	   in	   its	   promoter	   and	   that	  one	   is	  
enough	  to	  exert	  control	  over	  its	  transcription.	  ASH1	  and	  EGT2	  also	  have	  one	  potential	  Ace2p	  binding	  
site	  beyond	  1000	  base	  pairs	  upstream	  of	   the	  ATG	  at	   -­‐1375	  and	   -­‐1581	  respectively.	  However,	  both	  
genes	  have	  three	  other	  potential	  Ace2p	  binding	  sites	  closer	  to	  the	  ORF	  and	  within	  close	  proximity	  to	  
each	  other,	  the	  -­‐814	  to	  -­‐578	  and	  -­‐637	  to	  -­‐366	  base	  pair	  region	  respectively.	  Again	  this	  could	  indicate	  
that	   the	   site	   located	   past	   1000	   base	   pairs	   upstream	   of	   the	   ORF	   is	   out	   of	   range	   of	   the	   promoter	  
region	  and	  that	  potential	  Ace2p	  direct	  transcriptional	  regulation	  revolves	  around	  the	  three	  clustered	  
together	  closer	  to	  the	  start	  codon.	  The	  other	  genes,	  BUD9,	  DSE1,	  DSE2,	  DSE3,	  SCW11α,	  SCW11β	  and	  
SIC1,	  each	  have	  at	  least	  two	  potential	  Ace2p	  binding	  sites	  within	  256	  base	  pairs	  of	  each	  other.	  These	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results,	  combined	  with	  their	  Ace2p-­‐dependent	  expression,	  shows	  that	  this	  group	  of	  10	  genes,	  AMN1,	  
ASH1,	   BUD9,	   DSE1,	   DSE2,	   DSE3,	   EGT2,	   SCW11α,	   SCW11β	   and	   SIC1	   are	   likely	   to	   be	   directly	  
transcriptionally	   regulated	   by	   Ace2p	   binding	   to	   the	   promoter,	   although	   possibly	   not	   as	   positively	  
compared	   to	   CTS1	   due	   to	   the	   larger	   spacing	   between	   potential	   binding	   sites.	   To	   confirm	   this	  
assumption,	  further	  work	  using	  DNA	  binding	  assays	  to	  look	  at	  the	  protein-­‐DNA	  interaction	  would	  be	  
needed	  to	  prove	  whether	  Ace2p	  can	  bind	  directly	  to	  the	  DNA	  sequence	  in	  C.	  glabrata	  and	  therefore	  
exert	  direct	  transcriptional	  regulation	  over	  the	  genes.	  
A	   look	  at	   the	  sequence	  of	   the	  other	  two	  genes	  of	   the	  Ace2p	  regulon,	  ACF2	  and	  RME1,	   shows	  that	  
they	   lack	  any	  form	  of	  the	  Ace2p	  binding	  site	   in	  their	  upstream	  regions	   in	  C.	  glabrata	   (Figure	  3.2b),	  
while	  Gibbs	  analysis	  failed	  to	  detect	  any	  consensus	  motif	  found	  in	  the	  other	  10	  genes.	  Because	  both	  
ACF2	  and	  RME1	  display	  Ace2p-­‐dependent	  expression,	  but	  lack	  potential	  Ace2p	  binding	  sites	  in	  their	  
promoter	   regions,	   it’s	   likely	   that	   they	   are	   transcriptionally	   regulated	   through	   an	   intermediary	   or	  
series	   of	   intermediaries	   and	   not	   directly	   by	   Ace2p.	   It	   is	   therefore	   possible	   that	   they	   are	  
transcriptionally	   regulated	   by	   Ace2p	   via	   unknown	   proteins	   or	   mechanisms,	   which	   in	   turn	   exhibit	  
control	   over	   ACF2	   and	   RME1	   expression.	   It’s	   also	   possible	   that	   ACF2	   and	   RME1	   may	   be	  
transcriptionally	   regulated	  by	  one	  or	  more	  of	   the	  other	  Ace2p-­‐dependent	  genes	   in	  other	  potential	  
parts	  of	  Ace2p	  regulon,	  or	  even	  by	  the	  uncharacterised	  Dse1p.	  Further	  analysis	  of	  the	  regulation	  of	  
ACF2	  and	  RME1,	  their	  expression	  and	  the	  ability	  of	  other	  proteins	  to	  bind	  to	  their	  promoter	  regions	  
in	   vitro	   and	   in	   vivo	   will	   be	   required	   to	   determine	   the	   mechanism	   of	   their	   Ace2p-­‐dependent	  
expression.	  
	  
3.4.2	  C.	  glabrata	  ace2	  clumping	  phenotype	  
In	  both	  S.	   cerevisiae	   and	  C.	  glabrata,	  ace2	  null	  mutants	  display	  a	   clumpy,	   cell	   separation	  deficient	  
phenotype	  on	  both	  solid	  and	  liquid	  media	  [7,	  129].	  This	  is	  partly	  due	  to	  the	  lack	  of	  expression	  of	  the	  
Ace2p-­‐dependent	  chitinase,	  Cts1p,	  which	  hydrolyses	  the	  chitin	  components	  of	  the	  primary	  septum	  
to	   allow	   for	   separation	   of	   mother	   and	   daughter	   cells	   [102].	   Cts1p,	   although	   it	   plays	   a	   major	  
structural	   degradation	   role	   in	   separating	   mother	   from	   daughter,	   isn’t	   the	   sole	   arbiter	   of	   cell	  
separation.	   Many	   other	   components	   form	   the	   cell	   separation	   machinery	   and	   are	   necessary	   for	  
correct	   separation	   and	   dissemination	   of	   progeny	   in	   S.	   cerevisiae	   (reviewed	   by	   Yeong	   [125]).	  
Glucanases	  and	  other	  cell	  wall	  associated	  proteins	  have	  been	  shown	  to	  be	  crucial	  to	  cell	  separation,	  
displaying	  chains	  of	  linked	  cells	  or	  clumpy	  phenotypes	  when	  disrupted	  [125,	  133].	  It	  is	  thought	  that,	  
in	   conjunction	  with	  Cts1p-­‐mediated	   chitin	  degradation,	   glucanases	  act	   to	  hydrolyse	   the	   secondary	  
septum	  and/or	  the	  surrounding	  cell	  wall,	  allowing	  mother	  and	  daughter	  to	  separate	  [125].	  
The	  extreme	  clumpy	  phenotype	  displayed	  by	  ace2	  C.	  glabrata	  cells	  [7]	  is	  likely	  due	  to	  a	  combination	  
of	  failure	  of	  expression	  and	  therefore	  loss	  of	  action	  of	  Cts1p	  and	  the	  cell	  wall	  glucanases.	  Looking	  at	  
the	  reported	  functions	  of	  the	  C.	  glabrata	  Ace2p	  regulon	  homologues	  in	  S.	  cerevisiae,	  it	  is	  clear	  that	  
at	  least	  some	  of	  them	  play	  a	  role	  in	  glucan	  hydrolysis	  as	  part	  of	  the	  cell	  separation	  machinery.	  Four	  
genes,	  DSE2,	  DSE4,	  EGT2	   and	  SCW11,	   are	   thought	   to	  encode	   cell	  wall	   associated	  glucanases	   [101,	  
127,	  130,	  133,	  134],	  which	  are	  bud	  neck	  localised	  [143]	  and	  are	  therefore	  thought	  to	  play	  a	  role	  in	  
glucan	  hydrolysis.	   It	   is	  possible	  that	  they	  also	  play	  a	  role	  in	  cell	  wall	  maintenance.	  C.	  glabrata	  ace2	  
mutants	   show	   a	   16-­‐	   and	   38-­‐fold	   increase	   in	   release	   of	   the	   inflammatory	   cytokines,	   IL6	   and	   TNFα	  
respectively,	  during	   infection	   [233],	  which	  have	  been	  shown	  to	  play	  a	   role	   in	  host	  defence	  against	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Candida	   infections	   [234].	   It	   has	   been	   suggested	   that	   the	   massive	   inflammatory	   cytokine	   over-­‐
stimulation	   by	   ace2	  mutants	   represents	   a	   septic	   shock	   response;	   an	   inappropriate	   extreme	   host	  
response	  to	  infection,	  which	  can	  trigger	  multiple	  organ	  failure	  and	  subsequent	  death	  due	  in	  part	  to	  
reduced	  blood	  volume	  and	  pressure	  (reviewed	  by	  Sriskandan	  and	  Cohen)	  [233,	  235].	  It	  is	  therefore	  
possible	  that	  a	  change	  in	  the	  cell	  wall	  structure	  attributed	  to	  the	  absence	  of	  DSE2,	  DSE4,	  EGT2	  and	  
SCW11	  expression,	   and	   therefore	   the	   cell	  wall	   activities	  of	   their	   encoded	  glucanases,	   in	  ace2	   cells	  
causes	   a	   change	   in	   the	   immune	   recognition	   of	   the	   mutant	   C.	   glabrata	   cells,	   leading	   to	   the	  
inappropriate	  immune	  response.	  To	  test	  this	  theory	  macrophage	  stimulation	  assays	  using	  individual	  
dse2,	  dse4,	  egt2	   and	   scw11α	   and	   scw11β	  C.	   glabrata	   cells	  will	   be	   required,	  which	  will	   be	   able	   to	  
show	  whether	  or	  not	  their	  absence	  of	  expression	  causes	  changes	  in	  the	  cytokine	  response	  in	  vitro.	  
Two	  other	  genes	  in	  the	  Ace2p	  regulon,	  DSE1	  and	  DSE3	  encode	  proteins	  of	  unknown	  function	  [133,	  
143].	  Dse1p	  is	  thought	  to	  play	  a	  role	  in	  cell	  wall	  metabolism	  due	  to	  the	  increased	  cell	  wall	  targeted	  
condition	   sensitivity	   shown	  by	  dse1	   S.	   cerevisiae	   cells	   [101].	   This	   could	  mean	   that	   the	   absence	   of	  
Dse1p	  function	  may	  change	  cell	  wall	  metabolism,	  and	  therefore	   impact	   immune	  recognition	   in	  the	  
host	   and	   also	  may	   contribute	   to	   the	   cell	   separation	   defect	   of	   ace2	   cells.	   It	   is	   unknown	  what	   the	  
deletion	  of	  DSE3	  might	  cause,	  with	  regard	  to	  cell	  separation	  or	  immune	  recognition.	  
Bud9p	  has	  been	  highlighted	  as	  a	  cell	  wall	  associated	  cortical	  landmark,	  which	  plays	  a	  role	  in	  bipolar	  
budding	  [155-­‐157].	  It	  is	  known	  to	  be	  cell	  wall	  anchored	  and	  to	  have	  a	  large,	  heavily	  glycosylated	  N-­‐
terminal	   extracytoplasmic	   domain	   [156],	   which	   in	   theory,	   may	   contribute	   to	   immune	   recognition	  
and	  cell	  wall	  structure.	  This	  means	  that	  absence	  of	  BUD9	  expression	  may	  cause	  changes	  in	  the	  cell	  
wall	  structure	  and	  therefore	  alter	  the	  host	  pathogen	  interaction.	  Its	  role	  in	  the	  cell	  separation	  defect	  
displayed	   by	   ace2	   C.	   glabrata	   cells	   is	   unknown;	   however,	   its	   absence	   may	   disrupt	   the	   normal	  
budding	  pattern	  of	  C.	  glabrata	  cells.	  
The	  remaining	  genes	  of	  the	  Ace2p	  regulon,	  AMN1,	  ASH1,	  RME1	  and	  SIC1	  all	  play	  a	  role	  in	  cell	  cycle	  
control,	  and	  have	  no	  known	  direct	  effect	  on	  the	  cell	  wall	  or	  cell	  separation.	  Amn1p	  is	  a	  regulator	  of	  
mitotic	   exit	   that	   blocks	  G-­‐protein	   signalling,	   inhibiting	  MEN	   and	   allowing	   the	   cell	   to	   progress	   into	  
START	  and	  S-­‐phase	  [144].	  The	  absence	  of	  AMN1	  expression	  may	  play	  a	  role	  in	  the	  clumpy	  phenotype	  
by	  slowing	  the	  growth	  of	  cells	  and	  causing	  cell	  cycle	  arrest	  or	  delays.	  Equally	  amn1	   causes	  cells	   to	  
arrest,	  which	  could	  mean	  that	   it	  reduces	  budding	  frequency	  and	  therefore	  could	  also	  act	  to	   inhibit	  
the	  clumpy	  phenotype.	  It	  is	  unclear	  what	  role	  Amn1p	  would	  play	  in	  virulence	  or	  immune	  activation.	  
Ash1p	  has	  been	  shown	  to	  be	  involved	  in	  the	  control	  of	  mating-­‐type	  switching	  through	  the	  repression	  
of	  HO	  [147].	  It	  is	  unclear	  what	  role	  Ash1p	  has	  in	  C.	  glabrata	  due	  to	  its	  lack	  of	  a	  mating-­‐locus,	  or	  what	  
affect	  its	  deletion	  would	  have	  on	  immune	  activation	  or	  virulence.	  Rme1p	  represses	  IME1	  expression	  
and	  therefore	  the	  initiation	  of	  meiosis	  [181-­‐185].	  It	  has	  also	  been	  shown	  to	  promote	  mitosis	  through	  
Cln2p	  activation	   [189,	  190].	  S.	  cerevisiae	  rme1	  mutants	  have	  been	  shown	  to	  have	  reduced	  steady-­‐
state	  levels	  of	  CLN2	  expression	  and	  increased	  cell	  size	  [189,	  190].	  Absence	  of	  RME1	  expression	  could	  
therefore	  affect	  cell	  size	  and	  rate	  of	  budding,	  although	  it	  is	  unclear	  how	  this	  could	  promote	  a	  clumpy	  
phenotype.	   Finally,	   Sic1p	   has	   been	   shown	   to	   bind	   to	   and	   inhibit	   the	   Cdk1p-­‐Clbp	   histone	   kinase	  
complexes	  preventing	  premature	  progression	  to	  S-­‐phase	  and	  ensuring	  genomic	  integrity	  [209,	  210].	  
S.	   cerevisiae	   sic1	   mutants	   have	   been	   shown	   to	   exhibit	   partial	   mitotic	   arrest,	   premature	   DNA	  
replication	   and	   genome	   instability	   [208].	   It	   is	   unknown	  what	   contribution	   this	   could	  make	   to	   the	  
ace2	  clumpy	  phenotype,	  but	   it	   is	  possible	  that	   it	  could	   increase	  the	  generation	  time	  and	  therefore	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reduce	   the	   number	   of	   budding	   cells	   progressing	   through	   mitotic	   arrest,	   which	   could	   reduce	   the	  
clumpy	  phenotype.	  
For	  the	  first	  time	  in	  C.	  glabrata,	  it	  has	  been	  shown	  that	  12	  genes	  have	  Ace2p-­‐dependent	  expression	  
and	   that	  of	   the	  12	  genes,	  10	  of	   them	  are	   likely	   to	  be	  directly	   transcriptionally	   regulated	  by	  Ace2p	  
binding.	   It	   is	  now	  possible	  to	  use	  that	  data	  to	  expand	  upon	  our	  understanding	  of	  Ace2p	  within	  the	  
cell	  cycle,	  cell	  separation	  and	  virulence.	  Concurrently,	  now	  that	  the	  core	  of	  potential	  Ace2p	  binding	  
sites	  has	  been	  shown	  to	  exist	  within	  the	  promoter	  regions	  of	  Ace2p	  expression	  dependent	  genes	  in	  
C.	   glabrata,	   it	   is	   also	   possible	   to	   screen	   genes	  within	   the	  C.	   glabrata	   genome	   for	   potential	   direct	  
Ace2p	   transcriptional	   regulation	   via	   their	   sequence	   alone,	   as	  was	   shown	  with	   the	   investigation	  of	  
BUD9.	  	  
The	   extreme	   hypervirulence	   shown	   by	   ace2	   in	   C.	   glabrata	   [7]	   is	   most	   likely	   attributable	   to	   a	  
combination	  of	  gene	  absences	  and	  removal	  of	  their	  biological	  functions	  or	  physical	  interactions.	  It	  is	  
also	  possible	  that	  Ace2p	  exerts	  direct	  and	  indirect	  control	  over	  more	  genes	  than	  those	  defined	  here,	  
and	  that	  it	  is	  their	  change	  in	  expression	  levels	  that	  causes	  the	  hypervirulent	  phenotype.	  	  
In	   chapter	   4,	   to	   investigate	   the	   hypothesis	   that	   the	   partial	   Ace2p	   regulon,	   as	   defined	   within	   this	  
chapter,	  is	  responsible	  for	  the	  hypervirulent	  phenotype	  displayed	  by	  C.	  glabrata	  ace2	  cells,	  deletion	  
of	  each	  of	   the	  named	  genes,	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  DSE2,	  DSE3,	  ACF2,	  EGT2,	  RME1,	  SCW11α,	  
SCW11β,	   and	   SIC1,	   will	   be	   carried	   out.	   The	   effects	   of	   their	   deletion	   with	   regard	   phenotype,	  
sensitivity	  to	  stress	  conditions,	  and	  growth	  rate	  will	  be	  studied,	  in	  an	  effort	  to	  discern	  the	  effect	  of	  
their	  absence	  on	  C.	  glabrata.	  The	  null	  mutants	  will	  also	  be	  studied	  with	  regard	  for	  virulence	  in	  both	  
in	  vitro	  and	  in	  vivo,	  using	  immune	  stimulation	  assays	  and	  a	  murine	  model	  of	  systemic	  candidiasis,	  to	  
unearth	  the	  potential	  for	  each	  of	  the	  12	  genes	  to	  be	  antivirulence	  or	  virulence-­‐moderating	  genes.	  
An	   investigation	   into	   the	  uncharacterised	  gene	  DSE1	  will	  be	  carried	  out	   in	  chapter	  5	  using	  both	  C.	  
glabrata	  and	  S.	  cerevisiae	  in	  an	  effort	  to	  further	  our	  understanding	  of	  the	  cellular	  function	  and	  role	  
or	  roles	  that	  Dse1p	  has	  within	  C.	  glabrata.	  To	  that	  end	  phenotypic	  analysis,	  sensitivity	  screening	  and	  
a	   study	   of	   cell	   polarity	   using	   dse1	   nulls	   from	   both	   species	   of	   yeast	   will	   be	   conducted.	   Cellular	  
localisation	  of	  Dse1p	  within	  known	  interactor	  [165]	  nulls	  and	  structural	  prediction	  of	  Dse1p	  from	  C.	  
glabrata	  will	  also	  be	  employed	  in	  an	  attempt	  to	  gather	  enough	  data	  to	   identify	  possible	  roles,	  and	  
dismiss	  others	  suggested	  in	  the	  literature,	  for	  the	  previously	  unknown	  function	  of	  Dse1p.	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4	   Study	  of	  the	  Ace2	  regulon	  and	  its	  role	  in	  hypervirulence	  
	  
4.1	  Overview	  
4.1.1	  Conventional	  virulence	  factors	  in	  C.	  glabrata	  
Our	   understanding	   of	   the	   virulence	   of	  C.	   glabrata	   is	   in	   its	   infancy.	  Nevertheless,	   certain	   virulence	  
factors	   for	  C.	   glabrata	   have	   been	   identified	   and	   discussed	   in	   the	   Introduction.	   Briefly,	   phenotypic	  
switching	  has	  been	  suggested	  to	  play	  a	  role	  in	  host	  environment	  adaptation	  and	  therefore	  virulence,	  
displaying	  selectivity	  to	  anatomical	  site	  in	  clinical	  isolates	  [77,	  84].	  Adhesion	  is	  also	  known	  to	  play	  an	  
important	  role	  in	  C.	  glabrata	  virulence	  and	  biofilm	  formation,	  mediated	  by	  the	  EPA	  family	  of	  genes,	  
which	  are	  GPI-­‐anchored	  cell	  wall	  proteins	   similar	   to	   the	  ALS	  and	  HWP1	   genes	   found	   in	  C.	  albicans	  
[85].	  In	  S.	  cerevisiae,	  the	  EPA	  genes	  are	  predominantly	  located	  at	  sub-­‐telomeric	  loci	  and	  are	  subject	  
to	  SIR-­‐dependent	   transcriptional	   silencing	   (reviewed	  by	  Rusche	  et	   al.	   [236]).	   It	   is	   thought	   that	   the	  
transcriptional	   silencing	   found	   in	   S.	   cerevisiae	   is	   maintained	   within	   C.	   glabrata	   and	   that	   NAD+	   is	  
required	  as	  a	  co-­‐substrate	  for	  the	  Sir2p-­‐dependent	  deacetylation	  reaction	  that	  leads	  to	  repression	  of	  
C.	   glabrata	   EPA	   genes	   [89,	   92].	   Because	   C.	   glabrata	   lacks	   the	   ability	   to	   synthesise	   NAD+	   from	  
tryptophan,	   relying	   solely	   on	   salvaging	   pathways	   from	   vitamin	   precursors	   such	   as	   nicotinic	   acid,	  
nicotinamide	   and	   nicotinamide	   ridoside,	   it	   has	   been	   shown	   that	   in	   environments	   low	   in	   NAD+	  
vitamin	   precursors,	   such	   as	   the	   urine	   tract,	   cause	   the	   derepression	   of	   EPA	   expression	   and	   an	  
increase	   in	  adherence	  and	  therefore	  virulence	  [89].	  The	  highly	  conserved	  STE-­‐family	  of	  genes	  have	  
also	  been	  suggested	  to	  play	  a	  role	  in	  C.	  glabrata	  virulence	  with	  ste11,	  ste12	  and	  ste20	  null	  mutants	  
all	   showing	   attenuated	   virulence	   in	  murine	  models	   of	   disseminated	   candidiasis	   [81-­‐83].	   Ste12p,	   a	  
highly	  conserved	  transcriptional	  regulator,	   is	  activated	  by	  the	  MAP	  kinase	  signalling	  cascade	  and	   is	  
involved	  in	  pseudohyphal	  formation	  in	  S.	  cerevisiae,	  something	  that	  has	  yet	  to	  be	  proven	  as	  playing	  a	  
role	   in	   C.	   glabrata	   pathogenesis	   due	   to	   the	   lack	   of	   clinical	   isolates	   displaying	   pseudohyphal	  
formation	   [77].	   STE11	   and	   STE20	   encode	   protein	   kinases	   that	   play	   important	   roles	   in	   several	  
signalling	   cascades	   including	   the	   response	   to	   hypertonic	   stress,	   an	   important	   factor	   in	   the	   host-­‐
pathogen	  interaction	  and	  therefore	  unsurprisingly	  both	  proteins	  are	  required	  for	  wild	  type	  levels	  of	  
virulence	  [82,	  83].	  
C.	  glabrata’s	  virulence	  has	  often	  been	  put	  down	  to	  its	  innate	  and	  adaptive	  resistance	  to	  antifungals,	  
especially	  azoles,	  which	  target	  the	  ergosterol	  biosynthesis	  pathway.	  C.	  glabrata	  achieves	  resistance	  
though	   over	   expression	   of	   two	   ABC	   transporter	   genes	   CDR1	   and	   CDR2,	   which	   are	   overexpressed	  
causing	  azole	  efflux	  [18].	  The	  target	  of	  azoles,	  the	  lanosterol	  14-­‐α-­‐demethylase	  encoded	  by	  ERG11,	  
can	  also	  be	  upregulated	  in	  response	  to	  azole	  attack,	  which	  helps	  C.	  glabrata	  stave	  off	  the	  effects	  of	  
ergosterol	   synthesis	   disruption	   [19].	   Finally,	   C.	   glabrata	   can	   also	   increase	   free	   ergosterol	  
concentration	  through	  permanent	  or	  reversible	  loss	  of	  mitochondrial	  function,	  which	  not	  only	  aids	  in	  
resistance	   to	   azoles,	   but	   also	   to	   drugs	   that	   target	   and	   bind	   to	   ergosterol	   directly	   such	   as	  
amphotericin-­‐B	  and	  the	  rest	  of	  the	  polyene	  family	  [94].	  Another	  interesting	  virulence	  related	  factor	  
in	  C.	  glabrata’s	  favour	  over	  other	  Candida	  species	  is	  its	  reduced	  immune	  activation	  footprint	  [100].	  
Failure	   to	   induce	  appropriate	   levels	  of	   immune	  cytokine	  release	  could	  be	   the	  root	  of	   the	  difficulty	  
patients	  and	  clinicians	  experience	  in	  clearing	  C.	  glabrata	  infection	  from	  the	  immune	  compromised.	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4.1.2	  A	  novel	  antivirulence	  gene	  in	  C.	  glabrata	  
In	  2004,	  a	  novel	  antivirulence	  or	  virulence-­‐moderating	  gene	  was	  discovered	  in	  C.	  glabrata	  by	  Kamran	  
et	  al.	   in	  ACE2	   [7].	  This	  was	  the	  first	  discovery	  of	  an	  antivirulence	  gene	  in	  Candida	  species,	  and	  was	  
characterised	  by	  an	  extreme	  hypervirulence	  displayed	  by	  ace2	  cells,	  causing	  100%	  mortality	  in	  under	  
18-­‐hours	   post	   infection	   in	   a	   neutropenic	   murine	  model	   of	   disseminated	   candidiasis	   [7].	  ACE2,	   as	  
previously	   described,	   encodes	   a	   transcriptional	   regulator	   of	   the	   cell	   separation	   machinery	   that	  
hydrolyses	  the	  septum	  and	  allows	  for	  dissemination	  of	  progeny	  [101,	  102].	  The	  hypervirulence	  effect	  
was	  demonstrated	  to	  be	  independent	  of	  the	  clumpy,	  cell	  separation	  deficient	  phenotype	  displayed	  
by	  ace2	  cells,	  through	  manual	  separation	  of	  ace2	  cells	  by	  enzymatic	  digestion	  of	  the	  primary	  septum	  
using	  chitinase	  prior	  to	  inoculation	  [7].	  This	  conclusion	  was	  reinforced	  by	  the	  finding	  that	  ace2	  null	  
cells	  were	  avirulent	  in	  immunocompetent	  mice	  [237],	  and	  by	  the	  discovery	  of	  other	  clumpy	  strains	  
of	  C.	  albicans	  that	  have	  been	  shown	  to	  be	  avirulent	  in	  vivo	  such	  as	  tup1	  and	  och1	  [238,	  239].	  
As	  a	  fungal	  pathogen,	  it	  seems	  illogical	  on	  an	  evolutionarily	  scale	  to	  maintain	  a	  gene	  that	  causes	  such	  
a	  rapid	  and	  extreme	  hypervirulence	  advantage	  in	  its	  absence,	  unless	  its	  product	  has	  a	  crucial	  role	  in	  
cell	   survival	   and	   dissemination.	   As	   a	   cell	   separation	   machinery	   transcriptional	   regulator,	   it	   is	  
therefore	  likely	  that	  ACE2’s	  advantage	  must	  lie	  in	  its	  ability	  to	  aid	  dissemination	  of	  progeny.	  In	  fact	  C.	  
glabrata,	  unlike	  S.	  cerevisiae	  or	  C.	  albicans,	   lacks	  any	  known	  form	  of	   true	  morphological	   switching	  
between	  yeast	  and	  hyphal	  states,	  other	  than	  the	  formation	  of	  pseudohyphae	  in	  vitro	  [31].	  Therefore,	  
budding	  and	  subsequent	  cell	  separation	  is	  C.	  glabrata’s	  only	  currently	  known	  mode	  of	  dissemination	  
and	  therefore	  transmission,	  which	  might	  explain	  why	  such	  a	  potent	  antivirulence	  gene	  is	  maintained	  
as	  an	  evolutionary	  advantage	  [233].	  
	  
4.1.3	  The	  Ace2p	  regulon	  
As	  previously	  discussed	  Ace2p	  controls	  a	  suite	  of	  previously	  uninvestigated	  genes	   in	  C.	  glabrata	  as	  
defined	  in	  Chapter	  3	  as	  the	  partial	  Ace2p	  regulon.	  The	  Ace2p	  regulon	  includes	  many	  of	  the	  genes	  of	  
the	   cell	   separation	  machinery,	   including	   genes	   that	   encode	   cell	  wall	   associated	   glucanases	   (DSE2,	  
ACF2	   (DSE4),	   EGT2,	   SCW11α	   and	   SCW11β)	   and	   a	   chitinase	   (CTS1)	   [101,	   102,	   127,	   129,	   130,	   195].	  
Ace2p	   also	   controls	   the	   transcription	   of	   a	   regulator	   of	   mitotic	   exit	   (AMN1)	   [144],	   a	   regulator	   of	  
mating	   type-­‐switching,	   which	   is	   a	   process	   that	   as	   yet	   hasn’t	   been	   shown	   to	   exist	   in	   C.	   glabrata,	  
(ASH1)	  [149],	  a	  bud	  site	  selection	  marker	  (BUD9)	  [155-­‐157],	  a	  regulator	  of	  meiosis	  (RME1)	  [181-­‐185],	  
and	   a	   cyclin-­‐dependent	   kinase	   inhibitor	   involved	   in	   control	   of	   the	   G1	   to	   S-­‐phase	   transition	   (SIC1)	  
[209,	  210].	  Two	  genes	  of	  currently	  unknown	  function	  are	  also	  transcriptionally	  regulated	  by	  Ace2p	  in	  
C.	  glabrata:	  DSE1	  and	  DSE3.	  DSE1	  has	  recently	  been	  suggested	  as	  playing	  a	  role	   in	  cell	   separation,	  
bud	   site	   selection,	   invasive	   growth	   or	   mating	   in	   S.	   cerevisiae.	   DSE3	   shows	   daughter	   cell	   specific	  
expression	   and	   is	   localised	   to	   the	   bud	   neck,	   and	   therefore	   has	   been	   proposed	   to	   play	   a	   role	   in	  
determining	  daughter	  cell	   fate.	  CTS1	  has	  already	  been	   investigated	   in	  C.	  glabrata	   in	   relation	   to	   its	  
potential	  antivirulence	  effect	  [142],	  and	  although	  it	  was	  shown	  to	  cause	  a	  hypervirulent	  phenotype	  
in	   its	   absence,	   does	   not	   fully	   explain	   the	   extent	   of	   the	  ace2	   hypervirulence	   effect	   [7].	   The	   partial	  
Ace2p	  regulon	  genes	  have	  no	  obvious	  direct	  link	  with	  antivirulence	  from	  their	  characterisation	  in	  S.	  
cerevisiae	   and	   other	   species.	   Therefore	   investigation	   of	   the	   virulence	  moderating	   potential	   of	   the	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partial	  Ace2p	  regulon	  gene	  required	  deletion	  of	  each	  of	  the	  genes	  controlled	  by	  Ace2p	  and	  screening	  
for	  hypervirulence	  compared	  to	  the	  wild	  type	  C.	  glabrata	  strain,	  Cg2001.	  
To	   this	   end,	   two	  methods	   of	   gene	   deletion	  were	   employed,	   one	   using	   a	   fusion	   PCR	  methodology	  
[240]	  and	  another	  using	  a	  simpler	  one-­‐step	  PCR	  method	  [241].	  Deletions	  were	  created	  in	  either	  Cg	  
his3	  or	  CgΔΔΔ	  background	  strains	  by	  electroporation	  as	  described	  in	  section	  2.3.11.	  Once	  deletions	  
were	  confirmed	  via	  PCR	  and	  Southern	  analysis,	  the	  mutants	  were	  taken	  forward	  into	  phenotypic	  and	  
virulence	   screening.	   Deletion	  mutants	  were	   created	   for	   the	   first	   time	   in	  C.	   glabrata	   for	   10	   genes	  
including:	  AMN1,	   ASH1,	   BUD9,	   DSE1,	   DSE3,	   ACF2,	   EGT2,	   RME1,	   SCW11β	  and	   SIC1.	   The	   other	   two	  
genes	  DSE2	   and	  SCW11α	   remain	  undisrupted.	  None	  of	   the	   gene	  deletions	   created	   in	   this	   chapter	  
showed	  significant	  phenotypic	  differences	   from	   their	  parental	   strains	  under	   solid	  agar	  and	  growth	  
rate	  screening,	  apart	  the	  from	  a	  mild	  cell	  separation	  defect	  displayed	  by	  both	  dse1	  and	  egt2.	  	  
Historically,	  a	  murine	  model	  of	  candidiasis	  employing	  neutropenic	  male	  CD1	  mice	  has	  been	  used	  to	  
test	  for	  C.	  glabrata	  virulence	  [7,	  81].	  After	  initial	  pilot	  studies,	  a	  modified	  murine	  model	  of	  virulence	  
was	  used	  to	  screen	  the	  10	  individual	  Ace2p	  regulon	  deletions,	  with	  six	  different	  mutants	  displaying	  
significantly	   increased	   virulence	   when	   compared	   to	   the	  C.	   glabrata	   wild	   type.	   The	  mutants	   dse3,	  
acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1	  all	  induced	  100%	  mortality	  after	  5	  days	  compared	  with	  only	  40%	  
over	  14	  days	  for	  the	  wild	  type.	  The	  results	  indicate	  that	  the	  extreme	  hypervirulence	  observed	  in	  C.	  
glabrata	   ace2	   mutants	   is	   indeed	   a	  multifactorial	   effect,	   with	   combined	   gene	   absences	   creating	   a	  
synergistic	  effect	  on	  the	  virulence	  level	  of	  C.	  glabrata.	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4.2	  Materials	  and	  Methods	  	  
	  
4.2.1	  Construction	  of	  ash1,	  bud9,	  dse1,	  dse3,	  egt2	  and	  rme1	  null	  mutants	  by	  fusion	  PCR	  
Deletion	  of	  C.	  glabrata	  target	  genes	  was	  performed	  via	  a	  modified	  high-­‐throughput	  fusion	  PCR	  gene	  
deletion	   technique	   [240].	   A	   deletion	   cassette	   including	   a	   NAT	   resistance	   marker	   was	   created	   by	  
fusion	  PCR	  and	   transformed	   into	   the	  C.	  glabrata	  his3	   strain.	  Barcodes	   from	   the	  S.	   cerevisiae	   gene	  
deletion	   project	   [242,	   243]	   have	   been	   included	   for	   genes	   with	   S.	   cerevisiae	   homologues.	   The	  
approach	   is	   schematically	   demonstrated	   below.	   Primers,	   which	   are	   listed	   in	   Appendix	   3,	   are	  
indicated	  with	  their	  approximate	  relative	  position	  to	  the	  ORF	  of	  the	  gene	  in	  question.	  
	  
Figure	   4.1	   –	   Construction	   of	   C.	   glabrata	   deletion	   mutants	   by	   homologous	   recombination	   of	   a	   fusion	   PCR	   deletion	  
cassette.	  Primers,	  as	  listed	  in	  Appendix	  3,	  were	  designed	  to	  produce	  products	  containing	  500	  bp	  of	  homology	  with	  the	  5’	  
and	  3’	  UTRs	  of	  the	  target	  gene	  and	  20	  bp	  tails	  of	  the	  U2	  and	  D2	  regions	  of	  the	  NATR	  cassette.	  The	  deletion	  cassette	  was	  
then	  created	  by	  fusion	  PCR	  essentially	  as	  described	  by	  [240,	  244]	  and	  transformed	  into	  the	  C.	  glabrata	  his3	  strain	  using	  
electroporation.	   Flippase	   recognition	   target	   (FRT)	   sites	   for	  marker	   recycling	  and	  barcodes	   from	   the	  S.	   cerevisiae	   gene	  
deletion	  project	  [242,	  243]	  have	  been	  included	  for	  genes	  with	  S.	  cerevisiae	  homologues.	  
The	  deletion	  cassette	  was	  made	  through	  a	  fusion	  PCR	  process.	  First	  the	  5’	  and	  3’UTR	  regions	  of	  the	  
target	  gene	  were	  amplified	  using	  primer	  pairs,	  -­‐500-­‐F	  and	  -­‐1-­‐NAT-­‐R	  or	  +-­‐NAT-­‐F	  and	  +500-­‐R,	  including	  
an	  up	  or	  down	  tag	  which	  have	  been	  taken	  from	  the	  S.	  cerevisiae	  ORF	  barcoding	  system	  [243].	  The	  5’	  
and	  3’	  UTRs	  with	  homology	   in	  the	  U2	  and	  D2	  regions,	  as	   indicated	  above,	  are	  then	  fused	  with	  the	  
NAT	  resistance	  cassette	  to	  create	  the	  deletion	  cassette	  [245].	  The	  deletion	  cassette	  was	  transformed	  
into	   C.	   glabrata	   his3	   and	   selected	   on	   -­‐HIS	   dropout	   media	   supplemented	   with	   CloneNAT	   at	   200	  
µg/mL	  (nourseothricin,	  Werner	  BioAgents,	  Germany).	  Colony	  PCR	  and	  Southern	  analysis	  were	  used	  
to	  confirm	  gene	  deletion.	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A	  Southern	  DNA	  probe	  specific	  to	  the	  NAT	  resistance	  cassette	  was	  constructed	  via	  PCR	  using	  the	  DIG	  
PCR	   fluorescence	   labelling	   kit	   (Roche,	   UK)	   according	   to	   the	  manufacturer’s	   instructions,	   using	   the	  
primers	  listed	  in	  Appendix	  3.	  
The	  C.	   glabrata	  ash1	  null	  mutant	  was	   constructed	   by	   removing	   2229bps	   of	   the	  C.	   glabrata	  ASH1	  
gene	   (-­‐68	   to	   +2161	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +2136)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG2	  
(his3,	  ash1::NATR).	  
The	  C.	   glabrata	  bud9	  null	  mutant	  was	   constructed	  by	   removing	   1692bps	  of	   the	  C.	   glabrata	  BUD9	  
gene	   (-­‐29	   to	   +1663	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1587)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG3	  
(his3,	  bud9::NATR).	  	  
The	  C.	  glabrata	  dse1	  null	  mutant	  was	  constructed	  by	  removing	  1747bps	  of	  the	  C.	  glabrata	  DSE1	  gene	  
(-­‐4	   to	   +1743	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1701)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG4	  
(his3,	  dse1::NATR).	  
The	  C.	  glabrata	  dse3	  null	  mutant	  was	  constructed	  by	  removing	  1364bps	  of	  the	  C.	  glabrata	  DSE3	  gene	  
(-­‐44	   to	   +1320	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1314)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG6	  
(his3,	  dse3::NATR).	  	  
The	  C.	  glabrata	  egt2	  null	  mutant	  was	  constructed	  by	  removing	  2099bps	  of	  the	  C.	  glabrata	  EGT2	  gene	  
(-­‐41	   to	   +2058	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +2028)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG8	  
(his3,	  egt2::NATR).	  	  
The	  C.	  glabrata	   rme1	  null	  mutant	  was	   constructed	  by	   removing	  1850bps	  of	   the	  C.	  glabrata	  RME1	  
gene	   (-­‐56	   to	   +1794	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1641)	   via	   homologous	  
recombination	  using	  a	  NAT	  resistance	  cassette	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG9	  
(his3,	  rme1::NATR).	  
For	  a	  list	  of	  primers	  used	  in	  the	  creation	  of	  the	  Ace2p	  regulon	  null	  mutants	  please	  see	  Appendix	  3.	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4.2.2	  Construction	  of	  amn1,	  acf2,	  scw11b	  and	  sic1	  null	  mutants	  by	  Edlind	  method	  
Construction	  of	  four	  of	  the	  remaining	  partial	  Ace2p	  regulon	  genes	  was	  performed	  using	  a	  modified	  
Edlind	   method	   [241].	   Briefly,	   primer	   pairs	   and	   a	   one-­‐step	   PCR	   were	   used	   to	   create	   the	   deletion	  
cassette,	  which	  included	  60	  bps	  of	  homology	  ending	  at	  the	  start	  and	  stop	  codons	  of	  the	  target	  gene	  
plus	  a	  S.	  cerevisiae	  TRP1	  deletion	  marker	  [108].	  The	  deletion	  cassette	  was	  then	  transformed	  into	  C.	  
glabrata	  ΔΔΔ	  via	  electroporation	  and	  selected	  for	  on	  -­‐TRP	  dropout	  media.	  Colony	  PCR	  and	  Southern	  
analysis	  were	  used	  to	  confirm	  gene	  deletion.	  
	  
A	   Southern	   DNA	   probe	   specific	   to	   S.	   cerevisiae	   TRP1	   was	   constructed	   via	   PCR	   using	   the	   DIG	   PCR	  
fluorescence	  labelling	  kit	  (Roche,	  UK)	  according	  to	  the	  manufacturer’s	  instructions,	  using	  the	  primers	  
listed	  in	  Appendix	  3.	  
The	  C.	  glabrata	  amn1	  null	  mutant	  was	  constructed	  by	  removing	  1536bps	  of	  the	  C.	  glabrata	  AMN1	  
gene	   (1	   to	   +1536	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1533)	   via	   homologous	  
recombination	  using	  a	  S.	  cerevisiae	  TRP1	  gene	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG1	  
(his3,	  trp1,	  leu2,	  amn1::TRP1).	  	  
The	  C.	  glabrata	  acf2	  null	  mutant	  was	  constructed	  by	  removing	  2313bps	  of	  the	  C.	  glabrata	  ACF2	  gene	  
(1	   to	   +2313	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +2310)	   via	   homologous	  
Figure	   4.2	   –	   Construction	   of	   C.	   glabrata	   deletion	   mutants	   by	   homologous	   recombination	   of	   a	   one-­‐step	   Edlind	  
method	   disruption	   cassette.	   A.	   Primers	   were	   designed	   with	   20	   bp	   of	   homology	   to	   the	   ScTRP1	   marker	   and	  
containing	  60	  bp	  of	  homology	   to	   the	  5’	   and	  3’	  UTRs	  of	   the	   target	   gene	   up	   to	   the	   start	   and	   stop	   codons.	  B.	   The	  
disruption	  cassette	  was	  created	  via	  PCR	  to	  create	  the	  ScTRP1	  marker	  flanked	  by	  60	  bp	  of	  homology	  to	  the	  5’	  and	  3’	  
UTR	   of	   the	   target	   ORF.	   C.	   	   The	   disruption	   cassette	   was	   transformed	   into	   the	   C.	   glabrata	   ΔΔΔ 	   strain	   using	  
electroporation	  for	  disruption	  of	  the	  target	  ORF	  by	  homologous	  recombination.	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recombination	  using	  a	  S.	  cerevisiae	  TRP1	  gene	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG7	  
(his3,	  trp1,	  leu2,	  acf2::TRP1).	  
The	   C.	   glabrata	   scw11β	   null	   mutant	   was	   constructed	   by	   removing	   1497bps	   of	   the	   C.	   glabrata	  
SCW11β	   gene	   (1	   to	   +1497	   with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1494)	   via	  
homologous	   recombination	   using	   a	   S.	   cerevisiae	   TRP1	   gene	   as	   a	   selectable	   marker	   producing	   C.	  
glabrata	  SRSG11	  (his3,	  trp1,	  leu2,	  scw11β::TRP1).	  	  
The	  C.	  glabrata	  sic1	  null	  mutant	  was	  constructed	  by	  removing	  849bps	  of	  the	  C.	  glabrata	  SIC1	  gene	  (1	  
to	  +849	  with	  respect	  to	  the	  start	  codon,	  the	  stop	  codon	  is	  at	  +846)	  via	  homologous	  recombination	  
using	  a	  S.	  cerevisiae	  TRP1	  gene	  as	  a	  selectable	  marker	  producing	  C.	  glabrata	  SRSG12	  (his3,	  trp1,	  leu2,	  
sic1::TRP1).	  
	  
4.2.3	  Reconstitution	  of	  C.	  glabrata	  gene	  deletions	  
Reconstitution	   of	   C.	   glabrata	   Ace2p	   regulon	   gene	   deletions	   that	   showed	   hypervirulence	   when	  
compared	   to	   the	   parental	   strain	   was	   performed	   using	   the	   vector	   pBM51	   [Biao	   Ma	   (personal	  
communication)]	  due	  to	  the	  time	  constraints	  placed	  on	  this	  stage	  of	  the	  project,	  the	  reliability	  and	  
availability	  of	  the	  pBM51	  plasmid	  and	  the	  relative	  speed	  and	  ease	  of	  plasmid-­‐based	  reconstitution.	  
Briefly,	  primer	  pairs	  were	  used	  to	  create	  a	  PCR	  product	  containing	  only	  the	  target	  gene	  ORF	  from	  C.	  
glabrata	   flanked	  by	  suitable	  digestion	  sites,	  allowing	  use	  of	   the	  pBM51	  plasmid,	  driving	   the	   target	  
gene	  expression	  using	  its	  PGK1	  promoter	  and	  HIS3	  3’	  UTR.	  The	  poly	  A	  tails	  were	  then	  added	  to	  the	  
PCR	  product,	  which	  was	  then	  ligated	  into	  the	  TA	  TOPO	  pCR2.1	  vector	  using	  the	  TA	  TOPO	  cloning	  kit	  
(Bioline,	   UK)	   as	   per	   the	  manufacturer’s	   instructions	   and	   transformed	   into	  One-­‐Shot	   TOP10	   E.	   coli	  
chemically	  competent	  cells	  (Bioline,	  UK)	  as	  per	  the	  manufacturer’s	  instructions.	  A	  successfully	  cloned	  
colony	  was	  confirmed	  via	  colony	  PCR,	  then	  grown	  overnight,	  and	  then	  the	  vector	  was	  extracted	  via	  a	  
Mini-­‐prep	  kit	   (Sigma,	  UK)	  as	  per	   the	  manufacturer’s	   instructions.	  The	   target	  ORF	  was	   then	  excised	  
from	   the	   pCR2.1	   vector	   using	   unique	   restriction	   digest	   sites,	   as	   detailed	   below	   and	   described	   in	  
section	  2.3.5,	  and	  gel	  extracted	  using	  a	  Gel	  extraction	  kit	   (Sigma,	  UK).	  The	  ORF	  fragment	  was	  then	  
ligated	   into	   pBM51	   using	   Quick-­‐Stick	   Ligase	   (Bioline,	   UK)	   and	   then	   transformed	   into	   E.	   coli.	   The	  
vector	  was	  then	  extracted	  via	  Mini-­‐prep	  and	  confirmed	  via	  PCR.	  The	  correct	  sequence	  of	  the	  target	  
ORF	  and	  vector	  was	   confirmed	  via	   sequencing.	   The	   confirmed	  ORF	  plasmid	  was	   then	   transformed	  
into	  the	  target	  null	  using	  electroporation	  and	  grown	  on	  selective	  media.	  The	  reconstituted	  strain	  was	  
then	  restreaked	  twice	  from	  single	  colonies.	  
Reconstituted	   gene	   expression	  was	   confirmed	   via	   Northern	   analysis	   using	   internal	   probes	   for	   the	  
target	  ORF,	  as	  described	  in	  section	  2.3.15,	  comparing	  the	  null	  mutant	  with	  the	  reconstituted	  strain.	  
The	  C.	  glabrata	  DSE3	  reconstitution	  plasmid	  was	  constructed	  by	  cloning	  1317	  bps	  of	  the	  C.	  glabrata	  
DSE3	   gene	   (1	   to	   +1317	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1317)	   into	   pCR2.1	  
flanked	  by	  Sal1	  and	  Xma1	  restriction	  sites	  at	  the	  5’	  and	  3’	  ends	  respectively.	  The	  DSE3	  ORF	  was	  then	  
excised	  from	  pCR2.1	  via	  restriction	  digest	  with	  Sal1	  and	  Xma1	  and	  then	  ligated	  into	  pBM51	  to	  create	  
C.	  glabrata	  pSRSGR6	  (HIS3,	  DSE3).	  pSRSGR6	  was	  then	  transformed	  into	  C.	  glabrata	  SRSG6	  to	  create	  
C.	  glabrata	  SRSG6R	  (his3,	  dse3::NATR,	  pSRSGR6	  (HIS3,	  DSE3)).	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The	  C.	  glabrata	  AFC2	  reconstitution	  plasmid	  was	  constructed	  by	  cloning	  2031	  bps	  of	  the	  C.	  glabrata	  
ACF2	   gene	   (1	   to	   +2031	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +2031)	   into	   pCR2.1	  
flanked	  by	  Sal1	  and	  Xma1	  restriction	  sites	  at	  the	  5’	  and	  3’	  ends	  respectively.	  The	  ACF2	  ORF	  was	  then	  
excised	  from	  pCR2.1	  via	  restriction	  digest	  with	  Sac1	  and	  Xma1	  and	  then	  ligated	  into	  pBM51	  to	  create	  
C.	  glabrata	  pSRSGR7	  (HIS3,	  ACF2).	  pSRSGR7	  was	  then	  transformed	  into	  C.	  glabrata	  SRSG7	  to	  create	  
C.	  glabrata	  SRSG7R	  (his3,	  trp1,	  leu2,	  acf2::TRP1,	  pSRSGR7	  (HIS3,	  ACF2),	  YPCIII	  (LEU2)).	  
The	  C.	  glabrata	  EGT2	  reconstitution	  plasmid	  was	  constructed	  by	  cloning	  1317	  bps	  of	  the	  C.	  glabrata	  
EGT2	   gene	   (1	   to	   +1317	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1317)	   into	   pCR2.1	  
flanked	  by	  Sal1	  and	  Xma1	  restriction	  sites	  at	  the	  5’	  and	  3’	  ends	  respectively.	  The	  EGT2	  ORF	  was	  then	  
excised	  from	  pCR2.1	  via	  restriction	  digest	  with	  Sal1	  and	  Xma1	  and	  then	  ligated	  into	  pBM51	  to	  create	  
C.	  glabrata	  pSRSGR8	  (HIS3,	  EGT2).	  pSRSGR8	  was	  then	  transformed	  into	  C.	  glabrata	  SRSG8	  to	  create	  
C.	  glabrata	  SRSG8R	  (his3,	  egt2::NATR,	  pSRSGR8	  (HIS3,	  EGT2)).	  
The	  C.	  glabrata	  RME1	  reconstitution	  plasmid	  was	  constructed	  by	  cloning	  1644	  bps	  of	  the	  C.	  glabrata	  
RME1	   gene	   (1	   to	   +1644	  with	   respect	   to	   the	   start	   codon,	   the	   stop	   codon	   is	   at	   +1644)	   into	   pCR2.1	  
flanked	  by	  Sal1	  and	  Xma1	  restriction	  sites	  at	  the	  5’	  and	  3’	  ends	  respectively.	  The	  RME1	  ORF	  was	  then	  
excised	  from	  pCR2.1	  via	  restriction	  digest	  with	  Sal1	  and	  Xma1	  and	  then	  ligated	  into	  pBM51	  to	  create	  
pSRSGR9	  (HIS3,	  RME1).	  pSRSGR9	  was	  then	  transformed	  into	  C.	  glabrata	  SRSG9	  to	  create	  C.	  glabrata	  
SRSG9R	  (his3,	  rme1::NATR,	  pSRSGR9	  (HIS3,	  RME1)).	  
The	   C.	   glabrata	   SCW11β	   reconstitution	   plasmid	   was	   constructed	   by	   cloning	   1497	   bps	   of	   the	   C.	  
glabrata	  SCW11β	  gene	  (1	  to	  +1497	  with	  respect	  to	  the	  start	  codon,	  the	  stop	  codon	  is	  at	  +1497)	  into	  
pCR2.1	   flanked	  by	  Sal1	  and	  Xma1	   restriction	   sites	  at	   the	  5’	   and	  3’	   ends	   respectively.	   The	  SCW11β	  
ORF	  was	   then	  excised	   from	  pCR2.1	  via	   restriction	  digest	  with	  Sal1	  and	  Xma1	  and	  then	   ligated	   into	  
pBM51	   to	   create	   pSRSGR11	   (HIS3,	   SCW11β).	   pSRSGR11	   was	   then	   transformed	   into	   C.	   glabrata	  
SRSG11	   to	   create	  C.	  glabrata	   SRSG11R	   (his3,	   trp1,	   leu2,	   scw11β::TRP1,	   pSRSGR11	   (HIS3,	   SCW11β),	  
YPCIII	  (LEU2)).	  
The	  C.	  glabrata	  SIC1	  reconstitution	  plasmid	  was	  constructed	  by	  cloning	  849	  bps	  of	   the	  C.	  glabrata	  
SIC1	  gene	  (1	  to	  +849	  with	  respect	  to	  the	  start	  codon,	  the	  stop	  codon	  is	  at	  +849)	  into	  pCR2.1	  flanked	  
by	   EcoR1	   and	   Xma1	   restriction	   sites	   at	   the	   5’	   and	   3’	   ends	   respectively.	   The	   SIC1	  ORF	   was	   then	  
excised	   from	   pCR2.1	   via	   restriction	   digest	   with	   EcoR1	   and	   Xma1	   and	   then	   ligated	   into	   pBM51	   to	  
create	  pSRSGR12	  (HIS3,	  SIC1).	  pSRSGR12	  was	  then	  transformed	  into	  C.	  glabrata	  SRSG12	  to	  create	  C.	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Figure	   4.3	   –	   Plasmid	   map	   of	   pBM51.	   The	   target	   ORF	   for	   reconstitution	   was	   cloned	   into	   pBM51	   [Biao	  Ma	   (personal	  
communication)]	   between	   either	   2172	   (Sal1)	   and	   2211	   (Xma1)	   or	   between	   2199	   (EcoR1)	   and	   211	   (Xma1)	   using	   the	  
respective	  restriction	  digests.	  
	  
4.2.4	  Solid	  agar	  phenotypic	  screen	  
A	  series	  of	  phenotypic	  assays,	  described	  by	  Hampsey	  et	  al.	  [246]	  and	  listed	  in	  Table	  4.1	  below,	  were	  
carried	  out	  in	  an	  attempt	  to	  characterise	  putative	  roles	  for	  these	  proteins.	  
Strains	  were	   grown	   overnight	   in	   150	   μL	   YPD	   in	   a	   96-­‐well	   plate	   at	   37°C	  with	   shaking	   at	   120	   rpm.	  
Strains	   were	   counted	   under	   a	   Nikon	   80i	   eclipse	   microscope	   using	   a	   Neubauer	   0.0025	   mm2	  
haemocytometer	  and	  diluted	   to	  approximately	  1	  x	  107	  cells/mL,	   then	  serially	  diluted	   to	  obtain	  1	  x	  
106,	  1	  x	  105,	  1	  x104,	  1	  x	  103	  and	  1	  x	  102	  cells/mL.	  Strains	  were	  replicated	  onto	  the	  media	  described	  in	  
the	   table	  below	  using	  a	  multichannel	  pipette	   that	  delivered	  5	  μL,	  and	   incubated	  at	  37°C	   for	   three	  
days.	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Phenotype	   Assay	   Functional	  Implications	  
Control	  	   YPD	  37°C	   -­‐	  	  
Temperature	  sensitivity	   YPD	   4°C,	   Room	   temperature,	  
30°C,	  42°C	  
General	  growth	  defect	  
Nutrient	  stress	   Minimal	  media	  (YNB)	   Inability	  to	  synthesise	  
essential	  amino	  acids	  
pH	  phenotype	   YPD	  pH7	   Ability	  to	  grow	  at	  pH	  7	  
Respiratory	  deficiency	  	   3%	  (v/v)	  glycerol	  YPD	  	   Failure	  to	  produce	  respiratory	  
competent	  mitochondria	  	  
tBOOH	  (t-­‐butylhydroperoxide)	   1	  mM	  tBOOH	  YPD	   Oxidative	  stress	  
Ethanol	  sensitivity	   6%	  (v/v)	  ethanol	  YPD	   General	  protein	  defect	  	  
Formamide	  sensitivity	  	   2%	  (v/v)	  formamide	  YPD	   General	  protein	  defect	  	  
NaCl	  sensitivity	  	   1.5	  M	  NaCl	  YPD	   Defects	   in	   osmotic	   stress	  
response	  
Calcofluor	  White	   10	  µg/mL	  calcofluor	  white	  YPD	   Fluorochrome	  with	  antifungal	  
activity	   and	   high	   affinity	   for	  
cell	   wall	   chitin.	   Highlights	  
chitin	   biosythesis	   and	   cell	  
wall	  morphogenesis	  mutants	  
SDS	  sensitivity	  	   0.1%	  (v/v)	  SDS	  YPD	   Defects	  in	  cell	  wall	  biogenesis	  	  
Benomyl	  sensitivity	   0.5	  µg/mL	  benomyl	  YPD	   Defects	  in	  microtubule	  
formation	  
Vanadate	  	   7	  mM,	  2.5	  mM	  sodium-­‐o-­‐
vanadate	  YPD	  
Defects	  in	  protein	  
glycosylation,	  secretory	  
defects	  	  
FCS	  (Fetal	  Calf	  Serum)	   10%	  (v/v)	  FCS	  YPD	   Serum	  response	  
Caffeine	  sensitivity	   10	  mM	  caffeine	  YPD	   Purine	  analogue	  affecting	  
many	  cellular	  processes	  
including	  MAPK	  signalling	  
pathways	  
Drug	  sensitivity	   50	  µg/mL	  hygromycin	  YPD	   Defects	  in	  protein	  
glycosylation	  
Table	   4.1	   –	   Phenotypic	   conditions	   used	   to	   test	   the	   conditional	   sensitivity	   of	   the	   Ace2p-­‐dependent	   gene	   nulls	   in	   a	  
phenotypic	  screen	  [246].	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4.2.5	  Difference	  interference	  microscopy	  (DIC)	  
Yeast	   strains	  were	  grown	  overnight	   in	  5	  mL	  of	  YPD	  media	  at	  30°C/37°C,	  180	   rpm.	   In	   the	  morning,	  
cells	  were	  diluted	   to	  OD600	  =	  0.3	  and	  allowed	   to	  grow	  at	  30°C/37°C,	  180	   rpm	   for	  a	   further	   two	   to	  
three	  hours,	  till	  the	  OD600	  was	  between	  0.5-­‐1.	  Cells	  were	  spun	  down	  at	  900	  g	  and	  washed	  twice	  with	  
PBS	  (137	  mM	  NaCl,	  2.7	  mM	  KCl,	  8	  mM	  Na2HPO4,	  pH	  7.3)	  before	  being	  re-­‐suspended	  in	  approximately	  
200-­‐500	  μL	  of	  PBS.	  Approximately	  10	  μL	  of	  culture	  was	  mounted	  on	  microscope	  slides	  and	  visualised	  
using	  a	  Zeiss	  Axiovert	  200	   inverted	  microscope	  with	  a	  63x	  objective.	  The	  cells	  were	  photographed	  
using	  a	  Hamamatsu	  ORCA-­‐ER	  digital	  camera	  and	  images	  manipulated	  using	  HCImage,	  version	  2.1.1.0,	  
Hamamatsu	  Corporation,	  New	  Jersey,	  USA.	  
	  
4.2.6	  Growth	  rate	  analysis	  
Yeast	  cells	  were	  grown	  overnight	   in	  5	  mL	  of	  YPD	  media	  at	  37°C,	  180	  rpm.	   In	  the	  morning	  the	  cells	  
were	  diluted	  to	  OD600	  =	  0.1,	  plated	  out	  in	  triplicate	  into	  a	  96-­‐well	  plate	  and	  allowed	  to	  grow	  for	  24	  
hours	   at	   37°C	   in	   a	  Molecular	   devices	  Versamax	  Tunable	  Microplate	   reader,	   controlled	  by	   Softmax	  
Pro.	  The	  OD	  was	  recorded	  every	  3.5	  minutes	  after	  having	  been	  shaken	  before	  each	  time	  point.	  The	  
data	  was	  then	  manipulated	  in	  Excel.	  
	  
4.2.7	  Murine	  virulence	  studies	  
Virulence	  analysis	  of	  C.	  glabrata	  null	  mutants	  was	  carried	  out	  using	  a	  modified	  method	  as	  previously	  
described	  by	  Calcagno	  et	  al.	   [81].	  Groups	  of	   five	  outbred	  male	  CD1	  mice	  were	   immunosuppressed	  
via	  IP	  injection	  with	  200	  mg	  of	  cyclophosphamide	  per	  kg	  of	  body	  weight	  on	  day	  -­‐3,	  day	  -­‐1	  and	  every	  
fourth	  day	  for	  the	  duration	  of	  the	  study.	  Animals	  were	  infected	  with	  7	  x	  107	  C.	  glabrata	  cells	  in	  200	  
μL	   saline	   via	   tail	   vein	   injection	   (IV).	   The	  mice	  were	   observed	   and	  weighed	   daily	   and	   sacrificed	   at	  
predetermined	  endpoints,	  such	  as	  20%	  weight	  loss.	  	  
	  
4.2.8	  Histological	  examination	  of	  murine	  samples	  
Small	  samples	  of	  murine	  tissue	  from	  the	  liver,	  kidney,	  lung	  and	  spleen	  were	  removed	  and	  fixed	  in	  4%	  
(v/v)	  formaldehyde	  solution	  upon	  death.	  Samples	  were	  mounted	  in	  paraffin,	  sectioned,	  and	  stained	  
with	  haematoxylin	  and	  eosin	  (H	  &	  E),	  or	  Grocott’s	  methenamine	  silver	  and	  light	  green	  (GMS),	  by	  C	  &	  
C,	  London,	  UK.	  
Histological	   samples	  were	   observed	   using	   a	   Leitz	   Laborlux	   12	   light	  microscope	   and	   photographed	  
using	  a	  Nikon	  Coolpix	  990	  digital	  camera.	  
	  
4.2.9	  Fungal	  burden	  
The	   fungal	   burden	   of	   the	   infected	   mice	   from	   section	   4.2.8	   was	   calculated	   via	   kidneys	   that	   were	  
extracted	   from	   the	   animals	   at	   the	   point	   of	   sacrifice.	   A	   portion	   of	   each	   kidney	  was	   sectioned	   off,	  
weighed,	  homogenised,	  serially	  diluted	  and	  plated	  out	  onto	  YPD	  in	  triplicate	  and	  grown	  overnight	  at	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37°C.	  The	  colonies	  were	  then	  counted	  and	  a	  colony	  forming	  unit	  (CFU)	  count	  per	  gram	  of	  tissue	  was	  
calculated.	  
	  
4.2.10	  Macrophage	  stimulation	  with	  yeast	  
Murine	  RAW	  264.7	  macrophages	  were	  seeded	  into	  24-­‐well	  plates	  at	  2.5	  x	  105	  macrophages	  per	  well	  
and	  grown	  overnight	  in	  DMEM	  supplemented	  with	  10%	  (v/v)	  FCS,	  penicillin	  (100	  U/mL)	  (Invitrogen,	  
UK),	  streptomycin	  (100	  µg/mL)	  (Invitrogen,	  UK)	  at	  37°C,	  5%	  CO2.	  Overnight	  cultures	  of	  yeast	  strains	  
grown	  in	  the	  appropriate	  media	  were	  thoroughly	  washed	  with	  sterile	  PBS,	  counted	  and	  resuspended	  
to	   1.5	   x	   107	   yeast/mL	   in	   DMEM	  media	   as	   above.	   Before	   infection,	  macrophages	  were	   thoroughly	  
washed	  with	  fresh	  media.	  Yeast	  was	  then	  added	  to	  a	  yeast:macrophage	  ratio	  of	  30:1	  and	  allowed	  to	  
bind	   and	   be	   phagocytosed	   for	   40	   minutes	   at	   37°C,	   5%	   CO2.	   Macrophages	   were	   then	   washed	  
extensively	   with	   PBS	   to	   remove	   unbound	   yeast	   and	   incubated	   in	   0.5	  mL	   of	   fresh	  medium	   for	   six	  
hours	  at	  37°C,	  5%	  CO2.	  All	  infections	  were	  done	  three	  times	  independently	  and	  triplicate	  wells	  used	  
each	  time.	  	  
	  
4.2.11	  Enzyme-­‐Linked	  ImmunoSorbent	  Assay	  (ELISA)	  cytokine	  analysis	  
RAW	  264.7	  TNFα	  and	   IL-­‐6	  secretion	   levels	   from	  the	  macrophage	  stimulation	  assay	  were	  measured	  
using	   a	   Quantikine	   Mouse	   TNFα	   Immunoassay	   (R&D	   Systems,	   UK)	   and	   a	   Quantikine	   Mouse	   IL-­‐6	  
Immunoassay	   (R&D	   Systems,	   UK)	   as	   per	   the	   manufacturer’s	   instructions.	   The	   significance	   of	   the	  
variation	   between	   the	   wild	   type	   and	   the	   individual	   null	   mutants	   was	   analysed	   using	   a	   one-­‐way	  
ANOVA	  statistical	  test.	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4.3	  Results	  
	  
4.3.1	  Southern	  blot	  analysis	  
Fusion	  PCR,	  as	  described	  in	  section	  4.2.1,	  was	  used	  to	  construct	  C.	  glabrata	  ash1,	  bud9,	  dse1,	  dse3,	  
egt2	   and	   rme1.	   PCR	   and	   Southern	   analysis	   was	   used	   to	   confirm	   correct	   integration	   at	   the	   locus	  
(Appendix	  4).	  Faint	  alternate	  bands	  were	  displayed	  for	  the	  NAT	  probe	  for	  dse1	  mutants	  6,	  7	  and	  8	  
possibly	  indicating	  multiple	  integration	  of	  the	  deletion	  cassette,	  and	  will	  therefore	  be	  excluded	  from	  
further	  testing	  after	  the	  phenotypic	  screen	  as	  displayed	  in	  section	  4.3.2	  below.	  
The	  Edlind	  method	  one-­‐step	  PCR,	   as	  described	   in	   section	  4.2.2,	  was	  used	   to	   construct	  C.	  glabrata	  
amn1,	  acf2,	  scw11β	  and	  sic1.	  Between	  20	  and	  50	  colonies	  were	  screened	  per	  target	  gene	  using	  PCR	  
analysis,	  before	  Southern	  analysis	  was	  used	  to	  confirm	  correct	  integration	  at	  the	  locus	  (Appendix	  4).	  
	  
4.3.2	  Solid	  agar	  phenotypic	  screen	  
A	  selected	  range	  of	  phenotypic	  conditions	  as	  described	  by	  Hampsey	  et	  al.	   [246]	  and	  listed	  in	  Table	  
4.1	  were	  used	  to	  test,	  as	  described	  in	  section	  4.2.4,	  for	  any	  sensitivity	  of	  the	  mutants	  confirmed	  in	  
section	  4.3.1,	  to	  study	  gene	  function	  and	  to	  select	  one	  mutant	  for	  further	  in	  vitro	  and	  in	  vivo	  study.	  A	  
parental	  control	  was	  used,	  C.	  glabrata	  his3,	  with	  each	  strain	  plated	  using	  a	  serial	  dilution	  from	  1	  x	  
107	   to	   1	   x	   104	   cells.	   The	   C.	   glabrata	   ace2	   null	   strain	   was	   not	   used	   as	   a	   control	   during	   these	  
experiments	  as	  it	  was	  unavailable	  at	  the	  time.	  	  
Normal	  growth	  rates	  were	  displayed	  through	  most	  of	  the	  screen	  with	  growth	  observed	  through	  all	  
dilutions	  on	  all	  conditions	  apart	  from	  YPD	  4°C,	  minimal	  media	  and	  7	  mM	  vanadate	  from	  the	  parental	  
control.	   Slightly	   slower	   growth	   was	   noted	   on	   2.5	   mM	   vanadate	   by	   almost	   all	   mutants	   when	  
compared	   with	   the	   parental	   strain,	   which	   could	   indicate	   a	   mild	   defect	   in	   protein	   glycosylation.	  
Sensitivity	  to	  10	  mM	  caffeine	  was	  also	  shown	  by	  Δash1	  #5,	  Δash1	  #7,	  Δash1	  #8,	  Δdse1	  #4	  and	  Δdse1	  
#5,	   which	   could	   indicate	   defects	   various	   cellular	   processes,	   including	   Mpk1p-­‐mediated	   cell	   wall	  
integrity	  pathway	  [247].	  
The	  following	  mutants	  were	  selected	  for	  further	  screening:	  C.	  glabrata	  ash1	  #7,	  bud9	  #7,	  dse1	  #5,	  
dse3	  #18,	  egt2	  #6	  and	  rme1	  #6.
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Figure	   4.4	   –	   C.	   glabrata	   ash1,	   bud9,	   dse1,	   egt2	   and	   rme1	   show	   no	   sensitivity	   to	   seven	   test	   conditions.	   Growth	  
phenotypes	  of	  18	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  ASH1,	  BUD9,	  DSE1,	  DSE3,	  EGT2	  and	  RME1	  and	  
the	  parental	  strain	  C.	  glabrata	  his3	  (Δhis3).	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  
the	  parental	  control.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  
Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	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Figure	   4.5	   –	   C.	   glabrata	   ash1,	   bud9,	   dse1,	   egt2	   and	   rme1	   show	   no	   sensitivity	   to	   seven	   test	   conditions.	   Growth	  
phenotypes	  of	  18	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  ASH1,	  BUD9,	  DSE1,	  DSE3,	  EGT2	  and	  RME1	  and	  
the	  parental	  strain	  C.	  glabrata	  his3	  (Δhis3).	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  
the	  parental	  control.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  
Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	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Figure	   4.6	   –	  C.	   glabrata	  ash1,	   dse1,	   egt2	  and	   rme1	   show	  mild	   sensitivity	   to	   vanadate	   and	  ash1	  and	   dse1	   show	  mild	  
sensitivity	  to	  caffeine	  test	  conditions.	  Growth	  phenotypes	  of	  18	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  gene:	  
ASH1,	  BUD9,	  DSE1,	  DSE3,	  EGT2	  and	  RME1	  and	  the	  parental	  strain	  C.	  glabrata	  his3	  (Δhis3).	  No	  sensitivity	  was	  shown	  by	  
any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  parental	  control	  apart	  from	  2.5mM	  vanadate	  in	  which	  Δash1	  #5,	  Δash1	  
#7,	  Δash1	  #8,	  Δdse1	  #4,	  Δdse1	  #5,	  Δdse1	  #6,	  Δdse3	  #18,	  Δdse3	  #19,	  Δegt2	  #4,	  Δegt2	  #6,	  Δegt2	  #14,	  Δrme1	  #5,	  and	  Δrme1	  
#6	   showed	  sensitivity,	  and	  10	  mM	  caffeine	  to	  which	  Δash1	  #5,	  Δash1	  #7,	  Δash1	  #8,	  Δdse1	  #4	  and	  Δdse1	  #5	   showed	  a	  
sensitivity.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  
grown	  for	  three	  days	  on	  YPD	  at	  37°C	  unless	  otherwise	  stated.	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A	   selected	   range	   of	   phenotypic	   conditions	   as	   described	   by	  Hampsey	   [246]	   and	   listed	   in	   Table	   4.1	  
were	   used	   to	   test,	   as	   described	   in	   section	   4.2.4,	   for	   any	   sensitivity	   of	   the	   mutants	   confirmed	   in	  
section	  4.3.1,	  to	  study	  gene	  function	  and	  to	  select	  one	  mutant	  for	  further	  in	  vitro	  and	  in	  vivo	  study.	  A	  
parental	  control	  was	  used,	  C.	  glabrata	  ΔΔΔ,	  with	  each	  strain	  plated	  using	  a	  serial	  dilution	  from	  1x	  107	  
to	  1	  x	  104	  cells.	  The	  C.	  glabrata	  ace2	  null	  strain	  was	  not	  used	  as	  a	  control	  during	  these	  experiments	  
as	  it	  was	  unavailable	  at	  the	  time.	  
Normal	  growth	  rates	  were	  displayed	  through	  most	  of	  the	  screen	  with	  growth	  observed	  through	  all	  
dilutions	  on	  all	  conditions	  apart	   from	  YPD	  4°C,	  minimal	  media,	  7	  mM	  vanadate	  and	  1	  mM	  t-­‐BOOH	  
from	  the	  parental	  control.	  Sodium	  orthovanadate	  resistance	  has	  been	  shown	  to	  be	  associated	  with	  
glycosylation	  mutants	   in	  S.	   cerevisiae	   due	   to	   an	   ability	   to	   eliminate	   an	   intracellularly	   formed	   toxic	  
molecule	  [248,	  249].	  Mutants	  of	  ash1,	  acf2	  and	  sic1	  all	  showed	  mild	  sensitivity	  to	  2.5	  mM	  vanadate,	  
which	   could	   indicate	   a	   small	   permeability	   change	   to	   sodium	   orthovanadate,	   which	   is	   known	   to	  
inhibit	   phosphatase	   enzymes	   [250].	   All	   mutants	   also	   showed	   mild	   sensitivity	   to	   10	   mM	   caffeine,	  
which	  could	  indicate	  mild	  disruption	  of	  many	  cellular	  processes	  including	  Mpk1p-­‐mediated	  cell	  wall	  
integrity	  pathway	  [247].	  
The	  following	  mutants	  were	  selected	  for	  further	  screening:	  C.	  glabrata	  amn1	  #5,	  acf2	  #1,	  scw11β	  #4	  
and	  sic1	  #9.	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Figure	  4.7	  –	  C.	  glabrata	  amn1,	  acf2,	  scw11β ,	  and	  sic1	  show	  no	  sensitivity	  to	  seven	  test	  conditions.	  Growth	  phenotypes	  
of	  12	  Ace2p	   regulon	  null	  mutants,	   three	  nulls	   for	  each	  gene:	  AMN1,	  ACF2,	  SCW11β ,	  and	  SIC1	   and	   the	  parental	   strain	  
CgΔΔΔ .	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  parental	  control.	  5	  µL	  of	  each	  
strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  
YPD	  at	  37°C	  unless	  otherwise	  stated.	  
	  	  
	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
87	   	  
	   	  
	  
Figure	  4.8	  –	  C.	  glabrata	  amn1,	  acf2,	  scw11β ,	  and	  sic1	  show	  no	  sensitivity	  to	  seven	  test	  conditions.	  Growth	  phenotypes	  
of	  12	  Ace2p	   regulon	  null	  mutants,	   three	  nulls	   for	  each	  gene:	  AMN1,	  ACF2,	  SCW11β ,	  and	  SIC1	   and	   the	  parental	   strain	  
CgΔΔΔ .	  No	  sensitivity	  was	  shown	  by	  any	  of	  the	  null	  mutants	  when	  compared	  with	  the	  parental	  control.	  5	  µL	  of	  each	  
strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  
YPD	  at	  37°C	  unless	  otherwise	  stated.	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Figure	  4.9	  –	  C.	  glabrata	  amn1,	  acf2	  and	  sic1	  show	  mild	  sensitivity	  to	  vanadate	  and	  amn1,	  acf2,	  scw11β ,	  and	  sic1	  show	  
mild	  sensitivity	  to	  caffeine	  test	  conditions.	  Growth	  phenotypes	  of	  12	  Ace2p	  regulon	  null	  mutants,	  three	  nulls	  for	  each	  
gene:	  AMN1,	  ACF2,	   SCW11β ,	   and	   SIC1	   and	   the	   parental	   strain	   CgΔΔΔ .	   No	   sensitivity	  was	   shown	   by	   any	   of	   the	   null	  
mutants	  when	  compared	  with	  the	  parental	  control	  apart	   from	  2.5	  mM	  vanadate	   in	  which	  all	   the	  amn1,	  acf2	  and	   sic1	  
mutants	  showed	  mild	  sensitivity.	  All	  the	  mutants	  also	  showed	  mild	  sensitivity	  to	  10	  mM	  caffeine.	  5	  µL	  of	  each	  strain	  was	  
spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104	  cells/ml.	  Strains	  were	  grown	  for	  three	  days	  on	  YPD	  at	  
37°C	  unless	  otherwise	  stated.	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4.3.3	  Phenotypic	  microscopy	  
The	  C.	  glabrata	  null	  mutants	  identified	  in	  created	  in	  sections	  4.2.1	  and	  4.2.2	  were	  studied	  using	  DIC	  
microscopy,	  as	  described	  in	  section	  4.2.5,	  and	  shown	  in	  Figure	  4.10	  and	  Figure	  4.11.	  A	  parental	  strain	  
negative	   control	   and	   an	   ace2	   null	   HLS122	   positive	   control	   (Figure	   4.10	   only)	   were	   included	   for	  
reference.	  A	  clumpy	  phenotype	  was	  shown	  for	  both	  dse1	  and	  egt2	  with	  the	  remaining	  null	  mutants	  
all	  showing	  a	  parental	  phenotype.	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Figure	  4.10	  –	  C.	  glabrata	  dse1	  and	  egt2	   display	   a	   cell	   seperation	  defect	   similar	   to	  HLS122	   (ace2)	   in	   liquid	  media.	  DIC	  
microscopy	  of	  a	   representitive	   sample	  of	  each	  of	   the	  Ace2p	   regulon	  null	  mutants,	   their	  parental	   control	  and	  an	  ace2	  
null,	  HLS122.	  No	  phenotype	  difference	  was	  shown	  between	  the	  parental	  control	  and	  the	  ash1,	  bud9,	  dse3	  and	  rme1	  null	  
mutants.	   Both	   dse1	   and	   egt2	   null	   cells	   displayed	   a	   cell	   seperation	   defect	   similar,	   but	   not	   as	   pronounced,	   as	   that	  
displayed	  by	  HLS122.	  This	  shows	  that	  both	  DSE1	  and	  EGT2	  may	  encode	  proteins	  that	  play	  a	  more	  significant	  role	  in	  cell	  
seperation	  than	  those	  gene	  nulls	  that	  didn’t	  display	  a	  cell	  separation	  phenotype.	  Yeast	  strains	  were	  grown	  overnight	  in	  
YPD	  at	  37°C,	  180	  rpm,	  diluted,	  and	  grown	  to	  OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	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Figure	   4.11	   –	   C.	   glabrata	   amn1,	   acf2,	   scw11β	   and	   sic1	   show	   a	   cell	   separation	   competent	   phenotype	   similar	   to	   the	  
parental	   strain	   Cg	  ΔΔΔ	   in	   liquid	  media.	  DIC	  microscopy	   of	   a	   representitive	   sample	   of	   each	   of	   the	  Ace2p	   regulon	   null	  
mutants	  and	  their	  parental	  control	  Cg	  ΔΔΔ.	  No	  phenotypic	  difference	  was	  shown	  between	  the	  parental	  control	  and	  the	  
amn1,	  acf2,	   scw11β	  and	   sic1	  null	  mutants.	  Yeast	   strains	  were	  grown	  overnight	   in	  YPD	  at	  37°C,	  180	   rpm,	  diluted,	  and	  
grown	  to	  OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	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4.3.4	  Growth	  rate	  analysis	  
Growth	   rate	   curves	   were	   created	   to	   look	   at	   the	   growth	   rates	   of	   the	   Ace2p	   regulon	   mutants,	   to	  
determine	  if	  any	  of	  them	  showed	  any	  reduction	  in	  doubling	  time.	  All	  of	  the	  mutants	  showed	  similar	  
characteristics	   to	  both	  the	  wild	   type	  Cg2001	  and	  the	  parental	  strains	  C.	  glabrata	  his3	  and	  Cg	  ΔΔΔ.	  
None	  of	  the	  mutant	  growth	  rates	  were	  significantly	  different	  from	  the	  wild	  type,	  therefore	  none	  of	  
the	  mutants	  should	  be	  excluded	  from	  virulence	  analysis.	  
	  
Figure	  4.12	  –	  C.	  glabrata	  amn1,	  ash1,	  acf2,	  bud9,	  dse1,	  dse3,	  egt2,	  rme1,	  scw11β	  and	  sic1	  show	  similarity	  to	  wild	  type	  
and	  parental	  growth	  rates.	  The	  growth	  rate	  of	  each	  of	  the	  mutants,	  their	  parental	  types	  Cg	  his3	  and	  Cg	  ΔΔΔ,	  as	  well	  as	  
the	  C.	  glabrata	  wild	  type	  (Cg2001)	  over	  24	  hours.	  The	  growth	  rates	  of	  amn1,	  ash1,	  acf2,	  bud9,	  dse1,	  dse3,	  egt2,	  rme1,	  
scw11β	  and	  sic1	  showed	  similarity	  to	  that	  of	  their	  respective	  parental	  types	  and	  Cg2001.	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4.3.5	  Immune	  suppression	  survival	  pilot	  
An	  initial	  pilot	  survival	  analysis	  to	  test	  the	  addition	  of	  an	  extra	  immune	  suppression	  step	  at	  day	  -­‐1,	  
modifying	  the	  existing	  neutropenic	  model	  of	  disseminated	  candidiasis	  [81]	  to	  ensure	  neutropenia	  on	  
inoculation	   day,	   resulted	   in	   100%	   survival	   of	   the	   uninfected	   control	   group	   when	   run	   for	   the	  
maximum	  experimental	  period	  of	  the	  animal	  license	  (21	  days).	  
	  
Figure	   4.13	   –	   The	   addition	   of	   an	   extra	   immune	   suppression	   step	   at	   day	   -­‐1	   does	   not	   effect	   uninfected	   control	   group	  
survival.	  Survival	  of	  unifected	  mice	  (n	  =	  10,	  open	  squares)	  subjected	  to	  the	  modified	  immune	  suppression	  regime	  with	  IP	  
injection	   of	   200	   mg/kg	   cyclophosphamide	   at	   day	   0,	   2	   and	   every	   fourth	   day	   remained	   at	   100%	   through	   a	   21	   day	  
experiment.	   	  
	  	  
	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
94	   	  
	   	  
4.3.6	  Murine	  virulence	  model	  of	  systemic	  candidiasis	  
Mutants	  were	  transformed	  with	  pBM51	  and	  YPCIII	   to	  ensure	  autotrophy,	  and	  allow	  comparison	  to	  
the	  C.	  glabrata	  wild	  type	  strain,	  where	  applicable	  before	  being	  tested.	  To	  assess	  the	  roles	  that	  the	  
partial	   Ace2p	   regulon	   genes	   play	   in	   virulence	   a	   modified	   neutropenic	   murine	   model	   of	   systemic	  
candidiasis	   was	   used	   as	   described	   in	   section	   4.2.7.	   Groups	   of	   neutropenic	   male,	   CD1	   mice	   were	  
inoculated	  with	  7	  x	  107	  C.	  glabrata	  amn1,	  ash1,	  bud9,	  dse1,	  dse3,	  dse3::DSE3,	  acf2,	  acf2::ACF2,	  egt2,	  
egt2::EGT2,	   rme1,	   rme1::RME1,	   scw11β,	   scw11β::SCW11β,	   sic1,	   sic1::SIC1	  and	  2001	   cells	   to	  assess	  
the	  roles	  of	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  DSE3,	  ACF2,	  EGT2,	  RME1,	  SCW11β	  and	  SIC1	   respectively	   in	  
virulence.	  A	  comparison	  with	  C.	  glabrata	  ace2	  was	  not	  made	  due	  to	  time	  constraints	  and	  because	  an	  
ace2	  deletion	  strain	  suitable	  for	  virulence	  analysis	  was	  not	  available	  at	  the	  time	  of	  experimentation.	  
Each	  null	  mutant,	  and	  its	  reconstituted	  strain	  where	  applicable,	  are	  individually	  plotted	  against	  the	  
C.	  glabrata	  wild	  type.	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The	   C.	   glabrata	   amn1	   null	   displayed	   a	   phenotype	   that	   was	   indistinguishable	   from	   the	   wild	   type	  
control	  resulting	  in	  40%	  mortality	  by	  day	  five	  and	  therefore	  60%	  survival	  over	  14	  days	  matching	  the	  
60%	  survival	  over	  14	  days	  for	  the	  wild	  type	  control	  (Figure	  4.13	  Log-­‐rank	  (Mantel-­‐Cox)	  test;	  p	  =	  1)).	  
Therefore,	  the	  host-­‐fungal	  interaction	  is	  maintained	  in	  the	  C.	  glabrata	  amn1	  strain	  to	  wild	  type	  levels	  
displaying	  a	  similar	  response	  in	  the	  mouse	  model.	  
	  
Figure	   4.14	   –	   C.	   glabrata	   amn1	   cells	   are	   not	   hypervirulent	   in	   a	   neutropenic	   murine	   model	   of	   systemic	   candidasis.	  
Virulence	  was	   assayed	   in	   a	  modified	  neutropenic	  murine	  model	   of	   systemic	   infection	   [81]	   (n	   =	   5	   for	  wild	   type	   (open	  
squares),	  n	  =	  5	  for	  null	  mutant	  (closed	  triangles)).	  Intravenous	  infection	  with	  the	  C.	  glabrata	  amn1	  null	  mutant	  at	  7	  x	  107	  
cells/mouse	  resulted	  in	  a	  phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  60%	  survival	  over	  14	  days.	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The	  C.	  glabrata	  ash1	  null	  displayed	  a	  phenotype	  that	  resulted	   in	   increased	  mouse	  death	  with	  80%	  
mortality	  by	  day	  five	  and	  20%	  survival	  over	  14	  days,	  but	  was	  not	  significantly	  different	  from	  the	  wild	  
type	  control	   that	  displayed	  60%	  survival	  over	  14	  days	   (Figure	  4.15	  Log-­‐rank	   (Mantel-­‐Cox)	   test;	  p	  =	  
0.2207)).	  Therefore,	  the	  host-­‐fungal	   interaction	  is	  maintained	  in	  the	  C.	  glabrata	  ash1	  strain	  to	  wild	  
type	  levels	  displaying	  a	  similar	  response	  in	  the	  mouse	  model.	  
	  
Figure	   4.15	   –	   C.	   glabrata	   ash1	   cells	   are	   not	   hypervirulent	   in	   a	   neutropenic	   murine	   model	   of	   systemic	   candidasis.	  
Virulence	  was	   assayed	   in	   a	  modified	  neutropenic	  murine	  model	   of	   systemic	   infection	   [81]	   (n	   =	   5	   for	  wild	   type	   (open	  
squares),	  n	  =	  5	  for	  null	  mutant	  (closed	  triangles)).	  Intravenous	  infection	  with	  the	  	  C.	  glabrata	  ash1	  null	  mutant	  at	  7	  x	  107	  
cells/mouse	  resulted	  in	  a	  phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  20%	  survival	  over	  14	  days.	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The	  C.	  glabrata	  bud9	  null	  displayed	  a	  phenotype	  that	  resulted	   in	   increased	  mouse	  death	  with	  80%	  
mortality	  by	  day	  five	  and	  20%	  survival	  over	  14	  days,	  but	  was	  not	  significantly	  different	  from	  the	  wild	  
type	  control	   that	  displayed	  60%	  survival	  over	  14	  days	   (Figure	  4.16	  Log-­‐rank	   (Mantel-­‐Cox)	   test;	  p	  =	  
0.1659)).	  Therefore,	  the	  host-­‐fungal	  interaction	  is	  maintained	  in	  the	  C.	  glabrata	  bud9	  strain	  to	  wild	  
type	  levels	  displaying	  a	  similar	  response	  in	  the	  mouse	  model.	  
	  
Figure	   4.16	   –	   C.	   glabrata	   bud9	   cells	   are	   not	   hypervirulent	   in	   a	   neutropenic	   murine	   model	   of	   systemic	   candidasis.	  
Virulence	  was	   assayed	   in	   a	  modified	  neutropenic	  murine	  model	   of	   systemic	   infection	   [81]	   (n	   =	   5	   for	  wild	   type	   (open	  
squares),	  n	  =	  5	  for	  null	  mutant	  (closed	  triangles)).	  Intravenous	  infection	  with	  the	  	  C.	  glabrata	  bud9	  null	  mutant	  at	  7	  x	  107	  
cells/mouse	  resulted	  in	  a	  phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  20%	  survival	  over	  14	  days.	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The	   C.	   glabrata	   dse1	   null	   displayed	   a	   phenotype	   that	   was	   indistinguishable	   from	   the	   wild	   type	  
control	   resulting	   in	   40%	   mortality	   by	   day	   five	   and	   60%	   survival	   over	   14	   days	   matching	   the	   60%	  
survival	   over	   14	   days	   for	   the	   wild	   type	   control	   (Figure	   4.17	   Log-­‐rank	   (Mantel-­‐Cox)	   test;	   p	   =	   1)).	  
Therefore,	  the	  host-­‐fungal	  interaction	  is	  maintained	  in	  the	  C.	  glabrata	  dse1	  strain	  to	  wild	  type	  levels	  
displaying	  a	  similar	  response	  in	  the	  mouse	  model.	  
	  
Figure	   4.17	   –	   C.	   glabrata	   dse1	   cells	   are	   not	   hypervirulent	   in	   a	   neutropenic	   murine	   model	   of	   systemic	   candidasis.	  
Virulence	  was	   assayed	   in	   a	  modified	  neutropenic	  murine	  model	   of	   systemic	   infection	   [81]	   (n	   =	   5	   for	  wild	   type	   (open	  
squares),	  n	  =	  5	  for	  null	  mutant	  (closed	  triangles)).	  Intravenous	  infection	  with	  the	  	  C.	  glabrata	  dse1	  null	  mutant	  at	  7	  x	  107	  
cells/mouse	  resulted	  in	  a	  phenotype	  that	  was	  not	  significantly	  different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  
in	  60%	  survival	  over	  14	  days.	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The	  C.	  glabrata	  dse3	  null	  displayed	  a	  phenotype	  that	  was	  significantly	  different	  from	  the	  wild	  type	  
control	   resulting	   in	  40%	  mortality	  by	  day	   four	  and	  100%	  mortality	  by	  day	   five	  compared	  with	  60%	  
survival	  over	  14	  days	  for	  the	  wild	  type	  control	  (Figure	  4.18	  Log-­‐rank	  (Mantel-­‐Cox)	  test;	  p	  <	  0.05).	  The	  
reconstituted	  strain	  returned	  the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐
fungal	   interaction	   is	   altered	   in	   the	  C.	   glabrata	  dse3	   strain	   displaying	   a	   hypervirulent-­‐like	   immune	  
response	  in	  the	  mouse	  model.	  	  
	  
Figure	  4.18	  –	  C.	  glabrata	  dse3	  cells	  are	  hypervirulent	   in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	  dse3	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  hypervirulent	  phenotype	  that	  was	  significantly	  different	  
when	   compared	   to	   the	  wild	   type	   strain	   resulting	   in	   100%	  mortality	   after	   five	   days	   (p	   <	   0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  
analysis).	  Reconsitution	  of	  DSE3	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	  
	   	  
	  	  
	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
100	   	  
	   	  
The	  C.	  glabrata	  acf2	  null	  displayed	  a	  phenotype	  that	  was	  significantly	  different	   from	  the	  wild	  type	  
control	  resulting	  in	  100%	  mortality	  by	  day	  five	  compared	  with	  60%	  survival	  over	  14	  days	  for	  the	  wild	  
type	   control	   (Figure	  4.19,	   Log-­‐rank	   (Mantel-­‐Cox)	   test;	   p	   <	   0.05).	   The	   reconstituted	   strain	   returned	  
the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐fungal	  interaction	  is	  altered	  in	  
the	  C.	  glabrata	  acf2	  strain	  displaying	  a	  hypervirulent-­‐like	  immune	  response	  in	  the	  mouse	  model.	  	  
	  
Figure	  4.19	  –	  C.	  glabrata	  acf2	   cells	  are	  hypervirulent	   in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	  acf2	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  hypervirulent	  phenotype	  that	  was	  significantly	  different	  
when	   compared	   to	   the	  wild	   type	   strain	   resulting	   in	   100%	  mortality	   after	   five	   days	   (p	   <	   0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  
analysis).	  Reconsitution	  of	  ACF2	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	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The	  C.	  glabrata	  egt2	  null	  displayed	  a	  phenotype	  that	  was	  significantly	  different	  from	  the	  wild	  type	  
control	  resulting	  in	  100%	  mortality	  by	  day	  five	  compared	  with	  60%	  survival	  over	  14	  days	  for	  the	  wild	  
type	   control	   (Figure	  4.20,	   Log-­‐rank	   (Mantel-­‐Cox)	   test;	   p	   <	   0.05).	   The	   reconstituted	   strain	   returned	  
the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐fungal	  interaction	  is	  altered	  in	  
the	  C.	  glabrata	  egt2	  strain	  displaying	  a	  hypervirulent-­‐like	  immune	  response	  in	  the	  mouse	  model.	  	  
	  
Figure	  4.20	  –	  C.	  glabrata	  egt2	  cells	  are	  hypervirulent	   in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	  egt2	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  hypervirulent	  phenotype	  that	  was	  significantly	  different	  
when	   compared	   to	   the	  wild	   type	   strain	   resulting	   in	   100%	  mortality	   after	   five	   days	   (p	   <	   0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  
analysis).	  Reconsitution	  of	  EGT2	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	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The	  C.	  glabrata	  rme1	  null	  displayed	  a	  phenotype	  that	  was	  significantly	  different	  from	  the	  wild	  type	  
control	  resulting	  in	  100%	  mortality	  by	  day	  five	  compared	  with	  60%	  survival	  over	  14	  days	  for	  the	  wild	  
type	   control	   (Figure	  4.21,	   Log-­‐rank	   (Mantel-­‐Cox)	   test;	   p	   <	   0.05).	   The	   reconstituted	   strain	   returned	  
the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐fungal	  interaction	  is	  altered	  in	  
the	  C.	  glabrata	  rme1	  strain	  displaying	  a	  hypervirulent-­‐like	  immune	  response	  in	  the	  mouse	  model.	  	  
	  
Figure	  4.21	  –	  C.	  glabrata	  rme1	  cells	  are	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	  rme1	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	  in	  a	  hypervirulent	  phenotype	  that	  was	  significantly	  different	  
when	   compared	   to	   the	  wild	   type	   strain	   resulting	   in	   100%	  mortality	   after	   five	   days	   (p	   <	   0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  
analysis).	  Reconsitution	  of	  RME1	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	  
	   	  
	  	  
	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
103	   	  
	   	  
The	  C.	  glabrata	  scw11β	  null	  displayed	  a	  phenotype	  that	  was	  significantly	  different	  from	  the	  wild	  type	  
control	   resulting	   in	  60%	  mortality	  by	  day	   four	  and	  100%	  mortality	  by	  day	   five	  compared	  with	  60%	  
survival	  over	  14	  days	  for	  the	  wild	  type	  control	  (Figure	  4.22,	  Log-­‐rank	  (Mantel-­‐Cox)	  test;	  p	  <	  0.05).	  The	  
reconstituted	  strain	  returned	  the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐
fungal	  interaction	  is	  altered	  in	  the	  C.	  glabrata	  scw11β	  strain	  displaying	  a	  hypervirulent-­‐like	  immune	  
response	  in	  the	  mouse	  model.	  	  
	  
Figure	  4.22	  –	  C.	  glabrata	  sw11β	  cells	  are	  hypervirulent	  in	  a	  neutropenic	  murine	  model	  of	  systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	   scw11β	   null	   mutant	   at	   7	   x	   107	   cells/mouse	   resulted	   in	   a	   hypervirulent	   phenotype	   that	   was	   significantly	  
different	  when	  compared	  to	  the	  wild	  type	  strain	  resulting	  in	  100%	  mortality	  after	  five	  days	  (p	  <	  0.05,	  Log-­‐rank	  (Mantel-­‐
Cox)	  analysis).	  Reconsitution	  of	  SCW11β	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	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The	  C.	  glabrata	  sic1	  null	  displayed	  a	  phenotype	   that	  was	   significantly	  different	   from	  the	  wild	   type	  
control	   resulting	   in	  20%	  mortality	  by	  day	   four	  and	  100%	  mortality	  by	  day	   five	  compared	  with	  60%	  
survival	  over	  14	  days	  for	  the	  wild	  type	  control	  (Figure	  4.23,	  Log-­‐rank	  (Mantel-­‐Cox)	  test;	  p	  <	  0.05).	  The	  
reconstituted	  strain	  returned	  the	  virulence	  to	  that	  displayed	  by	  the	  wild	  type.	  Therefore,	  the	  host-­‐
fungal	   interaction	   is	   altered	   in	   the	   C.	   glabrata	   sic1	   strain	   displaying	   a	   hypervirulent-­‐like	   immune	  
response	  in	  the	  mouse	  model.	  
	  
Figure	  4.23	  –	  C.	  glabrata	  sic1	  cells	  are	  hypervirulent	   in	  a	  neutropenic	  murine	  model	  of	   systemic	  candidasis.	  Virulence	  
was	  assayed	  in	  a	  modified	  neutropenic	  murine	  model	  of	  systemic	  infection	  [81]	  (n	  =	  5	  for	  wild	  type	  (open	  squares),	  n	  =	  5	  
for	   null	   mutant	   (no	   symbol),	   n	   =	   5	   for	   the	   reconsituted	   strain	   (closed	   triangles)).	   Intravenous	   infection	   with	   the	   	   C.	  
glabrata	  sic1	  null	  mutant	  at	  7	  x	  107	  cells/mouse	  resulted	   in	  a	  hypervirulent	  phenotype	  that	  was	  significantly	  different	  
when	   compared	   to	   the	  wild	   type	   strain	   resulting	   in	   100%	  mortality	   after	   five	   days	   (p	   <	   0.05,	   Log-­‐rank	   (Mantel-­‐Cox)	  
analysis).	  Reconsitution	  of	  SIC1	  resulted	  in	  a	  return	  to	  wild	  type	  virulence	  levels.	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4.3.7	  Fungal	  burden	  
To	   estimate	   the	   fungal	   burden	   of	   each	   of	   the	   Ace2p	   regulon	   null	   strains,	   kidneys	  were	   extracted	  
from	  animals	  at	  the	  point	  of	  sacrifice,	  with	  a	  portion	  of	  known	  weight	  homogenised,	  serially	  diluted	  
and	  plated	  out	  onto	  YPD	   in	   triplicate	  and	  grown	  overnight.	  The	  colonies	  were	  then	  counted	  and	  a	  
CFU	  count	  per	  gram	  of	  tissue	  calculated.	  The	  hypervirulent	  strains	  of	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  
and	   sic1	  all	   showed	   significantly	   increased	   fungal	   burden	  when	   compared	   to	   the	  C.	   glabrata	   wild	  
type	  (unpaired	  two	  tailed	  t-­‐test,	  p	  <	  0.0001).	  The	  reconstitutions	  of	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  







Figure	  4.24	  –	  C.	  glabrata	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1	  show	  increased	  fungal	  burden	  when	  compared	  with	  the	  
wild	  type	  in	  a	  neutropenic	  murine	  model	  of	  candidaisis.	  The	  fungal	  burden	  as	  measured	  by	  kidney	  CFU/g	  from	  infected	  
mice.	  Kidneys	  were	  extracted	  at	   the	  point	  of	   sacrifice,	  weighed,	  homogenised,	  diluted,	  plated	  out	   in	   triplicate,	  grown	  
overnight	  at	  37°C	  and	  colony	  forming	  units	  counted.	  The	  CFU	  per	  gram	  per	  kidney	  per	   infected	  animal	  was	  calculated	  
and	  compared	  to	  the	  the	  wild	  type	  with	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1	  showing	  a	  significant	  increase	  in	  fungal	  
burden	  when	   compared	   to	   the	  wild	   type	   (unpaired	   two	   tailed	   t-­‐test,	   p	   <	   0.0001).	   Reconstitution	   of	   dse3,	  acf2,	  egt2,	  




























































































	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
106	   	  
	   	  
4.3.8	  Histology	  
Organ	  samples	  were	  extracted	  at	  the	  point	  of	  sacrifice	  with	  the	  tissue	  stained	  with	  either	  GMS	  or	  H	  
&	   E	   as	   described	   in	   section	   4.2.8.	   C.	   glabrata	   cells	   were	   observed	  within	   the	   parenchyma	   of	   the	  
kidney,	  liver	  and	  lung,	  with	  a	  notable	  absence	  of	  more	  than	  one	  or	  two	  cells	  within	  the	  liver	  (Figure	  
4.25).	  The	  lung	  is	  observed	  as	  the	  primary	  target	  organ.	  Larger	  colonies	  for	  the	  hypervirulent	  strains	  
dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1	  were	  present	  in	  the	  lung	  and	  kidney	  compared	  to	  the	  wild	  
type,	   with	   dse3::DSE3,	   acf2::ACF2,	   egt2::EGT2,	   rme1::RME1,	   scw11β::SCW11β	   and	   sic1::SIC1	  
reconstitutions	   displaying	   wild	   type	   levels	   of	   organ	   colonisation.	   The	   non-­‐hypervirulent	   strains	  
amn1,	  ash1,	  bud9	  and	  dse1	  also	  displayed	  wild	  type	  levels	  of	  organ	  colonisation.	  Staining	  by	  H	  &	  E	  
displayed	   no	   signs	   of	   organ	   tissue	   inflammation	   for	   all	   strains	   and	   organs	   examined	   (data	   not	  
shown).	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Figure	  4.25a	  –	  Histological	  examination	  of	   tissues	   taken	   from	  C.	  glabrata	  wild	   type	  experimentally	   infected	  mice.	  The	  
kidney,	   liver	   and	   lung	   from	   C.	   glabrata	   wild	   type	   infected	   mice	   were	   removed	   at	   sacrifice	   and	   stained	   using	   GMS.	  
Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	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Figure	  4.25b	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  amn1	  and	  ash1	  experimentally	  infected	  mice.	  
The	  kidney,	   liver	  and	  lung	  from	  C.	  glabrata	  amn1	  and	  ash1	   infected	  mice	  were	  removed	  at	  sacrifice	  and	  stained	  using	  
GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	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Figure	  4.25c	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  bud9	  and	  dse1	  experimentally	   infected	  mice.	  
The	  kidney,	   liver	  and	   lung	   from	  C.	  glabrata	  bud9	  and	  dse1	   infected	  mice	  were	  removed	  at	  sacrifice	  and	  stained	  using	  
GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	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Figure	  4.25d	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  dse3	  and	  dse3::DSE3	  experimentally	  infected	  
mice.	   The	   kidney,	   liver	   and	   lung	   from	  C.	   glabrata	  dse3	   and	  dse3::DSE3	   infected	  mice	  were	   removed	   at	   sacrifice	   and	  
stained	  using	  GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	  The	  reconstituted	  
strain,	  dse3::DSE3,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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Figure	  4.25e	  –	  Histological	  examination	  of	   tissues	   taken	   from	  C.	  glabrata	  acf2	  and	  acf2::AFC2	  experimentally	   infected	  
mice.	   The	   kidney,	   liver	   and	   lung	   from	   C.	   glabrata	   acf2	   and	   acf2::AFC2	   infected	  mice	   were	   removed	   at	   sacrifice	   and	  
stained	  using	  GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	  The	  reconstituted	  
strain,	  acf2::AFC2,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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Figure	  4.25e	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  egt2	  and	  egt2::EGT2	  experimentally	   infected	  
mice.	   The	   kidney,	   liver	   and	   lung	   from	  C.	   glabrata	   egt2	   and	   egt2::EGT2	   infected	  mice	  were	   removed	   at	   sacrifice	   and	  
stained	  using	  GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	  The	  reconstituted	  
strain,	  egt2::EGT2,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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Figure	  4.25f	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  rme1	  and	  rme1::RME1	  experimentally	  infected	  
mice.	  The	  kidney,	   liver	  and	   lung	   from	  C.	  glabrata	  rme1	  and	  rme1::RME1	   infected	  mice	  were	  removed	  at	  sacrifice	  and	  
stained	  using	  GMS.	  Staining	  revealed	  the	  lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	  The	  reconstituted	  
strain,	  rme1::RME1,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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Figure	  4.25g	  –	  Histological	  examination	  of	  tissues	  taken	  from	  C.	  glabrata	  scw11β	  and	  scw11β::SCW11β	  experimentally	  
infected	  mice.	  The	  kidney,	  liver	  and	  lung	  from	  C.	  glabrata	  scw11β	  and	  scw11β::SCW11β	  infected	  mice	  were	  removed	  at	  
sacrifice	  and	  stained	  using	  GMS.	  Staining	  revealed	  the	   lung	  to	  be	  the	  primary	  target	  organ	  for	  yeast	  colonisation.	  The	  
reconstituted	  strain,	  scw11β::SCW11β,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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Figure	   4.25h	   –	   Histological	   examination	   of	   tissues	   taken	   from	  C.	   glabrata	   sic1	   and	   sic1::SIC1	   experimentally	   infected	  
mice.	  The	  kidney,	  liver	  and	  lung	  from	  C.	  glabrata	  sic1	  and	  sic1::SIC1	  infected	  mice	  were	  removed	  at	  sacrifice	  and	  stained	  
using	  GMS.	  Staining	  revealed	  the	   lung	  to	  be	  the	  primary	  target	  organ	   for	  yeast	  colonisation.	  The	  reconstituted	  strain,	  
sic1::SIC1,	  displayed	  similar	  yeast	  colonisation	  to	  the	  wild	  type	  strain.	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4.3.9	  Macrophage	  stimulation	  assay	  
To	  test	  the	  potential	  for	  immune	  over-­‐stimulation	  and	  high	  levels	  of	  cytokine	  release,	  as	  is	  displayed	  
in	   experiments	   with	   the	   ace2	   null	   [7],	   a	   macrophage	   stimulation	   assay	   was	   conducted.	   The	  
hypervirulent	  nulls,	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1,	  were	  screened	  for	  their	  ability	  to	  elicit	  
TNFα	   and	   IL-­‐6	   production	   in	   vitro	   in	   mouse	   peritoneal	   macrophages	   (RAW	   264.7)	   after	   a	   short	  
infection	  as	  described	  in	  Section	  4.2.10.	  The	  C.	  glabrata	  sic1	  null	  was	  shown	  to	  elicit	  a	  significantly	  
different	  amount	  of	  TNFα	  and	  IL-­‐6	  production	  from	  the	  wild	  type	  using	  a	  one-­‐way	  ANOVA	  (p<0.005	  
and	  p<0.05	   respectively).	  The	  sic1	  null	   showed	  a	   four-­‐fold	   increase	   in	  TNFα	   release	  and	  a	  3.4-­‐fold	  
increase	  in	  IL-­‐6	  release	  compared	  to	  the	  wild	  type.	  Reconstitution	  of	  SIC1	  resulted	  in	  a	  return	  to	  wild	  
type	  TNFα	  and	  IL-­‐6	  production	  levels.	  
	  
Figure	   4.26	   –	   C.	   glabrata	   sic1	   shows	   a	   significant	   increase	   in	   TNFα	   production	   in	   a	   macrophage	   stimulation	   assay	  
compared	  to	  the	  wild	  type.	  C.	  glabrata	  2001,	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β ,	  sic1	  and	  sic1::SIC1	  were	  exposed	  to	  RAW	  
264.7	  macrophages	  at	  a	  ratio	  of	  30:1	  fungi:macrophage.	  After	  washing	  off	  unbound	  fungi,	  macrophages	  were	  incubated	  
for	  6	  hours	  at	  37°C,	  with	  supernatants	  then	  collected	   for	  TNFα	  quantification	  by	  ELISA	  kit	   (R&D	  Systems,	  UK).	  Results	  
(mean	  with	   standard	  deviation)	   are	  pooled	   triplicate	  data	   from	   three	   separate	   experiments.	  C.	   glabrata	   sic1	   showed	  
statistically	  significant	  increased	  levels	  of	  TNF-­‐α	  elicitation	  compared	  to	  the	  wild	  type	  C.	  glabrata	  2001	  (p	  <	  0.005,	  one-­‐
way	  ANOVA).	  Reconsitution	  of	  SIC1	  restored	  TNFα	  elicitation	  to	  wild	  type	  levels.	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Figure	   4.27	   –	   C.	   glabrata	   sic1	   shows	   a	   significant	   increase	   in	   IL-­‐6	   production	   in	   a	   macrophage	   stimulation	   assay	  
compared	  to	  the	  wild	  type.	  C.	  glabrata	  2001,	  dse3,	  acf2,	  egt2,	  rme1,	  scw11β ,	  sic1	  and	  sic1::SIC1	  were	  exposed	  to	  RAW	  
264.7	  macrophages	  at	  a	  ratio	  of	  30:1	  fungi:macrophage.	  After	  washing	  off	  unbound	  fungi,	  macrophages	  were	  incubated	  
for	  6	  hours	  at	  37°C,	  with	  supernatants	  then	  collected	  for	  IL-­‐6	  quantification	  by	  ELISA	  kit	  (R&D	  Systems).	  Results	  (mean	  
with	   standard	   deviation)	   are	   pooled	   triplicate	   data	   from	   three	   separate	   experiments.	   C.	   glabrata	   sic1	   showed	  
statistically	  significant	  increased	  levels	  of	  IL-­‐6	  elicitation	  compared	  to	  the	  wild	  type	  C.	  glabrata	  2001	  (p	  <	  0.05,	  one-­‐way	  
ANOVA).	  Reconsitution	  of	  SIC1	  restored	  IL-­‐6	  elicitation	  to	  wild	  type	  levels.	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4.3.10	  Reconstitution	  Northern	  Analysis	  
To	  show	  that	  reconstitution,	  as	  described	  in	  section	  4.2.3,	  successfully	  resulted	  in	  the	  expression	  of	  
the	  target	  gene	  within	  the	  null	  strains,	  Northern	  blotting,	  as	  described	  in	  section	  2.3.15,	  was	  used	  to	  
probe	  for	  the	  target	  gene	  in	  each	  null	  mutant	  and	  reconstituted	  strain.	  All	  six	  reconstituted	  strains	  
displayed	  expression	  of	  the	  target	  gene	  and	  not	  in	  the	  null	  mutant	  as	  displayed	  in	  Figure	  4.28.	  
	  
Figure	   4.28	   –	   C.	   glabrata	   dse3::DSE3,	   acf2::ACF2,	   egt2::EGT2,	   rme1::RME1,	   scw11β ::SCW11β 	   and	   sic1::SIC1	  
reconstitutions	   display	   expression	   of	   the	   reconstituted	   gene.	   C.	   glabrata	   dse3,	   dse3::DSE3,	   acf2,	   acf2::ACF2,	   egt2,	  
egt2::EGT2,	   rme1,	   rme1::RME1,	   scw11β ,	   scw11β::SCW11β,	   sic1	   and	   sic1::SIC1	  were	   cultured	   in	   selective	   media	   over	  
night,	  diluted	  down	  to	  0.1	  OD600	  and	  allowed	  to	  grow	  for	  three	  hours.	  Total	  RNA	  was	  extracted	  using	  a	  Qiagen	  RNeasy	  
mini	  kit	  as	  per	   the	  manufacturers	   instructions.	  Probes	  were	  constructed	  using	   internal	  primer	  pairs	   from	  the	  relevant	  
gene	  as	   indicated	  above	  each	  pair	  of	  panels.	  Primers	  are	   listed	  in	  Appendix	  3.	  The	  lower	  panels	  show	  methylene	  blue	  
loading	  controls.	  The	  target	  gene	  expression	  is	  suppressed	  in	  the	  null	  strains	  as	  indicated	  by	  a	  lack	  of	  a	  band	  in	  the	  KO	  
lane.	  All	  reconstituted	  strains	  display	  a	  black	  band	  in	  the	  R	  lane	  indicating	  expression	  of	  the	  reconstituted	  target	  gene.	  
	  
	   	  
	  	  
	   Chapter	  4	  –	  Study	  of	  the	  Ace2p	  regulon	  and	  its	  role	  in	  hypervirulence	   	  	   	  
119	   	  
	   	  
4.4	  Discussion	  
The	   results	   in	   this	   chapter	  have	   shown	   the	   first	   time	   that	   the	  ACE2	  virulence-­‐moderating	  effect	   is	  
created	  by	  multiple	  antivirulence	  genes	  under	   the	  transcriptional	   regulation	  of	  Ace2p,	  and	  that	  six	  
genes,	  DSE3,	  ACF2,	  EGT2,	  RME1,	  SCW11β	  and	  SIC1,	  act	  as	  virulence-­‐moderating	  genes	  in	  C.	  glabrata.	  
Of	  those	  antivirulence	  genes,	  only	  the	  C.	  glabrata	  sic1	  null	  mutant	  shows	  an	  ability	  to	  induce	  inflated	  
cytokine	   release	   in	   a	   macrophage	   model	   of	   immune	   stimulation.	   It	   has	   also	   been	   shown	   that	  
deletion	  of	  the	   individual	  genes	  that	   form	  part	  of	  the	  Ace2p-­‐dependent	  cell	  separation	  machinery,	  
apart	  from	  dse1	  and	  egt2,	  do	  not	  create	  a	  visible	  cell	  separation	  defect,	  indicating	  that	  there	  is	  likely	  
redundancy	  within	  the	  glucanases	  responsible	  for	  hydrolysis	  of	  the	  secondary	  septum	  in	  C.	  glabrata.	  
	  
4.4.1	  Deletion	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata	  
A	  reductionist	  approach	  was	  taken	  with	  regard	  the	  investigation	  of	  the	  antivirulence	  potential	  of	  the	  
Ace2p	   regulon,	   by	   creating	   single	   gene	   deletions	   of	   the	   Ace2p-­‐dependent	   genes	   in	   a	   suitable	   C.	  
glabrata	  background	  strain.	  The	   first	  batch	  of	   six	  genes	  were	  created	  by	   initial	  attempts	  using	   the	  
fusion	  PCR	  method	  for	  gene	  deletion,	  which	  created	  the	  deletion	  cassette	  using	  a	  fusion	  PCR	  cycle	  to	  
join	   5’	   and	   3’	   UTRs	   of	   the	   target	   gene	  with	   a	   NAT	   resistance	   cassette.	   The	   six	   genes	   successfully	  
disrupted	   were	   ASH1,	   BUD9,	   DSE1,	   DSE3,	   EGT2	   and	   RME1,	   which	   were	   confirmed	   by	   PCR	   and	  
Southern	   analysis	   as	   shown	   in	   Appendix	   4.	   Attempts	   to	   disrupt	   the	   remaining	   six	   Ace2p	   regulon	  
genes,	  AMN1,	  DSE2,	  ACF2,	   SCW11α,	   SCW11β	   and	   SIC1,	   using	   the	   same	  methodology	   failed	   after	  
many	   repeats.	   Several	   other	   deletion	   methodologies	   were	   then	   tried	   in	   an	   effort	   to	   disrupt	   the	  
remaining	   six	   genes.	  Moderate	   success	  was	   attained	   using	   a	   simpler	   one-­‐step	   PCR	   approach,	   the	  
Edlind	  method,	  with	  four	  successful	  deletions	  confirmed	  by	  PCR	  and	  Southern	  analysis	  of	  the	  genes	  
AMN1,	  ACF2,	  SCW11β	  and	  SIC1	  as	  shown	  in	  Appendix	  4.	  Many	  attempts	  were	  made	  to	  disrupt	  the	  
remaining	   two	   genes,	   DSE2	   and	   SCW11α,	   using	   the	   Edlind	   method	   and	   several	   other	   deletion	  
methods,	  but	  unfortunately	  time	  ran	  out	  for	  their	  inclusion	  within	  this	  project.	  
It	  was	   assumed	   that	  deletions	  of	  both	  DSE2	   and	  SCW11α	  were	  possible,	   that	   the	   genes	  were	  not	  
essential	  and	  that	  dse2	  and	  scw11α	  would	  be	  viable	  in	  C.	  glabrata,	  due	  to	  the	  fact	  that	  ace2	  mutants	  
were	   viable	   and	   that	   both	  DSE2	   and	   SCW11α	   show	   no	   transcription	   in	   the	   absence	   of	   Ace2p	   as	  
illustrated	  in	  chapter	  3.	  It	  is	  possible,	  however,	  that	  the	  two	  genes	  are	  protected	  in	  some	  way	  from	  
homologous	   recombination,	   which	   would	   prevent	   deletion	   via	   deletion	   cassette	   transformation,	  
possibly	  due	   to	   their	  position	  within	   the	  chromosome.	   It	   is	   also	  possible	   that	   the	  assumption	   that	  
DSE2	  and	  SCW11α	   are	  not	  essential	   could	  be	  wrong,	   and	   that	   they	  are	  essential	   for	   viability	   in	  C.	  
glabrata	  and	  that	  they	  are	  expressed	  in	  low	  levels	  that	  are	  undetectable	  via	  Northern	  analysis	  in	  the	  
absence	  of	  Ace2p.	  
	  
4.4.2	  Deletion	  screening	  
The	  putants	  for	  each	  of	  the	  10	  successfully	  disrupted	  genes	  were	  then	  subjected	  to	  a	  set	  of	  standard	  
phenotypic	  tests	  as	  used	  within	  the	  Haynes	  lab,	  and	  detailed	  by	  Hampsey	  et	  al.	  [246],	  which	  included	  
temperature,	  pH,	  nutrient	  and	  oxidative	  stress,	  as	  well	  as	  conditions	  to	  highlight	  cell	  wall	  and	  protein	  
glycosylation	   deficiencies.	   The	   screen	   was	   not	   only	   designed	   to	   test	   for	   sensitivity	   to	   a	   series	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conditions	  picked	  to	  show	  areas	  of	  possible	  gene	  function,	  but	  also	  to	  test	  for	  differences	  between	  
the	  deletion	  putants,	  for	  selection	  of	  one	  particular	  mutant	  for	  each	  gene	  for	  virulence	  analysis.	  The	  
phenotypic	  screen	  showed	  that	  there	  was	  no	  difference	  between	  the	  majority	  of	  the	  gene	  deletions	  
and	  the	  parental	  type	  for	  all	  of	  the	  screen	  conditions,	  apart	  from	  a	  mild	  sensitivity	  of	  the	  mutants	  for	  
AMN1,	  DSE1,	  DSE3,	  ACF2,	  EGT2,	  RME1	  and	  SIC1	   to	  vanadate,	  and	  a	  mild	  sensitivity	  of	  mutants	   for	  
AMN1,	  ACF2,	   SCW11β	   and	   SIC1	   to	   caffeine	   (Figures	   4.6	   and	   4.9).	   The	  minimal	   sensitivity	   for	   the	  
majority	  of	  test	  conditions	  was	  expected	  of	  the	  partial	  Ace2p	  regulon	  null	  mutants	  when	  compared	  
to	   the	   parental	   control,	   due	   to	   the	   lack	   of	   sensitivity	   shown	   by	   a	   similar	   screen	   of	   the	  ace2	   null	  
mutant	   HLS122	   [142].	   Sensitivity	   to	   2.5	   mM	   vanadate	   could	   indicate	   a	   small	   change	   to	   the	  
permeability	  of	  the	  cell	  to	  sodium	  orthovanadate,	  which	  is	  a	  known	  phosphatase	  inhibitor,	  and	  could	  
indicate	  possible	  protein	  glycosylation	  and	  secretion	  defects	  [250].	  Caffeine	  sensitivity	  is	  linked	  with	  
defects	   in	  quite	  a	   few	  cellular	  processes,	  which	   include	  MAPK	   signalling	  pathways,	   as	   the	   caffeine	  
molecule	  acts	  as	  a	  purine	  analogue	  once	  inside	  the	  cell	  and	  is	  currently	  used	  as	  phenotypic	  test	  for	  
the	  evaluation	  of	  function	  of	  the	  Mpk1p-­‐mediated	  cell	  wall	  integrity	  pathway	  [246,	  247,	  251].	  	  
The	   effects	   of	   gene	   deletions	   on	   cell	   separation	   were	   also	   analysed	   by	   microscopy.	   The	   results	  
indicate	  that	  the	  extreme	  clumpy	  phenotype	  and	  failure	  of	  cell	  separation	  shown	  by	  ace2	  mutants	  in	  
C.	   glabrata	   is	   multifactorial,	   and	   relies	   on	   the	   absence	   of	   expression	   of	   CTS1	   combined	   with	   the	  
absence	  of	  other	  members	  of	  the	  cell	  separation	  machinery.	  Both	  dse1	  and	  egt2	  display	  a	  relatively	  
mild	  cell	  separation	  defect	  when	  compared	  to	  that	  of	  ace2	  with	   lines	  of	  three	  or	  more	  joined	  cells	  
consistently	   displayed	   as	   shown	   in	   Figure	   4.10.	   Interestingly,	   the	   dse1	   cell	   separation	   defect	  
displayed	   in	   the	  haploid	  C.	  glabrata,	  mirrors	   that	  shown	   in	  diploid	  S.	  cerevisiae,	  but	  not	  haploid	  S.	  
cerevisiae	  lab	  strains	  [101].	  It	  was	  suggested	  that	  Dse1p	  might	  play	  a	  role	  in	  bud	  site	  selection	  [163],	  
invasive	   growth	   [166]	   and	   cross-­‐talk	   between	   the	  pheromone	  and	   invasive	   growth	  pathways	   in	  S.	  
cerevisiae,	  as	  well	  as	  a	  cell	  wall	  and	  filamentous	  growth	  role	  in	  C.	  albicans	  [169].	  The	  current	  results	  
indicate	   a	   probable	   role	   in	   cell	   separation	  due	   to	   the	   cell	   separation	  deficient	   phenotype	   and	   cell	  
wall/septum	   hydrolysis	   in	   C.	   glabrata,	   and	   cannot	   confirm	   or	   deny	   a	   role	   in	   bud	   site	   selection,	  
although	  a	  role	  invasive	  and	  filamentous	  growth	  within	  C.	  glabrata	  is	  improbable	  due	  to	  the	  lack	  of	  
true	  hyphal	   formation	  yet	   to	  be	  found	  within	  the	  species	   [233].	  EGT2	  encodes	  a	  GPI-­‐anchored	  cell	  
wall	  endoglucanase	  that	  is	  likely	  involved	  in	  cell	  separation	  in	  S.	  cerevisiae	  [127].	  The	  cell	  separation	  
defect,	  as	  shown	  in	  Figure	  4.10,	  indicates	  that	  Egt2p	  also	  plays	  a	  role	  in	  cell	  separation	  in	  C.	  glabrata,	  
and	  combined	  with	  the	  sequence	  homology	  of	  EGT2	  shown	  between	  the	  species	  suggests	  that	  it	  is	  a	  
cell	  wall	   endoglucanase	   that	   plays	   a	   role	   in	   digestion	  of	   the	   secondary	   septum.	  One	  mutant	   from	  
each	  of	  the	  gene	  deletions	  was	  selected	  to	  take	  forward	  through	  further	  testing	  
To	   see	  whether	   the	  Ace2p	   regulon	  gene	  deletions	  affected	  growth	   rates	   in	  C.	  glabrata,	   a	   24-­‐hour	  
growth	   assay	   was	   used	   to	   plot	   the	   start	   and	   ends	   of	   the	   lag,	   exponential	   and	   stationary	   growth	  
phases.	  Figure	  4.12	  shows	  that	  C.	  glabrata	  amn1,	  ash1,	  acf2,	  bud9,	  dse1,	  dse3,	  egt2,	  rme1,	  scw11β	  
and	  sic1	  show	  similar	  growth	  rates	  to	  the	  C.	  glabrata	  wild	  type	  and	  parental	  strains,	  and	  therefore	  
their	  growth	  is	  unaffected	  by	  the	  gene	  deletion.	  This	  means	  that	  any	  potential	  changes	  in	  virulence	  
will	  not	  be	  down	  to	  a	  change	  in	  growth	  rate	  of	  the	  null	  mutants,	  when	  compared	  to	  the	  wild	  type.	  
By	  comparing	  the	  extreme	  cell	  separation	  deficient	  phenotype	  displayed	  by	  C.	  glabrata	  ace2	  to	  the	  
individual	  Ace2p	  regulon	  gene	  deletions,	  it	  is	  probable	  that	  redundancy	  exists	  between	  the	  cell	  wall	  
glucanases,	   and	   that	   the	   absence	   of	   CTS1	   expression,	   which	   results	   in	   a	   clumpy	   cell	   separation	  
deficient	   phenotype	   [142],	   and	   therefore	   lack	   of	   chitin	   hydrolysis	   of	   the	   primary	   septum,	   forms	   a	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major	  part	  of	   the	  cell	   separation	  deficiency.	  Considering	  that	   five	  genes	  transcriptionally	   regulated	  
by	  Ace2p,	  DSE2,	  ACF2,	  EGT2,	  SCW11α	  and	  SCW11β,	  all	  encode	  cell	  wall	  associated	  glucanases	  and	  all	  
show	   localisation	   to	   the	  daughter	  cell	   side	  of	   the	  bud	  neck	   in	  S.	  cerevisiae,	   redundancy	  within	   the	  
genes	  is	  highly	  likely.	  
	  
4.4.3	  Virulence	  screening	  
The	  main	  focus	  of	  this	  study	  was	  to	  ascertain	  which	  genes	  transcriptionally	  regulated	  by	  Ace2p	  in	  C.	  
glabrata	  had	  potential	  for	  antivirulence,	  in	  an	  attempt	  to	  explain	  the	  virulence-­‐moderating	  effect	  of	  
ACE2.	   The	   primary	   method	   of	   assaying	   virulence	   for	   C.	   glabrata	   candidiasis	   is	   the	   neutropenic	  
murine	  model	   of	   disseminated	   candidiasis	   as	   defined	   and	   used	   in	   Haynes	   lab	   [7,	   81].	   Initial	   pilot	  
studies	  using	  the	  C.	  glabrata	  wild	  type	  were	  performed	  to	  define	  a	  standard	  under	  the	  conditions	  to	  
be	  used	  for	  the	  virulence	  analysis.	  It	  was	  found	  that	  a	  modification	  to	  the	  model,	  the	  addition	  of	  an	  
extra	  immune	  suppression	  step	  at	  day	  -­‐1	  to	  ensure	  neutropenia	  on	  inoculation	  day,	  made	  the	  results	  
more	   consistent	   and	   gave	   scope	   for	   detection	   of	   increased	   virulence	   even	  within	   small	   groups	   of	  
animals.	   A	   test	   group	   to	   determine	   whether	   the	   addition	   of	   the	   extra	   immune	   suppression	   step	  
caused	  a	  change	  in	  the	  uninfected	  control	  group’s	  survival	  was	  run	  for	  the	  maximum	  period	  of	  the	  
animal	   license	   (21	   days),	   with	   100%	   survival	   and	   no	   change	   from	   previously	   validated	   immune	  
suppression	  regimes	  (Figure	  4.13).	  It	  was	  decided	  that	  the	  modified	  neutropenic	  mouse	  model	  was	  
fit	  for	  purpose,	  and	  that	  virulence	  testing	  of	  the	  Ace2p	  regulon	  genes	  was	  to	  be	  carried	  out	  using	  it.	  
The	   results	   show	   that	   for	   the	   first	   time	   in	   C.	   glabrata,	   six	   genes	   transcriptionally	   dependent	   on	  
Ace2p	  are	   virulence	  moderating.	   In	   the	  modified	  murine	  model	  of	  disseminated	   candidiasis,	  dse3,	  
acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1	   all	   showed	   statistically	   significant	   hypervirulence,	   as	   tested	   by	  
Log-­‐rank	  (Mantel-­‐Cox)	  analysis,	  when	  compared	  to	  the	  wild	  type	  as	  shown	  in	  Figures	  4.18-­‐4.23.	  All	  
six	  deletions	   resulted	   in	  100%	  mortality	  after	   five	  days	  compared	   to	  a	  60%	  survival	   rate	   for	   the	  C.	  
glabrata	   wild	   type,	   with	   scw11β	   and	   dse3	   also	   displaying	   mouse	   mortality	   on	   day	   four.	  
Reconstitution	   of	   the	   hypervirulent	   null	   mutants	   was	   performed	   via	   plasmid	   transformation,	  
confirmed	   by	   Northern	   Analysis	   (Figure	   4.28),	   and	   assayed	   under	   the	   same	   modified	   model	  
conditions	   to	   confirm	   the	   validity	   of	   the	   virulence	   phenotypes	   shown,	   with	   all	   six	   reconstitutions	  
displaying	  a	  return	  to	  wild	  type	  virulence	  levels,	  statistically	  different	  from	  the	  deletion	  phenotypes	  
as	   tested	  by	   Log-­‐rank	   (Mantel-­‐Cox)	  analysis,	   validating	   the	  hypervirulence	  phenotype	  displayed	  by	  
dse3,	  acf2,	  egt2,	  rme1,	  scw11β	  and	  sic1.	  The	  other	  Ace2p	  regulon	  deletions	  amn1,	  ash1,	  bud9	  and	  
dse1	   showed	   wild	   type	   levels	   of	   virulence	   when	   compared	   with	   Cg2001	   (Figures	   4.14-­‐4.17),	  
indicating	   that	   they	   likely	  play	  no	  part	   in	   the	  ace2	  null	  hypervirulent	  phenotype	  when	   individually	  
disrupted.	  
The	   fungal	   burden	   created	   by	   each	   null	   strain	  was	   looked	   at	   in	   the	   kidneys	   of	   the	   infected	  mice.	  
Fungal	  burden	  was	  estimated	  using	  the	  commonly	  used	  CFU	  per	  gram	  of	  tissue,	  in	  this	  case	  kidney,	  
as	  a	  representative	  sample	  of	  colonisation.	  The	  results	  displayed	  in	  Figure	  4.24,	  show	  that	  the	  fungal	  
burden	  is	  increased	  by	  a	  factor	  of	  10	  to	  100	  correlating	  with	  those	  strains	  displaying	  hypervirulence.	  
The	   strain	   that	   showed	   the	   greatest	   increase	   in	   virulence,	   dse3,	   also	   showed	   the	   highest	   fungal	  
burden	  with	  1.1	  x	  107	  CFUs	  per	  gram	  of	  kidney,	  with	  rme1,	  egt2,	  scw11β,	  sic1	  and	  acf2	  decreasing	  in	  
fungal	   burden	   with	   9.9	   x	   106,	   7.1	   x	   106,	   6.6	   x	   106,	   3.1	   x	   106	   and	   2.5	   x	   106	   respectively.	   This	   is	  
compared	   to	   the	   fungal	   burden	   of	   just	   3.3	   x	   105	   CFU/g	   shown	   by	   the	  C.	   glabrata	   wild	   type.	   This	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indicates	  that	  the	  antivirulence	  displayed	  by	  the	  six	  genes	  of	  the	  partial	  Ace2p	  regulon	  in	  C.	  glabrata	  
also	   amounts	   to	   increased	   survival	   and	   proliferation	   within	   the	   host	   environment	   and	   likely	  
contributes	  to	  the	  increased	  mortality	  of	  the	  host.	  
Histological	  analysis	  of	  tissue	  from	  the	  kidney,	  liver	  and	  lungs	  of	  infected	  mice	  was	  also	  performed	  to	  
look	   for	   yeast	   colonisation	   and	   proliferation	   within	   the	   host	   tissue.	   Given	   that	   the	   mice	   were	  
infected	  with	  single	  cell	  solutions,	  C.	  glabrata	  displayed	  the	  ability	  to	  proliferate	   in	  vivo,	  with	  GMS	  
staining	   (Figure	   4.25)	   showing	   that	   the	   lungs	   were	   the	   primary	   target	   organ	   and	   that	   the	  
hypervirulent	   dse3,	   acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1	   strains	   formed	   larger	   colonies	   within	   host	  
tissue	  when	  compared	  to	  the	  wild	  type,	  as	  was	  found	  for	  C.	  glabrata	  ace2	  cells	  by	  Kamran	  et	  al.	  [7].	  
The	  kidneys	  also	  showed	  an	  increase	  in	  yeast	  colonisation	  in	  the	  hypervirulent	  strains,	  while	  neither	  
hypervirulent	  nor	  wild	  type	  strains	  showed	  much	  more	  than	  single	  yeast	  cells	   in	  the	   liver	  samples.	  
The	   reconstituted	   strains	   displayed	   similar	   yeast	   colonisation	   and	   proliferation	   to	   the	   wild	   type,	  
mirroring	   the	   return	   to	  wild	   type	   levels	  of	   virulence.	  No	   characteristic	   signs	  of	   inflammation	  were	  
visible	   in	  H	  &	  E	  stained	  samples	   indicating	  that	  neither	  wild	  type	  C.	  glabrata	  nor	  the	  hypervirulent	  
strains	  induce	  an	  inflammatory	  response	  from	  the	  host	  in	  the	  neutropenic	  model	  as	  was	  the	  case	  for	  
ace2	  null	  cells	  [7].	  
The	  hypervirulent	  results	  show	  that	  it	  is	  possible	  that	  when	  the	  absence	  of	  each	  of	  the	  DSE3,	  ACF2,	  
EGT2,	  RME1,	  SCW11β	  and	  SIC1	  genes	  are	  combined	  with	  the	  absence	  of	  CTS1,	  as	   is	   the	  case	   in	  an	  
ace2	  mutant,	  the	  hypervirulent	  affect	  is	  synergistic	  creating	  the	  extreme	  hypervirulence	  displayed	  by	  
ace2.	  To	  test	  this	  theory,	  deletions	  of	  all	   the	  seven	  genes,	  DSE3,	  ACF2,	  EGT2,	  RME1,	  SCW11β,	  SIC1	  
and	  CTS1,	  need	  to	  be	  created	  within	  one	  strain,	  creating	  the	  equivalent	  of	  an	  ace2	  null	  with	  regard	  
to	  the	  seven	  genes.	  
	  
4.4.4	  Immune	  activation	  and	  septic	  shock	  in	  Ace2p	  regulon	  hypervirulence	  
An	   immune	   over-­‐stimulation	   effect	   has	   been	   reported	   for	   ace2	   and	   has	   been	   suggested	   to	  
contribute	   to	   the	   hypervirulent	   phenotype	   displayed	   by	   the	   null	   strain	   in	   both	   CD1	   and	   BALB/c	  
neutropenic	  mouse	  models	  of	  candidiasis	  [233].	  The	  dramatically	  increased	  cytokine	  release	  of	  both	  
IL-­‐6	   and	   TNFα,	   16-­‐	   and	   38-­‐fold	   respectively,	   was	   suggested	   to	   contribute	   to	   the	   hypervirulent	  
phenotype	  of	  ace2,	  mirroring	  the	  response	  involved	  in	  septic	  shock	  [233,	  234].	  To	  study	  the	  ability	  of	  
the	   hypervirulent	   dse3,	   acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1	   C.	   glabrata	   strains	   to	   cause	   over-­‐
stimulation	   of	   macrophages	   and	   elicit	   cytokine	   release,	   a	   short	   macrophage	   infection	   assay	   was	  
conducted	  with	  the	  resulting	  supernatant	  tested	  for	  both	  IL-­‐6	  and	  TNFα	   levels	  by	  ELISA.	  Compared	  
to	  the	  C.	  glabrata	  wild	  type,	  only	  the	  sic1	  null	  showed	  the	  ability	  to	  significantly	  hyperstimulate	  the	  
macrophages	   resulting	   in	   a	   3.4-­‐fold	   increase	   in	   IL-­‐6	   release	   (P	   <	   0.05)	   and	   a	   four-­‐fold	   increase	   in	  
TNFα	   release	   (P	   <	   0.005)	  when	   compared	   to	   Cg2001,	  with	  dse3,	  acf2,	  egt2,	   rme1	   and	   scw11β	   all	  
exhibiting	  wild	  type	   levels	  as	  shown	  in	  Figures	  4.25	  and	  4.26.	  Reconstitution	  restored	  sic1	   IL-­‐6	  and	  
TNFα	  production	  to	  wild	  type	  levels.	  
Combining	  the	   in	  vitro	  cytokine	  release	  data	  with	  the	  fact	  that	  dse3,	  acf2,	  egt2,	  rme1	  and	  scw11β,	  
took	   four	   to	   five	  days	   to	   cause	  mortality	   in	   the	  mouse	  model	  of	   candidiasis,	   it	   is	  unlikely	   that	   the	  
hypervirulent	  phenotype	  is	  caused	  by	  induction	  of	  inappropriate	  cytokine	  release	  in	  vivo	  and	  septic	  
shock.	  The	  same	  could	  be	  said	  for	  sic1,	  however	  its	  ability	  to	  induce	  a	  3.4-­‐fold	  increase	  in	  IL-­‐6	  and	  a	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four-­‐fold	   increase	   in	  TNFα	   production	   in	   vitro	   suggests	   that	   it	   contributes	   to	   the	  hyperstimulation	  
displayed	  by	  the	  ace2	  null	  in	  vivo	  [7].	  
	  
4.4.5	  Potential	  effects	  of	  deletion	  of	  the	  Ace2p	  regulon	  genes	  
By	   looking	   at	   the	   current	   knowledge	   of	   the	   Ace2p	   regulon	   genes	   in	   S.	   cerevisiae,	   and	   the	   data	  
revealed	   in	   this	   chapter,	   it	   is	   possible	   to	   hypothesise	  what	   effect	   some	  of	   the	   gene	   deletions	  will	  
have	  on	  the	  C.	  glabrata	  cell.	  Amn1p	  is	  known	  to	  block	  G-­‐protein	  signalling	  by	  binding	  to	  Tem1p	  and	  
preventing	   the	   activation	   of	   the	   protein	   kinase	   Cdc15p,	   which	   in	   turn	   prevents	   activation	   of	   the	  
protein	   phosphatase	   Cdc14p,	   preventing	   MEN	   activation	   [144].	   In	   S.	   cerevisiae,	   amn1	   nulls	   have	  
been	  shown	  to	  exhibit	  premature	  mitotic	  exit	  with	  inappropriate	  activation	  of	  MEN,	  and	  have	  been	  
shown	  to	  also	  affect	  the	  expression	  of	  one	  of	  the	  other	  Ace2p	  regulon	  genes,	  DSE3	  [144,	  175].	  It	  is	  
likely	  that	  deletion	  of	  AMN1	  in	  C.	  glabrata	  will	  have	  a	  similar	  effect,	  with	  premature	  MEN	  activation	  
during	   spindle	   assembly	   or	   nuclear	   orientation	   checkpoints,	   although	   no	   obvious	   phenotype	   was	  
displayed	  apart	  from	  a	  mild	  sensitivity	  to	  10	  mM	  caffeine,	  which	  could	  indicate	  a	  mild	  disruption	  of	  
many	   cellular	   processes,	   including	   MAPK	   signalling	   pathways	   and	   the	   cell	   wall	   integrity	   pathway	  
[246,	  247,	  251].	  	  
Ash1p	  has	  been	  shown	  to	  be	  a	  repressor	  of	  HO	  transcription	  and	  therefore	  controls	  the	  initiation	  of	  
mating-­‐type	  switching	  in	  S.	  cerevisiae	  [147].	  Although	  three	  mating-­‐type	  loci	  have	  been	  found	  within	  
the	  C.	  glabrata	  genome	  and	  both	  a-­‐	  and	  α-­‐pheromone	  expressing	  strains	  exist	  [252],	  and	  that	  other	  
parts	   of	   the	   mating	   machinery	   are	   also	   encoded	   in	   the	   genome	   [253],	   no	   sexual	   cycle	   has	   been	  
discovered.	   It	   is	   therefore	   unknown	   what	   function	   Ash1p	   has	   within	   C.	   glabrata,	   although	   its	  
transcriptional	   regulation	   by	   Ace2p	   and	   therefore	   its	   cell	   cycle	   regulated	   daughter	   cell	   specific	  
expression,	  implies	  that	  it	  has	  a	  role	  in	  determining	  daughter	  cell	  fate.	  It	  is	  therefore	  unknown	  what	  
effect	   its	   deletion	   could	   have	   on	   the	   C.	   glabrata	   cellular	   processes,	   and	   given	   that	   no	   obvious	  
phenotype	  was	  displayed	   in	   screening	  apart	   from	  a	  mild	   sensitivity	   to	  10	  mM	  caffeine,	   the	   results	  
from	  this	  study	  do	  not	  point	  to	  any	  function	  either.	  
Bud9p	   has	   been	   shown	   to	   act	   as	   a	   cortical	   landmark	   for	   bud	   site	   selection	   in	   a	   bipolar	   budding	  
pattern	   [155-­‐157].	   It	  marks	   the	   distal	   pole	   of	   the	   cell	   within	   diploid	   S.	   cerevisiae	   cells,	   but	   is	   not	  
active	   in	   haploid	   S.	   cerevisiae,	   which	   display	   axial	   budding	   rather	   than	   bipolar	   [155,	   156].	   It	   is	  
unknown	  what	  role	  Bud9p	  plays	  in	  C.	  glabrata,	  due	  to	  its	  asymmetric	  and	  unipolar	  budding	  pattern	  
[31].	  However,	  it	  is	  possible	  that	  Bud9p	  marks	  the	  distal	  pole,	  from	  which	  the	  daughter	  cells	  tend	  to	  
bud	   [31],	   acting	   as	   a	   cortical	   landmark	   in	  C.	   glabrata	   as	  Bud9p	  does	   in	  S.	   cerevisiae.	   If	   that	   is	   the	  
case,	  deletion	  could	  cause	  a	  change	  in	  the	  budding	  pattern	  of	  the	  C.	  glabrata	  bud9	  null,	  however	  no	  
such	  change	  in	  budding	  pattern	  was	  observed	  when	  compared	  with	  the	  parental	  strain	  as	  shown	  in	  
Figure	  4.10.	  
Dse1p	  is	  a	  gene	  of	  unknown	  function	  in	  both	  S.	  cerevisiae	  and	  C.	  glabrata.	  It	  has	  been	  suggested	  that	  
Dse1p	   plays	   a	   role	   in	   cell	   wall	   metabolism	   in	   S.	   cerevisiae,	   with	   diploid	   dse1	   nulls	   displaying	  
sensitivity	  to	  cell	  wall	  targeted	  conditions	  [101],	  and	  a	  possible	  role	  in	  control	  of	  cross-­‐talk	  between	  
the	   invasive	  growth	  and	  pheromone	  response	  pathway	  [166];	  while	   in	  C.	  albicans,	  Dse1p	  has	  been	  
suggested	  as	  having	  a	  role	   in	  cell	  wall	  metabolism	  [169].	  Combined	  with	  the	  cell	  separation	  defect	  
displayed	   in	   Figure	   4.10,	   and	   Dse1p’s	   bud	   neck	   localisation	   in	   S.	   cerevisiae,	   it	   is	   likely	   that	   Dse1p	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plays	   a	   similar	   role	   in	   cell	   wall	   metabolism	   in	   C.	   glabrata,	   taking	   part	   in	   the	   degradation	   of	   the	  
secondary	   septum	   or	   cell	   wall.	   Considering	   three	   out	   of	   the	   five	   Ace2p-­‐dependent	   cell	   wall	  
glucanases,	  DSE2,	  ACF2,	  and	  SCW11β,	  all	   failed	  to	  show	  a	  cell	  separation	  defect	   in	  their	  respective	  
deletions	   as	   shown	   in	   Figures	   4.10	   and	   4.11,	   it	   is	   also	   possible	   that	   Dse1p	   either	   plays	   role	   in	  
regulating	  the	  action	  of	  multiple	  redundant	  glucanases,	  or	  that	  it	  plays	  a	  role	  in	  regulating	  the	  only	  
glucanase	  to	  show	  a	  cell	  separation	  defect,	  Egt2p.	  The	  sensitivity	  to	  10	  mM	  caffeine	  could	  indicate	  a	  
disruption	  to	  a	  range	  of	  cellular	  processes.	  
DSE3	   encodes	   a	   gene	   of	   unknown	   function	   that	   does	   not	   share	   sequence	   homology	   with	   other	  
characterised	   yeast	   genes,	   but	   is	   thought	   to	   play	   a	   role	   in	   control	   of	   daughter	   cell	   fate	   due	   its	  
daughter	  cell	  specific	  expression	  and	  localisation	  to	  the	  bud	  neck	  [133,	  143].	  It	  is	  also	  upregulated	  in	  
diploid	  S.	  cerevisiae	  amn1	  null	  cells,	  possibly	  indicating	  a	  role	  downstream	  from	  the	  MEN	  activation	  
inhibitor	  [175].	  It	   is	  unclear	  what	  role	  Dse3p	  could	  have	  within	  C.	  glabrata,	  which	  combined	  with	  a	  
lack	  of	  significant	  display	  of	  phenotype	  during	  sensitivity	  screening,	  means	  that	  it	   is	  unknown	  what	  
effect	  deletion	  of	  DSE3	  could	  have	  on	  its	  cellular	  processes.	  It	  is	  clear	  that	  DSE3	  has	  an	  antivirulence	  
role,	  but	  does	  not	  elicit	  increased	  or	  reduced	  levels	  of	  cytokine	  release	  compared	  to	  the	  wild	  type;	  
however	  further	  investigation	  into	  the	  function	  of	  Dse3p	  within	  C.	  glabrata	  is	  required.	  
DSE4	   in	   S.	   cerevisiae	   is	   part	   of	   the	   glycosyl	   hydrolase	   family	   81,	   and	   encodes	   a	   glucanase	   that	  
localises	  to	  the	  daughter	  cell	  side	  of	  the	  bud	  neck	  [171,	  176,	  177].	  Diploid	  dse4	  null	  cells	   in	  both	  S.	  
cerevisiae	  and	  C.	   albicans	   have	   also	   been	   shown	   to	   display	   a	   cell	   separation	   deficient	   phenotype,	  
indicating	   a	   probable	   role	   in	   hydrolysis	   of	   the	   secondary	   septum	   [130,	   177].	   It	   is	   therefore	   highly	  
likely	  that	  the	  DSE4	  homologue	  in	  C.	  glabrata,	  ACF2,	  encodes	  a	  glucanase	  that	  plays	  a	  role	  in	  cell	  wall	  
maintenance	   or	   secondary	   septum	   hydrolysis	   within	   the	   daughter	   cell.	   However	   acf2’s	   lack	   of	  
obvious	  phenotype	  apart	  from	  a	  mild	  sensitivity	  to	  10	  mM	  caffeine	  during	  testing,	  does	  not	  point	  to	  
any	   clear-­‐cut	   cellular	   role	   in	  C.	  glabrata	   other	   than	  as	  a	  general	   cell	  wall	   glucanase.	  However,	   the	  
hypervirulence	  displayed	  by	  acf2	   indicates	   that	  a	   change	  has	  occurred	   to	   the	  cellular	  processes	  of	  
the	  C.	  glabrata	  cell,	  perhaps	  in	  cell	  wall	  confirmation,	  increased	  glucan	  levels	  or	  metabolism;	  but	  its	  
inability	  to	  elicit	  an	  increased	  or	  decreased	  cytokine	  response	  also	  indicates	  that	  if	  a	  conformational	  
change	  has	  happened	  within	   the	   cell	  wall	   it	   has	  not	  exposed	  any	  new	  stimulatory	  antigens	   to	   the	  
host,	  as	  would	  be	  the	  case	  in	  a	  change	  in	  β-­‐glucan	  or	  mannan	  conformation	  [254].	  It	  is	  possible	  that	  
the	  deletion	  of	  ACF2,	  and	  loss	  of	  its	  action	  as	  a	  glucanase,	  has	  changed	  the	  confirmation	  of	  the	  cell	  
wall	  to	  hide	  antigenic	  markers	  normally	  present	  on	  the	  cell	  surface,	  but	  not	  those	  detectable	  by	  the	  
cytokine	  assays	  used	  here,	  increasing	  the	  difficulty	  of	  immune	  clearance	  and	  enhancing	  the	  survival	  
of	   the	   yeast.	   It	   has	   been	   reported	   in	   other	   species	   that	   ACE2	   deletion	   creates	   a	   reduction	   in	  
glucanase	   expression,	   and	   an	   increase	   in	   virulence,	   although	   the	   link	   between	   reduced	   glucanase	  
expression	  and	  virulence	  has	  yet	  to	  be	  explained	  [255].	  
In	   S.	   cerevisiae	   EGT2	   encodes	   another	   cell	   wall	   glucanase,	   which	   has	   been	   shown	   to	   delay	   cell	  
separation	   in	   its	  absence	  and	  therefore	  plays	  a	  role	   in	  the	  hydrolysis	  of	  the	  secondary	  septum	  and	  
surrounding	  cell	  wall	  [127,	  133].	  A	  similar	  role	  in	  C.	  glabrata	  is	  likely	  due	  to	  the	  cell	  separation	  defect	  
shown	   by	   egt2	   in	   Figure	   4.10.	   It	   is	   interesting	   to	   note	   that	   Egt2p	   is	   the	   only	   Ace2p-­‐dependent	  
glucanase	   tested	   here	   to	   show	   a	   cell	   separation	   defect	   in	   its	   absence	   in	  C.	   glabrata,	   which	   could	  
indicate	  that	  Egt2p	  is	  the	  primary	  glucanase	  involved	  in	  hydrolysis	  of	  the	  secondary	  septum	  during	  
cell	   separation,	  or	   that	   it	   is	   involved	   in	  degradation	  of	  a	  section	  of	   the	  septum	  or	  surrounding	  cell	  
wall	  that	  the	  other	  Ace2p-­‐dependent	  glucanases	  do	  not	  act	  on.	  The	  effects	  of	  egt2	  on	  virulence	  are	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similar	   to	   that	  of	  acf2,	  with	  no	  hyperstimulation	  of	  TNFα	  or	   IL-­‐6	  production,	  but	  hypervirulence	   is	  
shown	  in	  the	  murine	  model.	  It	  is	  again,	  unclear	  what	  link	  there	  is	  between	  the	  lack	  of	  expression	  of	  a	  
glucanase	  and	  virulence,	  but	  in	  the	  case	  of	  egt2,	  the	  cell	  separation	  deficient	  phenotype	  shown	  may	  
play	  a	  part,	  perhaps	  causing	  clogging	  of	  blood	  vessels.	  That	  hypothesis	  was	  however,	  discounted	  for	  
the	  extreme	  clumpy	  phenotype	  displaying	  ace2,	   through	  the	  use	  of	  chitinase	   to	  break	  up	  the	  cells	  
prior	  to	  inoculation	  as	  discussed	  previously	  [7].	  	  
RME1	   encodes	   a	   zinc	   finger-­‐like	   protein	   that	   acts	   as	   a	   suppressor	   of	   meiosis,	   by	   inhibiting	   the	  
expression	  of	  IME1,	  exclusively	  in	  haploid	  S.	  cerevisiae	  cells,	  and	  has	  been	  shown	  to	  promote	  mitosis	  
through	   activation	   of	  CLN2	   expression	   [7,	   181-­‐185].	   Disruption	   of	  RME1	   in	   S.	   cerevisiae	   has	   been	  
shown	  to	  create	  larger	  than	  wild	  type	  cells	  and	  a	  reduced	  steady-­‐state	  level	  of	  CLN2	  expression	  [189,	  
190].	  It	  is	  therefore	  possible	  that	  deletion	  of	  RME1	   in	  C.	  glabrata	  could	  affect	  CLN2	  expression	  and	  
therefore	   promotion	   of	   mitosis	   within	   the	   cell	   cycle,	   possibly	   causing	   a	   delay	   in	   cell	   cycle	  
progression,	   although	   this	  was	   not	   corroborated	   by	   any	   obvious	   phenotype	  or	   growth	   rate	   under	  
testing.	  The	  reason	  underlying	  the	  antivirulent	  potential	  of	  RME1	   is	  unclear.	  The	  wild	  type	  levels	  of	  
TNFα	  and	  IL-­‐6	  production	  upon	  macrophage	  stimulation	  suggest	  that	  the	  absence	  of	  RME1,	  does	  not	  
effect	   the	   cell	   surface	   receptors	   on	   the	   outside	   of	   the	   cell	   wall.	   IME1	   the	   target	   of	   RME1’s	  
transcriptional	   repression	   has	   also	   been	   shown	   to	   be	   positively	   transcriptionally	   regulated	   by	  
RIM101	  in	  S.	  cerevisiae	  [256].	  RIM101	  is	  involved	  in	  the	  environmental	  pH	  response	  [257],	  which	  has	  
been	  shown	  to	  be	  crucial	  to	  virulence	  and	  host-­‐environment	  survival.	  It	  is	  possible	  that	  derepression	  
of	  IME1	  could	  infer	  some	  sort	  of	  enhanced	  environmental	  adaptation,	  leading	  to	  increased	  pathogen	  
survival	   rates	   and	   hence	   increased	   virulence.	   Indeed,	   IME1	   has	   been	   linked	   to	   virulence	   potential	  
through	   its	   involvement	   in	   the	   hyphal	   and	   pseudohyphal	   growth	   [258],	   neither	   of	   which	   were	  
noticed	  in	  screening	  of	  the	  rme1	  mutant.	  
SCW11	   encodes	   a	   cell	   wall	   associated	   glucanase	   that	   may	   have	   roles	   in	   cell	   separation	   and	  
conjugation	  within	   S.	   cerevisiae	   [134,	   193,	   194].	   SCW11	   deletion	   has	   been	   shown	   to	   cause	   a	   cell	  
separation	  defect	  in	  S.	  cerevisiae	  [134],	  while	  it	  has	  been	  suggested	  as	  being	  essential	  in	  C.	  albicans	  
and	  has	  been	   shown	   to	  be	  down-­‐regulated	   in	  hyphal	   cells	   compared	   to	  yeast	   cells	   [197-­‐200].	   It	   is	  
therefore	  likely	  that	  the	  two	  SCW11	  homologues	  SCW11α	  and	  SCW11β	  in	  C.	  glabrata,	  play	  a	  role	  in	  
septum	  hydrolysis	  or	  cell	  wall	  metabolism,	  meaning	  that	  a	  deletion	  could	  affect	  septum	  degradation	  
and	  cell	   separation.	  The	  results	  of	   testing	  of	  scw11β	   in	  Figures	  4.7-­‐4.9,	  however,	  show	  no	  obvious	  
phenotypes	  apart	  from	  a	  mild	  sensitivity	  to	  caffeine,	  which	  could	  indicate	  a	  defect	  in	  several	  cellular	  
processes	   and	  MAPK	   signalling	   pathways	   including	   the	   cell	  wall	   integrity	   pathway	   [246,	   251].	   The	  
hypervirulent	  phenotype	  displayed	  by	  scw11β	  indicates	  a	  similar	  situation	  to	  acf2,	  maintaining	  wild	  
type	   levels	   of	   immune	   stimulation.	   Again	   it	   is	   unknown	   how	   the	   absence	   of	   SCW11β	   a	   cell	   wall,	  
septum-­‐associated	  glucanase,	  causes	  increased	  virulence.	  
The	   final	   gene	   in	   the	   Ace2p	   regulon,	   SIC1,	   has	   been	   shown	   to	   encode	   a	   cyclin-­‐dependent	   kinase	  
inhibitor	   in	   S.	   cerevisiae	   that	   targets	   the	   Cdk1p-­‐Clbp	   histone	   kinase	   complexes	   and	   prevents	  
premature	   initiation	   of	  DNA	   replication,	   S-­‐phase	   progression	   and	   insures	   genomic	   integrity	  within	  
the	   cell	   cycle	   [209,	   210].	   It	   is	   likely	   that	   the	   SIC1	   homologue	   in	   C.	   glabrata	   performs	   a	   similar	  
function,	   acting	   as	   part	   of	   a	   cell	   cycle	   checkpoint	   and	   controlling	   progression	   to	   S-­‐phase.	   SIC1	  
deletion	   might	   therefore	   cause	   loss	   of	   genomic	   stability	   and	   premature	   DNA	   replication.	   In	   S.	  
cerevisiae,	  sic1	  nulls	  show	  partial	  mitotic	  arrest,	  which	  could	  be	  corroborated	  by	  the	  mild	  sensitivity	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to	  10	  mM	  caffeine	  displayed	  in	  Figure	  4.9,	  and	  could	  cause	  a	  delay	  in	  cell	  cycle	  progression,	  but	  none	  
was	  presented	  by	  growth	  rate	  analysis	  as	  displayed	   in	  Figure	  4.12.	  On	   the	  antivirulence	   front,	   it	   is	  
unclear	  what	   role	  SIC1	   plays,	   although	   its	   deletion	  will	   create	   genome	   instability	   and	  possibly	   the	  
ability	  to	  acquire	  gain	  of	  function	  mutations.	  Sic1p’s	  inhibition	  target,	  Cdk1p,	  has	  been	  highlighted	  in	  
maintenance	  of	  pathogenicity	  in	  the	  smut	  fungus,	  Ustilago	  maydis	  [259],	  however	  it	  is	  unknown	  how	  
de-­‐inhibition	   of	   Cdk1p-­‐Clbp	   complex	   could	   aid	   C.	   glabrata	   virulence.	   The	   sic1	   null	   also	   displayed	  
over-­‐stimulation	   of	   TNFα	   and	   IL-­‐6	   production	   compared	   to	   the	   wild	   type,	   indicating	   that	   in	   the	  
absence	  of	  SIC1,	  conformational	  changes	  in	  the	  cell	  wall	  are	  made.	  No	  such	  observations	  have	  been	  
reported	   in	   the	   literature	   for	  S.	   cerevisiae	   or	   any	  other	  eukaryote,	  but	  premature	  DNA	   replication	  
and	  progression	  to	  S-­‐phase	  could	  result	  in	  any	  number	  of	  gene	  defects	  that	  could	  cause	  changes	  to	  
the	  protein	  components	  of	  the	  cell	  wall.	  
	  
4.4.6	  Ace2p	  regulon	  hypervirulence	  and	  ace2	  
Given	  that	  the	  other	  Ace2p	  regulon	  null	  mutants,	  amn1,	  ash1,	  bud9	  and	  dse1,	  only	  showed	  wild	  type	  
levels	   of	   virulence,	   it	   seems	   unlikely	   that	   they	   could	   contribute	   to	   either	   the	   hyperstimulation	   of	  
cytokine	  response	  or	  the	  extreme	  hypervirulence	  shown	  by	  ace2	  [7].	  Therefore	  the	  results	  presented	  
in	   this	   chapter	   suggest	   that	   the	   ace2	   hypervirulent	   phenotype	   is	   created	   by	   a	   combination	   of	  
antivirulence	  genes	  including	  DSE3,	  ACF2,	  EGT2,	  RME1,	  SCW11β	  and	  SIC1,	  as	  well	  as	  the	  previously	  
investigated	   CTS1,	   which	   in	   their	   individual	   deletions	   all	   show	   a	   hypervirulent	   phenotype	   that	   is	  
significantly	  different	  from	  the	  wild	  type,	  but	  milder	  than	  ace2.	  The	  combination	  of	  their	  individual	  
milder	  hypervirulence	  phenotypes	  could	  be	  the	  cause	  of	  the	  extreme	  ace2	  hypervirulence,	  although	  
it	   is	  unclear	  how	  ace2	   causes	   such	  a	   large	   increase	   in	  cytokine	   release,	  given	   that	  only	  one	  of	   the	  
Ace2p	  regulon	  deletions	  tested	  here	  elicited	  a	  four-­‐fold	  increase	  in	  TNFα	  release	  and	  only	  a	  3.4-­‐fold	  
increase	  in	  IL-­‐6	  release.	  Although	  the	  quantity	  of	  wild	  type	  C.	  glabrata	  cytokine	  detected	  between	  in	  
vivo	   and	   in	   vitro	   was	   roughly	   similar	   [7]	   there	   is	   a	   possibility	   that	   the	   ratio	   of	   cytokine	   release	  
between	  in	  vivo	  and	  in	  vitro	  testing	  as	  used	  in	  this	  study	  is	  not	  directly	  comparable,	  and	  all	  that	  can	  
be	  said	  is	  that	  sic1	  significantly	  increases	  cytokine	  release	   in	  vitro,	  but	  the	  extent	  to	  what	  might	  be	  
shown	   in	   vivo	   cannot	   be	   extrapolated.	   Therefore	   a	   repeat	   of	   the	   sic1	   cytokine	   release	   study,	   this	  
time	  in	  vivo,	  is	  required.	  
It	   is	   interesting	   to	  note	   that	  all	   the	  Ace2p-­‐dependent	  cell	  wall	  glucanases	  successfully	  disrupted	   in	  
this	   study	   display	   hypervirulence	   in	   their	   absence,	   but	   do	   not	   elicit	   increased	   levels	   of	   cytokine	  
release.	  It	  is,	  however,	  unclear	  how	  a	  cell	  bud	  neck	  area	  directed	  cell	  wall	  glucanase	  contributes	  to	  
virulence	  in	  its	  absence.	  
Study	   of	   the	   link	   between	   cell	   surface	   carbohydrates	   and	   virulence	   within	   C.	   albicans	   is	   a	   well-­‐
established	  field	  with	  N-­‐	  and	  O-­‐linked	  mannans	  and	  other	  cell	  wall	  associated	  glycoproteins	  playing	  a	  
role	   in	   both	   adherence	   and	   immune	   recognition	   (reviewed	   by	   Mora-­‐Montes	   et	   al.	   [260]).	   With	  
regard	   to	   the	   β-­‐glucan	   elements	   of	   the	   cell	   wall,	   maintenance	   of	   cell	   wall	   integrity	   and	   glucan	  
architecture	  have	  been	  shown	  to	  be	  crucial	  to	  virulence	  in	  C.	  albicans	  [261].	  For	  the	  most	  part,	  the	  
glucan	  components	  of	  the	  cell	  wall	  are	  hidden	  by	  an	  outer	  mannan	  coat	  that	  forms	  the	  first	  point	  of	  
contact	  with	  the	  host	  environment	  and	  therefore	  the	  immune	  cells	  of	  the	  host.	  At	  certain	  times	  and	  
within	  certain	  areas,	  such	  as	  budding	  and	  the	  bud	  scar,	  the	  glucan	  components	  of	  the	  cell	  wall	  within	  
C.	  albicans	   are	  more	  exposed	  and	   form	  part	  of	   the	   immune	   recognition	  of	   the	   fungal	   cells	   by	   the	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host	   through	   the	   β-­‐glucan	   receptor	   dectin-­‐1	   [261,	   262].	   In	   C.	   glabrata	   it	   is	   likely	   that	   a	   similar	  
exposure	   of	  β-­‐glucan	   occurs	   at	   the	   point	   of	   budding,	   aiding	   immune	   recognition	   by	   the	   host	   and	  
therefore	  clearance	  of	  the	  pathogen.	  Perhaps	  then,	  the	  deletion	  or	  suppression	  of	  Ace2p-­‐dependent	  
glucanase	   expression	   causes	   a	   change	   in	   the	  β-­‐glucan	   component	   or	   architecture	   of	   the	   cell	   wall	  
around	  the	  bud	  neck	  area	  that	  reduces	  the	  exposure	  of	  glucan-­‐based	  antigens	  to	  the	  host	  immune	  
system,	  thereby	  reducing	  immune	  recognition	  and	  enhancing	  the	  ability	  of	  C.	  glabrata	  to	  persist	  and	  
cause	  disease.	  To	  see	  whether	  a	  change	   in	  glucan	  architecture	   is	  present	   in	  C.	  glabrata	  acf2,	  etg2	  
and	  scw11β,	  glucan	  isolation	  and	  spectral	  analysis	  could	  be	  used	  to	  compare	  the	  glucan	  component	  
of	  the	  cell	  wall	  of	  the	  null	  mutant	  to	  that	  of	  the	  C.	  glabrata	  wild	  type.	  Glucan	  can	  be	  isolated	  via	  acid	  
extract	   as	  described	  by	  Müller	  et	   al.	   [263]	   and	   then	   solution-­‐state	   1H	  NMR	  spectroscopy	   could	  be	  
used	  to	  compare	  and	  contrast	   the	  structural	  composition	  of	   the	  glucans	   [264].	  Tunnelling	  Electron	  
Microscopy	  could	  also	  be	  used	  in	  a	  similar	  manner	  to	  the	  work	  performed	  with	  C.	  albicans	  by	  Netea	  
et	  al.	  [265]	  to	  visually	  inspect	  the	  cell	  wall	  structure	  of	  the	  null	  mutants	  for	  comparison	  with	  the	  wild	  
type,	   which	   would	   give	   an	   indication	   of	   any	   variation	   in	   thickness	   of	   the	   β-­‐glucan	   layer	   or	   any	  
possible	  conformational	  change	  of	  the	  cell	  wall	  due	  to	  the	  absence	  of	  glucanase	  activity	  contributed	  
by	   the	   Ace2p-­‐dependent	   glucanases.	   It	   would	   also	   be	   useful	   to	   perform	   a	   similar	   immune	  
stimulation	   assay	   as	   conducted	   in	   this	   chapter	   with	   a	   macrophage	   strain	   with	   greater	   dectin-­‐1	  
presentation	  to	  see	  whether	  there	  is	  a	  reduction	  in	  β-­‐glucan	  recognition	  in	  the	  C.	  glabrata	  acf2,	  etg2	  
and	  scw11β	  null	  strains	  compared	  to	  the	  wild	  type.	  Of	  course	  it	  may	  also	  be	  true	  that	  the	  cell	  wall	  
associated	   glucanases	   within	   the	   cell	   wall	   contribute	   directly	   to	   the	   immune	   recognition	   of	   C.	  
glabrata	  and	  therefore	  when	  absent	  from	  the	  cell	  wall	  cause	  a	  reduction	  in	  the	  immune	  recognition	  
foot	  print	  of	  the	  yeast	  that	  couldn’t	  be	  detected	  by	  the	  immune	  stimulation	  assays	  performed	  in	  this	  
study	  that	  were	  heavily	  biased	  towards	  over-­‐stimulation.	  
Two	  remaining	  genes,	  DSE2	  and	  SCW11α	  also	  encode	  cell	  wall	  glucanases.	  It	  would	  be	  interesting	  to	  
see	   if	   they	   too	   have	   antivirulence	   potential.	   Unfortunately	   they	   remain	   uninvestigated	   and	   it	   is	  
therefore	  necessary	   for	   further	  work	   to	  be	  done	  to	  disrupt,	  or	  silence	  their	  expression	  and	  to	   test	  
their	   antivirulence	   potential	   and	   ability	   to	   elicit	   a	   macrophage	   hyperstimulation	   response	   to	  
complete	  the	  partial	  Ace2p	  regulon	  antivirulence	  picture.	  It	  is	  clear,	  however,	  that	  the	  antivirulence	  
effect	  of	  ACE2	  is	  a	  multifactorial	  affair	  and	  that	  its	  ability	  to	  cause	  hypervirulence	  in	  its	  absence	  may	  
revolve	   around	  more	   than	   just	   the	   genes	   found	   to	   show	   Ace2p-­‐depedent	   expression.	   Ace2p	   has	  
been	  shown	  to	  affect	  the	  proteome	  of	  C.	  glabrata	  in	  many	  ways	  [231],	  and	  further	  investigation	  into	  
the	  transcriptome	  of	  Ace2p	  in	  C.	  glabrata	  is	  still	  needed.	  
	  
4.4.7	  Implications	  of	  antivirulence	  
On	   the	   surface	   of	   it,	   the	   occurrence	   of	   antivirulence	   or	   virulence	   moderating	   genes	   might	   seem	  
counterintuitive	  for	  a	  fungal	  pathogen	  like	  C.	  glabrata.	  However,	  for	  the	  maintenance	  of	  a	  gene	  that	  
causes	  increased	  ability	  to	  cause	  disease	  in	  its	  absence,	  there	  must	  be	  evolutionary	  pressure	  to	  keep	  
said	  gene.	  Unlike	  the	  majority	  of	   the	  rest	  of	   the	  pathogenic	  Candida	  species,	  C.	  glabrata	   lacks	  any	  
form	  of	  true	  hyphal	  morphology	  and	  only	  displays	  pseudohyphae	  in	  nitrogen	  starvation	  conditions	  in	  
vitro	   [31].	   This	   leaves	   budding	   and	   efficient	   cell	   separation	   as	   the	   only	   method	   of	   colonisation,	  
expansion	  and	  transmission	  between	  hosts	  available	  to	  C.	  glabrata.	  Therefore	  it	  has	  been	  suggested	  
that	  dissemination	  and	  transmission	  might	  be	  a	  cause	  of	  evolutionary	  selective	  pressure	  [266],	  which	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in	  this	  case	  requires	  maintenance	  of	  cell	  separation	  competency	  and	  therefore	   it	   is	  the	  most	   likely	  
reason	  for	  the	  maintenance	  of	  ACE2,	  which	  encodes	  the	  master	  transcriptional	  regulator	  for	  the	  cell	  
separation	  machinery	  [101].	   It	   is	  however,	  harder	  to	  justify	  the	  maintenance	  of	  some	  of	  the	  Ace2p	  
regulon	   genes,	   especially	   those	   that	   show	   sequence	   similarity	   and	   potential	   redundancy.	   For	  
instance	   the	   cell	   wall	   glucanases	   ACF2	   and	   SCW11β	   do	   not	   present	   a	   cell	   separation	   deficient	  
phenotype	   when	   disrupted	   individually,	   which	   suggests	   that	   there	   is	   redundancy	   in	   the	   cell	   wall	  
glucanases	   that	   hydrolyse	   the	   secondary	   septum,	   or	   that	   they	   do	   not	   play	   a	   primary	   role	   in	   cell	  
separation	   despite	   being	   localised	   to	   the	   bud	   neck.	   Interestingly	   EGT2	   was	   the	   only	   cell	   wall	  
glucanase	  tested	  here	  that	  showed	  a	  cell	  separation	  deficiency	  when	  disrupted,	  which	  could	  account	  
for	   the	   apparent	   evolutionary	   pressure	   to	   maintain	   its	   function	   within	   the	   cell	   even	   though	   it	   is	  
antivirulent.	  As	  we	  do	  not	  currently	  know	  the	  function	  of	  Dse3p	  within	  the	  cell,	  it	  is	  not	  possible	  to	  
ascertain	  why	   it	   is	  maintained	  when	   it	  harbours	  antivirulence	  potential.	   It	   is,	  however,	  possible	   to	  
rule	  out	  an	  essential	  role	  in	  cell	  separation	  due	  to	  the	  cell	  separation	  competent	  phenotype	  dse3	  null	  
cells	   present.	   Both	   RME1	   and	   SIC1	   are	   involved	   in	  multiple	   cell	   cycle	   related	   processes	   within	   C.	  
glabrata,	   therefore	   it	   is	   likely	   that	   maintenance	   of	   their	   function	   is	   critical	   for	   optimum	   cellular	  
function,	  although	  they	  have	  been	  shown	  to	  not	  be	  essential	  in	  C.	  glabrata	  by	  their	  deletion.	  
	  
Here	  we	  have	  found	  for	  the	  first	  time	  six	  more	  antivirulence	  genes	  in	  C.	  glabrata	  and	  have	  expanded	  
the	  knowledge	  of	   the	  mechanisms	  behind	   the	  ace2	  hypervirulence	  effect.	  A	  possible	   link	  between	  
the	  septum	  targeted	  glucanases	  and	  antivirulence	  has	  been	  made,	  but	  further	  work	  with	  these	  and	  
the	   other	   antivirulence	   genes	   is	   required	   to	   fully	   understand	   the	   mechanisms	   behind	   the	   ace2	  
antivirulence.	   It	   would	   be	   interesting	   to	   see	   whether	   other,	   non-­‐Ace2p-­‐dependent	   cell	   wall	  
glucanases	   have	   a	   similar	   antivirulence	   potential.	   It	   should	   be	   noted	   that	   due	   to	   the	   restrictive	  
sample	  sizes	  available	  within	  this	  study,	  negative	  results	  might	  not	  be	  definitive	  and	  future	  testing	  
with	  greater	  samples	  sizes	  is	  needed	  to	  confirm	  the	  lack	  of	  hypervirulence.	  
The	   finding	  of	   six	   independently	  antivirulent	  genes	  all	   transcriptionally	   regulated	  by	  Ace2p	  has	  set	  
out	   yet	   more	   targets	   for	   further	   investigation	   into	   this	   interesting	   and	   potentially	   significant	  
virulence	  work.	  The	  mechanism	  of	  C.	  glabrata	  virulence	  in	  vivo	  is	  not	  yet	  well	  understood,	  and	  these	  
studies	  have	  drawn	  a	  spotlight	  on	  previously	  innocuous	  genes,	  especially	  those	  showing	  redundancy,	  
that	   might	   play	   a	   role	   in	   vivo	   in	   the	   potential	   for	   onset	   of	   systemic	   candidiasis.	   Transcriptome	  
profiling	  of	  C.	  glabrata	  in	  vivo	  from	  both	  the	  wild	  type	  and	  ace2	  mutant	  is	  badly	  needed	  to	  see	  which	  
genes	   are	   up	   and	   down	   regulated	   in	   response	   to	   the	   host	   and	   to	   pinpoint	   any	   more	   potential	  
antivirulence	   or	   virulence-­‐moderating	   factors	   changed	   by	   the	   deregulation	   of	   the	   control	   systems	  
regulated	  by	  ACE2	  expression.	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5	   Study	  of	  the	  novel	  gene	  DSE1	  in	  yeast	  
	  
5.1	  Overview	  
During	  the	  investigation	  into	  the	  partial	  C.	  glabrata	  Ace2p	  regulon	  and	  the	  ace2	  hypervirulent	  effect,	  
a	  novel	  gene	  that	  encoded	  a	  protein	  of	  unknown	  function	  was	  highlighted.	  The	  gene	  in	  question	  was	  
CAGL0K02277g,	   which	   showed	   homology	   to	   the	   only	   uncharacterised	   S.	   cerevisiae	   gene	   to	   show	  
Ace2p-­‐dependent	  expression	  at	  the	  time,	  DSE1	  (YER124C)	  [101].	  DSE1	  within	  both	  S.	  cerevisiae	  and	  
C.	  glabrata	  shows	  no	  homology	  to	  other	  DSE	  genes	  such	  as	  DSE2	  and	  DSE4	  which	  encode	  cell	  wall	  
associated	  glucanases	  as	  discussed	  in	  chapters	  1	  and	  4.	  However,	  in	  both	  yeasts,	  dse1	  nulls	  display	  a	  
cell	   separation	   defect	   and	   as	   such	   are	   thought	   to	   play	   a	   role	   in	   cell	   separation.	   Therefore	   an	  
investigation	   into	   the	   function	   of	   this	   uncharacterised	   gene	   was	   undertaken	   to	   further	   our	  
knowledge	   of	   cell	   separation,	   a	   crucial	   part	   of	   the	   life	   cycle	   of	   yeast	   cells	   and	   in	   particular	   C.	  
glabrata,	  where	  budding	  marks	  the	  only	  dissemination	  and	  transmission	  mechanism	  available	  to	  this	  
important	  fungal	  pathogen,	  as	  previously	  discussed	  in	  chapter	  4.	  
In	  S.	  cerevisiae,	  DSE1	  has	  been	  shown	  to	  be	  expressed	  with	  other	  Ace2p-­‐dependent	  genes,	  in	  the	  run	  
up	   to	   cytokinesis	   and	   cell	   separation	   [101,	   133].	   It	   has	   also	   been	   shown	   to	   be	   transcriptionally	  
repressed	  by	  the	  Ace2p	  homologue	  Swi5p,	  which	  has	  also	  been	  shown	  to	  bind	  to	  the	  same	  binding	  
sites	  as	  Ace2p	  within	  the	  promoter	  regions	  of	  regulated	  genes	  [101,	  133,	  267].	  Knowing	  that	  DSE1	  
expression	   is	   dependent	   on	   a	   cell	   cycle	   regulated	   transcription	   factor	   it	   is	   unsurprising	   then	   that	  
DSE1	   shows	   cell	   cycle	   regulated	  expression,	  which	  peaks	   in	   the	   run	  up	   to	   cell	   separation	  with	   the	  
rest	  of	   the	  Ace2p-­‐dependent	  genes	   [101,	  133].	  Dse1p	  has	  also	  been	   shown	   to	   localise	   in	  a	   similar	  
manner	  to	  the	  cell	  separation	  machinery,	   localising	  to	  the	  bud	  neck	  area	  of	  the	  cell	   in	  S.	  cerevisiae	  
prior	   to	   cell	   separation	   [143].	   This	   observation	   indicates	   that	   Dse1p	   may	   have	   a	   role	   in	   cell	  
separation,	  although	  precisely	  what	  role	  is	  unclear.	  
A	   reductionist	  approach	  was	   taken	  by	  Doolin	  et	  al.	   in	   the	  study	  of	  DSE1,	  among	  other	  genes,	   in	  S.	  
cerevisiae,	   in	  which	  they	  showed	  that	  diploid	  dse1	  cells	  showed	  a	  cell	  separation	  defect	  that	  could	  
not	  be	  replicated	  in	  haploid	  cells	  [101].	  The	  diploid	  dse1	  cells	  also	  displayed	  a	  sensitivity	  to	  cell	  wall	  
targeted	   test	   conditions	   including	   SDS,	   calcofluor	  white	   and	   caffeine,	  which	  made	   them	   speculate	  
that	  Dse1p	  might	  be	  involved	  in	  cell	  wall	  metabolism	  and	  cell	  separation	  [101].	  Data	  from	  C.	  albicans	  
also	   hints	   at	   a	   cell	   wall	   metabolism	   role	   with	   a	   haploinsuffient	   DSE1	   C.	   albicans	   strain	   showing	  
increased	  sensitivity	   to	  calcofluor	  white,	  SDS	  and	  oxidative	  stress	   [268].	  A	  slightly	  decreased	  chitin	  
deposition	   in	   the	   cell	  wall	  was	   also	   recorded,	   as	  was	   an	   increased	   level	  of	   filamentous	   growth	  on	  
both	  solid	  and	  liquid	  media	  and	  delayed	  adhesion	  contributing	  to	  reduced	  virulence	  [268].	  Daher	  et	  
al.	   also	   suggested	   that	  DSE1	   was	   an	   essential	   gene	   in	  C.	   albicans	   due	   to	   their	   failure	   to	   create	   a	  
homozygous	  null	  strain	  [268].	  
Results	  of	  DSE1	  over	  expression	  also	  corroborate	   the	   theory	  of	  a	   cell	  wall	   and	  budding	  associated	  
role,	   this	   time	   displaying	   a	   budding-­‐within-­‐birth-­‐scar	   phenotype	   in	   haploid	   S.	   cerevisiae	   cells,	   a	  
phenotype	   that	   has	   never	   been	   recorded	   in	   wild	   type	   cells,	   with	   the	   closest	   being	   bud	   sites	  
overlapping	   the	  birth	   scar	   [163].	   The	  birth	   scar	   is	   typically	   a	  highly	  protected	  area	  within	  budding	  
yeast,	  defined	  as	  a	  zone	  of	  forbidden	  budding	  [163],	  which	  in	  turn	  hints	  that	  Dse1p	  may	  play	  a	  role	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in	   bud	   site	   selection.	   Other	   observations	   from	   DSE1	   over	   expression	   within	   S.	   cerevisiae	   also	  
reinforce	  the	  idea	  of	  a	  cell	  wall	  maintenance	  role,	  due	  to	  an	  observation	  that	  the	  cell	  wall	  integrity	  
pathway	  had	  been	  activated	  [163].	  	  
Draper	   et	   al.	   suggested	   that	   Dse1p	   could	   play	   a	   role	   in	   cross-­‐talk	   between	   the	   pheromone	   and	  
invasive	  growth	  pathways	  due	  to	  its	  ability	  to	  bind	  to	  both	  a	  Ste4p	  complex	  and	  Ste11p	  [166].	  They	  
showed	   that	  DSE1	   over	   expression	   could	   induce	   invasive	   growth	   in	   S.	   cerevisiae,	   and	   that	   it	   also	  
caused	  interference	  with	  the	  pheromone	  sensing	  pathway,	  conferring	  resistance	  to	  cell	  cycle	  arrest	  
in	   G1	   in	   response	   to	  mating	   factor	   exposure	   [166].	  DSE1	   deletion	   caused	   a	   twofold	   sensitivity	   to	  
pheromone-­‐induced	  cell	   cycle	  arrest	   in	  S.	   cerevisiae,	   supporting	   the	  hypothesis	   that	  Dse1p	  plays	  a	  
role	  in	  the	  pheromone	  sensing	  pathway	  [166].	  	  
Neither	  C.	  glabrata	  nor	  S.	  cerevisiae	  DSE1	  show	  much	  homology	  with	  other	  Ace2p-­‐dependent	  genes,	  
or	   any	   other	   characterised	   genes	   for	   that	   matter,	   within	   S.	   cerevisiae,	   Candida	   species	   or	   other	  
eukaryotes	  [170,	  171].	  Physical	  and	  genetic	  interaction	  data	  for	  Dse1p	  within	  S.	  cerevisiae	  shows	  32	  
different	   possible	   interactions	   with	   three	   of	   them	   pointing	   to	   a	   role	   in	   bud	   site	   selection	   or	   bud	  
formation	  [163-­‐165].	  Dse1p	  physically	  interacts	  with	  Boi1p,	  Boi2p	  and	  Zds2p,	  which	  are	  all	  thought	  
to	  play	  a	  role	  in	  budding	  and	  bud	  site	  selection	  [163-­‐165].	  Both	  Boi1p	  and	  Boi2p	  are	  thought	  to	  play	  
a	  role	  in	  polar	  growth	  [167].	  They	  both	  localise	  to	  the	  bud	  cortex	  with	  double	  null	  mutants	  displaying	  
an	   abnormally	   large,	   round	   phenotype	   and	   disruption	   of	   cell	   polarity	   maintenance	   [167].	   Double	  
boi1boi2	  mutants	  also	  display	  defective	  bud	  formation,	  indicating	  that	  they	  may	  play	  a	  role	  in	  more	  
than	   just	   bud	   site	   selection	   [167].	   Boi1p	   and	  Boi2p	   have	   been	   shown	   to	   interact	   themselves	  with	  
Bem1p,	  a	  protein	   that	  helps	  establish	   the	  cellular	  polarity	   required	   for	  budding	   [165,	  168],	  adding	  
support	   to	  the	  hypothesis	   that	  DSE1	   is	   involved	   in	  bud	  site	  selection.	  Another	  physical	   interaction,	  
this	   time	   with	   Ste11p,	   reinforces	   the	   theory	   that	   Dse1p	   plays	   a	   role	   in	   invasive	   growth	   and	  
pheromone	  sensing,	  due	   to	  Ste11p’s	   involvement	   in	  pseudohyphal	  growth	  [165,	  166].	   	  Ste11p	  has	  
also	  been	  shown	  to	  play	  a	  role	  in	  virulence	  in	  C.	  glabrata	  and	  along	  with	  Ste4p	  has	  been	  implicated	  
in	  pheromone	  sensing	  [82,	  165,	  166].	  
The	   data	   for	   DSE1	   suggests	   three	   potential	   roles	   within	   budding	   yeast.	   The	   first	   is	   a	   cell	   wall	  
metabolism	  and	  cell	  separation	  role,	  which	   is	  supported	  by	  bud	  neck	   localisation,	  activation	  of	  the	  
cell	  wall	  integrity	  pathway,	  sensitivity	  to	  cell	  wall	  targeted	  conditions	  in	  dse1	  nulls,	  a	  cell	  separation	  
defective	   phenotype	   in	   certain	   nulls	   and	   a	   peak	   expression	   in	   the	   run	   up	   to	   cell	   separation.	   The	  
second	   potential	   role	   is	   one	   of	   bud	   site	   selection,	   supported	   by	   a	   budding-­‐within-­‐birth-­‐scar	  
phenotype	   displayed	   with	  DSE1	   over	   expression	   and	   physical	   interactions	   with	   Boi1p,	   Boi2p	   and	  
Zds2p.	  The	  third	  and	  final	  role	  is	  one	  of	  pheromone	  sensing	  and	  hyphal	  growth,	  which	  is	  supported	  
by	  DSE1	  overexpression	  affording	  a	  resistance	  to	  pheromone	  induced	  arrest	  and	  enhanced	  invasive	  
growth;	  dse1	  nulls	  showing	  an	  increased	  sensitivity	  to	  pheromone	  induced	  arrest;	  as	  well	  as	  Dse1p’s	  
ability	  to	  physically	  interact	  with	  both	  Ste11p	  and	  Ste4p.	  
None	   of	   the	   three	   roles	   suggested	   in	   the	   literature	   have	   to	   exist	   in	   isolation,	   with	   each	   one	  
potentially	  overlapping	  the	  next.	  The	  true	  role	  for	  Dse1p	  in	  S.	  cerevisiae	  and	  C.	  glabrata	  is	  likely	  to	  be	  
a	  mix	  of	  the	  three,	  although	  the	  lack	  of	  hyphal	  growth	  in	  C.	  glabrata,	  with	  pseudohyphal	  growth	  only	  
visible	  under	  nitrogen	  starvation	  on	  solid	  media	  [31],	  and	  Ace2p-­‐dependence	  mean	  that	  the	  cell	  wall	  
metabolism	  and	  cell	  separation	  role	  or	  the	  bud	  site	  selection	  and	  bud	  formation	  roles	  are	  most	  likely	  
in	  the	  pathogenic	  yeast.	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Although	   the	   bulk	   of	   the	  work	   throughout	   this	   thesis	   has	   centred	   on	  C.	   glabrata,	   a	  much	   smaller	  
body	  of	  work	  and	  tools	  exist	  for	  the	  pathogenic	  yeast	  when	  compared	  with	  its	  close	  genetic	  relative	  
S.	   cerevisiae,	   which	   has	   been	   extensively	   studied	   and	   used	   as	   a	  model	   organism	   for	   the	   study	   of	  
many	  cellular	  processes	   for	  decades.	   This	  means	   that	   tools	   for	   investigating	   the	   roles	  of	  unknown	  
genes	  are	  much	  more	  developed	   in	  S.	  cerevisiae	  and	  resources	  such	  as	  the	  Yeast	  Knockout	  Library	  
(YKO),	  the	  Yeast	  GFP	  library	  and	  genetic	  tools	  such	  as	  the	  Gateway	  cloning	  system	  (Invitrogen,	  UK),	  
provide	  useful	  methods	  for	  study	  of	  the	  functions	  of	  Dse1p	  within	  yeast	  that	  simply	  aren’t	  available	  
in	  C.	   glabrata	   at	   this	   time.	   Therefore	   the	   experiments	   presented	   in	   this	   chapter	  will	   leverage	   the	  
tools	   available	   for	   S.	   cerevisiae,	   combined	   with	   study	   in	   C.	   glabrata	   where	   possible,	   to	   explore	  
possible	  functions	  for	  Dse1p	  within	  the	  two	  yeast	  species.	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5.2	  Materials	  and	  Methods	  
	  
5.2.1	  Analysis	  of	  the	  upstream	  region	  of	  DSE1	  in	  S.	  cerevisiae	  for	  potential	  Ace2p	  binding	  sites	  
The	  sequence	  for	  S.	  cerevisiae	  DSE1	  was	  downloaded	  from	  the	  S.	  cerevisiae	  Genome	  Database	  [170].	  
As	  described	  previously	   for	  C.	  glabrata	   genes	   in	   chapter	  3,	   the	   sequence	  was	   imported	   into	  Serial	  
Cloner,	   version	   2.1,	   Serial	   Basics,	   France.	   The	   ORF	   was	   then	  mapped,	   while	   the	   intergene	   region	  
upstream	   of	   DSE1	   was	   searched	   for	   the	   potential	   Ace2p	   binding	   site	   ACCAGC	   and	   its	   reverse	  
complement,	  as	  defined	  by	  Dohrmann	  et	  al.	  [152].	  Potential	  binding	  sites	  were	  then	  marked	  and	  the	  
distances	  in	  base	  pairs	  to	  the	  start	  codon	  of	  the	  target	  gene	  were	  calculated.	  
	  
5.2.2	  C.	  glabrata	  Dse1p	  structural	  prediction	  
The	   structure	   of	   C.	   glabrata	   Dse1p	   was	   investigated	   by	   computational	   structural	   analysis	   in	  
conjunction	  with	  Dr.	  Talavera	  (University	  of	  Manchester)	  [269].	  Briefly,	  the	  sequence	  of	  DSE1	  from	  C.	  
glabrata	  was	  analysed	  using	  mGenTHREADER	  and	  secondary	  structure	  recognition	  techniques	   that	  
identified	  a	  potential	  structural	  template	  [270,	  271].	  The	  amino	  acid	  sequence	  was	  then	  aligned	  to	  
the	  template	  and	  a	  model	  was	  built	  using	  Modeller	  [272].	  The	  model	  was	  then	  checked	  and	  refined	  
with	  MolProbity	  [273]	  and	  PROCHECK	  [274],	  as	  well	  as	  manual	  trial	  and	  error	  modification.	  
	  
5.2.3	  C.	  glabrata	  and	  S.	  cerevisiae	  dse1	  null	  vanadate	  sensitivity	  screen	  
A	  solid	  agar	  phenotypic	  screen	  was	  performed	  as	  described	  in	  sections	  4.2.4	  using	  only	  0.5,	  1,	  2,	  4,	  5	  
and	  6	  mM	  vanadate	  concentrations.	  
	  
5.2.4	  Yeast	  dse1	  null	  polarization	  study	  
The	   C.	   glabrata	  wild	   type	   (Cg2001),	   S.	   cerevisiae	   wild	   type	   (BY4741),	   and	   the	   C.	   glabrata	   and	   S.	  
cerevisiae	  dse1	  null	  cells	  were	  grown	  overnight	  in	  5	  mL	  of	  YPD	  media	  at	  30°C,	  180	  rpm.	  Cells	  were	  
spun	  down	  at	  900	  g	  and	  washed	  twice	  with	  PBS	  before	  being	  re-­‐suspended	  in	  approximately	  5	  mL	  of	  
PBS.	  Approximately	  10	  μL	  of	  culture	  was	  mounted	  on	  microscope	  slides	  and	  visualised	  using	  a	  Zeiss	  
Axiovert	   200	   inverted	   microscope	   with	   a	   63x	   objective.	   The	   cells	   were	   photographed	   using	   a	  
Hamamatsu	  ORCA-­‐ER	   digital	   camera.	   The	   images	  were	  manipulated	   and	   the	   cells	  measured	   using	  
Image	   J,	   version	   1.44p,	   National	   Institutes	   of	   Health,	   Maryland,	   USA.	   Briefly,	   the	   contrast	   was	  
enhanced,	  a	  mask	  was	  applied	  and	  then	  the	  cells	  selected	  using	  the	  boundary	  select	  tool.	  Each	  cell	  
was	   inputted	   into	   the	   POI	  manager,	   and	  measured	   for	   the	   smallest	   bounding	   rectangle	   using	   the	  
measure	  tool.	  300	  cells	  were	  counted	  per	  strain,	  and	  a	  ratio	  of	  each	  individual’s	  length	  to	  width	  was	  
calculated	  then	  averaged	  as	  a	  measure	  of	  the	  strain’s	  cell	  polarization.	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5.2.5	  Construction	  of	  Dse1p-­‐GFP	  Gateway	  plasmid	  
S.	   cerevisiae	   DSE1	   was	   cloned	   into	   pAG426GPD-­‐ccdB	   [275]	   featuring	   a	   GFP-­‐tag,	   constitutive	  
promoter	   and	   URA3	   marker	   using	   the	   Gateway	   Cloning	   System	   (Invitrogen,	   UK).	   Briefly,	   the	   S.	  
cerevisiae	  DSE1	  was	  cloned	  into	  a	  pENTRY	  vector	  using	  a	  two-­‐step	  PCR	  method	  and	  BP	  clonase.	  The	  
pENTRY	   vector	   containing	  DSE1	  was	   then	   transformed	   into	   E.	   coli	   TOP10	   as	   described	   in	   section	  
2.3.14,	   and	   incubated	   at	   37°C	   overnight	   on	   selective	   media.	   Successful	   transformation	   was	  
confirmed	  using	  PCR	  as	  described	  in	  section	  2.3.2	  with	  the	  target	  pENTRY	  vector	  extracted	  from	  an	  
overnight	  culture	  using	  a	  QIAprep©Spin	  MiniPrep	  kit	  (Qiagen	  Ltd,	  UK)	  as	  described	  in	  section	  2.3.10.	  
The	  successful	  insert	  was	  then	  cloned	  from	  the	  pENTRY	  vector	  into	  the	  URA3	  marker	  GFP	  destination	  
vector	  using	  LR	  clonase.	  The	  destination	  vector	  was	  then	  transformed	  into	  E.	  coli	  TOP10	  as	  described	  
in	  section	  2.3.14,	  and	  incubated	  at	  37°C	  overnight	  on	  selective	  media.	  Successful	  transformation	  was	  
confirmed	  using	  PCR	  as	  described	  in	  section	  2.3.2	  with	  the	  target	  destination	  vector	  extracted	  from	  
an	   overnight	   culture	   using	   a	   QIAprep©Spin	  MiniPrep	   kit	   (Qiagen	   Ltd,	   UK)	   as	   described	   in	   section	  
2.3.10.	  The	  successful	  plasmid	  constructs	  were	  then	  stored	  at	  -­‐20°C.	  
	  
5.2.6	  Localisation	  study	  of	  S.	  cerevisiae	  Dse1p	  in	  known	  interactor	  nulls	  
To	  see	  whether	  Dse1p’s	  localization	  was	  dependent	  on	  proteins	  shown	  to	  have	  physical	  interaction	  
with	  Dse1p	  in	  S.	  cerevisiae,	  a	  plasmid	  containing	  S.	  cerevisiae	  DSE1	  tagged	  with	  GFP	  as	  constructed	  
in	  section	  5.2.5,	  was	  transformed	  into	  target	  strains	  from	  the	  Yeast	  Knockout	  Library	  YKO,	  selected	  
for	  their	  physical	   interaction	  with	  Dse1p	  in	  S.	  cerevisiae,	  and	  the	  parental	  strain	  BY4741	  [165,	  242,	  
276].	   A	   GFP-­‐tagged	   Dse1p	   yeast	   strain	   from	   the	   commercially	   available	   Yeast-­‐GFP	   library	   was	  
included	  for	  comparison	   (Invitrogen,	  UK)	   [143].	  The	  yeast	  strains	  were	  grown	  overnight	   in	  5	  mL	  of	  
selective	  media	  at	  30°C,	  180	  rpm.	  In	  the	  morning,	  the	  cells	  were	  diluted	  to	  OD600	  =	  0.3	  and	  allowed	  
to	  grow	  at	  30°C,	  180	   rpm	  for	  a	   further	   two	  to	   three	  hours,	   till	   the	  OD600	  was	  between	  0.5-­‐1.	  Cells	  
were	  spun	  down	  at	  900	  g	  and	  washed	  twice	  with	  PBS	  before	  being	  re-­‐suspended	  in	  approximately	  
200-­‐500	  μL	  of	  PBS.	  Approximately	  10	  μL	  of	  culture	  was	  mounted	  on	  microscope	  slides	  and	  visualised	  
using	  a	  Zeiss	  Axiovert	  200	   inverted	  microscope	  with	  a	  63x	  objective.	  The	  cells	  were	  photographed	  
using	   a	   Hamamatsu	   ORCA-­‐ER	   digital	   camera	   with	   a	   DA/FI/TR/Cy5-­‐4X-­‐A	   Quad-­‐band	   filter	   set	  
(Semrock)	  to	  observe	  GFP	  tagged	  proteins,	  while	  images	  were	  manipulated	  using	  HCImage,	  version	  
2.1.1.0,	  Hamamatsu	  Corporation,	  New	  Jersey,	  USA.	  
	  
5.2.7	  Growth	  rate	  analysis	  
Yeast	  cells	  were	  grown	  overnight	   in	  5	  mL	  of	  YPD	  media	  at	  37°C,	  180	  rpm.	   In	  the	  morning	  the	  cells	  
were	  diluted	  to	  OD600	  =	  0.1,	  plated	  out	  in	  triplicate	  into	  a	  96-­‐well	  plate	  and	  allowed	  to	  grow	  for	  24	  
hours	   at	   37°C	   in	   a	  Molecular	   devices	  Versamax	  Tunable	  Microplate	   reader,	   controlled	  by	   Softmax	  
Pro.	  The	  OD	  was	  recorded	  every	  3.5	  minutes	  after	  having	  been	  shaken	  before	  each	  time	  point.	  The	  
data	  was	  then	  manipulated	  in	  Excel.	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5.3	  Results	  
5.3.1	  DSE1	  expression	  is	  Ace2p-­‐dependent	  in	  S.	  cerevisiae	  and	  C.	  glabrata	  	  
Through	  Northern	  Analysis	  of	  a	   tet-­‐regulated	  C.	  glabrata	  ACE2	  strain,	  HLS119,	  DSE1	  was	  shown	  to	  
have	   Ace2p-­‐dependent	   expression	   in	   chapter	   3	   (Figure	   3.1),	   which	   correlates	   with	   findings	   in	   S.	  
cerevisiae	  [101,	  133].	  
	  
5.3.2	  Potential	  Ace2p	  binding	   sites	   in	   the	  promoter	   region	  of	   both	  C.	   glabrata	  and	  S.	   cerevisiae	  
DSE1	  
Having	  shown	  the	  expression	  of	  C.	  glabrata	  DSE1	  to	  be	  Ace2p-­‐dependent	  in	  C.	  glabrata	  (Figure	  3.1),	  
and	  combined	  with	  the	  knowledge	  that	  S.	  cerevisiae	  DSE1	  also	  displays	  Ace2p-­‐dependent	  expression	  
[101,	  133],	  the	  upstream	  region	  of	  C.	  glabrata	  DSE1	  was	  screened	  for	  potential	  Ace2p	  binding	  sites	  
(ACCAGC)	  as	  defined	  by	  Dohrmann	  et	  al.	  [220],	  and	  presented	  in	  Figure	  3.2.	  The	  same	  technique	  was	  
then	  employed	  for	  S.	  cerevisiae	  DSE1	  using	  sequence	  data	  from	  the	  S.	  cerevisiae	  genome	  database	  
[170].	   S.	   cerevisiae	   DSE1	   shows	   three	   potential	   Ace2p	   binding	   sites,	   within	   its	   intergene	   region	  
upstream	  of	  the	  start	  codon	  and	  downstream	  of	  the	  next	  closest	  gene	  ORF	  (RSP5).	  The	  site	  positions	  
are	   mapped	   below	   in	   Figure	   5.1	   in	   relation	   to	   the	   start	   codon	   of	   the	   target	   gene,	   with	   all	   co-­‐




Figure	   5.1	   –	   Potential	   Ace2p	   binding	   sites	   exist	   in	   the	   intergene	   regions	   upstream	   of	   DSE1.	   The	   intergene	   region	  
upstream	  of	  the	  DSE1	  S.	  cerevisiae	   is	  displayed	  with	  potential	  Ace2p	  binding	  sites	  (ACCAGC)	  [220]	  marked	  for	  position	  
relative	   to	   the	   ATG	   of	   DSE1.	   C.	   glabrata	   DSE1	   is	   included	   from	   Figure	   3.2	   for	   reference.	   All	   co-­‐ordinates	   and	  
measurements	  are	   in	  base	  pairs,	  all	  sequences	  were	  taken	  from	  Génolevures	  [171]	  or	  SGD	  [170].	  Diagrams	  are	  not	  to	  
scale.	  A.	  C.	  glabrata	  DSE1	  has	  two	  potential	  Ace2p	  binding	  sites	  between	   it	  and	  RSP5.	  B.	  S.	  cerevisiae	  DSE1	  has	   three	  
potential	  Ace2p	  binding	  sites	  between	  it	  and	  RSP5.	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5.3.3	  C.	  glabrata	  Dse1p	  structural	  prediction	  
A	  structural	  prediction	  of	  C.	  glabrata	  Dse1p	  was	  created	  courtesy	  of	  Dr.	  Talavera	  of	  the	  University	  of	  
Manchester	  using	  mGenTHREADER	  and	  secondary	  structure	  recognition	  techniques	  combined	  with	  
trial	   and	  error	  model	   refinement	   [270,	  271]	   as	  described	   in	   section	  5.2.2.	   The	   resulting	  prediction	  
(Figure	  5.2)	  indicates	  that	  C.	  glabrata	  Dse1p	  has	  a	  β-­‐propeller,	  which	  may	  indicate	  an	  enzymatic	  role.	  
	  
Figure	   5.2	   –	   Structural	   prediction	   of	   C.	   glabrata	   Dse1p	   reveals	   a	   β -­‐propeller	   structure.	   Analysis	   of	   the	   predicted	  
structure,	  kindly	  performed	  by	  Dr.	  Talavera,	  University	  of	  Manchester,	  of	  the	  N-­‐terminus,	  minus	  20bps,	  of	  C.	  glabrata	  
Dse1p	  predicts	  a	  β-­‐propeller	  structure.	  The	  arrows	  represent	  β-­‐sheets	  and	  the	  coil	  an	  α-­‐helix.	  This	  predicted	  functional	  
structure	  may	  indicate	  an	  enzymatic	  function	  for	  the	  N-­‐terminus	  of	  Dse1p	  [269].	  
	  
	   	  
	  	  
	   Chapter	  5	  –	  Study	  of	  the	  novel	  gene	  DSE1	  in	  yeast	   	  	   	  
136	   	  
	   	  
	  
5.3.4	  C.	  glabrata	  dse1	  null	  phenotypic	  screen	  
A	  phenotypic	  screen	  was	  conducted	  in	  chapter	  4	  using	  a	  selected	  range	  of	  phenotypic	  conditions	  as	  
described	  by	  Hampsey	  et	  al.	   [246]	  and	   listed	   in	  Table	  4.1.	  As	  shown	   in	  Figures	  4.4-­‐4.6,	  C.	  glabrata	  
dse1	   showed	  normal	  growth	  on	  all	  conditions	  except	  for	  2.5	  mM	  vanadate,	  which	  could	   indicate	  a	  
mild	   defect	   in	   protein	   glycosylation,	   and	   10	  mM	   caffeine,	  which	   could	   indicate	   defects	   in	   various	  
cellular	  processes,	   including	  MAPK	  signalling	  pathways	  and	   the	  Mpk1p-­‐mediated	  cell	  wall	   integrity	  
pathway	  [247].	  
	  
5.3.5	  C.	  glabrata	  and	  S.	  cerevisiae	  vanadate	  sensitivity	  screen	  
After	  a	  phenotypic	  screen,	  as	  shown	  in	  Figures	  4.4-­‐4.6,	  identified	  a	  possible	  sensitivity	  to	  vanadate,	  a	  
screen	   of	   vanadate	   sensitivity	   using	   multiple	   concentrations	   of	   vanadate	   was	   performed	   on	   the	  
selected	  candidate	  for	  C.	  glabrata	  dse1	  and	  the	  S.	  cerevisiae	  dse1	  library	  strain,	  with	  their	  respective	  
wild	   types	   for	   comparison.	   No	   difference	   in	   sensitivity	  was	   observed	   between	   the	  dse1	  nulls	   and	  
their	   wild	   type	   strains	   (Figure	   5.3).	   S.	   cerevisiae	   shows	   increased	   resistance	   to	   vanadate	   than	   C.	  
glabrata	  from	  4	  mM	  to	  6	  mM	  vanadate.	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Figure	  5.3	  –	  C.	  glabrata	  dse1	  and	  S.	  cerevisiae	  dse1	  display	  no	  difference	  in	  vanadate	  sensitivity	  when	  compared	  to	  their	  
respective	  wild	   type	   strains.	   Growth	   phenotypes	   of	   the	  wild	   type	  C.	   glabrata	   strain	   Cg2001,	  C.	   glabrata	  dse1,	   the	   S.	  
cerevisiae	  wild	   type	  strain	  BY4741,	  and	  S.	  cerevisiae	  dse1.	  No	  sensitivity	  was	  shown	  by	  any	  of	   the	  null	  mutants	  when	  
compared	   with	   the	   wild	   type	   control.	   S.	   cerevisiae	   shows	   increased	   vanadate	   resistance	   when	   compared	   with	   C.	  
glabrata.	  5	  µL	  of	  each	  strain	  was	  spotted	  in	  serial	  dilutions	  of	  1	  x	  107,	  1	  x	  106,	  1	  x	  105	  and	  1	  x	  104.	  Strains	  were	  grown	  for	  
three	  days	  on	  YPD	  with	  the	  0.5	  mM,	  1	  mM,	  2	  mM,	  4	  mM,	  5	  mM	  or	  6	  mM	  of	  vanadate	  at	  30°C.	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5.3.6	  Yeast	  dse1	  null	  polarization	  study	  
To	   ascertain	   whether	   deletion	   of	   DSE1	   causes	   a	   change	   in	   cell	   polarity,	   C.	   glabrata	   dse1,	   the	   C.	  
glabrata	  wild	   type	   Cg2001,	  S.	   cerevisiae	  dse1	  and	   the	   S.	   cerevisiae	  wild	   type	   BY4741	  were	   grown	  
overnight,	  washed,	  mounted,	   and	  photographed	  using	  a	  microscope	  as	  described	   in	   section	  5.2.4.	  
The	  images	  were	  then	  analysed	  for	  individual	  cell	  polarity	  by	  measuring	  the	  ratio	  of	  their	  width	  and	  
height.	   300	   cells	   were	   measured	   per	   strain	   and	   the	   results	   averaged.	   Neither	   dse1	   nulls	   from	   S.	  
cerevisiae	  or	  C.	  glabrata	  show	  a	  difference	  in	  cell	  polarity	  from	  their	  respective	  wild	  types.	  
	  
	  
Figure	  5.4	  –	  Polarisation	  of	  C.	  glabrata	  and	  S.	  cerevisiae	  dse1	  is	  unchanged	  compared	  to	  the	  wild	  type.	  Chart	  showing	  cell	  
polarisation	  as	  measured	  the	  ratio	  of	  Length:Width	  for	  a	  sample	  of	  C.	  glabrata	  wild	  type	  (Cg2001),	  C.	  glabrata	  dse1	  null	  
(Cg	  Δdse1),	  S.	  cerevisiae	  wild	  type	  (BY4741)	  and	  S.	  cerevisiae	  dse1	  null	  (Sc	  Δdse1).	  No	  significant	  difference	  was	  observed	  
between	  the	  polarity	  of	  either	  of	  the	  dse1	  nulls	  and	  their	  associated	  wild	  type	  strains	  in	  their	  respective	  species.	  Yeast	  
strains	  were	  grown	  overnight	  in	  YPD	  at	  30°C/37°C,	  180	  rpm,	  diluted,	  and	  grown	  to	  OD600	  0.5-­‐1,	  washed,	  mounted	  and	  
visualised.	  Photos	  were	  then	  analysed	  for	  cell	  polarity	  using	  Image	  J.	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5.3.7	  Localisation	  study	  of	  S.	  cerevisiae	  Dse1p	  in	  known	  interactor	  nulls	  
The	  localisation	  of	  Dse1p	  was	  visualised	  in	  known	  interactor	  nulls	  from	  the	  S.	  cerevisiae	  YKO	  library	  
using	  a	  S.	  cerevisiae	  Dse1-­‐GFP	  plasmid	  as	  constructed	  in	  section	  5.2.5.	  The	  yeast	  strains,	  Dse1p-­‐GFP	  
library	  strain,	  BY4741	  +	  Dse1-­‐GFP,	  boi1	  +	  Dse1-­‐GFP,	  boi2	  +	  Dse1-­‐GFP,	  zds2	  +	  Dse1-­‐GFP,	  ste4	  +	  Dse1-­‐
GFP,	  ste11	  +	  Dse1-­‐GFP	  and	  the	  parental	  control	  BY4741	  were	  studied	  using	  fluorescence	  microscopy	  
as	  described	  in	  section	  5.2.6,	  and	  shown	  in	  Figure	  5.5.	  Dse1p	  shows	  no	  difference	  in	  localisation	  in	  
the	   interactor	   nulls	   localising	   to	   the	   bud	   neck	   apart	   from	   zds2,	   in	   which	   it	   displays	   an	   altered	  
localisation	  from	  the	  parental	  and	  control	  strains,	  localising	  to	  the	  cell	  wall	  but	  not	  the	  bud	  neck.	  
	  
	  
Figure	   5.5	   –	   Localisation	   of	   S.	   cerevisiae	   Dse1p-­‐GFP	   is	   altered	   in	   zds2	   null	   mutant.	   Florescence	   microscopy	   of	   a	  
representitive	  sample	  of	  the	  S.	  cerevisiae	  Dse1p-­‐GFP	  library	  strain,	  as	  well	  as	  BY4741	  and	  known	  interactors	  boi1,	  boi2,	  
zds2,	  ste4	  and	  ste11	  with	  pSRSG-­‐GD1	  (Dse1-­‐GFP)	  and	  their	  parental	  control	  BY4741.	  All	  strains	  show	  similar	  localisation	  
to	   the	   Dse1-­‐GFP	   library	   strain,	   with	   Dse1p	   primarily	   located	   to	   the	   bud	   neck	   area,	   apart	   from	   zds2	   in	   which	   Dse1p	  
localised	  to	  the	  cell	  wall	  but	  not	  the	  bud	  neck.	  Yeast	  strains	  were	  grown	  overnight	  in	  YPD	  at	  30°C,	  180	  rpm,	  diluted,	  and	  
grown	  to	  OD600	  0.5-­‐1,	  washed,	  mounted	  and	  visualised.	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5.3.8	  Growth	  rate	  analysis	  of	  C.	  glabrata	  dse1	  	  
The	  growth	  rate	  of	  the	  C.	  glabrata	  dse1	  null	  was	  analysed	  in	  chapter	  4	  as	  shown	  in	  Figure	  4.12.	  The	  
dse1	   null	   showed	   a	   similar	   growth	   rate	   compared	   to	   the	   C.	   glabrata	   wild	   type	   Cg2001	   and	   the	  
parental	  strain	  C.	  glabrata	  his3.	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5.4	  Discussion	  
The	  aim	  of	  the	  experiments	   in	  this	  chapter	  was,	   for	  the	  first	  time	   in	  C.	  glabrata,	   to	   investigate	  the	  
role	  of	  the	  uncharacterised	  gene	  DSE1,	  both	  directly	  in	  C.	  glabrata	  and	  through	  the	  use	  of	  available	  
tools	  within	  its	  close	  genetic	  relative,	  the	  model	  yeast	  S.	  cerevisiae.	  	  
	  
5.4.1	  Ace2p	  direct	  transcriptional	  regulation	  is	  likely	  in	  both	  C.	  glabrata	  and	  S.	  cerevisiae.	  
Work	  in	  S.	  cerevisiae	  showed	  that	  DSE1	  displays	  Ace2p-­‐dependent	  expression,	  and	  forms	  part	  of	  the	  
genes	  regulated	  by	  Ace2p	  that	  peak	  in	  expression	  during	  the	  run	  up	  to	  cell	  separation	  [101,	  133].	  To	  
investigate	  whether	  DSE1	  also	  showed	  Ace2p-­‐dependent	  expression	   in	  C.	  glabrata	  a	  study	  of	  DSE1	  
expression	   using	   an	   ACE2	   tet-­‐regulated	   strain,	   HLS119,	   was	   performed	   by	   Northern	   analysis	   in	  
chapter	  3.	  The	  results	  showed	  that	  DSE1	  displays	  Ace2p-­‐dependent	  expression	  in	  C.	  glabrata	  (Figure	  
3.1)	  with	  transcripts	  for	  DSE1	  present	  when	  ACE2	  is	  expressed	  and	  absent	  when	  ACE2	  expression	  is	  
inhibited.	  To	  see	  whether	  Ace2p	  could	  potentially	  directly	  regulate	  the	  expression	  of	  DSE1	  in	  both	  C.	  
glabrata	  and	  S.	  cerevisiae,	  sequence	  analysis	  of	  the	  upstream	  untranslated	  regions	  of	  DSE1	   in	  both	  
species	  was	  also	  performed	   in	  chapter	  3.	  The	   results	   showed	  that	  DSE1	   in	  both	  C.	  glabrata	  and	  S.	  
cerevisiae	  had	  potential	  Ace2p	  binding	  sites	  within	  each	  gene’s	  promoter	  region	  as	  shown	  in	  Figure	  
5.1.	  C.	  glabrata	  DSE1	  had	  two	  potential	  Ace2p	  binding	  sites,	  one	  at	  -­‐377	  bp	  and	  one	  at	  -­‐416	  bp	  from	  
the	   start	   codon,	   where	   as	   S.	   cerevisiae	   DSE1	   had	   three	   potential	   Ace2p	   binding	   sites	   within	   its	  
promoter	  region	  at	  -­‐248,	  -­‐393	  and	  -­‐441	  bp	  from	  the	  start	  codon.	  Combined	  with	  the	  known	  Ace2p-­‐
dependence	  of	  the	  gene	  in	  the	  two	  species	  [101,	  133],	  the	  results	  strongly	  suggest	  that	  Ace2p	  can	  
bind	  directly	  to	  the	  DSE1	  promoter	  to	  regulate	  its	  transcription	  as	  part	  of	  the	  Ace2p	  regulon	  within	  
both	  species	  of	  yeast.	  To	  confirm	  this	  you	  could	  use	  an	  electrophoretic	  mobility	  shift	  assay	  to	  test	  for	  
DNA-­‐binding	  of	  Ace2p	  to	  the	  promoter	  sequence	  of	  DSE1	  within	  C.	  glabrata	  and	  S.	  cerevisiae,	  which	  
coupled	  with	  the	  Ace2p-­‐dependence	  of	  DSE1	  expression	  in	  both	  strains,	  would	  prove	  Ace2p’s	  ability	  
to	  directly	  regulate	  the	  transcription	  of	  DSE1.	  
	  
5.4.2	  β -­‐propeller	  
The	  next	  stage	  of	  investigation	  into	  the	  role	  and	  function	  of	  DSE1	  in	  C.	  glabrata,	  was	  to	  look	  at	  the	  
structure	  of	  the	  transcribed	  protein.	  To	  this	  end,	  structural	  prediction	  was	  performed	  in	  partnership	  
with	  Dr.	  Talavera	  from	  the	  University	  of	  Manchester	  [269],	  which	  revealed	  that	  Dse1p	  in	  C.	  glabrata	  
has	  a	  predicted	  β-­‐propeller	  structure	  made	  of	  β-­‐sheets	  circling	  a	  central	  tunnel	  with	  one	  α-­‐helix	  coil	  
as	   illustrated	   in	   Figure	   5.2.	   The	  β-­‐propeller	   fold	   takes	   the	   form	  of	   a	   highly	   symmetrical	   structure;	  
normally	  featuring	  4	  to	  8-­‐fold	  repeats	  of	  antiparallel	  β-­‐sheet	  motifs	  [277].	  The	  antiparallel	  β-­‐sheets	  
form	   into	   ‘blades’,	  which	  are	  arranged	  radially	  around	  a	  central	  open	  tunnel,	  held	  together	  by	  the	  
predominantly	  hydrophobic	  interactions	  between	  the	  sheets	  [277].	  The	  circular	  conformation	  of	  the	  
β-­‐propeller	   structure	   is	   crucial	   to	   its	   function,	   and	   is	   held	   together	   in	   most	   cases	   by	   a	   β-­‐sheet	  
arrangement	  that	  locks	  the	  first	  and	  last	  blades	  together,	  described	  as	  ‘molecular	  Velcro’	  [277].	  Most	  
of	  the	  known	  propeller	  proteins	  use	  the	  central	  tunnel	  to	  execute	  their	  function	  within	  the	  cell,	  co-­‐
ordinating	  ligand	  position	  and	  binding	  or	  acting	  as	  the	  active	  site	  in	  catalytic	  proteins	  [277].	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β-­‐propeller	  structures	  are	  predominantly	  found	  in	  eukaryotes,	  with	  complete	  genome	  scanning	  only	  
highlighting	  one	  possible	  β-­‐propeller	  structure	  within	  archaebacterial	  genomes	  and	  only	  four	  found	  
within	   E.	   coli	   	   [277].	   In	   yeast,	   however,	   212	   predicted	   β-­‐propeller	   structures	   were	   found	   in	   S.	  
cerevisiae	   alone,	   with	   many	   showing	   homology	   to	   Gβ	   proteins	   [277].	   β-­‐propeller	   structures	   are	  
found	   in	   a	   diverse	   plethora	   of	   proteins	   ranging	   from	   G	   proteins	   carrying	   out	   signalling	   roles,	   to	  
enzymes	  such	  as	  Cytochrome	  cd1	  and	  Glucose	  dehydrogenase	  [277].	  β-­‐propeller	  structures	  have	  also	  
been	  associated	  with	  transcriptional	  repression,	  shown	  to	  exist	  in	  the	  β-­‐domain	  of	  the	  Snn6p-­‐Tup1p	  
repressor	  complex	  [278].	  The	  TUP1	  encoded	  protein	  has	  WD40	  repeats,	  which	  form	  the	  folds	  of	  β-­‐
sheets	   within	   the	   β-­‐propeller	   structure	   [278].	   The	   WD40	   repeats	   within	   the	   face	   of	   the	   radial	  
structure	  form	  the	  site	  of	  interaction	  with	  DNA-­‐binding	  proteins	  that	  recruit	  the	  Snn6p-­‐Tup1p	  active	  
repressor	  to	  the	  site	  of	  repression	  [278].	  The	  Ssn6p-­‐Tup1p	  complex	  has	  been	  shown	  to	  repress	  over	  
150	  genes	  in	  S.	  cerevisiae,	  with	  homologues	  shown	  to	  exist	  in	  other	  yeast	  species	  including	  Candida	  
species,	  mammals,	  flies	  and	  worms	  [278].	  
The	   discovery	   of	   a	   predicted	  β-­‐propeller	   structure	   for	  DSE1	  within	  C.	   glabrata	   could	   indicate	   that	  
Dse1p	   plays	   an	   enzymatic	   role,	   which	   could	   explain	   its	   Ace2p	   transcriptional	   regulation	   as	   an	  
effector	   of	   cell	   separation	   as	   part	   of	   the	   cell	   separation	   machinery.	   Equally,	   Dse1p	   could	   play	   a	  
similar	  role	  to	  Tup1p	  in	  transcriptional	  regulation,	  as	  either	  a	  repressor	  or	  activator	  of	  transcription.	  
It	  is	  also	  possible	  that	  Dse1p	  plays	  a	  signalling	  role	  like	  the	  numerous	  Gβ	  homologues	  within	  yeast,	  
which	  could	  support	  some	  of	  the	  suggested	  roles	  for	  Dse1p	  within	  S.	  cerevisiae	  and	  C.	  albicans.	  
	  
5.4.3	  Deletion	  of	  DSE1	  induces	  a	  cell	  separation	  defect	  
Having	   successfully	  disrupted	  DSE1	  within	  C.	  glabrata,	   the	  dse1	   null	  was	   subjected	   to	  a	   solid	   agar	  
phenotypic	  screen	  in	  an	  attempt	  to	  highlight	  any	  possible	  roles	  for	  Dse1p	  within	  the	  cell	  in	  chapter	  4.	  
The	  screen	  covered	  conditions	  targeted	  at	  cell	  wall	  metabolism,	  glycosylation,	  nutrient	  and	  oxidative	  
stress	   as	   well	   as	   temperature	   sensitivity.	   The	   C.	   glabrata	   dse1	   strain	   showed	   no	   difference	   in	  
sensitivity	   to	   the	   majority	   of	   the	   conditions,	   only	   displaying	   a	   mild	   sensitivity	   to	   vanadate	   and	  
caffeine	  when	  compared	  to	  the	  parental	  strain	  (Figure	  4.6).	  Further	  testing	  of	  the	  apparent	  vanadate	  
sensitivity	  was	  conducted	  using	  a	  greater	  range	  of	  concentrations.	  The	  results	  showed	  that	  neither	  
the	  C.	  glabrata	  dse1,	  nor	  the	  S.	  cerevisiae	  dse1	  from	  the	  YKO	  library,	  display	  a	  difference	  in	  vanadate	  
sensitivity	  compared	  to	  their	  respective	  wild	  types	  (Figure	  5.3)	  indicating	  that	  the	  original	  vanadate	  
sensitivity	  in	  Figure	  4.6	  might	  not	  be	  a	  real	  result.	  It’s	  interesting	  to	  note	  that	  S.	  cerevisiae	  displayed	  
considerably	   more	   resistance	   to	   the	   vanadate	   condition	   showing	   uninhibited	   grow	   on	   all	  
concentrations	   of	   vanadate	   up	   to	   the	   6	  mM	   tested	   here,	   where	   as	   C.	   glabrata	   showed	   inhibited	  
growth	   from	   4	   mM	   (Figure	   5.3).	   Caffeine	   sensitivity	   has	   been	   linked	   with	   defects	   in	   quite	   a	   few	  
cellular	  processes,	  which	  include	  MAPK	  signalling	  pathways,	  as	  the	  caffeine	  molecule	  acts	  as	  a	  purine	  
analogue	  once	   inside	  the	  cell	   [246,	  251].	  Caffeine	   is	   therefore	  typically	  used	   in	  phenotypic	  tests	  to	  
look	  for	  defects	  in	  the	  Mpk1p-­‐mediated	  cell	  wall	  integrity	  pathway	  [247].	  Therefore	  a	  mild	  sensitivity	  
to	   caffeine	   could	   indicate	   that	   DSE1	   plays	   a	   role	   in	   the	   cell	   wall	   integrity	   pathway,	   either	   as	   an	  
effector	  or	  as	  part	  of	  a	  signalling	  chain.	  
Another	   clue	   that	   Dse1p	  might	   be	   involved	   in	   cell	   wall	  maintenance,	  metabolism	   or	   the	   integrity	  
pathway	  comes	  from	  the	  phenotype	  displayed	  by	  dse1	  in	  C.	  glabrata.	  Figure	  4.10	  showed	  that	  dse1	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displays	  a	  cell	  separation	  deficient	  phenotype,	  forming	  branched	  chains	  of	  cells.	  The	  cell	  separation	  
phenotype	  is	  not	  on	  the	  same	  scale	  of	  the	  clumpy	  phenotype	  displayed	  by	  ace2	  C.	  glabrata	  cells	  (as	  
shown	  in	  Figure	  4.10	  for	  comparison),	  but	   is	  different	  from	  the	  cell	  separation	  competent	  parental	  
strain.	  This	  strongly	  indicates	  that	  Dse1p	  plays	  a	  role	  in	  cell	  separation	  or	  cell	  wall	  metabolism,	  which	  
combined	  with	  the	  mild	  sensitivity	  to	  caffeine	  and	  the	  transcriptional	  regulation	  by	  Ace2p,	  indicates	  
that	   Dse1p	   has	   a	   significant	   role	   in	   the	   cell	   separation	   machinery.	   Considering	   DSE1	   displays	   no	  
homology	  to	  cell	  wall	  glucanases,	   it	   is	   likely	  that	  Dse1p	  does	  not	  act	  directly	  on	  the	  cell	  wall	   itself,	  
but	   may	   form	   part	   of	   the	   initiation	   of	   the	   cell	   wall	   hydrolysis	   through	   recruitment,	   activation	   or	  
repression	  of	  effectors	  or	  perhaps	  by	  forming	  part	  of	  a	  signalling	  chain.	  
It	   has	   been	   suggested	   in	   the	   literature	   that	   Dse1p	   could	   have	   a	   role	   in	   bud	   site	   selection	   and	  
maintenance	  of	  cell	  polarity,	  mainly	  due	  to	  interaction	  data	  with	  Boi1p,	  Boi2p	  and	  Zds2p	  [163-­‐165].	  
To	   test	  whether	  deletion	  of	  DSE1	  within	  C.	  glabrata	  and	  S.	  cerevisiae	  affected	  the	  maintenance	  of	  
cell	  polarity	  a	  sample	  of	  300	  cells	  were	  photographed	  from	  each	  strain,	  which	  were	  then	  measured	  
comparing	  the	  ratio	  of	  length	  to	  width	  as	  a	  measure	  of	  cell	  polarity.	  C.	  glabrata	  dse1	  was	  compared	  
to	  the	  C.	  glabrata	  wild	  type,	  Cg2001,	  which	  showed	  no	  difference	   in	  polarity	  with	  a	  ratio	  of	  about	  
1.2.	   A	   comparison	   of	   S.	   cerevisiae	   dse1	   to	   the	   S.	   cerevisiae	   wild	   type	   BY4741	   also	   showed	   no	  
difference	  in	  polarity	  either,	  with	  a	  ratio	  of	  about	  1.1.	  A	  greater	  range	  of	  variation	  was	  apparent	  for	  
C.	  glabrata	  compared	  to	  S.	  cerevisiae,	  however	  ratios	  of	  polarity	  were	  within	  error	  limits	  across	  the	  
two	  species	  showing	  that	  C.	  glabrata	  and	  S.	  cerevisiae	  share	  roughly	  equal	  polarities.	  These	  results,	  
displayed	   in	   Figure	   5.4,	   can	   discount	   the	   theory	   that	  DSE1	  deletion	  would	   affect	   cell	   polarity	   and	  
suggests	  that	  if	  Dse1p	  plays	  a	  role	  in	  maintenance	  of	  polarity	  in	  C.	  glabrata	  and	  S.	  cerevisiae,	  it	  is	  not	  
essential.	   No	   evidence	   of	   an	   abnormal	   budding	   pattern	  was	   observed	   for	   either	  C.	   glabrata	   or	   S.	  
cerevisiae	  dse1	  during	  the	  course	  of	  this	  study	  or	  the	  images	  taken	  for	  Figure	  5.4,	  again	  suggesting	  
that	  if	  Dse1p	  plays	  a	  role	  in	  bud	  site	  selection,	  it	  is	  not	  an	  essential	  one.	  
Analysis	   of	   the	   growth	   rate	   of	   C.	   glabrata	   dse1	   compared	   to	   the	   wild	   type	   and	   parental	   strains,	  
showed	  similar	  growth	  rates	  and	  curves	  as	  shown	  in	  Figure	  4.12.	  
	  
5.4.4	  Localisation	  of	  Dse1p	  
To	   see	   whether	   the	   physical	   protein-­‐protein	   interactions	   shown	   by	   Dse1p	   in	   S.	   cerevisiae	   [165]	  
contribute	  to	  its	  localisation	  within	  the	  cell,	  a	  GFP-­‐tagged	  S.	  cerevisiae	  Dse1p	  plasmid	  was	  made	  and	  
used	   to	   study	   the	   localisation	   of	   Dse1p	   within	   known	   interactor	   nulls	   from	   the	   YKO	   library	   as	  
described	   in	   section	   5.2.6.	   By	   comparing	   the	   S.	   cerevisiae	   GFP	   library	   strain	   for	  DSE1	   to	   the	   YKO	  
strains	  transformed	  with	  the	  Dse1p-­‐GFP	  plasmid,	  it	  was	  possible	  to	  show	  that	  Dse1p	  localises	  to	  the	  
bud	  neck,	   as	  was	   previously	   reported	   in	   the	   literature	   [143],	   and	   that	   the	   localisation	  of	  Dse1p	   is	  
unchanged	   in	  the	  known	  Dse1p-­‐interactor	  deletions,	  boi1,	  boi2,	  ste4	  and	  ste11	  as	  shown	   in	  Figure	  
5.5.	   The	   S.	   cerevisiae	   zds2	   null	   mutant	   showed	   a	   slightly	   altered	   Dse1p	   localisation,	   displaying	  
localisation	   to	   the	   cell	   wall	   but	   not	   the	   bud	   neck.	   These	   results	   show	   that	   the	   Dse1p	   physical	  
interactors	   Boi1p,	   Boi2p,	   Ste4p	   and	   Ste11p	   have	   no	   effect	   on	   the	   localisation	   of	   Dse1p	   within	   S.	  
cerevisiae,	   but	   that	   Zds2p	   may	   play	   a	   role	   in	   the	   correct	   localisation	   of	   Dse1p.	   ZDS2,	   or	   Zillion	  
Different	  Screens	  2,	  has	  been	   linked	  with	  a	  plethora	  of	  cellular	  processes	   in	  S.	  cerevisiae	   including	  
telomeric	   silencing,	   transcriptional	   silencing,	   mitotic	   exit,	   mRNA	   export,	   regulation	   of	   Cdc42p,	  
calcium	  sensitivity,	  cell	  cycle	  regulation,	  cell	  wall	   integrity	  and	  many	  others,	  summarised	  by	  Yasutis	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et	   al.	   [279].	   ZDS2	   has	   also	   recently	   been	   shown	   to	   regulate	   the	   Swe1p	   kinase-­‐dependent	   G2/M	  
checkpoint	  that	  is	  responsible	  for	  maintenance	  of	  correct	  polarized	  growth	  and	  budding,	  which	  likely	  
acts	   through	   Cdc55p,	   a	   protein	   phosphatase	   2A	   regulatory	   subunit	   [279].	   This	   could	   indicate	   that	  
Dse1p	   plays	   a	   role	   in	   the	  G2/M	   checkpoint	   and	   that	   it	   has	   Zds2p-­‐dependent	   localisation,	   possibly	  
adding	  to	  the	  hypothesis	  of	  a	  bud	  site	  selection	  or	  polarisation	  role	  for	  Dse1p,	  or	  of	  course	  a	  role	  in	  
one	  of	  the	  many	  other	  cellular	  processes	  Zds2p	  has	  been	  linked	  with	  including	  the	  cell	  wall	  integrity	  
pathway.	  
	  
5.4.5	  Results	  and	  roles	  from	  the	  literature	  
The	  body	  of	  literature	  on	  DSE1	  from	  yeast	  and	  other	  fungi	  is	  far	  from	  comprehensive.	  As	  discussed	  
previously,	  three	  potential	  roles	  for	  Dse1p	  have	  been	  suggested.	  The	  first	   is	  a	  cell	  wall	  metabolism	  
and	   cell	   separation	   role,	   which	   Dse1p’s	   Ace2p-­‐dependence	   [101,	   133]	   and	   bud	   neck	   localisation	  
[143]	   in	   S.	   cerevisiae,	   as	   well	   as	   the	   cell	   separation	   defect	   and	   sensitivity	   to	   cell	   wall	   targeted	  
conditions	   found	   in	   S.	   cerevisiae	   dse1	   nulls	   [101]	   point	   to.	   Data	   from	   a	   haploinsufficient	  DSE1	   C.	  
albicans	  strain	  also	  supports	  a	  role	  in	  cell	  wall	  metabolism	  [268].	  In	  this	  regard	  the	  data	  collected	  in	  
this	  study	  supports	  a	  potential	  role	  in	  cell	  wall	  metabolism	  and	  cell	  separation,	  with	  C.	  glabrata	  dse1	  
nulls	  displaying	  a	  cell	  separation	  defect,	  while	  Dse1p	  localises	  to	  the	  cell	  wall	  and	  bud	  neck.	  DSE1’s	  
Ace2p-­‐dependent	  expression	  within	  C.	  glabrata	  also	  adds	  to	  the	  support	  of	  a	  role	  in	  cell	  separation	  
or	  associated	  cell	  wall	  metabolism,	  while	  its	  predicted	  β-­‐propeller	  structure	  could	  also	  support	  a	  cell	  
wall	  metabolism	  role.	  While	  none	  of	  the	  findings	  within	  this	  study	  provide	  any	  conclusive	  evidence	  
for	  a	  particular	  role,	  a	  cell	  wall	  metabolism	  and	  cell	  separation	  role	  has	  the	  most	  support.	  
To	  investigate	  the	  potential	  of	  Dse1p	  to	  have	  a	  direct	  effector	  role	   in	  cell	  wall	  metabolism	  and	  cell	  
separation,	   the	   next	   step	   would	   to	   be	   to	   look	   at	   the	   potential	   enzymatic	   qualities	   of	   Dse1p.	   For	  
instance	   even	   though	   Dse1p	   shows	   no	   homology	   to	   known	   putative	   glucanases,	   a	   role	   in	   glucan	  
degradation	   could	   still	   be	  possible	   and	   could	  be	   assayed	   through	   the	  use	  of	   a	   laminarin	  digestion	  
assay	  [280],	  with	  laminarin	  a	  glucan	  substitute.	  Alternatively,	  if	  Dse1p	  does	  play	  a	  direct	  effector	  role	  
in	   cell	   separation,	   it	   could	   be	   involved	   in	   chitin	   degradation,	   which	   could	   be	   tested	   using	   a	   4-­‐
methylumbelliferyl-­‐N-­‐acetyl-­‐beta-­‐D-­‐glucosaminide	  test	  [281]	  for	  instance.	  
Of	   course	   it’s	   also	  possible	   that	  Dse1p	  plays	   an	   indirect	   role	   in	   cell	  wall	  metabolism,	  perhaps	   in	   a	  
regulatory	  capacity.	  To	  test	  this	  transcriptome	  analysis	  of	  the	  S.	  cerevisiae	  and	  C.	  glabrata	  dse1	  null	  
could	  be	  performed	  using	  RNA-­‐seq,	  as	  described	  in	  Appendix	  5,	  or	  microarray	  analysis	  which	  would	  
be	  able	  to	  show	  whether	  any	  genes	  are	  up	  or	  down	  regulated	  in	  the	  dse1	  nulls	  and	  therefore	  show	  
whether	  Dse1p	  has	  any	  impact	  either	  directly	  or	  indirectly	  over	  gene	  expression,	  specifically	  looking	  
towards	  genes	  of	  the	  cell	  separation	  machinery.	  
Should	   a	   regulatory	   role	   be	   discovered,	   the	   next	   stage	   would	   be	   to	   assay	   for	   any	   DNA-­‐binding	  
potential	  of	  Dse1p.	  To	  test	   for	  DNA-­‐binding	  of	  Dse1p,	  an	  electrophoretic	  mobility	  shift	  assay	  could	  
be	  used	  to	  see	  whether	  Dse1p	  binds	  to	  DNA.	  Alternatively,	  a	  commercial	  transcription	  factor	  binding	  
assay	  such	  as	  the	  DuoSet	  Intracellular	  Active	  Transcription	  Factor	  Assays	  available	  from	  R&D	  Systems	  
could	  be	  used.	  At	  that	  point	  you	  could	  employ	  a	  similar	  DNA-­‐foot	  printing	  assay	  as	  described	  in	  the	  
original	   S.	   cerevisiae	   Ace2p	   binding	   site	   experiments	   by	   Dohrmann	   et	   al.	   [220],	   to	   find	   which	  
sequences	  were	  protected	  from	  digestion	  by	  the	  binding	  of	  Dse1p	  to	  DNA.	  That	  would	  give	  you	  an	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indication	  of	  the	  core	  of	  any	  Dse1p	  binding	  site,	  from	  which	  you	  could	  look	  to	  see	  which	  genes	  could	  
have	   potential	   Dse1p	   binding	   sites	   within	   their	   promoter	   regions	   in	   a	   similar	   manner	   to	   that	  
employed	  for	  Ace2p	  in	  chapter	  3.	  
In	  contrast,	   the	  results	  displayed	   in	  the	  polarization	  study	  shown	   in	  Figure	  5.4,	   indicate	  that	  a	  bud	  
site	  selection	  role,	  which	  was	  suggested	  by	  an	  over-­‐expression	  budding-­‐within-­‐birth-­‐scar	  phenotype	  
[163]	  and	  Dse1p’s	  physical	   interaction	  with	  Boi1p,	  Boi2p	  and	  Zds2p	   [165],	   is	  unlikely	  at	   least	   in	  C.	  
glabrata	   and	   S.	   cerevisiae,	   or	   that	   its	   role	   is	   not	   essential	   to	   the	   maintenance	   of	   cell	   polarity.	  
However,	   a	   change	   in	   localisation	   of	   Dse1p	  within	   S.	   cerevisiae	   zds2	   null	  mutants	   as	   observed	   in	  
Figure	   5.5	   does	   show	   that	   Zds2p	   plays	   some	   role,	  whether	   linked	   to	   bud	   site	   selection	   or	   not,	   in	  
Dse1p’s	  localisation	  in	  the	  cell.	  
To	  explicitly	  test	  whether	  Dse1p	  has	  any	  role	  in	  bud	  site	  selection,	  a	  look	  at	  the	  budding	  pattern	  of	  
the	   S.	   cerevisiae	   and	   C.	   glabrata	   dse1	   nulls	   could	   be	   performed	   using	   cell	   wall	   staining	   and	  
fluorescence	  microscopy	  in	  a	  similar	  manner	  to	  the	  study	  of	  budding	  within	  birth	  scar	  by	  Frydlova	  et	  
al.	  [163],	  taking	  a	  sample	  of	  photos	  of	  budding	  cells	  or	  clumps	  of	  cell	  separation	  deficient	  cells	  and	  
comparing	   the	   bud	   site	   selection	  with	   reference	   to	   the	   bud	   scar	   stained	   by	   calcofluor	   white	   and	  
ﬂuorescein	  isothiocyanate	  (FITC)-­‐labelled	  wheat	  germ	  agglutinin	  (WGA-­‐FITC).	  
The	  next	   stage	   in	   investigation	  of	  a	   cell	  polarity	   role	  could	  be	   to	   look	  at	   the	   localisation	  of	  known	  
Dse1p-­‐interactors	   like	   Boi1p,	   Boi2p,	   Zds2p,	   Ste4p	   and	   Ste11p	  within	  C.	   glabrata	   and	   S.	   cerevisiae	  
dse1	   nulls.	   This	   would	   help	   see	   whether	   Dse1p	   has	   any	   effect	   on	   the	   localisation	   of	   known	  
interactors	  and	  could	  be	  performed	  using	  the	  Gateway	  system	  as	  described	  for	  the	  creation	  of	  the	  
Dse1p-­‐GFP	  plasmid	  pSRSG-­‐GD1	  in	  section	  5.2.5.	  If	  the	  localisation	  of	  Boi1p	  or	  Boi2p	  was	  altered	  in	  a	  
dse1	  null	  for	  instance,	  it	  would	  strongly	  indicate	  that	  Dse1p	  plays	  at	  least	  some	  role	  in	  cell	  polarity	  
and	  bud	  site	  selection.	  On	  the	  other	  hand,	  if	  Ste4p	  or	  Ste11p	  showed	  altered	  localisation	  in	  the	  dse1	  
null,	  it	  would	  indicate	  that	  Dse1p	  might	  have	  a	  role	  in	  pseudohyphal	  growth.	  
None	  of	  the	  data	  presented	  within	  this	  study	  either	  supports	  or	  discourages	  the	  hypothesis	  of	  a	  role	  
for	   Dse1p	   in	   pheromone	   sensing	   or	   pseudohyphal	   growth	   that	   was	   suggested	   by	   the	   binding	   of	  
Ste11p	  and	   Ste4p	  as	  well	   as	   an	  over-­‐expression	   invasive	   growth	   and	  pheromone	   cell	   cycle	   arrest-­‐
resistant	  phenotype	  [166],	  although	  they	  were	  not	  looked	  at	  specifically	  as	  neither	  process	  has	  been	  
shown	  to	  be	  present	  in	  C.	  glabrata.	  
The	  next	  stage	  for	  general	  functional	  analysis	  of	  Dse1p	  within	  S.	  cerevisiae	  and	  C.	  glabrata	  could	  be	  
performed	   through	   the	   construction	   and	   use	   of	   partial	   DSE1	   deletions	   in	   the	   two	   species.	   By	  
disrupting	  the	  N-­‐	  or	  C-­‐terminal	  of	  DSE1	  at	  the	  locus	  you	  could	  assay	  for	  a	  change	  in	  phenotype,	  to	  
see	  whether	   the	   function	  of	   the	  partial	  protein	   is	  preserved	  or	  whether	  a	  cell	   separation	  defect	   is	  
displayed.	   It	  would	   also	   be	   interesting	   to	   see	  whether	   a	   partial	  DSE1	   disruption	  would	   also	   show	  
caffeine	  sensitivity	  similar	  to	  the	  null.	  
A	   similar	   method	   could	   be	   used	   to	   study	   the	   effect	   of	   the	   N-­‐	   and	   C-­‐terminal	   on	   the	   correct	  
localisation	  of	  Dse1p	   to	   the	  bud	  neck	  by	  cloning	   in	  partial	   fragments	  of	   the	  DSE1	   gene	   into	  a	  GFP	  
plasmid	  in	  a	  similar	  manner	  to	  that	  described	  in	  section	  5.2.5.	  Once	  successfully	  created	  the	  Dse1p	  
fragment	  plasmids	  could	  then	  be	  transformed	  into	  wild	  type	  C.	  glabrata	  or	  S.	  cerevisiae	  for	  study	  of	  
their	  localisation	  as	  performed	  in	  section	  5.3.7.	  This	  would	  indicate	  which	  parts	  of	  Dse1p	  are	  crucial	  
to	  its	  cellular	  localisation	  to	  the	  bud	  neck.	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5.4.6	  Summary	  
The	  results	  detailed	  in	  this	  thesis	  have	  shown	  for	  the	  first	  time	  that	  DSE1	  exhibits	  Ace2p-­‐dependent	  
expression	   in	   C.	   glabrata.	   It	   has	   also	   been	   shown	   that	   Ace2p	   binding	   sites	   exist	   within	   the	  DSE1	  
promoter	   region	   within	   C.	   glabrata,	   strongly	   indicating	   that	   Ace2p	   exhibits	   direct	   transcriptional	  
control	   over	   DSE1.	   Combining	   this	   data	   with	   the	   fact	   that	   Ace2p	   controls	   the	   cell	   separation	  
machinery,	  and	  that	  Dse1p	  has	  been	  shown	  to	  localise	  to	  the	  bud	  neck,	  strongly	  indicates	  that	  Dse1p	  
plays	   a	   role	   in	   cell	   separation	  either	  directly	   or	   through	  an	   intermediary.	   It	   is	   possible	   that	  Dse1p	  
plays	  a	  role	  in	  the	  activation	  of	  the	  cell	  wall	  integrity	  pathway,	  due	  to	  sensitivity	  to	  caffeine	  displayed	  
here,	   results	   shown	  within	   the	   literature	   [163],	   and	  Dse1p’s	   apparent	   Zds2p-­‐dependent	   bud	   neck	  
localisation	  in	  S.	  cerevisiae,	  indicating	  that	  Dse1p	  may	  play	  a	  larger	  role	  in	  cell	  wall	  metabolism	  than	  
just	  cell	  separation.	  
It	  has	  also	  been	  possible	  to	  show	  that	  cell	  polarity	  is	  maintained	  in	  both	  C.	  glabrata	  and	  S.	  cerevisiae	  
dse1	  nulls,	   allowing	   us	   to	   discount	   a	  major	   role	   for	   Dse1p	   in	  maintenance	   of	   cell	   polarity	   despite	  
showing	  Zds2p-­‐dependent	   localisation	   in	  S.	  cerevisiae.	  No	  obvious	  bud	  site	  selection	  changes	  were	  
observed	  in	  dse1	  nulls	  in	  either	  yeast	  species,	  indicating	  that	  if	  Dse1p	  has	  a	  role	  in	  bud	  site	  selection,	  
it	   is	  not	  essential	   for	   the	  normal	  bud	  site	  selection	  displayed	  by	  the	  wild	  type	  strains.	  None	  of	   the	  
results	  confirm	  or	  discount	  the	  hypothesis	  that	  Dse1p	  could	  have	  a	  role	  in	  pheromone	  sensing	  and	  
hyphal	   growth,	   however	   it	   is	   unlikely	   to	   do	   so	   in	   C.	   glabrata,	   which	   only	   exhibits	   pseudohyphal	  
growth	   in	   vitro	   under	   nitrogen	   starvation	   conditions	   [31].	   Further	   work	   is	   required	   to	   confirm	   or	  
discount	  a	  role	  in	  pseudohyphal	  growth	  within	  C.	  glabrata	  and	  to	  characterise	  the	  precise	  role	  Dse1p	  
has	  within	  cell	  separation	  and	  cell	  wall	  metabolism.	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6	   Summary	  and	  Conclusions	  
	  
6.1	  Summary	  
Fungal	   pathogens	   have	   become	   an	   increasingly	   serious	   clinical	   burden,	   primarily	   due	   to	   the	  
increased	  groups	  of	  patients	  who	  survive	  other	  conditions	  and	  are	  put	  ‘at	  risk’	  as	  a	  result	  [2,	  33,	  34].	  
This	   at	   risk	   group	   involves	   immune	   suppressed	   patients,	   either	   because	   of	   immune	   deficiency	  
diseases	  such	  as	  AIDS,	   through	  treatment	   for	  cancer,	  or	   those	  patients	  with	  transplants.	  Of	  course	  
another	  increasing	  at	  risk	  group	  is	  the	  elderly,	  and	  with	  modern	  medicine,	  better	  general	  health	  and	  
improved	  diet,	  the	  size	  of	  the	  elderly	  population	  is	  increasing.	  
Candida	  species	  have	  been	  shown	  to	  cause	  some	  10	  to	  15%	  of	  all	  nosocomial	  BSIs	  within	  the	  United	  
States	   [3],	   with	   the	   primary	   cause	   of	   candidaemia	   being	   C.	   albicans	   [48].	   Recently,	   an	   increasing	  
proportion	  of	  candidiasis	  and	  candidaemia	   infections	  have	  been	  caused	  by	  a	  relatively	   little	  known	  
Candida	  isolate,	  C.	  glabrata.	  In	  contrast	  to	  C.	  albicans,	  C.	  glabrata	  lacks	  any	  true	  hyphal	  morphology,	  
existing	   solely	   in	   yeast	   form.	   C.	   glabrata	   is	   also	   innately	   resistant	   to	   antifungal	   drugs,	   especially	  
azoles,	  which	  are	  commonly	  used	  within	  the	  clinical	  setting.	  This	  has	  meant	  that	  positive	  selection	  of	  
C.	  glabrata	  over	  other	  Candida	  and	  fungal	  species	  has	  occurred	  within	  the	  nosocomial	  setting	  [51],	  
which	  means	  that	  an	  increase	  in	  resistant	  Candida	  species	  poses	  a	  serious	  issue	  for	  clinical	  treatment	  
of	  Candida	  infections.	  
Little	  is	  known	  about	  C.	  glabrata	  virulence.	  As	  a	  close	  genetic	  relative	  to	  S.	  cerevisiae	  it	  shares	  many	  
traits	   with	   the	   traditionally	   non-­‐pathogenic	   commensal	   organism.	   Like	   other	   Candida	   species,	   C.	  
glabrata	   is	   a	   human	   commensal	   organism	   also,	   but	   is	   categorised	   as	   an	   opportunistic	   pathogen,	  
causing	  systemic	  disease	  only	  when	  a	  patient’s	  immune	  system	  becomes	  compromised.	  
In	  2004,	  Kamran	  et	  al.	  discovered	  a	  hypervirulence	   factor	  within	  C.	  glabrata	   [7].	  What	   they	   found	  
was	   an	   antivirulence,	   or	   virulence-­‐moderating	   gene	   with	   homology	   to	   the	   S.	   cerevisiae	   cell	  
separation	   transcriptional	   regulator	   ACE2.	   C.	   glabrata	   ace2	   nulls	   displayed	   an	   extreme	  
hypervirulence,	  resulting	   in	  100%	  mortality	  within	  18-­‐hours	  post	   infection	   in	  a	  neutropenic	  murine	  
model	  of	  candidiasis	  [7].	  Being	  a	  transcription	  factor	  controlling	  the	  expression	  of	  the	  genes	  of	  the	  
cell	  separation	  machinery	   in	  S.	  cerevisiae,	   it	  was	  no	  surprise	  that	  C.	  glabrata	  ace2	  also	  displayed	  a	  
clumpy,	   cell	   separation	   deficient	   phenotype.	   However,	   Kamran	   et	   al.	   showed,	   through	   the	   use	   of	  
chitinase	  treatment,	  that	  the	  hypervirulence	  displayed	  by	  ace2	  was	  not	  due	  to	  blockade	  by	  clumps	  
of	  cells	  but	  rather	  other	  factors,	  including	  the	  suggestion	  of	  a	  septic	  shock-­‐like	  response	  [7].	  
	  
6.1.1	  The	  Ace2p	  regulon	  in	  C.	  glabrata	  
An	   investigation	   into	   the	   cause	   of	   the	   antivirulence	   of	   ACE2	   was	   required.	   To	   start,	   the	   genes	  
regulated	  by	  Ace2p	  in	  C.	  glabrata	  had	  to	  be	  defined	  (chapter	  3).	  Northern	  analysis	  of	  a	  tetracycline-­‐
regulated	  strain	  of	  ACE2	  was	  used	  to	  define	  a	  partial	  Ace2p	  regulon,	  which	  contained	  12	  genes,	  as	  
well	  as	   the	  previously	   investigated	  CTS1.	  The	  12	  genes	   included	  homologues	  of	  S.	  cerevisiae	  genes	  
involved	   in	   cell	   cycle	   regulation,	   bud	   site	   selection	   and	   cell	  wall	   associated	   glucanases.	   The	   genes	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with	   expression	   shown	   to	   be	  Ace2p-­‐dependent	   in	  C.	   glabrata	   include:	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  
DSE2,	  DSE3,	  ACF2/DSE4,	  EGT2,	  RME1,	  SCW11α,	  SCW11β,	  and	  SIC1.	  
To	   see	   whether	   the	   12	   genes	   of	   the	   Ace2p	   regulon	   were	   likely	   to	   be	   directly	   transcriptionally	  
regulated	   by	   Ace2p,	   their	   promoter	   regions	   were	   analysed	   for	   potential	   Ace2p	   binding	   sites	   as	  
defined	  by	  Dohrmann	  et	  al.	  [132].	  Out	  of	  the	  12	  genes,	  10	  genes	  including	  AMN1,	  ASH1,	  BUD9,	  DSE1,	  
DSE2,	   DSE3,	   EGT2,	   SCW11α,	   SCW11β	   and	   SIC1,	   have	   at	   least	   two	   potential	   Ace2p-­‐binding	   sites	  
within	   their	   promoter	   regions,	   indicating	   strongly	   that	   Ace2p	   exhibits	   direct	   regulation	   over	   their	  
expression.	  
Once	   the	   partial	   Ace2p	   regulon	   was	   established	   it	   was	   possible	   to	   investigate	   the	   potential	  
antivirulence	  of	  the	  individual	  genes	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata	  (chapter	  4).	  10	  out	  of	  the	  12	  
genes	  were	   disrupted	   and	   subjected	   to	   preliminary	   phenotypic	   testing.	   The	   deletions	   displayed	   a	  
similar	   sensitivity	   profile	   to	   the	   C.	   glabrata	   ace2	   null,	   only	   showing	   sensitivity	   to	   vanadate	   and	  
caffeine,	   which	   are	   linked	  with	   glycosylation	   and	   secretion	   defects,	   or	   cell	   wall	   integrity	   pathway	  
defects	   respectively.	   Further	   testing	   showed	   that	   only	   egt2	   and	   dse1	   displayed	   cell	   separation	  
defects	  in	  liquid	  media.	  
Virulence	  testing	  of	  the	  individual	  null	  mutants	  showed	  that	  six	  out	  of	  the	  10	  assayed	  Ace2p	  regulon	  
mutants	   displayed	   significant	   hypervirulence	   in	   a	   neutropenic	   murine	   model	   of	   candidiasis	   when	  
compared	   to	   the	  wild	   type	   control.	   The	   six	  mutants,	  dse3,	  acf2,	   egt2,	   rme1,	   scw11β	   and	   sic1,	   all	  
caused	  100%	  mortality	  within	  five	  days,	  which	  contrasted	  to	  the	  60%	  survival	  displayed	  by	  the	  wild	  
type	  Cg2001	  over	  14	  days.	  The	  resulting	  hypervirulence	  was	  not	  as	  extreme	  as	  that	  displayed	  by	  the	  
ace2	  null	  however,	  which	  caused	  100%	  mortality	  within	  18-­‐hours	  post	   infection	  [7].	  Given	  that	  the	  
ace2	   hypervirulence	   phenotype	   was	   suggested	   as	   being	   caused	   by	   immune	   over-­‐stimulation	   and	  
septic	  shock,	   immune	  activation	  assays	  were	  performed	  with	  the	  hypervirulent	  mutants.	  Of	  the	  six	  
mutants	   tested,	   only	   sic1	   showed	   significantly	   higher	   elicitation	   of	   TNFα	   and	   IL-­‐6	   production	   as	  
assayed	   by	   ELISA,	   with	   a	   four-­‐fold	   and	   3.4-­‐fold	   increase	   respectively.	   This	   indicates	   that	   sic1	  
contributes,	  at	  least	  in	  part,	  to	  the	  immune	  over-­‐stimulation	  induced	  by	  the	  ace2	  null,	  but	  the	  exact	  
cause	   of	   said	   over-­‐stimulation	   is	   unclear	   as	   SIC1	   plays	   a	   role	   in	   genome	   stability	   and	   the	  G1	   to	   S-­‐
phase	  progression.	  
Through	  deletion	  and	  virulence	  analysis	  it	  has	  been	  shown	  for	  the	  first	  time	  that	  six	  separate	  genes	  
contribute	   to	   the	   antivirulence	   displayed	   by	   ACE2	   in	   C.	   glabrata,	   indicating	   that	   the	   extreme	  
hypervirulence	  shown	  by	  ace2	  nulls	  is	  most	  likely	  a	  synergy	  of	  multiple	  absences	  of	  gene	  expression.	  
	  
6.1.2	  DSE1	  a	  novel	  gene	  likely	  to	  be	  involved	  in	  cell	  separation	  in	  C.	  glabrata	  
The	  as-­‐yet	  uncharacterised	  gene	  DSE1,	  YER124C	  in	  S.	  cerevisiae	  and	  its	  homologue	  CAGL0K02277g	  in	  
C.	   glabrata,	   was	   highlighted	   as	   a	   gene	   of	   interest	   in	   the	   course	   of	   investigation	   into	   the	   Ace2p	  
regulon	   in	  C.	  glabrata	   and	   therefore	  became	   the	   subject	  of	  a	   study	  within	   chapter	  5.	  DSE1	   shows	  
Ace2p-­‐dependent	  expression	   in	  both	  S.	  cerevisiae	  [101,	  133]	  and	  C.	  glabrata.	   It	   is	  expressed	   in	  the	  
run	  up	   to	  cell	   separation	  with	   the	   rest	  of	   the	  Ace2p-­‐dependent	  cell	   separation	  machinery	  and	  has	  
two	   potential	   Ace2p	   binding	   sites	   within	   its	   promoter	   region	  within	   C.	   glabrata.	   Dse1p	   has	   been	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shown	  to	  localise	  to	  the	  bud	  neck,	  and	  in	  both	  S.	  cerevisiae	  and	  C.	  glabrata,	  dse1	  nulls	  present	  with	  a	  
cell	  separation	  defect.	  
Dse1p	  has	  been	  suggested	   to	  play	  a	   role	   in	   three	  different	  cellular	   functions:	   cell	  wall	  metabolism	  
and	  cell	  separation;	  bud	  site	  selection	  and	  maintenance	  of	  cell	  polarity;	  and	  pheromone	  sensing	  and	  
hyphal	  growth.	  The	  data	  collected	  in	  this	  study	  suggests	  that	  a	  role	  in	  cell	  wall	  metabolism	  and	  cell	  
separation	   is	   most	   likely	   due	   Zds2-­‐dependent	   bud	   neck	   localisation	   combined	   with	   the	   cell	  
separation	  defect	  and	  sensitivity	  to	  caffeine	  displayed	  by	  C.	  glabrata	  dse1.	  The	  predicted	  C.	  glabrata	  
Dse1p	  structure	   features	  a	  β-­‐propeller,	  and	  could	   indicate	   that	  Dse1p	  has	   some	  sort	  of	   regulatory	  
role	  over	  the	  cell	  separation	  machinery,	  or	  a	  direct	  enzymatic	  role.	  More	  work	  is	  required	  to	  define	  
the	  precise	  role	  Dse1p	  plays	  in	  cell	  separation.	  An	  assay	  for	  cell	  polarization	  showed	  that	  neither	  C.	  
glabrata	  nor	  S.	  cerevisiae	  dse1	  cells	  showed	  any	  alteration	  in	  cell	  polarity	  compared	  to	  the	  wild	  type,	  
while	  a	  change	  in	  bud	  site	  selection	  and	  budding	  pattern	  was	  also	  not	  observed.	  This	  puts	  doubt	  on	  a	  
role	  for	  Dse1p	  in	  bud	  site	  selection	  and	  maintenance	  of	  cell	  polarity.	  
C.	   glabrata	   lacks	   a	   true	   hyphal	   morphology,	   and	   only	   presents	   pseudohyphae	   under	   nitrogen	  
starvation	  conditions	   in	   vitro	   [31].	  C.	  glabrata	   also	   lacks	  any	  described	   sexual	   cycle	  or	  pheromone	  
sensing,	  indicating	  that	  if	  Dse1p	  plays	  a	  role	  in	  hyphal	  growth	  and	  pheromone	  sensing	  in	  S.	  cerevisiae	  
or	  other	  yeast	  species,	  it	  is	  unlikely	  to	  do	  so	  within	  C.	  glabrata.	  
	  
6.2	  Future	  work	  
While	   the	   results	   presented	   in	   this	   thesis	   answer	   some	   of	   the	   questions	   regarding	   ACE2	  
antivirulence,	   as	  with	  all	   research,	   it	  has	   raised	  yet	  more.	  Presented	  below	  are	   some	  experiments	  
and	  lines	  of	  enquiry	  that	  could	  be	  employed	  to	  answer	  some	  of	  these	  questions	  and	  round	  out	  our	  
knowledge	  of	  ACE2	  antivirulence	  within	  C.	  glabrata	  and	  the	  function	  of	  Dse1p.	  
	  
Having	  disrupted	  10	  out	  of	  the	  12	  genes	   identified	  within	  the	  partial	  Ace2p	  regulon	   in	  C.	  glabrata,	  
two	   genes	  DSE2	   and	   SCW11α	   remain	   undisrupted.	   Alternative	   strategies	   should	   be	   employed	   to	  
study	  the	  effects	  of	  inhibition	  of	  their	  expression	  within	  C.	  glabrata	  with	  reference	  to	  any	  potential	  
antivirulence.	   Partial	   disruption	   of	   the	   genes	   via	   traditional	   disruption	   methods	   like	   the	   Edlind	  
method	  or	   Fusion	  PCR	   as	   described	   in	   chapter	   4	   could	   be	  used	   to	   inhibit	   the	   function	  of	   the	   two	  
genes.	   Disruption	   of	   each	   gene’s	   promoter	   region	   could	   also	   be	   used	   via	   the	   same	   methods.	  
Alternatively	  the	  use	  of	  RNAi,	  which	  has	  recently	  been	  shown	  possible	  within	  S.	  cerevisiae	  and	  other	  
budding	  yeasts	  [282],	  could	  be	  a	  viable	  method	  of	  silencing	  DSE2	  and	  SCW11α.	  The	  first	  stage	  would	  
be	  to	  confirm	  the	  presence	  of,	  or	   restore	   the	  essential	  RNAi	  machinery,	  AGO1	  and	  DCR1	  within	  C.	  
glabrata	  as	  has	  been	  shown	  possible	  in	  S.	  cerevisiae	  [282].	  Then	  RNAi	  of	  DSE2	  and	  SCW11α	  could	  be	  
performed	  using	  either	  in	  vitro	  transcription	  using	  a	  PCR	  product	  for	  the	  gene	  and	  a	  commercial	  kit	  
such	  as	  the	  Ambion	  MEGAscript	  T7	  kit	  (Applied	  Biosystems,	  Warrington,	  UK),	  or	  through	  the	  use	  of	  a	  
custom	  RNAi	  plasmid	  targeted	  against	  the	  two	  genes.	  Once	  the	  expression	  of	  DSE2	  and	  SCW11α	  has	  
been	   inhibited,	   virulence	   and	   cytokine	   release	   studies	   should	   be	   carried	   out	   mirroring	   those	  
presented	   in	   chapter	   4.	   This	  would	  be	   able	   to	   complete	   the	  picture	  of	   antivirulence	  of	   the	  Ace2p	  
regulon	  as	  defined	  in	  chapter	  3.	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Here	  it	  has	  been	  hypothesised	  that	  the	  antivirulence	  shown	  by	  the	  Ace2p	  regulon	  in	  C.	  glabrata,	  as	  
presented	  in	  chapter	  4,	  is	  synergistic	  in	  its	  effects	  to	  create	  the	  extreme	  hypervirulence	  shown	  by	  C.	  
glabrata	  ace2	  cells.	  To	  test	  this,	  multiple	  gene	  deletions	  of	  the	  six	  genes,	  ACF2,	  DSE3,	  EGT2,	  SCW11β	  
and	  SIC1	  that	  show	  antivirulence	  could	  be	  constructed	  within	  one	  strain.	  To	  do	  this	  a	  combination	  of	  
markers	  will	  be	  required.	  The	  CgΔΔΔ	  strain	  affords	  the	  use	  of	  three	  markers,	  HIS,	  TRP	  and	  LEU,	  while	  
other	  deletions	  can	  be	  created	  with	  the	  use	  of	  a	  NATR	  or	  GENR	  marker,	  and	  if	  necessary	  an	  inducible	  
flipase	  marker	  recycling	  system	  as	  detailed	  by	  Reuss	  et	  al.	  [245].	  Once	  a	  combination	  of	  the	  Ace2p	  
regulon	   genes	   has	   been	   disrupted	   within	   one	   C.	   glabrata	   strain	   it	   will	   be	   possible	   to	   test	   for	  
hypervirulence	   and	   see	   whether	   the	   combination	   of	   gene	   deletions	   enhances	   the	   hypervirulence	  
phenotype	  closer	  to	  that	  displayed	  by	  ace2	  null	  mutants.	  
Proteomics	  of	  the	  ace2	  null	   in	  C.	  glabrata	  has	  shown	  that	  many	  more	  proteins	  are	  affected	  by	  the	  
disruption	  of	   the	   cell	   separation	  machinery	   transcription	   factor	   than	   just	   those	  defined	  within	   the	  
partial	   Ace2p	   regulon	   [231].	   To	   fully	   understand	   the	   nature	   of	   the	   effect	   and	   highlight	   any	   other	  
potentially	  up	  or	  down-­‐regulated	  genes	  that	  could	  contribute	  to	  the	  hypervirulence	  observed	   in	  C.	  
glabrata	  ace2	  nulls,	  transcriptomics	  to	  compare	  the	  C.	  glabrata	  wild	  type	  and	  ace2	  transcriptomes	  is	  
required.	   Several	   failed	   attempts,	   as	   detailed	   in	   Appendix	   5,	   were	  made	  within	   this	   study	   to	   use	  
RNA-­‐seq	   to	   study	   the	   ace2	   transcriptome	   within	   the	   host	   environment.	   However,	   RNA-­‐seq	   or	  
microarray	  analysis	  would	  help	  to	  highlight	  other	  genes	  for	  potential	  virulence	  analysis,	  and	  would	  
aid	  in	  our	  understanding	  of	  the	  mechanisms	  within	  C.	  glabrata	  of	  not	  only	  ace2	  virulence,	  but	  also	  
wild	  type	  virulence.	  
Having	  shown	  that	  potential	  Ace2p	  binding	  sites	  exist	   in	  genes	  known	  to	  display	  Ace2p-­‐dependent	  
expression,	   and	   also	   shown	   that	   it	   is	   possible	   to	   find	   and	   test	   the	   Ace2p-­‐dependence	   of	   other,	  
previously	   unknown	  Ace2p	   regulated	   genes	   like	  BUD9	   (chapter	   3),	   analysis	   of	   other	   genes	   for	   the	  
adjacent	  Ace2p	  binding	  site	  sequences	  would	  help	  further	  our	  understanding	  of	  the	  impact	  of	  ACE2	  
deletion.	   A	   similar	   process	   as	   detailed	   in	   chapter	   3	   could	   be	   employed,	   on	   a	   gene-­‐by-­‐gene	   basis,	  
once	  they	  have	  been	  highlighted	  by	  transcriptomics	  or	  through	  other	  means.	  
In	   vitro	   analysis	   of	   Ace2p	   binding	   to	  C.	   glabrata	   Ace2p-­‐regulon	   genes	   shown	   to	   contain	   potential	  
Ace2p	   binding	   sites	   within	   their	   promoter	   (chapter	   3)	   would	   be	   able	   to	   definitively	   tell	   whether	  
those	   genes	   are	   indeed	  directly	   regulated	  by	  Ace2p	  binding.	   By	   creating	   oligomers	   containing	   the	  
promoter	   regions	  of	   the	   target	   genes	   it	  would	  be	  possible	   to	  assay	   for	  Ace2p	  binding	  by	  using	  an	  
electrophoretic	  mobility	  shift	  assay,	  looking	  for	  a	  change	  in	  mobility	  of	  the	  oligomer	  associated	  with	  
protein	   binding.	   Alternatively	   a	   transcription	   factor	   binding	   assay	   such	   as	   the	  DuoSet	   Intracellular	  
Active	  Transcription	  Factor	  Assays	  available	  from	  R&D	  Systems	  could	  be	  used.	  
To	   look	   at	   how	   the	   deletion	   of	   SIC1	   affects	   the	   cellular	   process	   of	   C.	   glabrata	   and	   causes	  
hypervirulence	  as	  shown	  in	  chapter	  4,	  transcriptomics	  could	  be	  employed	  in	  a	  similar	  manner	  to	  that	  
described	   for	   study	   of	   the	   ace2	   transcriptome.	   By	   identifying	   which	   genes	   are	   up	   and	   down	  
regulated	  in	  response	  to	  SIC1	  deletion,	  it	  would	  hopefully	  be	  possible	  to	  look	  into	  how	  the	  deletion	  
of	   a	   gene	   encoding	   a	   cyclin	   dependent	   kinase	   inhibitor,	   responsible	   for	   prevention	   of	   premature	  
entry	  into	  S-­‐phase	  and	  ensuring	  genomic	  integrity,	  results	  in	  hypervirulence	  within	  C.	  glabrata.	  
To	   see	   whether	   the	   in	   vitro	   immune	   over-­‐stimulation	   shown	   by	   C.	   glabrata	   sic1	   cells	   in	   a	  
macrophage	   infection	   assay	   mirrors	   what	   happens	   in	   vivo,	   an	   murine	   infection	   assay	   should	   be	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carried	   out	   to	   collect	   blood	   to	   test	   for	   cytokine	   levels	   in	   comparison	   to	   C.	   glabrata	   wild	   type	  
infection,	   as	   detailed	   previously	   by	   Kamran	   et	   al.	   for	   ace2	   cells	   [7].	   	   The	   results	   will	   help	   show	  
whether	  sic1	  immune	  over-­‐stimulation	  completely	  explains	  the	  over-­‐stimulation	  shown	  by	  ace2	  [7].	  
The	  results	  described	  in	  chapter	  5	  suggest	  that	  Dse1p	  may	  have	  a	  regulatory	  role	  within	  C.	  glabrata.	  
To	   test	   this,	   transcriptomics	  could	  be	  employed	  as	  previously	  described	   for	  ace2	  and	  sic1	  cells.	  By	  
comparing	  the	  transcriptome	  of	  dse1	  to	  that	  of	  the	  C.	  glabrata	  wild	  type,	  it	  would	  be	  possible	  to	  see	  
whether	   any	   genes	   involved	   in	   the	   cell	   separation	   machinery	   are	   up	   or	   down-­‐regulated	   in	   the	  
absence	  of	  Dse1p	  and	  help	  confirm	  or	  reject	  the	  regulatory	  role	  hypothesis.	  
Coupled	  with	   transcriptomics	   to	   study	   the	   regulatory	   role	   of	  Dse1p,	   the	  DNA	  binding	   potential	   of	  
Dse1p	  could	  also	  be	  looked	  at	  in	  vitro.	  By	  using	  a	  similar	  method	  as	  described	  above	  to	  study	  Ace2p	  
DNA	   binding,	   an	   electrophoretic	   mobility	   shift	   assay	   could	   be	   used	   to	   assay	   for	   potential	   Dse1p	  
binding	  to	  DNA.	  This	  would	  aid	  in	  the	  analysis	  of	  the	  role	  of	  Dse1p	  as	  a	  transcription	  factor,	  similar	  to	  
other	  characterised	  β-­‐propeller	  proteins	  within	  yeast.	  
To	  determine	  the	  role	  of	  the	  N-­‐	  and	  C-­‐	  terminals	  on	  the	  function	  of	  Dse1p,	  partial	  disruption	  of	  DSE1	  
within	  C.	  glabrata	  could	  be	  conducted,	  via	  a	  disruption	  method	  as	  described	  in	  chapter	  5	  and	  above,	  
and	  analysed	  for	  a	  cell	  separation	  defect	  and	  sensitivity	  to	  caffeine,	  as	  well	  as	  for	  a	  change	  in	  growth	  
rate	  when	  compared	  to	  the	  wild	  type.	  This	  would	  help	  see	  which	  domains	  within	  Dse1p	  are	  crucial	  
for	  function.	  
Partial	   disruption	   of	   Dse1p	   could	   be	   used	   to	   study	   its	   localisation	   too.	   By	   creating	   a	   partial	  DSE1	  
fragment	   containing	   either	   the	   N-­‐	   or	   C-­‐terminal	   end	   of	   the	   gene	   from	   either	   S.	   cerevisiae	   or	   C.	  
glabrata	  within	  a	  GFP	  plasmid,	  its	  localisation	  using	  fluorescence	  can	  be	  analysed	  to	  see	  which	  end	  
of	  the	  protein	  and	  subsequent	  domains	  are	  crucial	  to	  bud	  neck	  localisation.	  
The	  results	   from	  chapter	  5	  also	  suggest	  that	  Dse1p	  may	  have	  a	  catalytic	  role	   in	  cell	  separation.	  To	  
test	  this	  hypothesis,	  catalytic	  analysis	  of	  Dse1p	  should	  be	  carried	  out	  to	  test	  its	  ability	  to	  hydrolyse	  
the	  components	  of	  the	  C.	  glabrata	  cell	  wall,	  namely	  glucan	  and	  chitin.	  A	  laminarin	  digest	  assay,	  for	  
instance,	  could	  be	  used	  to	  test	  glucan	  hydrolysis	  [280],	  where	  as	  chitinase	  activity	  could	  be	  tested	  by	  
a	   traditional	   plate	   assay	   or	   through	   the	   use	   of	   a	   rapid	   4-­‐methylumbelliferyl-­‐N-­‐acetyl-­‐beta-­‐D-­‐
glucosaminide	  test	  [281].	  
By	   following	  some	  of	   the	   lines	  of	   investigation	  detailed	  above,	   it	  would	  be	  possible	   to	  expand	  our	  
knowledge	  of	  ACE2	   antivirulence	  and	  virulence	  of	  C.	  glabrata	   in	  general	  as	  well	  as	   come	  closer	   to	  
fully	  characterising	  the	  still	  as-­‐yet	  gene	  of	  unknown	  function	  DSE1.	  
	  
6.3	  Conclusions	  
In	   conclusion,	   we	   have	   defined	   the	   partial	   Ace2p	   regulon	   of	   genes	   that	   show	   Ace2p-­‐dependent	  
expression	   in	   C.	   glabrata,	   which	   mirrors	   that	   found	   in	   S.	   cerevisiae	   with	   the	   addition	   of	   two	  
homologues	   of	   SCW11	   and	   the	   addition	   of	   BUD9.	   We	   have	   also	   confirmed	   that	   potential	   Ace2p	  
binding	  sites	  exist	  within	  10	  out	  of	  the	  12	  genes	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata	   indicating	  that	  
they	  are	  most	  likely	  directly	  regulated	  by	  Ace2p.	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At	  least	  seven	  genes	  of	  the	  Ace2p	  regulon	  in	  C.	  glabrata	  have	  been	  shown	  to	  exhibit	  antivirulence,	  
six	  discovered	   in	   this	   study	  plus	   the	  previously	   investigated	  CTS1.	  We	  can	   therefore	   conclude	   that	  
the	   ace2	   hypervirulence	   displayed	   in	   C.	   glabrata	   [7]	   is	   multifactorial,	   with	   a	   combination	   of	  
antivirulence	  genes	   contributing	   to	   the	  extreme	  hypervirulence	  displayed	   in	  a	  neutropenic	  murine	  
model	   of	   candidiasis.	   We	   have	   also	   shown	   that	   sic1	  mutants	   have	   the	   ability	   to	   over-­‐stimulate	  
macrophages	  and	  elicit	  significantly	  increased	  cytokine	  release	   in	  vitro.	  This	  leads	  to	  the	  conclusion	  
that	  the	  immune	  over-­‐stimulation	  and	  cytokine	  release	  displayed	  by	  ace2	  cells	  is	  also	  multifactorial	  
with	  at	  least	  sic1	  contributing	  to	  the	  potential	  septic	  shock	  response.	  	  
Due	  to	  the	  results	  presented	  in	  chapter	  5,	  including	  the	  fact	  that	  dse1	  nulls	  in	  C.	  glabrata	  show	  a	  cell	  
separation	  defect	  and	  sensitivity	  to	  caffeine,	  it	  is	  also	  possible	  to	  conclude	  that	  Dse1p	  in	  C.	  glabrata	  
likely	   plays	   a	   role	   in	   cell	   separation	   and	   the	   cell	   wall,	   possibly	   in	   a	   regulatory	   or	   enzymatic	   role,	  
although	  it	  may	  also	  play	  roles	  in	  pheromone	  response	  and	  hyphal	  growth	  in	  other	  yeast	  species.	  
Our	   understanding	   of	   the	   virulence	  mechanisms	  within	  C.	   glabrata	   are	   still	   in	   their	   infancy	  when	  
compared	   to	  other	  human	  pathogens,	  despite	  presenting	  a	   significant	  and	  growing	  clinical	  burden	  
(as	  discussed	  in	  chapter	  1).	  The	  results	  presented	  in	  this	  thesis	  take	  a	  significant	  step	  forward	  in	  the	  
understanding	  of	  the	  Ace2p	  regulon	  and	  ACE2	  antivirulence	  in	  C.	  glabrata,	  as	  well	  as	  virulence	  within	  
C.	  glabrata	  as	  a	  whole.	  We	  hope	  that	  this	  body	  of	  work	  will	  pave	  the	  way	  for	  further	  research	  into	  
the	  mechanisms	  and	  genes	  behind	  ACE2	  antivirulence	  and	  provide	  another	  step	  on	  the	  way	  to	  fully	  
characterising	  the	  role	  and	  function	  of	  DSE1.	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Appendix	  1	  -­‐	  Strains	  
	  
A1.1	  Yeast	  Strains	  
C.	  albicans	  SC5314	  –	  Wild	  type	  [283]	  
C.	  glabrata	  ATC2001	  (Cg2001)	  –	  Wild	  type	  (American	  Type	  Culture	  Collection	  (Rockville,	  MD,	  USA))	  
C.	  glabrata	  HLS119	  –	  Δhis3,	  Δtrp1,	  ACE2::tetR::GAL4AD::TRP1	  [180]	  
C.	  glabrata	  HLS122	  –	  Δhis3::URA3	  Δura3	  Δtrp1	  Δace2::HIS3	  (pCgACT-­‐14	  [TRP1])	  [7]	  
C.	  glabrata	  his3	  –	  Δura3::pUC18,	  Δhis3::URA3	  [284]	  
C.	  glabrata	  ΔΔΔ	  –	  Δhis3,	  Δtrp1,	  Δleu2	  [285]	  
SRSG1	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δamn1::TRP1	  [This	  study]	  
SRSG1P	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δamn1::TRP1,	  pBM51	  (HIS3),	  YPCIII	  (LEU2)	  [This	  study]	  	  
SRSG2	  –	  Δhis3,	  Δash1::NATR	  [This	  study]	  
SRSG2P	  –	  Δhis3,	  Δash1::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG3	  –	  Δhis3,	  Δbud9::NATR	  [This	  study]	  
SRSG3P	  –	  Δhis3,	  Δbud9::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG4	  –	  Δhis3,	  Δdse1::NATR	  [This	  study]	  
SRSG4P	  –	  Δhis3,	  Δdse1::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG6	  –	  Δhis3,	  Δdse3::NATR	  [This	  study]	  
SRSG6P	  –	  Δhis3,	  Δdse3::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG6R	  –	  Δhis3,	  Δdse3::NATR,	  pSRSGR6	  (HIS3,	  DSE3)	  [This	  study]	  
SRSG7	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δacf2::TRP1	  [This	  study]	  
SRSG7P	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δacf2::TRP1,	  pBM51	  (HIS3),	  YPCIII	  (LEU2)	  [This	  study]	  
SRSG7R	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δacf2::TRP1,	  pSRSGR7	  (HIS3,	  ACF2),	  YPCIII	  (LEU2)	  [This	  study]	  
SRSG8	  –	  Δhis3,	  Δegt2::NATR	  [This	  study]	  
SRSG8P	  –	  Δhis3,	  Δegt2::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG8R	  –	  Δhis3,	  Δegt2::NATR,	  pSRSGR8	  (HIS3,	  EGT2)	  [This	  study]	  
SRSG9	  –	  Δhis3,	  Δrme1::NATR	  [This	  study]	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SRSG9P	  –	  Δhis3,	  Δrme1::NATR,	  pBM51	  (HIS3)	  [This	  study]	  
SRSG9R	  –	  Δhis3,	  Δrme1::NATR,	  pSRSGR9	  (HIS3,	  RME1)	  [This	  study]	  
SRSG11	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δscw11β::TRP1	  [This	  study]	  
SRSG11P	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δscw11β::TRP1,	  pBM51	  (HIS3),	  YPCIII	  (LEU2)	  [This	  study]	  
SRSG11R	  –	  his3,	  trp1,	  leu2,	  scw11β::TRP1,	  pSRSGR11	  (HIS3,	  SCW11β),	  YPCIII	  (LEU2)	  [This	  study]	  
SRSG12	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δsic1::TRP1	  [This	  study]	  
SRSG12P	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δsic1::TRP1,	  pBM51	  (HIS3),	  YPCIII	  (LEU2)	  [This	  study]	  
SRSG12R	  –	  Δhis3,	  Δtrp1,	  Δleu2,	  Δsic1::TRP1,	  pSRSGR12	  (HIS3,	  SIC1),	  YPCIII	  (LEU2)	  [This	  study]	  
S.	  cerevisiae	  BY4741	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3	  [242]	  
S.	  cerevisiae	  Yeast	  GFP-­‐tagged	  DSE1	  library	  strain	  –	  MATa	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  HIS3,	  DSE1-­‐
GFP	  [242]	  
S.	  cerevisiae	  Yeast	  Knockout	  library	  strains	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX	  	  [242]	  
S.	  cerevisiae	  YKO	  dse1	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δdse1	  	  [242]	  
S.	  cerevisiae	  YKO	  boi1	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δboi1	  	  [242]	  
S.	  cerevisiae	  YKO	  boi2	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δboi2	  	  [242]	  
S.	  cerevisiae	  YKO	  ste4	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δste4	  	  [242]	  
S.	  cerevisiae	  YKO	  ste11	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δste11	  	  [242]	  
S.	  cerevisiae	  YKO	  zds2	  –	  MATa	  ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δzds2	  	  [242]	  
SRSGB1-­‐DGFP	  –	  MATa	   ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δboi1,	  pSRSG-­‐GD1	   (DSE1-­‐GFP)	   [This	  
study]	  
SRSGB2-­‐DGFP	  –	  MATa	   ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δboi2,	  pSRSG-­‐GD1	   (DSE1-­‐GFP)	   [This	  
Study]	  	  
SRSGZ2-­‐DGFP	  –	  MATa	   ,	  Δhis3,	  Δleu2,	  Δmet15,	  Δura3,	  KanMX,	  Δzds2,	  pSRSG-­‐GD1	   (DSE1-­‐GFP)	   [This	  
study]	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Appendix	  2	  -­‐	  Plasmids	  
	  
A2.1	  Yeast	  plasmids	  
pBM51	  –	  C.	  glabrata	  plasmid	  containing	  HIS3,	  PGK	  constitutive	  promoter	  and	  HIS3	  3’	  UTR	  as	  shown	  
in	  Figure	  4.3	  [Biao	  Ma	  (personal	  communication)]	  
YPCIII	  –	  S.	  cerevisiae	  episomal	  plasmid	  containing	  LEU2	  [286]	  
pAG426GPD-­‐ccdB	  –	  Gateway	  GFP	  destination	  vector	  [275]	  
pSRSG-­‐GD1	  –	  Gateway	  plasmid	  containing	  GFP	  tagged	  S.	  cerevisiae	  DSE1	  [This	  study]	  
pSRSGR6	  –	  pBM51::CgDSE3	  [This	  study]	  
pSRSGR7	  –	  pBM51::CgACF2	  [This	  study]	  
pSRSGR8	  –	  pBM51::CgEGT2	  [This	  study]	  
pSRSGR9	  –	  pBM51::CgRME1	  [This	  study]	  
pSRSGR11	  –	  pBM51::CgSCW11β	  [This	  study]	  
pSRSGR12	  –	  pBM51::CgSIC1	  [This	  study]	  
	  
A2.2	  E.	  coli	  plasmids	  
pCR2.1-­‐TOPO	  –	  Part	  of	  the	  Invitrogen	  TOPO	  TA	  Cloning	  kit	  [Invitrogen,	  UK]	  
pSRSGE6	  –	  pCR2.1::CgDSE3	  [This	  study]	  
pSRSGE7	  –	  pCR2.1::CgACF2	  [This	  study]	  
pSRSGE8	  –	  pCR2.1::CgEGT2	  [This	  study]	  
pSRSGE9	  –	  pCR2.1::CgRME1	  [This	  study]	  
pSRSGE11	  –	  pCR2.1::CgSCW11β	  [This	  study]	  
pSRSGE12	  –	  pCR2.1::CgSIC1	  [This	  study]	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Appendix	  3	  –	  Primers	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NAT-5’-R  catccaaagtagtagac 
NAT-3’-F  atgtctatgccatgtcc 
Gatway system 
  
pGBT9 Check For tcatcggaagagagtagtaa 













ScDSE1 INT F ctgcttattgcccatggtag 
ScDSE1 INT RC tccacatcctgcagatatgc 
Edlind KO Method 
  
TRP Int F (n) atgtctgttattaatttcacagg 
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SIC1+TRPRC gaataaatgaaaatctgaaagaaaggaataaaataaatagtgaagctgttatggggactatttcttagcatttttgacga 




CgDSE2 check F gtatggcgtaagaatagg 
CgDSE2 check RC gttccgacctattcattcc 
























CgSIC1 check F gaagtctgggaaccaccaac 
CgSIC1 check RC gtgtccgaatgggaggttag 
Reconsitution 
  
Dse3 Sal1 F cattggtagtcgacatgcctagaaagtttttagg 
Dse3 Xma1 RC ttaacattcccgggctaggttgcaaagtggtcac 
Egt2 Sal1 F cgtagccagtcgacatgaaatttacaactacatttc 
Egt2 Xma1 RC ttaacattcccgggaatcatagcaggagagcgatg 
Acf2 Sal1 F ttaacattgtcgacatgtcatacaaccgccctcc 
Acf2 Xma1 RC tactatatcccgggtcaaatgaacgcacctgaataagc 
Rme1 Sal1 F ttaacattgtcgacatgctgaggactaaagacag 
Rme1 Xma1 RC cattggtacccgggtcacttatttcttaccttatc 
Scw11b Sal1 F cattggtagtcgacatgctaccgttcatacaattac 
Scw11b Xma1 RC ttaacattcccgggtcatggcaggttgtccaagatac 
Sic1 EcoR1 F tgaacatagaattcatgacaccttctactccgcc 
Sic1 Xma1 RC gtaacagtcccgggctatttcttgtctctcttaag 
Reconstitution Sequencing 
  
Dse3 Seq 1 atgcctagaaagtttttagg 
Dse3 Seq 2 taaaccgttgatcgagaagg 
Dse3 Seq 3 atggctcatacacaactgcg 
Acf2 Seq 1 atgtcatacaaccgccctcc 
Acf2 Seq 2 taatgcgttcccaggatttg 
Acf2 Seq 3 ttgcgatgttgtaaatgcag 
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Acf2 Seq 4 cagcaacaattaccgctaag 
Acf2 Seq 5 ctatggggtatggtttctgg 
Egt2 Seq 1 acaactacatttctgctcac 
Egt2 Seq 2 cactgcttggtttactcttg 
Egt2 Seq 3 acactaatggtacagcatcc 
Egt2 Seq 4 gagcgaatacgaattcttgg 
Egt2 Seq 5 gtacatccaggcaatacaac 
RME1 Seq 1 atgctgaggactaaagacag 
RME1 Seq 2 caggcatcattagatcatgc 
RME1 Seq 3 tgatgaactgcccttaagag 
RME1 Seq 4 ctaaacttaactgaggatgcc 
Scw11b Seq 1 ctaactagcgatgttctcgc 
Scw11b Seq 2 tcgtcatccatacagtcatc 
Scw11b Seq 3 caggtgttgattccatcgac 
Scw11b Seq 4 tctagaagccactaacaacc 
Sic1 Seq 1 agacagagaaggcacgattc 
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Appendix	  4	  –	  Gene	  deletion	  confirmations	  
	  
	  
Figure	  S.1	  –	  Construction	  and	  confirmation	  of	  the	  C.	  glabrata	  amn1	  null	  mutant.	  A	  null	  allele	  of	  C.	  glabrata	  AMN1	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  AMN1	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+1536)	  of	  AMN1	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  AMN1	  
deletion	   cassette.	   A	   675	   bp	   fragment	   of	   S.	   cerevisiae	   TRP1	   was	   amplified	   flanked	   by	   60	   bps	   of	   AMN1	   5’	   and	   3’	   as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  AMN1	  deletion	  cassette	  at	  the	  AMN1	  locus	  removing	  1536	  bps	  of	  
AMN1	  from	  +1	  to	  +1536.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  AMN1.	  Total	  genomic	  DNA	  was	  digested	  with	  
NsiI	   and	   probed	   with	   672	   bp	   fragment	   of	   ScTRP1	   as	   described	   in	   Chapter	   4.	   The	   null	   allele	   yielded	   a	   1023	   bp	   NSiI	  
fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  3,	  5	  and	  9.	  
The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  AMN1	  (A)	  or	  ScTRP1	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	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Figure	  S.2	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  ash1	  null	  mutant.	  A	  null	  allele	  of	  C.	  glabrata	  ASH1	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  ASH1	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+2139)	  of	  ASH1	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  ASH1	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   471	   bps	   and	   538	   bps	   of	  ASH1	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  ASH1	  deletion	  cassette	  at	  the	  ASH1	   locus	  removing	  2229	  bps	  of	  
ASH1	  from	  -­‐68	  to	  +2161.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  ASH1.	  Total	  genomic	  DNA	  was	  digested	  with	  ClaI	  
and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  4744	  bp	  ClaI	  
fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  5,	  7	  and	  8,	  
with	  a	  slanted	  gel	  resulting	  in	  sloping	  bands.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  ASH1	  (A)	  or	  the	  
NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	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Figure	  S.3	  –	  Construction	  and	  confirmation	  of	  the	  C.	  glabrata	  bud9	  null	  mutant.	  A	  null	  allele	  of	  C.	  glabrata	  BUD9	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  BUD9	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+1590)	  of	  BUD9	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  BUD9	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   504	   bps	   and	   484	   bps	   of	   BUD9	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  BUD9	  deletion	  cassette	  at	  the	  BUD9	  locus	  removing	  1693	  bps	  of	  
BUD9	   from	  -­‐29	  to	  +1664.	   	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  BUD9.	  Total	  genomic	  DNA	  was	  digested	  with	  
NSiI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  3138	  bp	  
NsiI	  fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  in	  mutants	  6,	  7	  and	  
8.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  BUD9	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  
scale.	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Figure	  S.4	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  dse1	   null	  mutant.	  A	  null	   allele	  of	  C.	  glabrata	  DSE1	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  DSE1	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+1704)	  of	  DSE1	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  DSE1	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   516	   bps	   and	   531	   bps	   of	  DSE1	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	   	  C.	  Targeted	  integration	  of	  the	  DSE1	  deletion	  cassette	  at	  the	  DSE1	   locus	  removing	  1747	  bps	  of	  
DSE1	  from	  -­‐4	  to	  +1743.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  DSE1.	  Total	  genomic	  DNA	  was	  digested	  with	  FspI	  
and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  3100	  bp	  FspI	  
fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  4,	  5,	  6.	  The	  
coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  DSE1	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	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Figure	  S.5	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  dse3	   null	  mutant.	  A	  null	   allele	  of	  C.	  glabrata	  DSE3	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  DSE3	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+1317)	  of	  DSE3	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  DSE3	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   492	   bps	   and	   494	   bps	   of	  DSE3	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	   	  C.	  Targeted	  integration	  of	  the	  DSE3	  deletion	  cassette	  at	  the	  DSE3	   locus	  removing	  1364	  bps	  of	  
DSE3	  from	  -­‐44	  to	  +1320.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  DSE3.	  Total	  genomic	  DNA	  was	  digested	  with	  SpeI	  
and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  7508	  bp	  SpeI	  
fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  10,	  12,	  18,	  
19	  and	  21.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  DSE3	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  
not	  to	  scale.	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Figure	   S.6	   –	  Construction	  and	   confirmation	  of	   the	  C.	  glabrata	  acf2	   null	  mutant.	  A	  null	   allele	  of	  C.	  glabrata	  ACF2	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  ACF2	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+2313)	  of	  ACF2	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  ACF2	  
deletion	  cassette.	  A	  675	  bp	  fragment	  of	  S.	  cerevisiae	  TRP1	  was	  amplified	  flanked	  by	  60	  bps	  of	  ACF2	  5’	  and	  3’	  as	  described	  
in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  ACF2	  deletion	  cassette	  at	  the	  ACF2	  locus	  removing	  2313	  bps	  of	  ACF2	  from	  +1	  
to	  +2313.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  ACF2.	  Total	  genomic	  DNA	  was	  digested	  with	  XbaI	  and	  probed	  
with	  672	  bp	  fragment	  of	  ScTRP1	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  1182	  bp	  XbaI	  fragment.	  The	  presence	  
of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  
codon	  of	  ACF2	  (A)	  or	  ScTRP1	  (B,	  C).	  The	  diagram	  is	  not	  to	  scale.	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Figure	  S.7	  –	  Construction	  and	  confirmation	  of	   the	  C.	  glabrata	  egt2	   null	  mutant.	  A	  null	   allele	  of	  C.	  glabrata	  EGT2	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  EGT2	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+2031)	  of	  EGT2	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  EGT2	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   494	   bps	   and	   483	   bps	   of	   EGT2	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	   	  C.	  Targeted	  integration	  of	  the	  EGT2	  deletion	  cassette	  at	  the	  EGT2	   locus	  removing	  2101	  bps	  of	  
EGT2	   from	  -­‐27	   to	  +2031.	   	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  EGT2.	  Total	  genomic	  DNA	  was	  digested	  with	  
BstBI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  4778	  bp	  
BstBI	  fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  4,	  6	  
and	  14.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  EGT2	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  
to	  scale.	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Figure	  S.8	  –	  Construction	  and	  confirmation	  of	  the	  C.	  glabrata	  rme1	  null	  mutant.	  A	  null	  allele	  of	  C.	  glabrata	  RME1	  was	  
constructed	  as	  described	  in	  Chapter	  4.	  	  A.	  The	  C.	  	  glabrata	  RME1	  locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	  codon	  (+1644)	  of	  RME1	  are	  shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	  shown.	  	  B.	  The	  C.	  glabrata	  RME1	  
deletion	   cassette.	   A	   NAT	   cassette	   was	   amplified	   flanked	   by	   463	   bps	   and	   508	   bps	   of	  RME1	   5’	   and	   3’	   respectively	   as	  
described	  in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  RME1	  deletion	  cassette	  at	  the	  RME1	  locus	  removing	  1850	  bps	  of	  
RME1	  from	  -­‐150	  to	  +1700.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  RME1.	  Total	  genomic	  DNA	  was	  digested	  with	  
NsiI	  and	  probed	  with	  567	  bp	  fragment	  of	  the	  NAT	  cassette	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  5624	  bp	  
NsiI	  fragment.	  The	  presence	  of	  a	  band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  1,	  5,	  6,	  
7	  and	  8.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  RME1	  (A)	  or	  the	  NAT	  cassette	  (B,	  C).	  The	  diagram	  is	  not	  
to	  scale.	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Figure	  S.9	  –	  Construction	  and	  confirmation	  of	  the	  C.	  glabrata	  scw11β	  null	  mutant.	  A	  null	  allele	  of	  C.	  glabrata	  SCW11β	  
was	  constructed	  as	  described	  in	  Chapter	  4.	   	  A.	  The	  C.	   	  glabrata	  SCW11β	   locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  
(+1)	  and	   stop	  codon	   (+1497)	  of	  SCW11β	   are	   shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	   shown.	   	  B.	   The	  C.	  
glabrata	  SCW11β	  deletion	  cassette.	  A	  675	  bp	  fragment	  of	  S.	  cerevisiae	  TRP1	  was	  amplified	  flanked	  by	  60	  bps	  of	  SCW11β	  
5’	   and	   3’	   as	   described	   in	   Chapter	   4.	   	   C.	   Targeted	   integration	   of	   the	   SCW11β	   deletion	   cassette	   at	   the	   SCW11β	   locus	  
removing	  1497	  bps	  of	  SCW11β	  from	  +1	  to	  +1497.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  SCW11β.	  Total	  genomic	  
DNA	  was	  digested	  with	  ClaI	  and	  probed	  with	  672	  bp	  fragment	  of	  ScTRP1	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  
a	   848	   bp	   ClaI	   fragment.	   The	   presence	   of	   a	   band	   confirms	   that	   correct	   integration	   of	   the	   cassette	   has	   occurred	   for	  
mutants	  1,	  4	  and	  5.	  The	  coordinates	  are	  shown	  relative	  to	  the	  start	  codon	  of	  SCW11β	  (A)	  or	  ScTRP1	  (B,	  C).	  The	  diagram	  is	  
not	  to	  scale.	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Figure	   S.10	  –	  Construction	  and	   confirmation	  of	   the	  C.	  glabrata	   sic1	   null	  mutant.	  A	  null	   allele	  of	  C.	  glabrata	   SIC1	  was	  
constructed	  as	  described	  in	  Chapter	  4.	   	  A.	  The	  C.	   	  glabrata	  Sic1	   locus.	  Coding	  regions	  are	  shown	  in	  blue,	  ATG	  (+1)	  and	  
stop	   codon	   (+849)	  of	  SIC1	   are	   shown.	  The	  upstream	  and	  downstream	  genes	  are	  also	   shown.	   	  B.	   The	  C.	  glabrata	  SIC1	  
deletion	  cassette.	  A	  675	  bp	  fragment	  of	  S.	  cerevisiae	  TRP1	  was	  amplified	  flanked	  by	  60	  bps	  of	  Sic1	  5’	  and	  3’	  as	  described	  
in	  Chapter	  4.	  	  C.	  Targeted	  integration	  of	  the	  Sic1	  deletion	  cassette	  at	  the	  Sic1	  locus	  removing	  849	  bps	  of	  SIC1	  from	  +1	  to	  
+849.	  	  D.	  Southern	  analysis	  of	  putative	  null	  alleles	  of	  SIC1.	  Total	  genomic	  DNA	  was	  digested	  with	  NsiI	  and	  probed	  with	  
672	  bp	  fragment	  of	  ScTRP1	  as	  described	  in	  Chapter	  4.	  The	  null	  allele	  yielded	  a	  1062	  bp	  NsiI	  fragment.	  The	  presence	  of	  a	  
band	  confirms	  that	  correct	  integration	  of	  the	  cassette	  has	  occurred	  for	  mutants	  2,	  9	  and	  13.	  The	  coordinates	  are	  shown	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A5.1	  C.	  elegans	  invertebrate	  model	  of	  innate	  immune	  response	  
	  
Prior	   to	   vertebrate	   study	   of	   virulence	   of	   the	   Ace2p	   regulon	   it	   was	   decided	   that	   an	   invertebrate	  
model	   of	   virulence	   would	   be	   useful	   in	   discerning	   which	   strains	   are	   likely	   to	   present	   with	   a	  
hypervirulent	  phenotype	  without	  invoking	  ethical	  concerns	  or	  cost	  issues.	  
Recent	  work	  with	  C.	  elegans	  showed	  that	  it	  was	  possible	  to	  use	  the	  model	  nematode	  worm	  to	  study	  
fungal	   pathogenesis,	   through	   an	   intermediate	   disease	   phenotype	   [103].	   The	   benefit	   of	   using	   C.	  
elegans	   as	   a	  model	   of	   fungal	   virulence	   is	   three	   fold;	   firstly,	   as	   a	   very	   well	   studied	   organism,	   the	  
genome	  of	  C.	  elegans	  has	  been	  sequenced,	  annotated	  and	  a	  range	  of	  genetic	  knockouts	  are	  available	  
[287];	  secondly,	  an	  intermediate	  disease	  phenotype	  is	  possible	  with	  yeast	  infection	  giving	  the	  ability	  
to	  study	  both	  hyper-­‐	  and	  hypovirulence	  [103];	  and	  finally,	  the	  maintenance	  of	  C.	  elegans	  cultures	  is	  
cheap,	  they	  have	  fast	  generation	  times,	  do	  not	  require	  a	  licence	  to	  experiment	  on	  and	  there	  are	  no	  
ethical	   issues	   about	   animal	   use	   to	   take	   into	   account.	   For	   the	   study	   of	   yeast	   pathogenesis	  with	   S.	  
cerevisiae	   and	   C.	   glabrata	   the	   possible	   advantages	   to	   using	   C.	   elegans	   as	   a	   model	   of	   the	   innate	  
immune	  system	  are	  clear.	  
An	  attempt	  was	  made	  to	  establish	  a	  C.	  elegans	   infectivity	  model	  with	  C.	  glabrata.	   It	  was	  based	  on	  
the	   feeding	   model	   already	   established	   for	   S.	   cerevisiae	   [103],	   substituting	   C.	   glabrata	   for	   S.	  
cerevisiae.	  Initial	  pilot	  experiments	  proved	  that	  just	  as	  C.	  elegans	  can	  ingest	  and	  become	  infected	  by	  
S.	   cerevisiae,	   C.	   elegans	   could	   successfully	   ingest	   and	   become	   infected	   by	   C.	   glabrata.	   The	   yeast	  
infection	   manifests	   itself	   as	   a	   posterior	   anal	   swelling	   called	   deformed	   anal	   region	   or	   dar.	   The	  
infection	   is	   established	   as	   the	   yeast	   cells	   pass	   through	   the	   digestive	   tract	   of	   the	   nematode	   and	  
adhere	   to	   the	   posterior	   anal	   wall,	   establishing	   an	   infection	   and	   causing	   an	   immune	   response	   to	  
infection	  through	  the	  ERK	  MAP	  kinase	  pathway	  [288]	  characterised	  by	  dar.	  The	  extent	  of	  virulence	  is	  
assayed	  by	  counting	  the	  number	  of	  nematodes	  with	  visible	  dar	  after	  a	  given	  maturation	  point	  and	  
producing	  a	  ratio	  of	  infected	  to	  non-­‐infected	  as	  a	  measure	  of	  comparative	  virulence.	  
Once	   the	   ability	   of	   C.	   glabrata	   to	   infect	   C.	   elegans	   was	   established,	   initial	   studies	   using	   the	   C.	  
glabrata	   wild	   type,	   Cg2001,	   and	   the	   hypervirulent	   ace2	   null	   strain,	   HLS122,	   were	   performed	   to	  
establish	   a	   baseline	   of	   dar	   for	   virulence	   analysis.	   Unfortunately	   a	   consistent	   baseline	   level	   of	   dar	  
could	  not	  be	  established	   for	  either	  Cg2001	  or	  HLS122.	  Many	   repeats	  and	  variations	  of	   food,	  plate	  
media,	  number	  and	  age	  of	  worms,	  concentration	  of	  yeast,	  ratios	  of	  yeast	  to	  E.	  coli	  and	  also	  duration	  
of	  experiment	  were	  tried	  over	  18	  months.	  It	  was	  decided	  that	  after	  18	  months	  without	  being	  able	  to	  
establish	  a	  consistent	  baseline	  of	  wild	  type	  virulence	  within	  the	  C.	  elegans	  model	  it	  was	  not	  suitable	  
for	  virulence	  analysis	  of	  the	  Ace2p	  regulon	  mutants	  within	  C.	  glabrata	  and	  therefore	  was	  abandoned	  
in	  favour	  of	  direct	  vertebrate	  virulence	  analysis.	  
A	  brief	  review	  of	  the	  materials	  and	  methods	  is	  included	  below	  for	  reference.	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A5.1.1	  Materials	  and	  Methods	  
Four	   nematode	   growth	   medium	   (NGM)	   plates	   were	   spotted	   with	   E.	   coli	   OP50	   and	   incubated	  
overnight	  at	  37°C.	  Several	  L4	  larvae	  were	  transferred	  onto	  each	  plate	  and	  incubated	  at	  20°C	  for	  four	  
days.	  On	  day	  three,	  OP50	  and	  yeast	  strains	  were	  grown	  overnight	  in	  5	  mL	  of	  LB	  or	  selective	  media	  at	  
30°C/37°C,	  180	  rpm.	  	  
On	  day	  four,	  yeast	  and	  E.	  coli	  were	  centrifuged	  and	  washed	  twice	  with	  sterile	  water.	  The	  cells	  were	  
resuspended	  in	  sterile	  water	  to	  a	  concentration	  of	  20	  mg/mL	  for	  yeast	  and	  200	  mg/mL	  for	  E.	  coli.	  A	  
suspension	   of	   yeast,	   E.	   coli,	   and	   streptomycin	   was	   made	   with	   the	   ratio	   of	   3:1:4	   by	   volume	  
respectively	  for	  each	  of	  the	  target	  yeast	  strains.	  Triplicate	  plates	  were	  then	  made	  by	  spotting	  20	  μL	  
of	  the	  suspension	  onto	  fresh	  NGM	  plates	  and	  being	  allowed	  to	  dry.	  
A	  C.	   elegans	  egg	   suspension	  was	   then	  made	  by	  washing	  off	   the	  worms	   from	   the	   four	   four-­‐day	  C.	  
elegans	  plates	  with	  M9	  buffer	  (3	  g	  KH2PO4,	  6	  g	  Na2HPO4,	  5	  g	  NaCl,	  1	  mL	  1	  M	  MgSO4,	  water	  to	  1	  litre,	  
autoclave)	   into	   a	   15	  mL	   conical	   tube.	   The	   eggs	  were	   collected	   by	   centrifugation	   at	   900	   g	   for	   two	  
minutes	   and	   washed	   twice	   with	   M9	   buffer.	   The	   pellet	   was	   then	   resuspended	   in	   bleach	   solution	  
(0.0625	  M	  sodium	  hydroxide)	  and	  mixed	  slowly	  for	  three	  minutes	  by	  inversion.	  The	  eggs	  were	  then	  
collected	   via	   centrifugation	   at	   2000	   g	   for	   two	   minutes,	   washed	   twice	   with	   M9	   buffer	   and	  
resuspended	   to	  a	   concentration	  of	  6000	  eggs/mL.	  Approximately	  30	  eggs	  were	   then	   spotted	  onto	  
the	   previously	   prepared	   yeast	   NGM	   plates	   in	   50	   µL	   of	   egg	   suspension.	   The	   plates	   were	   then	  
incubated	  at	  20°C	  for	  four	  days,	  observed	  each	  day.	  
The	  total	  number	  of	  worms	  were	  counted	  and	  compared	  to	  the	  number	  of	  worms	  showing	  dar	  on	  
the	  fourth	  day.	  A	  triplicate	  plate	  set	  of	  E.	  coli	  and	  streptomycin	  only	  was	  used	  as	  a	  control.	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A5.2	   Study	   and	   comparison	   of	   the	   transcriptome	   of	   Candida	   species	  
infection	  of	  murine	  model	  
	  
Our	  understanding	  of	  the	  processes	  involved	  with	   in	  vivo	   infection	  of	  C.	  glabrata	  and	  other	  Candia	  
species	  is	  limited.	  It	  is	  obvious	  that	  the	  study	  of	  the	  transcriptome	  of	  Candida	  infection	  is	  required.	  
Study	  of	  the	  proteome	  and	  secretome	  of	  the	  hypervirulent	  ace2	  null	  in	  C.	  glabrata	  has	  already	  been	  
completed	  with	  many	  proteins	  showing	  significant	  changes	  in	  production	  levels	  outside	  of	  the	  Ace2p	  
regulon	  and	  the	  cell	  separation	  machinery	  [180,	  231].	  By	  studying	  and	  comparing	  the	  transcriptome	  
from	  C.	  glabrata	  wild	  type	  from	  within	  the	  host	  environment	  and	   in	  vitro,	  the	  genes	  up	  and	  down-­‐
regulated	  during	  infection	  can	  be	  shown	  with	  the	  potential	  to	  reveal	  virulence	  factors	  and	  infection	  
associated	   genes.	   Subsequent	   analysis	   of	   the	   transcriptome	   of	   the	   hypervirulent	  C.	   glabrata	  ace2	  
from	  within	  the	  host	  will	  allow	  us	  to	  compare	  and	  contrast	  which	  genes	  are	  up	  and	  down	  regulated	  
in	  response	  to	  the	  host	  and	  see	  which	  gene	  expression	  changes	  are	  different	  between	  the	  wild	  type	  
and	  the	  hypervirulent	  mutant.	  In	  this	  way	  it	  will	  be	  possible	  to	  identify	  genes	  that	  contribute	  to	  the	  
hypervirulent	  phenotype	  displayed	  by	  ace2	  null	  cells	  in	  C.	  glabrata	  [7].	  Once	  target	  genes	  have	  been	  
identified,	  analysis	  of	  their	  virulence	  potential	  can	  be	  studied	  in	  a	  similar	  manner	  to	  that	  employed	  
within	  this	  study	  for	  the	  Ace2p	  regulon.	  
To	   this	   end	   a	   series	   of	   experiments	   totalling	   to	   six	  months	  work	  was	   conducted	   in	   an	   attempt	   to	  
profile	  the	  transcriptome	  of	  both	  C.	  glabrata	  and	  C.	  albicans	  wild	  types	  from	  within	  a	  murine	  model	  
of	  candidiasis,	  as	  well	  as	   the	  transcriptome	  of	   the	  C.	  glabrata	  ace2	  null,	  HLS122.	  The	  profiling	  was	  
conducted	   in	   collaboration	  with	   the	   Illumina	   facility	  within	   the	  Department	   of	   Biosciences,	   Exeter	  
University,	  Devon.	  It	  was	  based	  around	  the	  use	  of	  RNA-­‐seq,	  a	  system	  of	  high-­‐throughput	  sequencing	  
of	  cDNA	  made	  from	  RNA	  samples,	  which	  promised	  to	  sequence	  the	  total	  RNA	  extracted	  from	  murine	  
organs	  infected	  with	  Candida,	  and	  to	  be	  able	  to	  separate	  out	  the	  fungal	  transcripts	  from	  those	  of	  the	  
host.	  The	  primary	  advantage	  of	  using	  RNA-­‐seq	  over	  a	  traditional	  microarray	  was	  the	  proposed	  ability	  
to	   handle	   total	   RNA,	   which	  would	   remove	   the	   requirement	   for	   extraction	   of	   the	   yeast	   infectious	  
units	  prior	  to	  RNA	  extraction	  and	  in	  turn	  save	  time,	  give	  a	  more	  accurate	  profile	  of	  the	  transcriptome	  
mid-­‐infection	  and	  allow	  us	  to	  look	  at	  both	  the	  yeast	  and	  host	  transcriptomes	  simultaneously.	  
The	  experiments	  to	  compare	  and	  contrast	  the	  transcriptomes	  of	  the	  wild	  type	  Candida	  strains	  from	  
host	   infections	   required	   two	   different	   host	   conditions,	   with	   C.	   glabrata	   requiring	   a	   neutropenic	  
mouse	   model,	   and	   C.	   albicans	   requiring	   an	   immune	   competent	   model.	   A	   model	   of	   systemic	  
candidiasis	  was	  selected,	  with	  72	  hours	  given	  for	  the	  yeast	  to	  establish	  a	  disease	  condition	  prior	  to	  
harvesting.	  The	  mice	  were	  culled	  at	  72-­‐hours	  post	  infection,	  with	  the	  kidneys	  immediately	  extracted	  
into	   liquid	   nitrogen	   or	   RNAlater	   (Qiagen,	   UK).	   The	   total	   RNA	   was	   then	   extracted,	   cleaned	   and	  
transported	  to	  Exeter	  for	  processing	  on	  dry	  ice.	  
A	  similar	  procedure	  was	  adopted	  for	  comparison	  of	  the	  transcriptome	  of	  C.	  glabrata	  ace2	  infection	  
to	  that	  of	  Cg2001,	  the	  C.	  glabrata	  wild	  type.	  C.	  glabrata	  ace2	  cells	  cause	  100%	  mortality	  within	  18-­‐
hours	  post	  infection,	  therefore	  the	  infection	  period	  was	  reduced	  to	  15	  hours	  to	  ensure	  RNA	  integrity	  
at	   the	  point	  of	  harvesting.	  The	  mice	  were	  culled	  15-­‐hours	  post	   infection	  and	  the	  organs,	   including	  
the	  lungs,	  harvested	  into	  RNAlater	  for	  extraction,	  clean-­‐up	  and	  transport	  to	  Exeter	  on	  dry	  ice.	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After	  several	  repeats	  of	  both	  infections	  and	  RNA	  extractions	  from	  different	  organs,	  the	  RNA-­‐seq	  was	  
unable	  to	  detect	  and	  discern	  enough	  Candida	  RNA	  from	  the	  strong	  mouse	  RNA	  signal	  after	  multiple	  
runs	   through	   the	   Illumina	   G2.	   As	   running	   the	   animal	   experiments	   to	   generate	   the	   RNA	  was	   time	  
consuming	  and	  not	  of	   insignificant	  cost,	  and	  each	  run	  of	   the	   Illumina	  G2	  was	   time	  consuming	  and	  
also	   carried	   significant	   cost,	   it	   was	   decided	   to	   abandon	   attempts	   to	   study	   the	   transcriptome	   of	  
Candida	  species	  from	  within	  the	  host.	  
A	  brief	  review	  of	  the	  materials	  and	  methods	  is	  included	  below	  for	  reference.	  
	  
A5.2.1	  Materials	  and	  Methods	  
A5.2.1.1	  72-­‐hour	  murine	  infection	  assay	  for	  transcriptome	  analysis	  of	  Candida	  species	  
	  
A	  murine	  infection	  assay	  using	  wild	  type	  C.	  glabrata	  (Cg2001)	  and	  C.	  albicans	  SC5314	  was	  carried	  out	  
using	  a	  modification	  of	  the	  method	  as	  previously	  described	  by	  Calcagno	  et	  al.	  [81].	  Two	  groups	  of	  10	  
outbred	  male	  CD1	  mice	  were	  used,	  one	  for	  C.	  glabrata	   infection	  and	  one	  for	  C.	  albicans	   infection.	  
The	  C.	  glabrata	  group	  of	  10	  mice	  were	  immunosuppressed	  via	  IP	  with	  200	  mg	  of	  cyclophosphamide	  
per	  kg	  of	  body	  weight	  on	  day	  -­‐3	  and	  day	  two.	  Half	  the	  animals	  were	  infected	  with	  7	  x	  107	  C.	  glabrata	  
cells	  in	  200	  μL	  saline	  via	  tail	  vein	  injection	  (IV)	  on	  day	  one,	  the	  other	  left	  as	  a	  control.	  The	  C.	  albicans	  
group	  of	  10	  mice	  were	  split	  into	  two;	  five	  mice	  were	  infected	  with	  3	  x	  104	  C.	  albicans	  cells	  per	  gram	  
of	  body	  weight	  in	  200	  μL	  saline	  via	  tail	  vein	  injection	  (IV)	  on	  day	  one,	  the	  other	  left	  as	  a	  control.	  The	  
mice	   were	   observed	   and	   weighed	   daily	   and	   sacrificed	   after	   72	   hours	   post	   infection.	   The	   mouse	  
kidneys	  were	  immediately	  extracted	  upon	  death	  into	  liquid	  nitrogen	  or	  RNAlater	  and	  stored	  at	  -­‐80°C.	  
	  A5.2.1.2	  15-­‐hour	  murine	  infection	  assay	  for	  transcriptome	  analysis	  of	  C.	  glabrata	  ace2	  
	  
A	   murine	   infection	   assay	   using	   wild	   type	   C.	   glabrata	   (Cg2001),	   C.	   glabrata	   ace2	   and	   a	   negative	  
control	  was	  carried	  out	  using	  a	  modification	  of	  the	  method	  as	  previously	  described	  by	  Calcagno	  et	  al.	  
[81].	   Three	   groups	   of	   five	   outbred	  male	   CD1	  mice	  were	   used,	   one	   per	   condition.	   The	  mice	  were	  
immunosuppressed	  via	  IP	  with	  200	  mg	  of	  cyclophosphamide	  per	  kg	  of	  body	  weight	  on	  day	  -­‐3.	  Two	  
groups,	  Cg2001	  and	  ace2,	  were	  infected	  with	  7	  x	  107	  cells	  in	  200	  μL	  saline	  via	  tail	  vein	  injection	  (IV)	  
on	  day	  one,	  the	  third	  group	  was	  left	  as	  an	  uninfected	  control.	  The	  mice	  were	  observed	  and	  weighed	  
and	  sacrificed	  after	  15	  hours	  post	   infection.	  The	  mouse	  kidneys,	   liver	  and	   lungs	  were	   immediately	  
extracted	  upon	  death	  into	  RNAlater	  (Qiagen	  Ltd,	  UK)	  and	  stored	  at	  -­‐80°C.	  
	  A5.2.1.3	  RNA	  preparation	  for	  RNA-­‐seq	  
 
Two	  methods	  for	  RNA	  extraction	  were	  used.	  	  
For	  liquid	  nitrogen	  flash	  frozen	  samples	  total	  kidney	  RNA	  samples	  were	  prepared	  via	  phenol	  (TRIzol)-­‐
chloroform	   extraction.	   All	   glass	   and	   ceramics	   were	   cleaned	   of	   RNAase	   prior	   to	   use,	   double	  
autoclaved	  ddH2O	  (daddH2O)	  was	  used	  throughout,	  and	  all	  steps	  were	  kept	  on	  ice	  unless	  otherwise	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stated.	  Briefly,	  the	  kidneys	  were	  ground	  in	  a	  frozen	  pestle	  and	  mortar,	  with	  regular	  addition	  of	  liquid	  
nitrogen.	  The	  ground	  kidney	  was	   then	   transferred	   to	  a	  50	  mL	   tube	  before	  being	  homogenized	   for	  
one	  minute	  in	  4	  mL	  of	  TRIzol	  Reagent	  (Invitrogen,	  UK)	  and	  incubated	  at	  room	  temperature	  for	  five	  
minutes.	   The	   mixture	   was	   then	   shaken	   vigorously	   by	   hand	   for	   15	   seconds	   with	   0.4	   volumes	   of	  
chloroform,	  before	  being	   incubated	  at	   room	   temperature	   for	   a	   further	   five	  minutes.	   The	  aqueous	  
phase	  was	  then	  separated	  via	  centrifugation	  at	  12000	  g	  for	  five	  minutes	  at	  4°C,	  and	  transferred	  to	  a	  
fresh	  tube.	  The	  RNA	  was	  then	  precipitated	  by	  incubation	  at	  room	  temperature	  for	  10	  minutes	  with	  
0.5	  mL	  of	  isopropanol	  per	  mL	  of	  solution.	  The	  RNA	  was	  then	  collected	  via	  centrifugation	  at	  12000	  g	  
for	  five	  minutes	  at	  4°C,	  and	  the	  supernatant	  removed.	  The	  RNA	  was	  then	  washed	  with	  70%	  ethanol	  
and	   allowed	   to	   air	   dry	   for	   15	   minutes.	   The	   RNA	   was	   then	   dissolved	   in	   500	   µL	   of	   daddH2O	   and	  
transferred	  to	  a	  fresh	  microfuge	  tube.	  
The	  RNA	  was	  then	  left	  to	  precipitate	  in	  one	  volume	  of	  LiCl	  buffer	  (4	  M	  Lithium	  chloride,	  20	  mM	  Tris-­‐
Cl	   pH	   7.5,	   10	  mM	  EDTA)	   for	   one	   hour	   at	   -­‐20°C.	   The	   RNA	  was	   then	   collected	   via	   centrifugation	   at	  
16000	  g	  for	  30	  minutes	  at	  4°C,	  and	  washed	  twice	  with	  70%	  ethanol	  before	  being	  left	  to	  air	  dry.	  The	  
RNA	  was	  then	  resuspended	  in	  50	  µL	  of	  daddH20	  and	  cleaned	  using	  a	  Qiagen	  RNeasy	  Mini	  Kit	  (Qiagen	  
Ltd,	  UK)	  as	  per	  the	  manufacturer’s	  instructions,	  then	  stored	  at	  -­‐80°C.	  
For	  kidney	  and	  lung	  tissue	  stored	  in	  RNAlater	  (Qiagen	  Ltd,	  UK),	  tissue	  samples	  were	  weighed	  and	  cut	  
into	  30	  mg	  divisions,	  disrupted	  and	  homogenized	  using	  a	   rotor-­‐stator	  homogenizer	   for	  30	  seconds	  
and	  processed	  using	  a	  RNeasy	  Mini	  Kit	  (Qiagen	  Ltd,	  UK)	  as	  per	  the	  manufacturer’s	  instructions.	  
	  A5.2.1.4	  RNA-­‐seq	  
	  
The	   prepared	   RNA	   samples	   were	   sent	   to	   the	   Sequencing	   service	   within	   the	   Department	   of	  
Biosciences	   at	   the	   University	   of	   Exeter,	   Devon,	   UK,	   for	   RNA-­‐seq	   (Whole	   Transcriptome	   Shotgun	  
Sequencing) [289]. 
	  
